molecule_chembl_id,target_chembl_id,target_pref_name,standard_type,standard_relation,standard_value,standard_units,assay_chembl_id,assay_type,assay_description,document_chembl_id,readout,smiles,pActivity
CHEMBL173499,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,364.0,nM,CHEMBL766135,B,Affinity for Prostanoid EP1 receptor expressed in COS-7 cells.,CHEMBL1132967,IC50,O=C(O)CCCCCC[C@@H]1[C@@H](CCC(O)CSc2cccc(F)c2)[C@H](O)C[C@@H]1O,6.438898616350944
CHEMBL434173,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,5000.0,nM,CHEMBL766135,B,Affinity for Prostanoid EP1 receptor expressed in COS-7 cells.,CHEMBL1132967,IC50,O=C(O)CCCCCC[C@@H]1[C@@H](CCC(O)CNc2ccccc2)[C@H](O)C[C@@H]1O,5.301029995663981
CHEMBL37853,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,496.0,nM,CHEMBL766135,B,Affinity for Prostanoid EP1 receptor expressed in COS-7 cells.,CHEMBL1132967,IC50,O=C(O)CCC/C=C\C[C@@H]1[C@@H](/C=C/[C@@H](O)COc2cccc(Cl)c2)[C@H](O)C[C@@H]1O,6.304518323509802
CHEMBL290969,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,5600.0,nM,CHEMBL766135,B,Affinity for Prostanoid EP1 receptor expressed in COS-7 cells.,CHEMBL1132967,IC50,O=C(O)CCCCCC[C@@H]1[C@@H](CC[C@@H](O)CCc2ccccc2)[C@H](O)C[C@@H]1O,5.251811972993799
CHEMBL173299,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,912.0,nM,CHEMBL766135,B,Affinity for Prostanoid EP1 receptor expressed in COS-7 cells.,CHEMBL1132967,IC50,O=C(O)CCCCCC[C@@H]1[C@@H](CCC(O)CSc2ccccc2)[C@H](O)C[C@@H]1O,6.0400051616715835
CHEMBL172250,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,2700.0,nM,CHEMBL766135,B,Affinity for Prostanoid EP1 receptor expressed in COS-7 cells.,CHEMBL1132967,IC50,O=C(O)CCCCCC[C@@H]1[C@@H](CCC(O)CSc2cccc(C(F)(F)F)c2)[C@H](O)C[C@@H]1O,5.568636235841012
CHEMBL369797,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,1100.0,nM,CHEMBL766135,B,Affinity for Prostanoid EP1 receptor expressed in COS-7 cells.,CHEMBL1132967,IC50,O=C(O)CCCCCC[C@@H]1[C@@H](CCC(O)CSc2cccs2)[C@H](O)C[C@@H]1O,5.958607314841775
CHEMBL425681,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,713.0,nM,CHEMBL766135,B,Affinity for Prostanoid EP1 receptor expressed in COS-7 cells.,CHEMBL1132967,IC50,O=C(O)CCCCCC[C@@H]1[C@@H](CC[C@@H](O)COc2ccccc2)[C@H](O)C[C@@H]1O,6.146910470148134
CHEMBL36041,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,1360.0,nM,CHEMBL766135,B,Affinity for Prostanoid EP1 receptor expressed in COS-7 cells.,CHEMBL1132967,IC50,O=C(O)CCCCCC[C@@H]1[C@@H](CC[C@@H](O)COc2cccc(Cl)c2)[C@H](O)C[C@@H]1O,5.866461091629782
CHEMBL176692,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,4600.0,nM,CHEMBL766135,B,Affinity for Prostanoid EP1 receptor expressed in COS-7 cells.,CHEMBL1132967,IC50,Cc1cccc(SCC(O)CC[C@@H]2[C@@H](CCCCCCC(=O)O)[C@@H](O)C[C@H]2O)c1,5.337242168318426
CHEMBL815,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,380.0,nM,CHEMBL766135,B,Affinity for Prostanoid EP1 receptor expressed in COS-7 cells.,CHEMBL1132967,IC50,CCCCC[C@H](O)/C=C/[C@@H]1[C@@H](C/C=C\CCCC(=O)O)[C@@H](O)C[C@H]1O,6.42021640338319
CHEMBL815,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,220.0,nM,CHEMBL766137,B,In vitro binding at EP1 human prostaglandin receptor using [3H]PGE-2 as radioligand,CHEMBL1134785,IC50,CCCCC[C@H](O)/C=C/[C@@H]1[C@@H](C/C=C\CCCC(=O)O)[C@@H](O)C[C@H]1O,6.657577319177793
CHEMBL290969,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,1100.0,nM,CHEMBL766784,B,Displacement of [3H]PGE-2 from Prostaglandin E receptor EP1 expressed in CHO-KI cells,CHEMBL1133030,IC50,O=C(O)CCCCCC[C@@H]1[C@@H](CC[C@@H](O)CCc2ccccc2)[C@H](O)C[C@@H]1O,5.958607314841775
CHEMBL289568,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,10000.0,nM,CHEMBL766784,B,Displacement of [3H]PGE-2 from Prostaglandin E receptor EP1 expressed in CHO-KI cells,CHEMBL1133030,IC50,O=C(O)CCCCCC[C@@H]1[C@@H](CC[C@@H](O)CCc2cccc(F)c2)[C@H](O)C[C@@H]1O,5.0
CHEMBL36911,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,3450.0,nM,CHEMBL766784,B,Displacement of [3H]PGE-2 from Prostaglandin E receptor EP1 expressed in CHO-KI cells,CHEMBL1133030,IC50,O=C(O)CCCCCC[C@@H]1[C@@H](CC[C@@H](O)CCc2ccc(F)cc2)[C@H](O)C[C@@H]1O,5.462180904926726
CHEMBL289373,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,3100.0,nM,CHEMBL766784,B,Displacement of [3H]PGE-2 from Prostaglandin E receptor EP1 expressed in CHO-KI cells,CHEMBL1133030,IC50,O=C(O)CCCCCC[C@@H]1[C@@H](CC[C@@H](O)CCc2ccccc2F)[C@H](O)C[C@@H]1O,5.508638306165727
CHEMBL37244,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,10000.0,nM,CHEMBL766784,B,Displacement of [3H]PGE-2 from Prostaglandin E receptor EP1 expressed in CHO-KI cells,CHEMBL1133030,IC50,Cc1ccccc1CC[C@H](O)CC[C@@H]1[C@@H](CCCCCCC(=O)O)[C@@H](O)C[C@H]1O,5.0
CHEMBL382197,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,18550.0,nM,CHEMBL869623,B,Binding affinity to human EP1 receptor expressed in HEK293 cells,CHEMBL1146126,IC50,O=C(O)c1ccc(CCCN2C(=O)CC[C@@H]2CCC(O)Cc2cccc(-c3ccccc3)c2)s1,4.731656086048935
CHEMBL362543,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,6.31,nM,CHEMBL870036,B,Displacement of [3H]PGE2 from human EP1 receptor expressed in CHO-K1 cells,CHEMBL1147700,IC50,O=C(O)c1cccc(-c2sccc2-c2cc(Cl)ccc2OCc2ccccc2)c1,8.199970640755865
CHEMBL207175,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,398.11,nM,CHEMBL870036,B,Displacement of [3H]PGE2 from human EP1 receptor expressed in CHO-K1 cells,CHEMBL1147700,IC50,O=C(O)c1cccc(-c2nccnc2-c2cc(Cl)ccc2OCc2ccccc2)c1,6.399996913372259
CHEMBL210268,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,316.23,nM,CHEMBL870036,B,Displacement of [3H]PGE2 from human EP1 receptor expressed in CHO-K1 cells,CHEMBL1147700,IC50,O=C(O)c1cccc(-c2cnccc2-c2cc(Cl)ccc2OCc2ccccc2)c1,6.499996931948306
CHEMBL209244,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,79.43,nM,CHEMBL870036,B,Displacement of [3H]PGE2 from human EP1 receptor expressed in CHO-K1 cells,CHEMBL1147700,IC50,O=C(O)c1cccc(-c2ccncc2-c2cc(Cl)ccc2OCc2ccccc2)c1,7.100015437450609
CHEMBL206096,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,100.0,nM,CHEMBL870036,B,Displacement of [3H]PGE2 from human EP1 receptor expressed in CHO-K1 cells,CHEMBL1147700,IC50,O=C(O)c1cccc(-c2ncccc2-c2cc(Cl)ccc2OCc2ccccc2)c1,7.0
CHEMBL207174,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,50.12,nM,CHEMBL870036,B,Displacement of [3H]PGE2 from human EP1 receptor expressed in CHO-K1 cells,CHEMBL1147700,IC50,O=C(O)c1cccc(-c2ccccc2-c2cc(Cl)ccc2OCc2ccccc2)c1,7.299988937677888
CHEMBL208030,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,79.43,nM,CHEMBL870036,B,Displacement of [3H]PGE2 from human EP1 receptor expressed in CHO-K1 cells,CHEMBL1147700,IC50,O=C1OCC(c2cc(Cl)ccc2OCc2ccccc2)=C1c1cccc(C(=O)O)c1,7.100015437450609
CHEMBL207293,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,125.89,nM,CHEMBL870036,B,Displacement of [3H]PGE2 from human EP1 receptor expressed in CHO-K1 cells,CHEMBL1147700,IC50,O=C(O)c1cccc(-n2cncc2-c2cc(Cl)ccc2OCc2ccccc2)c1,6.900008766455316
CHEMBL380667,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,79.43,nM,CHEMBL870036,B,Displacement of [3H]PGE2 from human EP1 receptor expressed in CHO-K1 cells,CHEMBL1147700,IC50,O=C(O)c1cccc(-n2nccc2-c2cc(Cl)ccc2OCc2ccccc2)c1,7.100015437450609
CHEMBL207688,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,199.53,nM,CHEMBL870036,B,Displacement of [3H]PGE2 from human EP1 receptor expressed in CHO-K1 cells,CHEMBL1147700,IC50,Cc1ccc(-c2cccc(C(=O)O)c2)n1-c1cc(Cl)ccc1OCc1ccccc1,6.699991797446187
CHEMBL383090,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,10.0,nM,CHEMBL870036,B,Displacement of [3H]PGE2 from human EP1 receptor expressed in CHO-K1 cells,CHEMBL1147700,IC50,O=C(O)c1cccc(-n2cccc2-c2cc(Cl)ccc2OCc2ccccc2)c1,8.0
CHEMBL377649,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,7.943,nM,CHEMBL870036,B,Displacement of [3H]PGE2 from human EP1 receptor expressed in CHO-K1 cells,CHEMBL1147700,IC50,Cc1ccc(-c2cc(Br)ccc2OCc2ccccc2)n1-c1cccc(C(=O)O)c1,8.100015437450608
CHEMBL377852,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,7.943,nM,CHEMBL870036,B,Displacement of [3H]PGE2 from human EP1 receptor expressed in CHO-K1 cells,CHEMBL1147700,IC50,Cc1ccc(-c2cc(Cl)ccc2OCc2ccccc2)n1-c1cccc(C(=O)O)c1,8.100015437450608
CHEMBL207577,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,12.59,nM,CHEMBL870036,B,Displacement of [3H]PGE2 from human EP1 receptor expressed in CHO-K1 cells,CHEMBL1147700,IC50,O=C(O)c1cccc(C2=C(c3cc(Cl)ccc3OCc3ccccc3)CCC2)c1,7.899974269892137
CHEMBL362543,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,5.0,nM,CHEMBL870036,B,Displacement of [3H]PGE2 from human EP1 receptor expressed in CHO-K1 cells,CHEMBL1147700,IC50,O=C(O)c1cccc(-c2sccc2-c2cc(Cl)ccc2OCc2ccccc2)c1,8.301029995663981
CHEMBL208891,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,100.0,nM,CHEMBL865352,B,Inhibition of [3H]PGE2 binding to EP1 receptor expressed in CHO cells,CHEMBL1138923,IC50,Cc1ccc(-c2cc(Br)ccc2OCc2c(F)cccc2C(F)(F)F)n1-c1cccc(C(=O)O)c1,7.0
CHEMBL212471,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,12.59,nM,CHEMBL865352,B,Inhibition of [3H]PGE2 binding to EP1 receptor expressed in CHO cells,CHEMBL1138923,IC50,Cc1ccc(-c2cc(Br)ccc2OCc2ccc(C(F)(F)F)cc2F)n1-c1cccc(C(=O)O)c1,7.899974269892137
CHEMBL379753,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,12.59,nM,CHEMBL865352,B,Inhibition of [3H]PGE2 binding to EP1 receptor expressed in CHO cells,CHEMBL1138923,IC50,Cc1ccc(-c2cc(Br)ccc2OCc2c(F)cccc2Cl)n1-c1cccc(C(=O)O)c1,7.899974269892137
CHEMBL208882,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,15.85,nM,CHEMBL865352,B,Inhibition of [3H]PGE2 binding to EP1 receptor expressed in CHO cells,CHEMBL1138923,IC50,Cc1ccc(-c2cc(Br)ccc2OCc2ccc(F)cc2Cl)n1-c1cccc(C(=O)O)c1,7.79997073344623
CHEMBL378464,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,100.0,nM,CHEMBL865352,B,Inhibition of [3H]PGE2 binding to EP1 receptor expressed in CHO cells,CHEMBL1138923,IC50,Cc1ccc(-c2cc(Br)ccc2OCc2ccc(Cl)c(Cl)c2)n1-c1cccc(C(=O)O)c1,7.0
CHEMBL211059,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,5.012,nM,CHEMBL865352,B,Inhibition of [3H]PGE2 binding to EP1 receptor expressed in CHO cells,CHEMBL1138923,IC50,Cc1ccc(-c2cc(Br)ccc2OCc2ccc(Cl)cc2Cl)n1-c1cccc(C(=O)O)c1,8.299988937677888
CHEMBL211700,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,10.0,nM,CHEMBL865352,B,Inhibition of [3H]PGE2 binding to EP1 receptor expressed in CHO cells,CHEMBL1138923,IC50,Cc1ccc(-c2cc(Br)ccc2OCc2ccc(Cl)cc2)n1-c1cccc(C(=O)O)c1,8.0
CHEMBL210261,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,10.0,nM,CHEMBL865352,B,Inhibition of [3H]PGE2 binding to EP1 receptor expressed in CHO cells,CHEMBL1138923,IC50,Cc1ccc(-c2cc(Br)ccc2OCc2cccc(Cl)c2)n1-c1cccc(C(=O)O)c1,8.0
CHEMBL380046,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,12.59,nM,CHEMBL865352,B,Inhibition of [3H]PGE2 binding to EP1 receptor expressed in CHO cells,CHEMBL1138923,IC50,Cc1ccc(-c2cc(Br)ccc2OCc2ccccc2Cl)n1-c1cccc(C(=O)O)c1,7.899974269892137
CHEMBL210394,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,1.585,nM,CHEMBL865352,B,Inhibition of [3H]PGE2 binding to EP1 receptor expressed in CHO cells,CHEMBL1138923,IC50,Cc1ccc(-c2cc(Br)ccc2OCc2c(F)cc(F)cc2F)n1-c1cccc(C(=O)O)c1,8.79997073344623
CHEMBL211534,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,1.0,nM,CHEMBL865352,B,Inhibition of [3H]PGE2 binding to EP1 receptor expressed in CHO cells,CHEMBL1138923,IC50,Cc1ccc(-c2cc(Br)ccc2OCc2c(F)cccc2F)n1-c1cccc(C(=O)O)c1,9.0
CHEMBL378641,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,6.31,nM,CHEMBL865352,B,Inhibition of [3H]PGE2 binding to EP1 receptor expressed in CHO cells,CHEMBL1138923,IC50,Cc1ccc(-c2cc(Br)ccc2OCc2cccc(F)c2F)n1-c1cccc(C(=O)O)c1,8.199970640755865
CHEMBL209078,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,7.943,nM,CHEMBL865352,B,Inhibition of [3H]PGE2 binding to EP1 receptor expressed in CHO cells,CHEMBL1138923,IC50,Cc1ccc(-c2cc(Br)ccc2OCc2cc(F)ccc2F)n1-c1cccc(C(=O)O)c1,8.100015437450608
CHEMBL208934,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,5.012,nM,CHEMBL865352,B,Inhibition of [3H]PGE2 binding to EP1 receptor expressed in CHO cells,CHEMBL1138923,IC50,Cc1ccc(-c2cc(Br)ccc2OCc2ccc(F)c(F)c2)n1-c1cccc(C(=O)O)c1,8.299988937677888
CHEMBL208791,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,6.31,nM,CHEMBL865352,B,Inhibition of [3H]PGE2 binding to EP1 receptor expressed in CHO cells,CHEMBL1138923,IC50,Cc1ccc(-c2cc(Br)ccc2OCc2ccc(F)cc2)n1-c1cccc(C(=O)O)c1,8.199970640755865
CHEMBL212672,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,3.162,nM,CHEMBL865352,B,Inhibition of [3H]PGE2 binding to EP1 receptor expressed in CHO cells,CHEMBL1138923,IC50,Cc1ccc(-c2cc(Br)ccc2OCc2ccccc2F)n1-c1cccc(C(=O)O)c1,8.500038134403809
CHEMBL377910,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,15.85,nM,CHEMBL865352,B,Inhibition of [3H]PGE2 binding to EP1 receptor expressed in CHO cells,CHEMBL1138923,IC50,Cc1ccc(-c2cc(Br)ccc2OCc2ccc(OC(F)(F)F)cc2)n1-c1cccc(C(=O)O)c1,7.79997073344623
CHEMBL210994,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,79.43,nM,CHEMBL865352,B,Inhibition of [3H]PGE2 binding to EP1 receptor expressed in CHO cells,CHEMBL1138923,IC50,Cc1ccc(-c2cc(Br)ccc2OCc2cccc(OC(F)F)c2)n1-c1cccc(C(=O)O)c1,7.100015437450609
CHEMBL377034,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,50.12,nM,CHEMBL865352,B,Inhibition of [3H]PGE2 binding to EP1 receptor expressed in CHO cells,CHEMBL1138923,IC50,COc1ccc(COc2ccc(Br)cc2-c2ccc(C)n2-c2cccc(C(=O)O)c2)cc1,7.299988937677888
CHEMBL377134,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,50.12,nM,CHEMBL865352,B,Inhibition of [3H]PGE2 binding to EP1 receptor expressed in CHO cells,CHEMBL1138923,IC50,COc1cccc(COc2ccc(Br)cc2-c2ccc(C)n2-c2cccc(C(=O)O)c2)c1,7.299988937677888
CHEMBL379514,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,39.81,nM,CHEMBL865352,B,Inhibition of [3H]PGE2 binding to EP1 receptor expressed in CHO cells,CHEMBL1138923,IC50,Cc1ccc(-c2cc(Br)ccc2OCc2ccc(C(F)(F)F)cc2)n1-c1cccc(C(=O)O)c1,7.400007822415902
CHEMBL376996,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,251.19,nM,CHEMBL865352,B,Inhibition of [3H]PGE2 binding to EP1 receptor expressed in CHO cells,CHEMBL1138923,IC50,Cc1ccc(-c2cc(Br)ccc2OCc2cccc(C(F)(F)F)c2)n1-c1cccc(C(=O)O)c1,6.599997654072045
CHEMBL209685,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,2.512,nM,CHEMBL865352,B,Inhibition of [3H]PGE2 binding to EP1 receptor expressed in CHO cells,CHEMBL1138923,IC50,Cc1ccc(COc2ccc(Br)cc2-c2ccc(C)n2-c2cccc(C(=O)O)c2)cc1,8.599980364934842
CHEMBL208797,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,19.95,nM,CHEMBL865352,B,Inhibition of [3H]PGE2 binding to EP1 receptor expressed in CHO cells,CHEMBL1138923,IC50,Cc1ccccc1COc1ccc(Br)cc1-c1ccc(C)n1-c1cccc(C(=O)O)c1,7.700057099977233
CHEMBL209746,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,25.12,nM,CHEMBL865352,B,Inhibition of [3H]PGE2 binding to EP1 receptor expressed in CHO cells,CHEMBL1138923,IC50,Cc1cc(COc2ccc(Br)cc2-c2ccc(C)n2-c2cccc(C(=O)O)c2)no1,7.599980364934842
CHEMBL212679,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,199.53,nM,CHEMBL865352,B,Inhibition of [3H]PGE2 binding to EP1 receptor expressed in CHO cells,CHEMBL1138923,IC50,Cc1noc(C)c1COc1ccc(Br)cc1-c1ccc(C)n1-c1cccc(C(=O)O)c1,6.699991797446187
CHEMBL378120,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,5.012,nM,CHEMBL865352,B,Inhibition of [3H]PGE2 binding to EP1 receptor expressed in CHO cells,CHEMBL1138923,IC50,Cc1ccc(-c2cc(Br)ccc2OCC(C)C)n1-c1cccc(C(=O)O)c1,8.299988937677888
CHEMBL209800,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,5.012,nM,CHEMBL865352,B,Inhibition of [3H]PGE2 binding to EP1 receptor expressed in CHO cells,CHEMBL1138923,IC50,Cc1ccc(-c2cc(Cl)ccc2OCC(C)C)n1-c1cccc(C(=O)O)c1,8.299988937677888
CHEMBL378090,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,39.81,nM,CHEMBL865352,B,Inhibition of [3H]PGE2 binding to EP1 receptor expressed in CHO cells,CHEMBL1138923,IC50,Cc1ccc(-c2cc(Cl)ccc2OCC2CCCO2)n1-c1cccc(C(=O)O)c1,7.400007822415902
CHEMBL208684,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,15.85,nM,CHEMBL865352,B,Inhibition of [3H]PGE2 binding to EP1 receptor expressed in CHO cells,CHEMBL1138923,IC50,Cc1ccc(-c2cc(Br)ccc2OCC2CCCC2)n1-c1cccc(C(=O)O)c1,7.79997073344623
CHEMBL380197,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,25.12,nM,CHEMBL865352,B,Inhibition of [3H]PGE2 binding to EP1 receptor expressed in CHO cells,CHEMBL1138923,IC50,Cc1ccc(-c2cc(Cl)ccc2OCC2CCCC2)n1-c1cccc(C(=O)O)c1,7.599980364934842
CHEMBL212680,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,39.81,nM,CHEMBL865352,B,Inhibition of [3H]PGE2 binding to EP1 receptor expressed in CHO cells,CHEMBL1138923,IC50,Cc1ccc(-c2cc(Cl)ccc2OCC2CCOCC2)n1-c1cccc(C(=O)O)c1,7.400007822415902
CHEMBL378226,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,31.62,nM,CHEMBL865352,B,Inhibition of [3H]PGE2 binding to EP1 receptor expressed in CHO cells,CHEMBL1138923,IC50,Cc1ccc(-c2cc(C(F)(F)F)ccc2OCC2CCCCC2)n1-c1cccc(C(=O)O)c1,7.50003813440381
CHEMBL210987,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,39.81,nM,CHEMBL865352,B,Inhibition of [3H]PGE2 binding to EP1 receptor expressed in CHO cells,CHEMBL1138923,IC50,Cc1ccc(-c2cc(Br)ccc2OCC2CCCCC2)n1-c1cccc(C(=O)O)c1,7.400007822415902
CHEMBL377831,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,125.89,nM,CHEMBL865352,B,Inhibition of [3H]PGE2 binding to EP1 receptor expressed in CHO cells,CHEMBL1138923,IC50,Cc1ccc(-c2cc(Cl)ccc2OCC2CCCCC2)n1-c1cccc(C(=O)O)c1,6.900008766455316
CHEMBL377135,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,794.33,nM,CHEMBL865352,B,Inhibition of [3H]PGE2 binding to EP1 receptor expressed in CHO cells,CHEMBL1138923,IC50,Cc1c(Br)cc(-c2cc(Cl)ccc2OCc2ccccc2)n1-c1cccc(C(=O)O)c1,6.0999990348465305
CHEMBL211088,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,3.981,nM,CHEMBL865352,B,Inhibition of [3H]PGE2 binding to EP1 receptor expressed in CHO cells,CHEMBL1138923,IC50,Cc1ccc(-c2cc(Cl)ccc2OCc2ccc(F)cc2F)n1-c1cccc(C(=O)O)c1,8.400007822415901
CHEMBL208912,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,6.31,nM,CHEMBL865352,B,Inhibition of [3H]PGE2 binding to EP1 receptor expressed in CHO cells,CHEMBL1138923,IC50,Cc1ccc(-c2cc(Cl)ccc2OCc2ccc(F)cc2)n1-c1cccc(C(=O)O)c1,8.199970640755865
CHEMBL379155,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,79.43,nM,CHEMBL865352,B,Inhibition of [3H]PGE2 binding to EP1 receptor expressed in CHO cells,CHEMBL1138923,IC50,CCc1ccc(-c2cc(Br)ccc2OCc2ccccc2)n1-c1cccc(C(=O)O)c1,7.100015437450609
CHEMBL379143,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,100.0,nM,CHEMBL865352,B,Inhibition of [3H]PGE2 binding to EP1 receptor expressed in CHO cells,CHEMBL1138923,IC50,CCc1ccc(-c2cc(Cl)ccc2OCc2ccccc2)n1-c1cccc(C(=O)O)c1,7.0
CHEMBL377338,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,25.12,nM,CHEMBL865352,B,Inhibition of [3H]PGE2 binding to EP1 receptor expressed in CHO cells,CHEMBL1138923,IC50,O=C(O)c1cccc(-n2c(Cl)ccc2-c2cc(Cl)ccc2OCc2ccccc2)c1,7.599980364934842
CHEMBL208660,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,100.0,nM,CHEMBL865352,B,Inhibition of [3H]PGE2 binding to EP1 receptor expressed in CHO cells,CHEMBL1138923,IC50,O=C(O)c1cccc(-n2c(-c3cc(Cl)ccc3OCc3ccc(F)cc3F)ccc2C(F)(F)F)c1,7.0
CHEMBL209326,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,199.53,nM,CHEMBL865352,B,Inhibition of [3H]PGE2 binding to EP1 receptor expressed in CHO cells,CHEMBL1138923,IC50,O=C(O)c1cccc(-n2c(-c3cc(Cl)ccc3OCc3ccc(F)cc3)ccc2C(F)(F)F)c1,6.699991797446187
CHEMBL383090,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,10.0,nM,CHEMBL865352,B,Inhibition of [3H]PGE2 binding to EP1 receptor expressed in CHO cells,CHEMBL1138923,IC50,O=C(O)c1cccc(-n2cccc2-c2cc(Cl)ccc2OCc2ccccc2)c1,8.0
CHEMBL379163,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,630.96,nM,CHEMBL865352,B,Inhibition of [3H]PGE2 binding to EP1 receptor expressed in CHO cells,CHEMBL1138923,IC50,Cc1ccc(-c2cc(-c3ccsc3)ccc2OCc2ccccc2)n1-c1cccc(C(=O)O)c1,6.199998172182031
CHEMBL377245,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,398.11,nM,CHEMBL865352,B,Inhibition of [3H]PGE2 binding to EP1 receptor expressed in CHO cells,CHEMBL1138923,IC50,Cc1ccc(-c2cc(-c3ccccc3)ccc2OCc2ccccc2)n1-c1cccc(C(=O)O)c1,6.399996913372259
CHEMBL211776,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,19.95,nM,CHEMBL865352,B,Inhibition of [3H]PGE2 binding to EP1 receptor expressed in CHO cells,CHEMBL1138923,IC50,Cc1ccc(-c2ccccc2OCc2ccccc2)n1-c1cccc(C(=O)O)c1,7.700057099977233
CHEMBL212742,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,25.12,nM,CHEMBL865352,B,Inhibition of [3H]PGE2 binding to EP1 receptor expressed in CHO cells,CHEMBL1138923,IC50,Cc1ccc(-c2cc(S(C)(=O)=O)ccc2OCc2ccccc2)n1-c1cccc(C(=O)O)c1,7.599980364934842
CHEMBL212688,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,5.012,nM,CHEMBL865352,B,Inhibition of [3H]PGE2 binding to EP1 receptor expressed in CHO cells,CHEMBL1138923,IC50,Cc1ccc(-c2cc(C(F)(F)F)ccc2OCc2ccccc2)n1-c1cccc(C(=O)O)c1,8.299988937677888
CHEMBL377649,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,7.943,nM,CHEMBL865352,B,Inhibition of [3H]PGE2 binding to EP1 receptor expressed in CHO cells,CHEMBL1138923,IC50,Cc1ccc(-c2cc(Br)ccc2OCc2ccccc2)n1-c1cccc(C(=O)O)c1,8.100015437450608
CHEMBL377852,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,7.943,nM,CHEMBL865352,B,Inhibition of [3H]PGE2 binding to EP1 receptor expressed in CHO cells,CHEMBL1138923,IC50,Cc1ccc(-c2cc(Cl)ccc2OCc2ccccc2)n1-c1cccc(C(=O)O)c1,8.100015437450608
CHEMBL213221,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,6.457,nM,CHEMBL864259,B,Displacement of [3H]PGE2 from EP1 receptor expressed in CHO-K1 cells,CHEMBL1149349,IC50,Cc1cc(C(=O)O)nn1Cc1cc(Br)ccc1OCc1ccccc1,8.18996921359416
CHEMBL378197,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,2570.4,nM,CHEMBL864259,B,Displacement of [3H]PGE2 from EP1 receptor expressed in CHO-K1 cells,CHEMBL1149349,IC50,O=C(O)c1nn(Cc2cc(Br)ccc2OCc2ccccc2)cc1C(F)(F)F,5.589999287456538
CHEMBL214639,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,676.08,nM,CHEMBL864259,B,Displacement of [3H]PGE2 from EP1 receptor expressed in CHO-K1 cells,CHEMBL1149349,IC50,O=C(O)c1nn(Cc2cc(Br)ccc2OCc2ccccc2)cc1CO,6.17000191130262
CHEMBL215690,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,457.09,nM,CHEMBL864259,B,Displacement of [3H]PGE2 from EP1 receptor expressed in CHO-K1 cells,CHEMBL1149349,IC50,O=C(O)c1nn(Cc2cc(Br)ccc2OCc2ccccc2)cc1Br,6.339998279897117
CHEMBL380297,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,426.58,nM,CHEMBL864259,B,Displacement of [3H]PGE2 from EP1 receptor expressed in CHO-K1 cells,CHEMBL1149349,IC50,Cc1cn(Cc2cc(Br)ccc2OCc2ccccc2)nc1C(=O)O,6.369999510099088
CHEMBL213669,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,123.03,nM,CHEMBL864259,B,Displacement of [3H]PGE2 from EP1 receptor expressed in CHO-K1 cells,CHEMBL1149349,IC50,O=C(O)c1nn(Cc2cc(Br)ccc2OCc2ccccc2)cc1F,6.909988975992853
CHEMBL213412,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,9.772,nM,CHEMBL864259,B,Displacement of [3H]PGE2 from EP1 receptor expressed in CHO-K1 cells,CHEMBL1149349,IC50,O=C(O)c1ccn(Cc2cc(Br)ccc2OCc2ccccc2)n1,8.010016541698601
CHEMBL214971,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,0.1318,nM,CHEMBL864259,B,Displacement of [3H]PGE2 from EP1 receptor expressed in CHO-K1 cells,CHEMBL1149349,IC50,Cc1cc(C(=O)O)nn1Cc1cc(Br)ccc1OCc1ccc(Cl)cc1Cl,9.880084589742008
CHEMBL378533,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,5248.07,nM,CHEMBL864259,B,Displacement of [3H]PGE2 from EP1 receptor expressed in CHO-K1 cells,CHEMBL1149349,IC50,Cc1cc(C(=O)O)nn1Cc1cc(Br)ccc1OCc1cc(C(F)(F)F)cc(C(F)(F)F)c1,5.280000380871156
CHEMBL386532,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,1230.27,nM,CHEMBL864259,B,Displacement of [3H]PGE2 from EP1 receptor expressed in CHO-K1 cells,CHEMBL1149349,IC50,Cc1cc(C(=O)O)nn1Cc1cc(Br)ccc1OCc1ccc(C(C)(C)C)cc1,5.90999956608739
CHEMBL215687,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,575.44,nM,CHEMBL864259,B,Displacement of [3H]PGE2 from EP1 receptor expressed in CHO-K1 cells,CHEMBL1149349,IC50,Cc1cc(C(=O)O)nn1Cc1cc(Br)ccc1OCc1ccc(Cl)c(C(F)(F)F)c1,6.2399999527072705
CHEMBL425076,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,309.03,nM,CHEMBL864259,B,Displacement of [3H]PGE2 from EP1 receptor expressed in CHO-K1 cells,CHEMBL1149349,IC50,Cc1cc(C(=O)O)nn1Cc1cc(Br)ccc1OCc1cccc(C(F)(F)F)c1,6.509999358109048
CHEMBL212667,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,125.89,nM,CHEMBL864259,B,Displacement of [3H]PGE2 from EP1 receptor expressed in CHO-K1 cells,CHEMBL1149349,IC50,Cc1cccc(COc2ccc(Br)cc2Cn2nc(C(=O)O)cc2C)c1,6.900008766455316
CHEMBL215667,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,114.82,nM,CHEMBL864259,B,Displacement of [3H]PGE2 from EP1 receptor expressed in CHO-K1 cells,CHEMBL1149349,IC50,Cc1cc(C(=O)O)nn1Cc1cc(Br)ccc1OCc1cccc(Cl)c1,6.9399824574684
CHEMBL387454,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,17.78,nM,CHEMBL864259,B,Displacement of [3H]PGE2 from EP1 receptor expressed in CHO-K1 cells,CHEMBL1149349,IC50,Cc1cc(C(=O)O)nn1Cc1cc(Br)ccc1OCc1cccc(Br)c1,7.750068243365805
CHEMBL215573,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,14.79,nM,CHEMBL864259,B,Displacement of [3H]PGE2 from EP1 receptor expressed in CHO-K1 cells,CHEMBL1149349,IC50,Cc1cc(C(=O)O)nn1Cc1cc(Br)ccc1OCc1c(F)cccc1F,7.830031826003108
CHEMBL215956,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,35.48,nM,CHEMBL864259,B,Displacement of [3H]PGE2 from EP1 receptor expressed in CHO-K1 cells,CHEMBL1149349,IC50,Cc1cc(C(=O)O)nn1Cc1cc(Br)ccc1OCc1ccc(C(F)(F)F)cc1,7.450016388840311
CHEMBL402880,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,3.162,nM,CHEMBL864259,B,Displacement of [3H]PGE2 from EP1 receptor expressed in CHO-K1 cells,CHEMBL1149349,IC50,Cc1cc(C(=O)O)nn1Cc1cc(Br)ccc1OCc1ccccc1Cl,8.500038134403809
CHEMBL215453,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,7.413,nM,CHEMBL864259,B,Displacement of [3H]PGE2 from EP1 receptor expressed in CHO-K1 cells,CHEMBL1149349,IC50,Cc1cc(C(=O)O)nn1Cc1cc(Br)ccc1OCc1ccc(F)cc1,8.130005999878257
CHEMBL215400,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,8.71,nM,CHEMBL864259,B,Displacement of [3H]PGE2 from EP1 receptor expressed in CHO-K1 cells,CHEMBL1149349,IC50,Cc1cc(C(=O)O)nn1Cc1cc(Br)ccc1OCc1ccc(Cl)cc1,8.059981844992336
CHEMBL214967,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,0.5248,nM,CHEMBL864259,B,Displacement of [3H]PGE2 from EP1 receptor expressed in CHO-K1 cells,CHEMBL1149349,IC50,Cc1cc(C(=O)O)nn1Cc1cc(Br)ccc1OCc1ccc(F)cc1F,9.280006173632396
CHEMBL385620,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,354.81,nM,CHEMBL864259,B,Displacement of [3H]PGE2 from EP1 receptor expressed in CHO-K1 cells,CHEMBL1149349,IC50,Cc1cc(C(=O)O)nn1Cc1cc(F)ccc1OCc1ccc(Cl)cc1Cl,6.450004148469349
CHEMBL362543,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,3.548,nM,CHEMBL864259,B,Displacement of [3H]PGE2 from EP1 receptor expressed in CHO-K1 cells,CHEMBL1149349,IC50,O=C(O)c1cccc(-c2sccc2-c2cc(Cl)ccc2OCc2ccccc2)c1,8.45001638884031
CHEMBL214900,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,194.98,nM,CHEMBL864259,B,Displacement of [3H]PGE2 from EP1 receptor expressed in CHO-K1 cells,CHEMBL1149349,IC50,O=C(O)c1cc(-c2cccs2)n(Cc2cc(Br)ccc2OCc2ccccc2)n1,6.710009933945681
CHEMBL426913,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,1.995,nM,CHEMBL906324,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHOK1 cell membrane,CHEMBL1144577,IC50,Cc1c(N)cc(-n2c(C)ccc2-c2cc(Cl)ccc2OCc2ccccc2)cc1C(=O)O,8.700057099977233
CHEMBL388294,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,3.162,nM,CHEMBL906324,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHOK1 cell membrane,CHEMBL1144577,IC50,Cc1c(N)cc(-n2c(C)ccc2-c2cc(Br)ccc2OCc2ccccc2)cc1C(=O)O,8.500038134403809
CHEMBL228592,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,3.981,nM,CHEMBL906324,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHOK1 cell membrane,CHEMBL1144577,IC50,Cc1c(N)cc(-n2c(C)ccc2-c2cc(C(F)(F)F)ccc2OCc2ccccc2)cc1C(=O)O,8.400007822415901
CHEMBL228593,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,0.7943,nM,CHEMBL906324,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHOK1 cell membrane,CHEMBL1144577,IC50,Cc1c(N)cc(-n2c(C)ccc2-c2cc(Br)ccc2OCc2ccc(F)cc2)cc1C(=O)O,9.100015437450608
CHEMBL228644,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,3.981,nM,CHEMBL906324,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHOK1 cell membrane,CHEMBL1144577,IC50,Cc1c(N)cc(-n2c(C)ccc2-c2cc(C(F)(F)F)ccc2OCc2ccc(F)cc2)cc1C(=O)O,8.400007822415901
CHEMBL388510,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,15.85,nM,CHEMBL906324,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHOK1 cell membrane,CHEMBL1144577,IC50,Cc1ccc(OCc2ccc(F)cc2)c(-c2ccc(C)n2-c2cc(N)c(C)c(C(=O)O)c2)c1,7.79997073344623
CHEMBL228695,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,6.31,nM,CHEMBL906324,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHOK1 cell membrane,CHEMBL1144577,IC50,Cc1ccc(-c2cc(Cl)ccc2OCc2ccccc2)n1-c1cc(C(=O)O)c2ccccc2c1,8.199970640755865
CHEMBL390081,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,12.59,nM,CHEMBL906324,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHOK1 cell membrane,CHEMBL1144577,IC50,Cc1ccc(-c2cc(Br)ccc2OCc2ccccc2)n1-c1cc(C(=O)O)c2ccccc2c1,7.899974269892137
CHEMBL228746,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,5.012,nM,CHEMBL906324,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHOK1 cell membrane,CHEMBL1144577,IC50,Cc1ccc(-c2cc(Br)ccc2OCc2ccc(F)cc2)n1-c1cc(C(=O)O)c2ccccc2c1,8.299988937677888
CHEMBL414978,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,2.512,nM,CHEMBL906324,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHOK1 cell membrane,CHEMBL1144577,IC50,Cc1ccc(-c2cc(Br)ccc2OCc2ccc(F)cc2F)n1-c1cc(C(=O)O)c2ccccc2c1,8.599980364934842
CHEMBL269514,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,79.43,nM,CHEMBL906324,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHOK1 cell membrane,CHEMBL1144577,IC50,Cc1ccc(OCc2ccc(F)cc2)c(-c2ccc(C)n2-c2cc(C(=O)O)c3ccccc3c2)c1,7.100015437450609
CHEMBL397226,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,25.12,nM,CHEMBL906324,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHOK1 cell membrane,CHEMBL1144577,IC50,Cc1ccc(-c2cc(F)ccc2OCc2ccc(F)cc2)n1-c1cc(C(=O)O)c2ccccc2c1,7.599980364934842
CHEMBL208791,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,6.31,nM,CHEMBL906324,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHOK1 cell membrane,CHEMBL1144577,IC50,Cc1ccc(-c2cc(Br)ccc2OCc2ccc(F)cc2)n1-c1cccc(C(=O)O)c1,8.199970640755865
CHEMBL387969,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,0.3981,nM,CHEMBL906324,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHOK1 cell membrane,CHEMBL1144577,IC50,CC(=O)Nc1ccc(-n2c(C)ccc2-c2cc(Br)ccc2OCc2ccc(F)cc2F)cc1C(=O)O,9.400007822415901
CHEMBL387878,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,0.631,nM,CHEMBL906324,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHOK1 cell membrane,CHEMBL1144577,IC50,Cc1ccc(-c2cc(Br)ccc2OCc2ccc(F)cc2F)n1-c1ccc(OC(F)F)c(C(=O)O)c1,9.199970640755865
CHEMBL228638,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,1.995,nM,CHEMBL906324,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHOK1 cell membrane,CHEMBL1144577,IC50,Cc1ccc(-c2cc(Br)ccc2OCc2ccc(F)cc2)n1-c1ccc(OC(F)F)c(C(=O)O)c1,8.700057099977233
CHEMBL374824,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,5.012,nM,CHEMBL906324,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHOK1 cell membrane,CHEMBL1144577,IC50,Cc1ccc(-c2cc(Br)ccc2OCc2ccccc2)n1-c1ccc(OC(F)F)c(C(=O)O)c1,8.299988937677888
CHEMBL228586,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,0.3981,nM,CHEMBL906324,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHOK1 cell membrane,CHEMBL1144577,IC50,COc1ccc(-n2c(C)ccc2-c2cc(Br)ccc2OCc2ccc(F)cc2F)cc1C(=O)O,9.400007822415901
CHEMBL395488,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,1.995,nM,CHEMBL906324,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHOK1 cell membrane,CHEMBL1144577,IC50,Cc1ccc(-c2cc(Br)ccc2OCc2ccc(F)cc2F)n1-c1ccc(O)c(C(=O)O)c1,8.700057099977233
CHEMBL395248,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,1.259,nM,CHEMBL906324,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHOK1 cell membrane,CHEMBL1144577,IC50,Cc1ccc(-n2c(C)ccc2-c2cc(Br)ccc2OCc2ccc(F)cc2F)cc1C(=O)O,8.899974269892137
CHEMBL397655,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,2.512,nM,CHEMBL906324,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHOK1 cell membrane,CHEMBL1144577,IC50,Cc1ccc(-n2c(C)ccc2-c2cc(Cl)ccc2OCc2ccc(F)cc2F)cc1C(=O)O,8.599980364934842
CHEMBL231184,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,5.012,nM,CHEMBL906324,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHOK1 cell membrane,CHEMBL1144577,IC50,Cc1ccc(-n2c(C)ccc2-c2cc(Cl)ccc2OCc2ccc(F)cc2)cc1C(=O)O,8.299988937677888
CHEMBL230875,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,2.512,nM,CHEMBL906324,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHOK1 cell membrane,CHEMBL1144577,IC50,Cc1ccc(-c2cc(Br)ccc2OCc2ccc(F)cc2)n1-c1ccc(Cl)c(C(=O)O)c1,8.599980364934842
CHEMBL230874,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,12.59,nM,CHEMBL906324,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHOK1 cell membrane,CHEMBL1144577,IC50,Cc1ccc(-c2cc(F)ccc2OCc2ccc(F)cc2)n1-c1ccc(F)c(C(=O)O)c1,7.899974269892137
CHEMBL230873,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,15.85,nM,CHEMBL906324,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHOK1 cell membrane,CHEMBL1144577,IC50,Cc1ccc(OCc2ccc(F)cc2)c(-c2ccc(C)n2-c2ccc(F)c(C(=O)O)c2)c1,7.79997073344623
CHEMBL388478,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,7.943,nM,CHEMBL906324,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHOK1 cell membrane,CHEMBL1144577,IC50,Cc1ccc(-c2cc(C(F)(F)F)ccc2OCc2ccc(F)cc2)n1-c1ccc(F)c(C(=O)O)c1,8.100015437450608
CHEMBL230766,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,1.995,nM,CHEMBL906324,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHOK1 cell membrane,CHEMBL1144577,IC50,Cc1ccc(-c2cc(C(F)(F)F)ccc2OCc2ccccc2)n1-c1ccc(F)c(C(=O)O)c1,8.700057099977233
CHEMBL230765,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,1.259,nM,CHEMBL906324,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHOK1 cell membrane,CHEMBL1144577,IC50,Cc1ccc(-c2cc(Br)ccc2OCc2ccc(F)cc2)n1-c1ccc(F)c(C(=O)O)c1,8.899974269892137
CHEMBL228963,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,1.259,nM,CHEMBL906324,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHOK1 cell membrane,CHEMBL1144577,IC50,Cc1ccc(-c2cc(Cl)ccc2OCc2ccccc2)n1-c1cc(C(=O)O)c2cc[nH]c2c1,8.899974269892137
CHEMBL208791,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,6.31,nM,CHEMBL906324,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHOK1 cell membrane,CHEMBL1144577,IC50,Cc1ccc(-c2cc(Br)ccc2OCc2ccc(F)cc2)n1-c1cccc(C(=O)O)c1,8.199970640755865
CHEMBL208791,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,6.31,nM,CHEMBL890027,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cell membranes,CHEMBL1146289,IC50,Cc1ccc(-c2cc(Br)ccc2OCc2ccc(F)cc2)n1-c1cccc(C(=O)O)c1,8.199970640755865
CHEMBL234728,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,5.012,nM,CHEMBL890027,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cell membranes,CHEMBL1146289,IC50,COC(=O)Nc1cc(C(=O)O)cc(-n2c(C)ccc2-c2cc(Cl)ccc2OCc2ccccc2)c1,8.299988937677888
CHEMBL388038,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,7.943,nM,CHEMBL890027,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cell membranes,CHEMBL1146289,IC50,Cc1ccc(-c2cc(C(F)(F)F)ccc2OCc2ccc(F)cc2)n1-c1cc(C(=O)O)cc(N2CCCS2(=O)=O)c1,8.100015437450608
CHEMBL390660,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,5.012,nM,CHEMBL890027,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cell membranes,CHEMBL1146289,IC50,Cc1ccc(-c2cc(Cl)ccc2OCc2ccccc2)n1-c1cc(C(=O)O)cc(N2CCCS2(=O)=O)c1,8.299988937677888
CHEMBL428367,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,1.259,nM,CHEMBL890027,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cell membranes,CHEMBL1146289,IC50,Cc1ccc(-c2cc(Br)ccc2OCc2ccc(F)cc2F)n1-c1cc(C(=O)O)cc(N2CCCCC2=O)c1,8.899974269892137
CHEMBL234946,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,1.995,nM,CHEMBL890027,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cell membranes,CHEMBL1146289,IC50,Cc1ccc(-c2cc(Br)ccc2OCc2ccc(F)cc2F)n1-c1cc(C(=O)O)cc(N2CCCC2=O)c1,8.700057099977233
CHEMBL390238,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,1.259,nM,CHEMBL890027,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cell membranes,CHEMBL1146289,IC50,CC(=O)N(C)c1cc(C(=O)O)cc(-n2c(C)ccc2-c2cc(Br)ccc2OCc2ccc(F)cc2F)c1,8.899974269892137
CHEMBL234945,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,1.585,nM,CHEMBL890027,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cell membranes,CHEMBL1146289,IC50,Cc1ccc(-c2cc(Cl)ccc2OCc2ccc(F)cc2)n1-c1cc(NS(C)(=O)=O)cc(C(=O)O)c1,8.79997073344623
CHEMBL234727,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,1.259,nM,CHEMBL890027,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cell membranes,CHEMBL1146289,IC50,CC(=O)Nc1cc(C(=O)O)cc(-n2c(C)ccc2-c2cc(C(F)(F)F)ccc2OCc2ccccc2)c1,8.899974269892137
CHEMBL390038,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,1.585,nM,CHEMBL890027,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cell membranes,CHEMBL1146289,IC50,CC(=O)Nc1cc(C(=O)O)cc(-n2c(C)ccc2-c2cc(I)ccc2OCc2ccc(F)cc2F)c1,8.79997073344623
CHEMBL427844,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,0.3981,nM,CHEMBL890027,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cell membranes,CHEMBL1146289,IC50,CC(=O)Nc1cc(C(=O)O)cc(-n2c(C)ccc2-c2cc(Br)ccc2OCc2ccc(F)cc2F)c1,9.400007822415901
CHEMBL430360,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,0.7943,nM,CHEMBL890027,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cell membranes,CHEMBL1146289,IC50,CC(=O)Nc1cc(C(=O)O)cc(-n2c(C)ccc2-c2cc(Br)ccc2OCc2ccc(F)cc2)c1,9.100015437450608
CHEMBL234519,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,1.259,nM,CHEMBL890027,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cell membranes,CHEMBL1146289,IC50,CC(=O)Nc1cc(C(=O)O)cc(-n2c(C)ccc2-c2cc(Br)ccc2OCc2ccccc2)c1,8.899974269892137
CHEMBL390190,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,2.512,nM,CHEMBL890027,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cell membranes,CHEMBL1146289,IC50,CC(=O)Nc1cc(C(=O)O)cc(-n2c(C)ccc2-c2cc(Cl)ccc2OCc2ccc(F)cc2)c1,8.599980364934842
CHEMBL234518,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,1.995,nM,CHEMBL890027,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cell membranes,CHEMBL1146289,IC50,CC(=O)Nc1cc(C(=O)O)cc(-n2c(C)ccc2-c2cc(Cl)ccc2OCc2ccccc2)c1,8.700057099977233
CHEMBL234303,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,3.981,nM,CHEMBL890027,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cell membranes,CHEMBL1146289,IC50,CC(=O)Nc1cc(C(=O)O)cc(-n2c(C)ccc2-c2cc(F)ccc2OCc2ccc(F)cc2)c1,8.400007822415901
CHEMBL390189,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,0.5012,nM,CHEMBL890027,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cell membranes,CHEMBL1146289,IC50,Cc1ccc(-c2cc(Br)ccc2OCc2ccc(F)cc2F)n1-c1cc(N)cc(C(=O)O)c1,9.299988937677888
CHEMBL234302,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,3.162,nM,CHEMBL890027,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cell membranes,CHEMBL1146289,IC50,Cc1ccc(-c2cc(Br)ccc2OCc2ccccc2)n1-c1cc(N)cc(C(=O)O)c1,8.500038134403809
CHEMBL234301,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,3.981,nM,CHEMBL890027,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cell membranes,CHEMBL1146289,IC50,Cc1ccc(-c2cc(Cl)ccc2OCc2ccccc2)n1-c1cc(N)cc(C(=O)O)c1,8.400007822415901
CHEMBL388243,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,12.59,nM,CHEMBL890027,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cell membranes,CHEMBL1146289,IC50,Cc1ccc(-c2cc(Br)ccc2OCc2ccc(F)cc2F)n1-c1cc(C(=O)O)cc(C(F)(F)F)c1,7.899974269892137
CHEMBL429259,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,10.0,nM,CHEMBL890027,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cell membranes,CHEMBL1146289,IC50,Cc1ccc(-c2cc(Cl)ccc2OCc2ccc(F)cc2F)n1-c1cc(C(=O)O)cc(C(F)(F)F)c1,8.0
CHEMBL388242,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,5.012,nM,CHEMBL890027,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cell membranes,CHEMBL1146289,IC50,Cc1ccc(-c2cc(Cl)ccc2OCc2ccc(F)cc2F)n1-c1cc(Br)cc(C(=O)O)c1,8.299988937677888
CHEMBL234722,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,5.012,nM,CHEMBL890027,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cell membranes,CHEMBL1146289,IC50,Cc1ccc(-c2cc(Cl)ccc2OCc2ccccc2)n1-c1cc(Br)cc(C(=O)O)c1,8.299988937677888
CHEMBL389995,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,3.981,nM,CHEMBL890027,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cell membranes,CHEMBL1146289,IC50,Cc1ccc(-c2cc(Br)ccc2OCc2ccc(F)cc2F)n1-c1cc(Cl)cc(C(=O)O)c1,8.400007822415901
CHEMBL234721,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,3.981,nM,CHEMBL890027,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cell membranes,CHEMBL1146289,IC50,Cc1ccc(-c2cc(Cl)ccc2OCc2ccc(F)cc2F)n1-c1cc(Cl)cc(C(=O)O)c1,8.400007822415901
CHEMBL233872,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,125.89,nM,CHEMBL890027,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cell membranes,CHEMBL1146289,IC50,CCOc1ccc(C(=O)O)cc1-n1c(C)ccc1-c1cc(Cl)ccc1OCc1ccccc1,6.900008766455316
CHEMBL233871,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,251.19,nM,CHEMBL890027,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cell membranes,CHEMBL1146289,IC50,COc1ccc(C(=O)O)cc1-n1c(C)ccc1-c1cc(Cl)ccc1OCc1ccccc1,6.599997654072045
CHEMBL395756,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,158.49,nM,CHEMBL890027,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cell membranes,CHEMBL1146289,IC50,Cc1ccc(-c2cc(Cl)ccc2OCc2ccc(F)cc2F)n1-c1cc(C(=O)O)ccc1Cl,6.799998134593398
CHEMBL233665,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,316.23,nM,CHEMBL890027,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cell membranes,CHEMBL1146289,IC50,Cc1ccc(-c2cc(Cl)ccc2OCc2ccc(F)cc2)n1-c1cc(C(=O)O)ccc1Cl,6.499996931948306
CHEMBL395310,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,6.31,nM,CHEMBL890027,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cell membranes,CHEMBL1146289,IC50,Cc1ccc(-c2cc(Br)ccc2OCc2ccc(F)cc2)n1-c1cc(C(=O)O)ccc1F,8.199970640755865
CHEMBL395523,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,6.31,nM,CHEMBL890027,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cell membranes,CHEMBL1146289,IC50,Cc1ccc(-c2cc(C(F)(F)F)ccc2OCc2ccccc2)n1-c1cc(C(=O)O)ccc1F,8.199970640755865
CHEMBL266258,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,6.31,nM,CHEMBL890027,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cell membranes,CHEMBL1146289,IC50,Cc1ccc(-c2cc(Cl)ccc2OCc2ccc(F)cc2F)n1-c1cc(C(=O)O)ccc1F,8.199970640755865
CHEMBL395582,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,6.31,nM,CHEMBL889917,B,Inhibition of human EP1 receptor,CHEMBL1146277,IC50,O=C(O)c1cccc(C2=C(c3ccccc3OCc3ccccc3)CCC2)c1,8.199970640755865
CHEMBL234940,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,2.512,nM,CHEMBL889917,B,Inhibition of human EP1 receptor,CHEMBL1146277,IC50,O=C(O)c1cccc(C2=C(c3cc(Cl)ccc3OCc3ccc(F)cc3F)CCC2)n1,8.599980364934842
CHEMBL389996,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,1.995,nM,CHEMBL889917,B,Inhibition of human EP1 receptor,CHEMBL1146277,IC50,O=C(O)c1cncc(C2=C(c3cc(Cl)ccc3OCc3ccc(F)cc3F)CCC2)n1,8.700057099977233
CHEMBL234939,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,158.49,nM,CHEMBL889917,B,Inhibition of human EP1 receptor,CHEMBL1146277,IC50,O=C(O)c1ccnc(C2=C(c3cc(Cl)ccc3OCc3ccccc3)CCC2)n1,6.799998134593398
CHEMBL389994,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,199.53,nM,CHEMBL889917,B,Inhibition of human EP1 receptor,CHEMBL1146277,IC50,O=C(O)c1cc(C2=C(c3cc(Cl)ccc3OCc3ccccc3)CCC2)ncn1,6.699991797446187
CHEMBL233245,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,6.31,nM,CHEMBL889917,B,Inhibition of human EP1 receptor,CHEMBL1146277,IC50,O=C(O)c1cnnc(C2=C(c3cc(Cl)ccc3OCc3ccc(F)cc3F)CCC2)c1,8.199970640755865
CHEMBL233044,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,39.81,nM,CHEMBL889917,B,Inhibition of human EP1 receptor,CHEMBL1146277,IC50,O=C(O)c1cc(C2=C(c3cc(Cl)ccc3OCc3ccccc3)CCC2)cnn1,7.400007822415902
CHEMBL389796,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,1.585,nM,CHEMBL889917,B,Inhibition of human EP1 receptor,CHEMBL1146277,IC50,Cc1ncc(C2=C(c3cc(Cl)ccc3OCc3ccc(F)cc3)CCC2)cc1C(=O)O,8.79997073344623
CHEMBL233043,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,10.0,nM,CHEMBL889917,B,Inhibition of human EP1 receptor,CHEMBL1146277,IC50,O=C(O)c1cncc(C2=C(c3cc(C(F)(F)F)ccc3OCc3ccccc3)CCC2)c1,8.0
CHEMBL395542,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,3.162,nM,CHEMBL889917,B,Inhibition of human EP1 receptor,CHEMBL1146277,IC50,O=C(O)c1ccnc(C2=C(c3cc(Br)ccc3OCc3ccc(F)cc3)CCC2)c1,8.500038134403809
CHEMBL234290,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,39.81,nM,CHEMBL889917,B,Inhibition of human EP1 receptor,CHEMBL1146277,IC50,O=C(O)c1cc(C2=C(c3cc(C(F)(F)F)ccc3OCc3ccccc3)CCC2)ccn1,7.400007822415902
CHEMBL234289,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,199.53,nM,CHEMBL889917,B,Inhibition of human EP1 receptor,CHEMBL1146277,IC50,N#Cc1ccc(OCc2ccc(Cl)cc2)c(C2=C(c3cccc(C(=O)O)c3)CCC2)c1,6.699991797446187
CHEMBL397957,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,39.81,nM,CHEMBL889917,B,Inhibition of human EP1 receptor,CHEMBL1146277,IC50,N#Cc1ccc(OCc2ccc(F)cc2F)c(C2=C(c3cccc(C(=O)O)c3)CCC2)c1,7.400007822415902
CHEMBL234082,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,398.11,nM,CHEMBL889917,B,Inhibition of human EP1 receptor,CHEMBL1146277,IC50,N#Cc1ccc(OCc2ccc(F)cc2)c(C2=C(c3cccc(C(=O)O)c3)CCC2)c1,6.399996913372259
CHEMBL234924,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,100.0,nM,CHEMBL889917,B,Inhibition of human EP1 receptor,CHEMBL1146277,IC50,N#Cc1ccc(OCc2ccccc2)c(C2=C(c3cccc(C(=O)O)c3)CCC2)c1,7.0
CHEMBL234710,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,15.85,nM,CHEMBL889917,B,Inhibition of human EP1 receptor,CHEMBL1146277,IC50,CS(=O)(=O)c1ccc(OCc2ccc(F)cc2F)c(C2=C(c3cccc(C(=O)O)c3)CCC2)c1,7.79997073344623
CHEMBL395311,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,79.43,nM,CHEMBL889917,B,Inhibition of human EP1 receptor,CHEMBL1146277,IC50,CS(=O)(=O)c1ccc(OCc2ccc(F)cc2)c(C2=C(c3cccc(C(=O)O)c3)CCC2)c1,7.100015437450609
CHEMBL265086,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,79.43,nM,CHEMBL889917,B,Inhibition of human EP1 receptor,CHEMBL1146277,IC50,CS(=O)(=O)c1ccc(OCc2ccccc2)c(C2=C(c3cccc(C(=O)O)c3)CCC2)c1,7.100015437450609
CHEMBL234709,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,15.85,nM,CHEMBL889917,B,Inhibition of human EP1 receptor,CHEMBL1146277,IC50,CSc1ccc(OCc2ccc(F)cc2F)c(C2=C(c3cccc(C(=O)O)c3)CCC2)c1,7.79997073344623
CHEMBL389596,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,31.62,nM,CHEMBL889917,B,Inhibition of human EP1 receptor,CHEMBL1146277,IC50,CSc1ccc(OCc2ccc(F)cc2)c(C2=C(c3cccc(C(=O)O)c3)CCC2)c1,7.50003813440381
CHEMBL234281,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,63.1,nM,CHEMBL889917,B,Inhibition of human EP1 receptor,CHEMBL1146277,IC50,CSc1ccc(OCc2ccccc2)c(C2=C(c3cccc(C(=O)O)c3)CCC2)c1,7.199970640755866
CHEMBL234280,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,39.81,nM,CHEMBL889917,B,Inhibition of human EP1 receptor,CHEMBL1146277,IC50,COc1ccc(COc2ccc(Br)cc2C2=C(c3cccc(C(=O)O)c3)CCC2)cc1,7.400007822415902
CHEMBL390188,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,2.512,nM,CHEMBL889917,B,Inhibition of human EP1 receptor,CHEMBL1146277,IC50,O=C(O)c1cccc(C2=C(c3cc(Br)ccc3OCc3ccc(Cl)cc3F)CCC2)c1,8.599980364934842
CHEMBL387605,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,5.012,nM,CHEMBL889917,B,Inhibition of human EP1 receptor,CHEMBL1146277,IC50,O=C(O)c1cccc(C2=C(c3cc(Br)ccc3OCc3ccc(F)cc3F)CCC2)c1,8.299988937677888
CHEMBL234069,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,100.0,nM,CHEMBL889917,B,Inhibition of human EP1 receptor,CHEMBL1146277,IC50,O=C(O)c1cccc(C2=C(c3cc(Br)ccc3OCc3ccc(Cl)c(Cl)c3)CCC2)c1,7.0
CHEMBL395284,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,19.95,nM,CHEMBL889917,B,Inhibition of human EP1 receptor,CHEMBL1146277,IC50,O=C(O)c1cccc(C2=C(c3cc(Br)ccc3OCc3ccc(F)cc3)CCC2)c1,7.700057099977233
CHEMBL428370,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,12.59,nM,CHEMBL889917,B,Inhibition of human EP1 receptor,CHEMBL1146277,IC50,O=C(O)c1cccc(C2=C(c3cc(Br)ccc3OCc3ccc(Cl)cc3)CCC2)c1,7.899974269892137
CHEMBL397687,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,12.59,nM,CHEMBL889917,B,Inhibition of human EP1 receptor,CHEMBL1146277,IC50,O=C(O)c1cccc(C2=C(c3cc(Br)ccc3OCc3ccccc3)CCC2)c1,7.899974269892137
CHEMBL207577,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,5.012,nM,CHEMBL889917,B,Inhibition of human EP1 receptor,CHEMBL1146277,IC50,O=C(O)c1cccc(C2=C(c3cc(Cl)ccc3OCc3ccccc3)CCC2)c1,8.299988937677888
CHEMBL233858,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,100.0,nM,CHEMBL889917,B,Inhibition of human EP1 receptor,CHEMBL1146277,IC50,COc1ccc(COc2ccccc2C2=C(c3cccc(C(=O)O)c3)CCC2)cc1,7.0
CHEMBL388655,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,50.12,nM,CHEMBL889917,B,Inhibition of human EP1 receptor,CHEMBL1146277,IC50,O=C(O)c1cccc(C2=C(c3ccccc3OCc3ccc(Cl)cc3F)CCC2)c1,7.299988937677888
CHEMBL233231,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,398.11,nM,CHEMBL889917,B,Inhibition of human EP1 receptor,CHEMBL1146277,IC50,O=C(O)c1cccc(C2=C(c3ccccc3OCc3ccc(Cl)c(Cl)c3)CCC2)c1,6.399996913372259
CHEMBL233230,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,25.12,nM,CHEMBL889917,B,Inhibition of human EP1 receptor,CHEMBL1146277,IC50,O=C(O)c1cccc(C2=C(c3ccccc3OCc3ccc(F)cc3F)CCC2)c1,7.599980364934842
CHEMBL377852,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,7.943,nM,CHEMBL897085,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cells,CHEMBL1148842,IC50,Cc1ccc(-c2cc(Cl)ccc2OCc2ccccc2)n1-c1cccc(C(=O)O)c1,8.100015437450608
CHEMBL233772,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,158.49,nM,CHEMBL897085,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cells,CHEMBL1148842,IC50,Cc1ccc(-c2cc(Br)ccc2OCc2ccc(F)cc2F)n1-c1ccc2c(c1)C(=O)NC2=O,6.799998134593398
CHEMBL391456,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,501.19,nM,CHEMBL897085,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cells,CHEMBL1148842,IC50,Cc1ccc(-c2cc(Cl)ccc2OCc2ccccc2)n1-c1ccc(-n2cncn2)cc1,6.299997602857746
CHEMBL233565,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,39.81,nM,CHEMBL897085,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cells,CHEMBL1148842,IC50,Cc1ccc(-c2cc(Br)ccc2OCc2ccc(F)cc2F)n1-c1ccc(-c2cnc[nH]2)cc1,7.400007822415902
CHEMBL438126,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,63.1,nM,CHEMBL897085,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cells,CHEMBL1148842,IC50,Cc1cc(=O)[nH]c2cc(-n3c(C)ccc3-c3cc(Cl)ccc3OCc3ccccc3)ccc12,7.199970640755866
CHEMBL233361,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,63.1,nM,CHEMBL897085,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cells,CHEMBL1148842,IC50,CC(=O)Nc1cccc(-n2c(C)ccc2-c2cc(Cl)ccc2OCc2ccccc2)c1,7.199970640755866
CHEMBL233359,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,199.53,nM,CHEMBL897085,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cells,CHEMBL1148842,IC50,Cc1nc(-c2cccc(-n3c(C)ccc3-c3cc(Br)ccc3OCc3ccc(F)cc3F)c2)no1,6.699991797446187
CHEMBL233160,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,39.81,nM,CHEMBL897085,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cells,CHEMBL1148842,IC50,Cc1nnc(-c2cccc(-n3c(C)ccc3-c3cc(Br)ccc3OCc3ccc(F)cc3F)c2)o1,7.400007822415902
CHEMBL233159,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,63.1,nM,CHEMBL897085,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cells,CHEMBL1148842,IC50,Cc1ccc(-c2cc(Br)ccc2OCc2ccc(F)cc2F)n1-c1cccc(-c2nc3ccccc3[nH]2)c1,7.199970640755866
CHEMBL393743,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,125.89,nM,CHEMBL897085,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cells,CHEMBL1148842,IC50,Cc1ccc(-c2cc(Br)ccc2OCc2ccc(F)cc2F)n1-c1cccc(-c2ncccn2)c1,6.900008766455316
CHEMBL234183,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,251.19,nM,CHEMBL897085,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cells,CHEMBL1148842,IC50,Cc1ccc(-c2cc(Br)ccc2OCc2ccc(F)cc2F)n1-c1cccc(-c2ccccn2)c1,6.599997654072045
CHEMBL234182,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,125.89,nM,CHEMBL897085,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cells,CHEMBL1148842,IC50,Cc1ccc(-c2cc(Br)ccc2OCc2ccc(F)cc2F)n1-c1cccc(-c2cccnc2)c1,6.900008766455316
CHEMBL392047,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,39.81,nM,CHEMBL897085,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cells,CHEMBL1148842,IC50,Cc1ccc(-c2cc(Cl)ccc2OCc2ccccc2)n1-c1ccc2[nH]ncc2c1,7.400007822415902
CHEMBL234181,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,39.81,nM,CHEMBL897085,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cells,CHEMBL1148842,IC50,Cc1ccc(-c2cc(Cl)ccc2OCc2ccccc2)n1-c1ccc2cn[nH]c2c1,7.400007822415902
CHEMBL233975,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,25.12,nM,CHEMBL897085,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cells,CHEMBL1148842,IC50,Cc1ccc(-c2cc(Cl)ccc2OCc2ccccc2)n1-c1ccc2nn[nH]c2c1,7.599980364934842
CHEMBL233971,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,630.96,nM,CHEMBL897085,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cells,CHEMBL1148842,IC50,Cc1ccc(-c2ccccc2OCc2ccc(F)cc2F)n1-c1ccc2nn[nH]c2c1,6.199998172182031
CHEMBL233768,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,1.585,nM,CHEMBL897085,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cells,CHEMBL1148842,IC50,Cc1ccc(-c2cc(Cl)ccc2OCc2ccccc2)n1-c1ccc(C(=O)N[C@H](C)c2ccccc2)cc1,8.79997073344623
CHEMBL391931,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,39.81,nM,CHEMBL897085,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cells,CHEMBL1148842,IC50,Cc1ccc(-c2cc(Cl)ccc2OCc2ccccc2)n1-c1cccc(C(=O)N[C@H](C)c2ccccc2)c1,7.400007822415902
CHEMBL391228,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,316.23,nM,CHEMBL897085,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cells,CHEMBL1148842,IC50,Cc1ccc(-c2cc(Cl)ccc2OCc2ccccc2)n1-c1cccc(C(=O)N[C@@H](C)c2ccccc2)c1,6.499996931948306
CHEMBL233146,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,63.1,nM,CHEMBL897085,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cells,CHEMBL1148842,IC50,Cc1ccc(-c2cc(Cl)ccc2OCc2ccccc2)n1-c1cccc(C(=O)NCc2ccncc2)c1,7.199970640755866
CHEMBL233141,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,63.1,nM,CHEMBL897085,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cells,CHEMBL1148842,IC50,Cc1ccc(-c2cc(Cl)ccc2OCc2ccccc2)n1-c1cccc(C(=O)NCc2cccnc2)c1,7.199970640755866
CHEMBL399800,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,50.12,nM,CHEMBL897085,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cells,CHEMBL1148842,IC50,Cc1ccc(-c2cc(Cl)ccc2OCc2ccccc2)n1-c1cccc(C(=O)NCc2ccccn2)c1,7.299988937677888
CHEMBL233140,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,25.12,nM,CHEMBL897085,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cells,CHEMBL1148842,IC50,Cc1ccc(-c2cc(Cl)ccc2OCc2ccccc2)n1-c1cccc(C(=O)NCc2ccccc2)c1,7.599980364934842
CHEMBL391930,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,501.19,nM,CHEMBL897085,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cells,CHEMBL1148842,IC50,Cc1ccc(-c2cc(Br)ccc2OCc2ccc(F)cc2F)n1-c1cccc(C(=O)Nc2ccccc2)c1,6.299997602857746
CHEMBL231723,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,10.0,nM,CHEMBL897085,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cells,CHEMBL1148842,IC50,Cc1ccc(-c2cc(Br)ccc2OCc2ccc(F)cc2F)n1-c1cccc(C(=O)N(C)C)c1,8.0
CHEMBL231722,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,19.95,nM,CHEMBL897085,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cells,CHEMBL1148842,IC50,CNC(=O)c1cccc(-n2c(C)ccc2-c2cc(Br)ccc2OCc2ccc(F)cc2F)c1,7.700057099977233
CHEMBL393416,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,63.1,nM,CHEMBL897085,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cells,CHEMBL1148842,IC50,Cc1ccc(-c2cc(Cl)ccc2OCc2ccccc2)n1-c1cccc(C(N)=O)c1,7.199970640755866
CHEMBL393374,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,501.19,nM,CHEMBL897085,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cells,CHEMBL1148842,IC50,Cc1ccc(-c2ccccc2OCc2ccc(F)cc2F)n1-c1cccc(C(N)=O)c1,6.299997602857746
CHEMBL391026,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,5.012,nM,CHEMBL897085,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cells,CHEMBL1148842,IC50,Cc1ccc(-c2cc(Cl)ccc2OCc2ccccc2)n1-c1ccc(C(=O)N[C@@H](C)c2ccccc2)cc1,8.299988937677888
CHEMBL232537,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,63.1,nM,CHEMBL897085,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cells,CHEMBL1148842,IC50,Cc1ccc(-c2cc(Cl)ccc2OCc2ccccc2)n1-c1ccc(C(=O)NCc2ccncc2)cc1,7.199970640755866
CHEMBL401023,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,12.59,nM,CHEMBL897085,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cells,CHEMBL1148842,IC50,Cc1ccc(-c2cc(Cl)ccc2OCc2ccccc2)n1-c1ccc(C(=O)NCc2cccnc2)cc1,7.899974269892137
CHEMBL232117,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,2.512,nM,CHEMBL897085,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cells,CHEMBL1148842,IC50,Cc1ccc(-c2cc(Cl)ccc2OCc2ccccc2)n1-c1ccc(C(=O)NCc2ccccn2)cc1,8.599980364934842
CHEMBL234176,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,25.12,nM,CHEMBL897085,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cells,CHEMBL1148842,IC50,Cc1ccc(-c2cc(Cl)ccc2OCc2ccccc2)n1-c1ccc(C(=O)NCc2ccccc2)cc1,7.599980364934842
CHEMBL439381,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,15.85,nM,CHEMBL897085,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cells,CHEMBL1148842,IC50,Cc1ccc(-c2cc(Br)ccc2OCc2ccc(F)cc2F)n1-c1ccc(C(=O)NC(C)(C)C)cc1,7.79997073344623
CHEMBL234174,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,50.12,nM,CHEMBL897085,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cells,CHEMBL1148842,IC50,CCN(CC)C(=O)c1ccc(-n2c(C)ccc2-c2cc(Br)ccc2OCc2ccc(F)cc2F)cc1,7.299988937677888
CHEMBL233138,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,15.85,nM,CHEMBL897085,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cells,CHEMBL1148842,IC50,Cc1ccc(-c2cc(Br)ccc2OCc2ccc(F)cc2F)n1-c1ccc(C(=O)N(C)C)cc1,7.79997073344623
CHEMBL233137,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,3.981,nM,CHEMBL897085,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cells,CHEMBL1148842,IC50,CNC(=O)c1ccc(-n2c(C)ccc2-c2cc(Br)ccc2OCc2ccc(F)cc2F)cc1,8.400007822415901
CHEMBL232932,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,7.943,nM,CHEMBL897085,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cells,CHEMBL1148842,IC50,Cc1ccc(-c2cc(Br)ccc2OCc2ccc(F)cc2F)n1-c1ccc(C(N)=O)cc1,8.100015437450608
CHEMBL393187,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,19.95,nM,CHEMBL897085,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cells,CHEMBL1148842,IC50,Cc1ccc(-c2cc(Cl)ccc2OCc2ccccc2)n1-c1ccc(S(N)(=O)=O)cc1,7.700057099977233
CHEMBL232931,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,31.62,nM,CHEMBL897085,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cells,CHEMBL1148842,IC50,Cc1ccc(-c2cc(Br)ccc2OCc2ccccc2)n1-c1ccc(S(C)(=O)=O)cc1,7.50003813440381
CHEMBL232930,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,19.95,nM,CHEMBL897085,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cells,CHEMBL1148842,IC50,Cc1ccc(-c2cc(Cl)ccc2OCc2ccccc2)n1-c1ccc(S(C)(=O)=O)cc1,7.700057099977233
CHEMBL439388,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,501.19,nM,CHEMBL897085,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cells,CHEMBL1148842,IC50,Cc1ccc(-c2ccccc2OCc2ccccc2)n1-c1ccc(S(C)(=O)=O)cc1,6.299997602857746
CHEMBL232734,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,199.53,nM,CHEMBL897085,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cells,CHEMBL1148842,IC50,Cc1ccc(-c2cc(Br)ccc2OCc2ccccc2)n1-c1cccc(S(C)(=O)=O)c1,6.699991797446187
CHEMBL232733,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,125.89,nM,CHEMBL897085,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cells,CHEMBL1148842,IC50,Cc1ccc(-c2cc(Cl)ccc2OCc2ccccc2)n1-c1cccc(S(C)(=O)=O)c1,6.900008766455316
CHEMBL232544,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,25.12,nM,CHEMBL897085,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cells,CHEMBL1148842,IC50,Cc1ccc(-c2cc(Br)ccc2OCc2ccc(F)cc2F)n1-c1cccc(C(O)(C(F)(F)F)C(F)(F)F)c1,7.599980364934842
CHEMBL232543,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,7.943,nM,CHEMBL897085,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cells,CHEMBL1148842,IC50,Cc1ccc(-c2cc(Cl)ccc2OCc2ccccc2)n1-c1ccc(S(=O)(=O)NC(=O)c2ccccc2)cc1,8.100015437450608
CHEMBL394173,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,79.43,nM,CHEMBL897085,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cells,CHEMBL1148842,IC50,Cc1ccc(-c2cc(Cl)ccc2OCc2ccccc2)n1-c1cccc(S(=O)(=O)NC(=O)c2ccccc2)c1,7.100015437450609
CHEMBL391287,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,5.012,nM,CHEMBL897085,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cells,CHEMBL1148842,IC50,Cc1noc(C)c1S(=O)(=O)NC(=O)c1cccc(-n2c(C)ccc2-c2ccccc2OCc2ccccc2)c1,8.299988937677888
CHEMBL232341,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,2.512,nM,CHEMBL897085,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cells,CHEMBL1148842,IC50,Cc1ccc(-c2ccccc2OCc2ccccc2)n1-c1cccc(C(=O)NS(=O)(=O)c2ccccc2)c1,8.599980364934842
CHEMBL232340,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,2.512,nM,CHEMBL897085,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cells,CHEMBL1148842,IC50,Cc1ccc(-c2cc(Cl)ccc2OCc2ccccc2)n1-c1cccc(C(=O)NS(=O)(=O)c2ccccc2)c1,8.599980364934842
CHEMBL391286,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,3.981,nM,CHEMBL897085,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cells,CHEMBL1148842,IC50,Cc1ccc(-c2cc(Br)ccc2OCc2ccc(F)cc2F)n1-c1cccc(C(=O)NS(C)(=O)=O)c1,8.400007822415901
CHEMBL234600,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,63.0,nM,CHEMBL896726,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cell membrane,CHEMBL1149562,IC50,CCc1ccccc1N(CC(=O)OCc1ccc(OC)cc1)S(=O)(=O)c1ccc(C)cc1,7.200659450546418
CHEMBL233155,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,25.12,nM,CHEMBL896726,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cell membrane,CHEMBL1149562,IC50,CCc1ccccc1N(Cc1nnc(COc2ccc(OC)cc2)o1)S(=O)(=O)c1ccc(C)cc1,7.599980364934842
CHEMBL231699,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,251.19,nM,CHEMBL896726,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cell membrane,CHEMBL1149562,IC50,Cc1ccc(S(=O)(=O)N(CC(=O)NCCc2ccc(Cl)cc2)c2ccccc2C)cc1,6.599997654072045
CHEMBL233356,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,19.95,nM,CHEMBL896726,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cell membrane,CHEMBL1149562,IC50,COc1ccc(NCc2nnc(CN(c3cccc(Cl)c3C)S(=O)(=O)c3ccc(C)cc3)o2)cc1,7.700057099977233
CHEMBL233157,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,501.19,nM,CHEMBL896726,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cell membrane,CHEMBL1149562,IC50,CCc1ccccc1N(Cc1nnc(CNc2ccc(OC)cc2)o1)S(=O)(=O)c1ccc(C)cc1,6.299997602857746
CHEMBL232950,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,7.943,nM,CHEMBL896726,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cell membrane,CHEMBL1149562,IC50,COc1ccc(Nc2nnc(CN(c3cccc(Cl)c3Cl)S(=O)(=O)c3ccc(C(F)(F)F)cc3)o2)cc1,8.100015437450608
CHEMBL391270,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,39.81,nM,CHEMBL896726,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cell membrane,CHEMBL1149562,IC50,COc1ccc(Nc2nnc(CN(c3cccc(Cl)c3Cl)S(=O)(=O)c3ccc(C)cc3)o2)cc1,7.400007822415902
CHEMBL233545,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,31.62,nM,CHEMBL896726,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cell membrane,CHEMBL1149562,IC50,COc1ccc(Nc2nnc(CN(c3cccc(Cl)c3C)S(=O)(=O)c3ccc(C)cc3)o2)cc1,7.50003813440381
CHEMBL233335,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,2.512,nM,CHEMBL896726,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cell membrane,CHEMBL1149562,IC50,CCOc1ccc(Cc2nnc(CN(c3cccc(Cl)c3Cl)S(=O)(=O)c3ccc(C(F)(F)F)cc3)o2)cc1,8.599980364934842
CHEMBL233134,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,19.95,nM,CHEMBL896726,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cell membrane,CHEMBL1149562,IC50,COc1ccc(Cc2nnc(CN(c3cccc(Cl)c3Cl)S(=O)(=O)c3ccc(Cl)cc3)o2)cc1,7.700057099977233
CHEMBL232926,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,63.1,nM,CHEMBL896726,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cell membrane,CHEMBL1149562,IC50,Cc1ccc(S(=O)(=O)N(Cc2nnc(Cc3ccc(Cl)cc3Cl)o2)c2cccc(Cl)c2C)cc1,7.199970640755866
CHEMBL232925,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,63.1,nM,CHEMBL896726,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cell membrane,CHEMBL1149562,IC50,Cc1ccc(S(=O)(=O)N(Cc2nnc(Cc3c(Cl)cccc3Cl)o2)c2cccc(Cl)c2C)cc1,7.199970640755866
CHEMBL232924,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,158.49,nM,CHEMBL896726,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cell membrane,CHEMBL1149562,IC50,Cc1ccc(S(=O)(=O)N(Cc2nnc(Cc3cccc(Cl)c3)o2)c2cccc(Cl)c2C)cc1,6.799998134593398
CHEMBL232531,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,79.43,nM,CHEMBL896726,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cell membrane,CHEMBL1149562,IC50,Cc1ccc(S(=O)(=O)N(Cc2nnc(Cc3ccccc3Cl)o2)c2cccc(Cl)c2C)cc1,7.100015437450609
CHEMBL400025,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,316.23,nM,CHEMBL896726,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cell membrane,CHEMBL1149562,IC50,Cc1ccc(S(=O)(=O)N(Cc2nnc(Cc3cccc(F)c3)o2)c2cccc(Cl)c2C)cc1,6.499996931948306
CHEMBL233808,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,501.19,nM,CHEMBL896726,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cell membrane,CHEMBL1149562,IC50,Cc1ccc(S(=O)(=O)N(Cc2nnc(Cc3ccccc3F)o2)c2cccc(Cl)c2C)cc1,6.299997602857746
CHEMBL393376,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,199.53,nM,CHEMBL896726,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cell membrane,CHEMBL1149562,IC50,Cc1ccc(S(=O)(=O)N(Cc2nnc(Cc3ccc(F)cc3)o2)c2cccc(Cl)c2C)cc1,6.699991797446187
CHEMBL232389,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,50.12,nM,CHEMBL896726,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cell membrane,CHEMBL1149562,IC50,Cc1ccc(S(=O)(=O)N(Cc2nnc(Cc3ccc(C(F)(F)F)cc3)o2)c2cccc(Cl)c2C)cc1,7.299988937677888
CHEMBL439559,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,12.59,nM,CHEMBL896726,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cell membrane,CHEMBL1149562,IC50,Cc1ccc(S(=O)(=O)N(Cc2nnc(Cc3ccc(N(C)C)cc3)o2)c2cccc(Cl)c2C)cc1,7.899974269892137
CHEMBL441126,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,6.31,nM,CHEMBL896726,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cell membrane,CHEMBL1149562,IC50,CCOc1ccc(Cc2nnc(CN(c3cccc(Cl)c3Cl)S(=O)(=O)c3ccc(C)cc3)o2)cc1,8.199970640755865
CHEMBL399614,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,7.943,nM,CHEMBL896726,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cell membrane,CHEMBL1149562,IC50,COc1ccc(Cc2nnc(CN(c3cccc(Cl)c3Cl)S(=O)(=O)c3ccc(C)cc3)o2)cc1,8.100015437450608
CHEMBL231759,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,3.981,nM,CHEMBL896726,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cell membrane,CHEMBL1149562,IC50,CCOc1ccc(Cc2nnc(CN(c3cccc(Cl)c3C)S(=O)(=O)c3ccc(C)cc3)o2)cc1,8.400007822415901
CHEMBL399613,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,6.31,nM,CHEMBL896726,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cell membrane,CHEMBL1149562,IC50,COc1ccc(Cc2nnc(CN(c3cccc(Cl)c3C)S(=O)(=O)c3ccc(C)cc3)o2)cc1,8.199970640755865
CHEMBL232160,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,63.1,nM,CHEMBL896726,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cell membrane,CHEMBL1149562,IC50,COc1ccc(Cc2nnc(CN(c3cccc(C(F)(F)F)c3C)S(=O)(=O)c3ccc(C)cc3)o2)cc1,7.199970640755866
CHEMBL232159,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,125.89,nM,CHEMBL896726,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cell membrane,CHEMBL1149562,IC50,CCOc1ccc(Cc2nnc(CN(c3ccccc3CC)S(=O)(=O)c3ccc(C)cc3)o2)cc1,6.900008766455316
CHEMBL232158,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,125.89,nM,CHEMBL896726,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cell membrane,CHEMBL1149562,IC50,CCc1ccccc1N(Cc1nnc(Cc2ccc(OC)cc2)o1)S(=O)(=O)c1ccc(C)cc1,6.900008766455316
CHEMBL401432,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,398.11,nM,CHEMBL896726,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cell membrane,CHEMBL1149562,IC50,CCc1ccccc1N(Cc1nnc(Cc2ccc(Cl)cc2)o1)S(=O)(=O)c1ccc(C)cc1,6.399996913372259
CHEMBL231964,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,1000.0,nM,CHEMBL896726,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cell membrane,CHEMBL1149562,IC50,CCc1ccccc1N(Cc1nnc(Cc2ccccc2)o1)S(=O)(=O)c1ccc(C)cc1,6.0
CHEMBL234600,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,63.1,nM,CHEMBL896726,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cell membrane,CHEMBL1149562,IC50,CCc1ccccc1N(CC(=O)OCc1ccc(OC)cc1)S(=O)(=O)c1ccc(C)cc1,7.199970640755866
CHEMBL234399,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,7.943,nM,CHEMBL896726,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cell membrane,CHEMBL1149562,IC50,CCc1ccccc1N(CC(=O)NCCc1ccc(OC)c(OC)c1)S(=O)(=O)c1ccc(C)cc1,8.100015437450608
CHEMBL234398,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,25.12,nM,CHEMBL896726,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cell membrane,CHEMBL1149562,IC50,CCc1ccccc1N(CC(=O)NCc1ccc(OC)cc1)S(=O)(=O)c1ccc(C)cc1,7.599980364934842
CHEMBL232158,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,126.0,nM,CHEMBL896726,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cell membrane,CHEMBL1149562,IC50,CCc1ccccc1N(Cc1nnc(Cc2ccc(OC)cc2)o1)S(=O)(=O)c1ccc(C)cc1,6.899629454882437
CHEMBL234398,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,25.0,nM,CHEMBL896726,B,Displacement of [3H]PGE2 from human recombinant EP1 receptor expressed in CHO cell membrane,CHEMBL1149562,IC50,CCc1ccccc1N(CC(=O)NCc1ccc(OC)cc1)S(=O)(=O)c1ccc(C)cc1,7.6020599913279625
CHEMBL207577,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,12.59,nM,CHEMBL934144,B,Displacement of [3H]PGE2 from EP1 receptor,CHEMBL1143119,IC50,O=C(O)c1cccc(C2=C(c3cc(Cl)ccc3OCc3ccccc3)CCC2)c1,7.899974269892137
CHEMBL273145,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,794.33,nM,CHEMBL934144,B,Displacement of [3H]PGE2 from EP1 receptor,CHEMBL1143119,IC50,O=C(O)c1cccc(Oc2cc(Cl)ccc2OCc2ccccc2)n1,6.0999990348465305
CHEMBL404760,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,50.12,nM,CHEMBL934144,B,Displacement of [3H]PGE2 from EP1 receptor,CHEMBL1143119,IC50,O=C([O-])Cc1csc(-c2cc(Cl)ccc2OCc2ccccc2)n1.[Na+],7.299988937677888
CHEMBL270162,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,630.96,nM,CHEMBL934144,B,Displacement of [3H]PGE2 from EP1 receptor,CHEMBL1143119,IC50,O=C([O-])c1csc(-c2cc(Cl)ccc2OCc2ccccc2)n1.[Na+],6.199998172182031
CHEMBL401768,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,25.12,nM,CHEMBL934144,B,Displacement of [3H]PGE2 from EP1 receptor,CHEMBL1143119,IC50,O=C([O-])c1csc(Nc2cc(Cl)ccc2OCc2ccccc2)n1.[Na+],7.599980364934842
CHEMBL403329,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,39.81,nM,CHEMBL934144,B,Displacement of [3H]PGE2 from EP1 receptor,CHEMBL1143119,IC50,CC(C)COc1ccc(Cl)cc1Cc1cccc(C(=O)O)n1,7.400007822415902
CHEMBL403330,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,3.162,nM,CHEMBL934144,B,Displacement of [3H]PGE2 from EP1 receptor,CHEMBL1143119,IC50,CC(C)COc1ccc(Cl)cc1Cc1ccc(C(=O)[O-])o1.[Na+],8.500038134403809
CHEMBL255009,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,7.943,nM,CHEMBL934144,B,Displacement of [3H]PGE2 from EP1 receptor,CHEMBL1143119,IC50,CC(C)COc1ccc(Cl)cc1Cc1nc(C(=O)[O-])cs1.[Na+],8.100015437450608
CHEMBL270208,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,10.0,nM,CHEMBL934144,B,Displacement of [3H]PGE2 from EP1 receptor,CHEMBL1143119,IC50,Cc1cc(C(=O)[O-])nn1Cc1cc(Cl)ccc1OCC(C)C.[Na+],8.0
CHEMBL258303,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,630.96,nM,CHEMBL934144,B,Displacement of [3H]PGE2 from EP1 receptor,CHEMBL1143119,IC50,O=C([O-])c1cncc(Cc2cc(Cl)ccc2OCc2ccccc2)c1.[Na+],6.199998172182031
CHEMBL270174,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,158.49,nM,CHEMBL934144,B,Displacement of [3H]PGE2 from EP1 receptor,CHEMBL1143119,IC50,O=C(O)c1cccc(Cc2cc(Cl)ccc2OCc2ccccc2)n1,6.799998134593398
CHEMBL404239,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,316.23,nM,CHEMBL934144,B,Displacement of [3H]PGE2 from EP1 receptor,CHEMBL1143119,IC50,O=C([O-])c1cccc(Cc2cc(Cl)ccc2OCc2ccccc2)c1.[Na+],6.499996931948306
CHEMBL256674,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,39.81,nM,CHEMBL934144,B,Displacement of [3H]PGE2 from EP1 receptor,CHEMBL1143119,IC50,O=C([O-])c1csc(Cc2cc(Cl)ccc2OCc2ccccc2)c1.[Na+],7.400007822415902
CHEMBL408367,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,50.12,nM,CHEMBL934144,B,Displacement of [3H]PGE2 from EP1 receptor,CHEMBL1143119,IC50,O=C([O-])c1ccc(Cc2cc(Cl)ccc2OCc2ccccc2)s1.[Na+],7.299988937677888
CHEMBL407175,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,10.0,nM,CHEMBL934144,B,Displacement of [3H]PGE2 from EP1 receptor,CHEMBL1143119,IC50,Cc1cc(C(=O)[O-])oc1Cc1cc(Cl)ccc1OCc1ccccc1.[Na+],8.0
CHEMBL272793,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,6.31,nM,CHEMBL934144,B,Displacement of [3H]PGE2 from EP1 receptor,CHEMBL1143119,IC50,O=C([O-])c1ccc(Cc2cc(Cl)ccc2OCc2ccccc2)o1.[Na+],8.199970640755865
CHEMBL535640,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,316.23,nM,CHEMBL934144,B,Displacement of [3H]PGE2 from EP1 receptor,CHEMBL1143119,IC50,Cl.Cn1cc(C(=O)O)nc1Cc1cc(Cl)ccc1OCc1ccccc1,6.499996931948306
CHEMBL257846,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,630.96,nM,CHEMBL934144,B,Displacement of [3H]PGE2 from EP1 receptor,CHEMBL1143119,IC50,O=C([O-])c1cnc(Cc2cc(Cl)ccc2OCc2ccccc2)s1.[Na+],6.199998172182031
CHEMBL258057,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,25.12,nM,CHEMBL934144,B,Displacement of [3H]PGE2 from EP1 receptor,CHEMBL1143119,IC50,O=C([O-])c1nc(Cc2cc(Cl)ccc2OCc2ccccc2)cs1.[Na+],7.599980364934842
CHEMBL257464,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,19.95,nM,CHEMBL934144,B,Displacement of [3H]PGE2 from EP1 receptor,CHEMBL1143119,IC50,O=C([O-])c1coc(Cc2cc(Cl)ccc2OCc2ccccc2)n1.[Na+],7.700057099977233
CHEMBL255652,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,6.31,nM,CHEMBL934144,B,Displacement of [3H]PGE2 from EP1 receptor,CHEMBL1143119,IC50,O=C([O-])c1csc(Cc2cc(Cl)ccc2OCc2ccccc2)n1.[Na+],8.199970640755865
CHEMBL403459,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,158.49,nM,CHEMBL934144,B,Displacement of [3H]PGE2 from EP1 receptor,CHEMBL1143119,IC50,Cc1cc(C(=O)O)cn1Cc1cc(Cl)ccc1OCc1ccccc1,6.799998134593398
CHEMBL403460,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,79.43,nM,CHEMBL934144,B,Displacement of [3H]PGE2 from EP1 receptor,CHEMBL1143119,IC50,O=C([O-])c1ccn(Cc2cc(Cl)ccc2OCc2ccccc2)n1.[Na+],7.100015437450609
CHEMBL404525,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,10.0,nM,CHEMBL934144,B,Displacement of [3H]PGE2 from EP1 receptor,CHEMBL1143119,IC50,Cc1cc(C(=O)[O-])nn1Cc1cc(Cl)ccc1OCc1ccccc1.[Na+],8.0
CHEMBL213221,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,6.31,nM,CHEMBL934144,B,Displacement of [3H]PGE2 from EP1 receptor,CHEMBL1143119,IC50,Cc1cc(C(=O)O)nn1Cc1cc(Br)ccc1OCc1ccccc1,8.199970640755865
CHEMBL234940,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,2.512,nM,CHEMBL934144,B,Displacement of [3H]PGE2 from EP1 receptor,CHEMBL1143119,IC50,O=C(O)c1cccc(C2=C(c3cc(Cl)ccc3OCc3ccc(F)cc3F)CCC2)n1,8.599980364934842
CHEMBL209800,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,5.012,nM,CHEMBL934144,B,Displacement of [3H]PGE2 from EP1 receptor,CHEMBL1143119,IC50,Cc1ccc(-c2cc(Cl)ccc2OCC(C)C)n1-c1cccc(C(=O)O)c1,8.299988937677888
CHEMBL377852,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,7.943,nM,CHEMBL934144,B,Displacement of [3H]PGE2 from EP1 receptor,CHEMBL1143119,IC50,Cc1ccc(-c2cc(Cl)ccc2OCc2ccccc2)n1-c1cccc(C(=O)O)c1,8.100015437450608
CHEMBL257997,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,6.31,nM,CHEMBL931249,B,Displacement of [3H]PGE2 from human EP1 receptor expressed in CHOK1 cells,CHEMBL1144841,IC50,CC(C)Cc1cn(-c2nc(C(=O)[O-])cs2)c2cc(Cl)ccc12.[Na+],8.199970640755865
CHEMBL257997,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,6.3,nM,CHEMBL931249,B,Displacement of [3H]PGE2 from human EP1 receptor expressed in CHOK1 cells,CHEMBL1144841,IC50,CC(C)Cc1cn(-c2nc(C(=O)[O-])cs2)c2cc(Cl)ccc12.[Na+],8.200659450546418
CHEMBL258184,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,6.31,nM,CHEMBL931249,B,Displacement of [3H]PGE2 from human EP1 receptor expressed in CHOK1 cells,CHEMBL1144841,IC50,Cc1cc(C(=O)[O-])nn1Cc1cc(Br)ccc1OCc1ccccc1.[Na+],8.199970640755865
CHEMBL257998,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,39.81,nM,CHEMBL931249,B,Displacement of [3H]PGE2 from human EP1 receptor expressed in CHOK1 cells,CHEMBL1144841,IC50,CC(C)COc1ccc(Cl)cc1Cc1cccc(C(=O)[O-])n1.[Na+],7.400007822415902
CHEMBL258041,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,158.49,nM,CHEMBL931249,B,Displacement of [3H]PGE2 from human EP1 receptor expressed in CHOK1 cells,CHEMBL1144841,IC50,O=C([O-])c1cccc(Cc2cc(Cl)ccc2OCc2ccccc2)n1.[Na+],6.799998134593398
CHEMBL401768,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,25.12,nM,CHEMBL931249,B,Displacement of [3H]PGE2 from human EP1 receptor expressed in CHOK1 cells,CHEMBL1144841,IC50,O=C([O-])c1csc(Nc2cc(Cl)ccc2OCc2ccccc2)n1.[Na+],7.599980364934842
CHEMBL255009,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,7.943,nM,CHEMBL931249,B,Displacement of [3H]PGE2 from human EP1 receptor expressed in CHOK1 cells,CHEMBL1144841,IC50,CC(C)COc1ccc(Cl)cc1Cc1nc(C(=O)[O-])cs1.[Na+],8.100015437450608
CHEMBL255652,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,6.31,nM,CHEMBL931249,B,Displacement of [3H]PGE2 from human EP1 receptor expressed in CHOK1 cells,CHEMBL1144841,IC50,O=C([O-])c1csc(Cc2cc(Cl)ccc2OCc2ccccc2)n1.[Na+],8.199970640755865
CHEMBL436656,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,158.49,nM,CHEMBL931249,B,Displacement of [3H]PGE2 from human EP1 receptor expressed in CHOK1 cells,CHEMBL1144841,IC50,O=C([O-])c1csc(-n2cc(Cc3ccccc3)c3ccc(Cl)cc32)n1.[Na+],6.799998134593398
CHEMBL403890,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,39.81,nM,CHEMBL931249,B,Displacement of [3H]PGE2 from human EP1 receptor expressed in CHOK1 cells,CHEMBL1144841,IC50,CC(C)c1cn(-c2nc(C(=O)[O-])cs2)c2cc(Cl)ccc12.[Na+],7.400007822415902
CHEMBL403082,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,39.81,nM,CHEMBL931249,B,Displacement of [3H]PGE2 from human EP1 receptor expressed in CHOK1 cells,CHEMBL1144841,IC50,Cc1c(CC(C)C)c2ccc(Cl)cc2n1-c1nc(C(=O)[O-])cs1.[Na+],7.400007822415902
CHEMBL256334,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,39.81,nM,CHEMBL931249,B,Displacement of [3H]PGE2 from human EP1 receptor expressed in CHOK1 cells,CHEMBL1144841,IC50,CC(C)Cc1cn(-c2nc(C(=O)[O-])cs2)c2ccc(Cl)cc12.[Na+],7.400007822415902
CHEMBL255928,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,630.96,nM,CHEMBL931249,B,Displacement of [3H]PGE2 from human EP1 receptor expressed in CHOK1 cells,CHEMBL1144841,IC50,CC(C)Cc1cn(-c2cccc(C(=O)[O-])c2)c2cc(Cl)ccc12.[Na+],6.199998172182031
CHEMBL254763,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,63.1,nM,CHEMBL931249,B,Displacement of [3H]PGE2 from human EP1 receptor expressed in CHOK1 cells,CHEMBL1144841,IC50,CC(C)Cc1cn(-c2cccc(C(=O)[O-])n2)c2cc(Cl)ccc12.[Na+],7.199970640755866
CHEMBL403892,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,6.31,nM,CHEMBL931249,B,Displacement of [3H]PGE2 from human EP1 receptor expressed in CHOK1 cells,CHEMBL1144841,IC50,CC(C)Cc1cn(Cc2nc(C(=O)[O-])cs2)c2cc(Cl)ccc12.[Na+],8.199970640755865
CHEMBL257413,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,158.49,nM,CHEMBL931249,B,Displacement of [3H]PGE2 from human EP1 receptor expressed in CHOK1 cells,CHEMBL1144841,IC50,CC(C)Cc1cn(-c2nc(CC(=O)[O-])cs2)c2cc(Cl)ccc12.[Na+],6.799998134593398
CHEMBL402608,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,50.12,nM,CHEMBL931249,B,Displacement of [3H]PGE2 from human EP1 receptor expressed in CHOK1 cells,CHEMBL1144841,IC50,CC(C)Cc1cn(-c2ccc(C(=O)[O-])s2)c2cc(Cl)ccc12.[Na+],7.299988937677888
CHEMBL403407,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,25.12,nM,CHEMBL931249,B,Displacement of [3H]PGE2 from human EP1 receptor expressed in CHOK1 cells,CHEMBL1144841,IC50,CC(C)Cc1cn(-c2ccc(C(=O)[O-])o2)c2cc(Cl)ccc12.[Na+],7.599980364934842
CHEMBL401698,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,100.0,nM,CHEMBL931249,B,Displacement of [3H]PGE2 from human EP1 receptor expressed in CHOK1 cells,CHEMBL1144841,IC50,CC(C)Cc1cn(-c2ncc(C(=O)[O-])s2)c2cc(Cl)ccc12.[Na+],7.0
CHEMBL402338,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,7.943,nM,CHEMBL931249,B,Displacement of [3H]PGE2 from human EP1 receptor expressed in CHOK1 cells,CHEMBL1144841,IC50,CC(C)Cc1cn(-c2nc(C(=O)[O-])co2)c2cc(Cl)ccc12.[Na+],8.100015437450608
CHEMBL402656,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,10.0,nM,CHEMBL931249,B,Displacement of [3H]PGE2 from human EP1 receptor expressed in CHOK1 cells,CHEMBL1144841,IC50,Cc1ccc2c(CC(C)C)cn(-c3nc(C(=O)[O-])cs3)c2c1.[Na+],8.0
CHEMBL402392,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,12.59,nM,CHEMBL931249,B,Displacement of [3H]PGE2 from human EP1 receptor expressed in CHOK1 cells,CHEMBL1144841,IC50,CC(C)Cc1cn(-c2nc(C(=O)[O-])cs2)c2cc(C(F)(F)F)ccc12.[Na+],7.899974269892137
CHEMBL257134,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,3.981,nM,CHEMBL931249,B,Displacement of [3H]PGE2 from human EP1 receptor expressed in CHOK1 cells,CHEMBL1144841,IC50,CC(C)Cc1cn(-c2nc(C(=O)[O-])cs2)c2cc(Br)ccc12.[Na+],8.400007822415901
CHEMBL257135,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,39.81,nM,CHEMBL931249,B,Displacement of [3H]PGE2 from human EP1 receptor expressed in CHOK1 cells,CHEMBL1144841,IC50,CC(C)Cc1cn(-c2nc(C(=O)[O-])cs2)c2cc(F)ccc12.[Na+],7.400007822415902
CHEMBL401785,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,158.49,nM,CHEMBL931249,B,Displacement of [3H]PGE2 from human EP1 receptor expressed in CHOK1 cells,CHEMBL1144841,IC50,CC(C)Cc1cn(-c2nc(C(=O)[O-])cs2)c2ccccc12.[Na+],6.799998134593398
CHEMBL255319,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,1000.0,nM,CHEMBL931249,B,Displacement of [3H]PGE2 from human EP1 receptor expressed in CHOK1 cells,CHEMBL1144841,IC50,CN(C)C(=O)c1cn(-c2nc(C(=O)[O-])cs2)c2cc(Cl)ccc12.[Na+],6.0
CHEMBL404309,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,100.0,nM,CHEMBL931249,B,Displacement of [3H]PGE2 from human EP1 receptor expressed in CHOK1 cells,CHEMBL1144841,IC50,CC(C)C(=O)c1cn(-c2nc(C(=O)[O-])cs2)c2cc(Cl)ccc12.[Na+],7.0
CHEMBL256336,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,251.19,nM,CHEMBL931249,B,Displacement of [3H]PGE2 from human EP1 receptor expressed in CHOK1 cells,CHEMBL1144841,IC50,O=C([O-])c1csc(-n2cc(CC(F)(F)F)c3ccc(Cl)cc32)n1.[Na+],6.599997654072045
CHEMBL404176,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,125.89,nM,CHEMBL931249,B,Displacement of [3H]PGE2 from human EP1 receptor expressed in CHOK1 cells,CHEMBL1144841,IC50,CCc1cn(-c2nc(C(=O)[O-])cs2)c2cc(Cl)ccc12.[Na+],6.900008766455316
CHEMBL255880,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,31.62,nM,CHEMBL931249,B,Displacement of [3H]PGE2 from human EP1 receptor expressed in CHOK1 cells,CHEMBL1144841,IC50,CCCc1cn(-c2nc(C(=O)[O-])cs2)c2cc(Cl)ccc12.[Na+],7.50003813440381
CHEMBL255675,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,6.31,nM,CHEMBL931249,B,Displacement of [3H]PGE2 from human EP1 receptor expressed in CHOK1 cells,CHEMBL1144841,IC50,CC(C)(C)CCc1cn(-c2nc(C(=O)[O-])cs2)c2cc(Cl)ccc12.[Na+],8.199970640755865
CHEMBL254764,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,31.62,nM,CHEMBL931249,B,Displacement of [3H]PGE2 from human EP1 receptor expressed in CHOK1 cells,CHEMBL1144841,IC50,CC(C)(C)Cc1cn(-c2nc(C(=O)[O-])cs2)c2cc(Cl)ccc12.[Na+],7.50003813440381
CHEMBL377852,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,7.943,nM,CHEMBL937605,B,Displacement of [3H]PGE2 from human PGE2-EP1 receptor expressed in CHO-K1 cells,CHEMBL1143088,IC50,Cc1ccc(-c2cc(Cl)ccc2OCc2ccccc2)n1-c1cccc(C(=O)O)c1,8.100015437450608
CHEMBL402326,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,398.11,nM,CHEMBL937605,B,Displacement of [3H]PGE2 from human PGE2-EP1 receptor expressed in CHO-K1 cells,CHEMBL1143088,IC50,O=C(Cc1ccccn1)Nc1ccn(Cc2cc(Cl)ccc2OCc2ccccc2)n1,6.399996913372259
CHEMBL257969,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,158.49,nM,CHEMBL937605,B,Displacement of [3H]PGE2 from human PGE2-EP1 receptor expressed in CHO-K1 cells,CHEMBL1143088,IC50,O=C(Cc1ccccc1)Nc1ccn(Cc2cc(Cl)ccc2OCc2ccccc2)n1,6.799998134593398
CHEMBL255485,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,251.19,nM,CHEMBL937605,B,Displacement of [3H]PGE2 from human PGE2-EP1 receptor expressed in CHO-K1 cells,CHEMBL1143088,IC50,O=C(Nc1ccn(Cc2cc(Cl)ccc2OCc2ccccc2)n1)c1ccccc1,6.599997654072045
CHEMBL255701,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,63.1,nM,CHEMBL937605,B,Displacement of [3H]PGE2 from human PGE2-EP1 receptor expressed in CHO-K1 cells,CHEMBL1143088,IC50,Cc1cc(NC(=O)OC2CCOCC2)nn1Cc1cc(Cl)ccc1OCC(C)C,7.199970640755866
CHEMBL255876,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,50.12,nM,CHEMBL937605,B,Displacement of [3H]PGE2 from human PGE2-EP1 receptor expressed in CHO-K1 cells,CHEMBL1143088,IC50,Cc1cc(NC(=O)OC(C)(C)C(F)(F)F)nn1Cc1cc(Cl)ccc1OCC(C)C,7.299988937677888
CHEMBL258183,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,50.12,nM,CHEMBL937605,B,Displacement of [3H]PGE2 from human PGE2-EP1 receptor expressed in CHO-K1 cells,CHEMBL1143088,IC50,Cc1cc(NC(=O)OC(C)C)nn1Cc1cc(Cl)ccc1OCC(C)C,7.299988937677888
CHEMBL402770,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,31.62,nM,CHEMBL937605,B,Displacement of [3H]PGE2 from human PGE2-EP1 receptor expressed in CHO-K1 cells,CHEMBL1143088,IC50,Cc1cc(NC(=O)OC(C)(C)C)nn1Cc1cc(Cl)ccc1OCC(C)C,7.50003813440381
CHEMBL429321,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,79.43,nM,CHEMBL937605,B,Displacement of [3H]PGE2 from human PGE2-EP1 receptor expressed in CHO-K1 cells,CHEMBL1143088,IC50,Cc1cc(NC(=O)O[C@H]2CCOC2)nn1Cc1cc(Cl)ccc1OCc1ccccc1,7.100015437450609
CHEMBL258439,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,199.53,nM,CHEMBL937605,B,Displacement of [3H]PGE2 from human PGE2-EP1 receptor expressed in CHO-K1 cells,CHEMBL1143088,IC50,COC(=O)Nc1cc(C)n(Cc2cc(Cl)ccc2OCc2ccccc2)n1,6.699991797446187
CHEMBL258226,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,79.43,nM,CHEMBL937605,B,Displacement of [3H]PGE2 from human PGE2-EP1 receptor expressed in CHO-K1 cells,CHEMBL1143088,IC50,CCOC(=O)Nc1cc(C)n(Cc2cc(Cl)ccc2OCc2ccccc2)n1,7.100015437450609
CHEMBL256560,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,25.12,nM,CHEMBL937605,B,Displacement of [3H]PGE2 from human PGE2-EP1 receptor expressed in CHO-K1 cells,CHEMBL1143088,IC50,Cc1cc(NC(=O)OCC(C)C)nn1Cc1cc(Cl)ccc1OCc1ccccc1,7.599980364934842
CHEMBL253538,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,79.43,nM,CHEMBL937605,B,Displacement of [3H]PGE2 from human PGE2-EP1 receptor expressed in CHO-K1 cells,CHEMBL1143088,IC50,Cc1cc(NC(=O)OCc2ccccn2)nn1Cc1cc(Cl)ccc1OCc1ccccc1,7.100015437450609
CHEMBL254963,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,79.43,nM,CHEMBL937605,B,Displacement of [3H]PGE2 from human PGE2-EP1 receptor expressed in CHO-K1 cells,CHEMBL1143088,IC50,Cc1cc(NC(=O)OCc2ccccc2)nn1Cc1cc(Cl)ccc1OCc1ccccc1,7.100015437450609
CHEMBL256092,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,31.62,nM,CHEMBL937605,B,Displacement of [3H]PGE2 from human PGE2-EP1 receptor expressed in CHO-K1 cells,CHEMBL1143088,IC50,Cc1cc(NC(=O)OC(C)C)nn1Cc1cc(Cl)ccc1OCc1ccccc1,7.50003813440381
CHEMBL258199,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,25.12,nM,CHEMBL937605,B,Displacement of [3H]PGE2 from human PGE2-EP1 receptor expressed in CHO-K1 cells,CHEMBL1143088,IC50,Cc1cc(NC(=O)OC(C)(C)C)nn1Cc1cc(Cl)ccc1OCc1ccccc1,7.599980364934842
CHEMBL258413,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,25.12,nM,CHEMBL937605,B,Displacement of [3H]PGE2 from human PGE2-EP1 receptor expressed in CHO-K1 cells,CHEMBL1143088,IC50,Cc1cc(NC(=O)C2CCCC2)nn1Cc1cc(Cl)ccc1OCC(C)C,7.599980364934842
CHEMBL258200,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,31.62,nM,CHEMBL937605,B,Displacement of [3H]PGE2 from human PGE2-EP1 receptor expressed in CHO-K1 cells,CHEMBL1143088,IC50,Cc1cc(NC(=O)C2CCCCC2)nn1Cc1cc(Cl)ccc1OCC(C)C,7.50003813440381
CHEMBL403580,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,25.12,nM,CHEMBL937605,B,Displacement of [3H]PGE2 from human PGE2-EP1 receptor expressed in CHO-K1 cells,CHEMBL1143088,IC50,Cc1cc(NC(=O)C(F)(F)c2ccccn2)nn1Cc1cc(Cl)ccc1OCc1ccccc1,7.599980364934842
CHEMBL254558,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,39.81,nM,CHEMBL937605,B,Displacement of [3H]PGE2 from human PGE2-EP1 receptor expressed in CHO-K1 cells,CHEMBL1143088,IC50,Cc1cc(NC(=O)C(F)(F)c2ccccc2)nn1Cc1cc(Cl)ccc1OCc1ccccc1,7.400007822415902
CHEMBL437796,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,15.85,nM,CHEMBL937605,B,Displacement of [3H]PGE2 from human PGE2-EP1 receptor expressed in CHO-K1 cells,CHEMBL1143088,IC50,Cc1cc(NC(=O)C(C)(C)c2ccccn2)nn1Cc1cc(Cl)ccc1OCc1ccccc1,7.79997073344623
CHEMBL254559,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,63.1,nM,CHEMBL937605,B,Displacement of [3H]PGE2 from human PGE2-EP1 receptor expressed in CHO-K1 cells,CHEMBL1143088,IC50,Cc1cc(NC(=O)C(C)(C)c2ccccc2)nn1Cc1cc(Cl)ccc1OCc1ccccc1,7.199970640755866
CHEMBL404481,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,50.12,nM,CHEMBL937605,B,Displacement of [3H]PGE2 from human PGE2-EP1 receptor expressed in CHO-K1 cells,CHEMBL1143088,IC50,Cc1cc(NC(=O)Cc2ccncc2)nn1Cc1cc(Cl)ccc1OCc1ccccc1,7.299988937677888
CHEMBL257544,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,39.81,nM,CHEMBL937605,B,Displacement of [3H]PGE2 from human PGE2-EP1 receptor expressed in CHO-K1 cells,CHEMBL1143088,IC50,Cc1cc(NC(=O)Cc2cccnc2)nn1Cc1cc(Cl)ccc1OCc1ccccc1,7.400007822415902
CHEMBL257138,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,19.95,nM,CHEMBL937605,B,Displacement of [3H]PGE2 from human PGE2-EP1 receptor expressed in CHO-K1 cells,CHEMBL1143088,IC50,Cc1cc(NC(=O)Cc2ccccn2)nn1Cc1cc(Cl)ccc1OCc1ccccc1,7.700057099977233
CHEMBL256933,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,12.59,nM,CHEMBL937605,B,Displacement of [3H]PGE2 from human PGE2-EP1 receptor expressed in CHO-K1 cells,CHEMBL1143088,IC50,Cc1cc(NC(=O)Cc2ccccc2)nn1Cc1cc(Cl)ccc1OCc1ccccc1,7.899974269892137
CHEMBL404026,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,12.59,nM,CHEMBL937605,B,Displacement of [3H]PGE2 from human PGE2-EP1 receptor expressed in CHO-K1 cells,CHEMBL1143088,IC50,Cc1cc(NC(=O)c2c(F)cccc2F)nn1Cc1cc(Cl)ccc1OCc1ccccc1,7.899974269892137
CHEMBL254990,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,15.85,nM,CHEMBL937605,B,Displacement of [3H]PGE2 from human PGE2-EP1 receptor expressed in CHO-K1 cells,CHEMBL1143088,IC50,Cc1cc(NC(=O)c2ccccc2)nn1Cc1cc(Cl)ccc1OCc1ccccc1,7.79997073344623
CHEMBL403939,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,63.1,nM,CHEMBL937605,B,Displacement of [3H]PGE2 from human PGE2-EP1 receptor expressed in CHO-K1 cells,CHEMBL1143088,IC50,Cc1cc(NC(=O)C2CCOCC2)nn1Cc1cc(Cl)ccc1OCc1ccccc1,7.199970640755866
CHEMBL403940,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,39.81,nM,CHEMBL937605,B,Displacement of [3H]PGE2 from human PGE2-EP1 receptor expressed in CHO-K1 cells,CHEMBL1143088,IC50,Cc1cc(NC(=O)C2CCOC2)nn1Cc1cc(Cl)ccc1OCc1ccccc1,7.400007822415902
CHEMBL256731,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,39.81,nM,CHEMBL937605,B,Displacement of [3H]PGE2 from human PGE2-EP1 receptor expressed in CHO-K1 cells,CHEMBL1143088,IC50,Cc1cc(NC(=O)C2CCCO2)nn1Cc1cc(Cl)ccc1OCc1ccccc1,7.400007822415902
CHEMBL404297,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,6.31,nM,CHEMBL937605,B,Displacement of [3H]PGE2 from human PGE2-EP1 receptor expressed in CHO-K1 cells,CHEMBL1143088,IC50,Cc1cc(NC(=O)CC2CCCCC2)nn1Cc1cc(Cl)ccc1OCc1ccccc1,8.199970640755865
CHEMBL254151,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,15.85,nM,CHEMBL937605,B,Displacement of [3H]PGE2 from human PGE2-EP1 receptor expressed in CHO-K1 cells,CHEMBL1143088,IC50,Cc1cc(NC(=O)C2CCCC2)nn1Cc1cc(Cl)ccc1OCc1ccccc1,7.79997073344623
CHEMBL254150,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,10.0,nM,CHEMBL937605,B,Displacement of [3H]PGE2 from human PGE2-EP1 receptor expressed in CHO-K1 cells,CHEMBL1143088,IC50,Cc1cc(NC(=O)CC(C)(C)C)nn1Cc1cc(Cl)ccc1OCc1ccccc1,8.0
CHEMBL254152,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,25.12,nM,CHEMBL937605,B,Displacement of [3H]PGE2 from human PGE2-EP1 receptor expressed in CHO-K1 cells,CHEMBL1143088,IC50,Cc1cc(NC(=O)C(C)C)nn1Cc1cc(Cl)ccc1OCc1ccccc1,7.599980364934842
CHEMBL402604,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,316.23,nM,CHEMBL937605,B,Displacement of [3H]PGE2 from human PGE2-EP1 receptor expressed in CHO-K1 cells,CHEMBL1143088,IC50,CC(=O)Nc1cc(C)n(Cc2cc(Cl)ccc2OCc2ccccc2)n1,6.499996931948306
CHEMBL402202,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,251.19,nM,CHEMBL937605,B,Displacement of [3H]PGE2 from human PGE2-EP1 receptor expressed in CHO-K1 cells,CHEMBL1143088,IC50,Cc1cc(C(=O)NN2CCOCC2)nn1Cc1cc(Cl)ccc1OCC(C)C,6.599997654072045
CHEMBL256532,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,199.53,nM,CHEMBL937605,B,Displacement of [3H]PGE2 from human PGE2-EP1 receptor expressed in CHO-K1 cells,CHEMBL1143088,IC50,Cc1cc(C(=O)NN2CCCCC2)nn1Cc1cc(Cl)ccc1OCC(C)C,6.699991797446187
CHEMBL256737,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,125.89,nM,CHEMBL937605,B,Displacement of [3H]PGE2 from human PGE2-EP1 receptor expressed in CHO-K1 cells,CHEMBL1143088,IC50,Cc1cc(C(N)=O)nn1Cc1cc(Cl)ccc1OCC(C)C,6.900008766455316
CHEMBL256736,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,79.43,nM,CHEMBL937605,B,Displacement of [3H]PGE2 from human PGE2-EP1 receptor expressed in CHO-K1 cells,CHEMBL1143088,IC50,Cc1cc(C(=O)NCc2ccncc2)nn1Cc1cc(Cl)ccc1OCc1ccccc1,7.100015437450609
CHEMBL254553,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,50.12,nM,CHEMBL937605,B,Displacement of [3H]PGE2 from human PGE2-EP1 receptor expressed in CHO-K1 cells,CHEMBL1143088,IC50,Cc1cc(C(=O)NCc2cccnc2)nn1Cc1cc(Cl)ccc1OCc1ccccc1,7.299988937677888
CHEMBL254554,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,25.12,nM,CHEMBL937605,B,Displacement of [3H]PGE2 from human PGE2-EP1 receptor expressed in CHO-K1 cells,CHEMBL1143088,IC50,Cc1cc(C(=O)NCc2ccccn2)nn1Cc1cc(Cl)ccc1OCc1ccccc1,7.599980364934842
CHEMBL257146,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,39.81,nM,CHEMBL937605,B,Displacement of [3H]PGE2 from human PGE2-EP1 receptor expressed in CHO-K1 cells,CHEMBL1143088,IC50,Cc1cc(C(=O)NCc2ccccc2)nn1Cc1cc(Cl)ccc1OCc1ccccc1,7.400007822415902
CHEMBL257147,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,125.89,nM,CHEMBL937605,B,Displacement of [3H]PGE2 from human PGE2-EP1 receptor expressed in CHO-K1 cells,CHEMBL1143088,IC50,Cc1cc(C(=O)Nc2ccccn2)nn1Cc1cc(Cl)ccc1OCc1ccccc1,6.900008766455316
CHEMBL404711,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,10.0,nM,CHEMBL937605,B,Displacement of [3H]PGE2 from human PGE2-EP1 receptor expressed in CHO-K1 cells,CHEMBL1143088,IC50,Cc1cc(C(=O)Nc2c(F)cccc2F)nn1Cc1cc(Cl)ccc1OCc1ccccc1,8.0
CHEMBL256579,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,79.43,nM,CHEMBL937605,B,Displacement of [3H]PGE2 from human PGE2-EP1 receptor expressed in CHO-K1 cells,CHEMBL1143088,IC50,Cc1cc(C(=O)Nc2ccc(F)cc2)nn1Cc1cc(Cl)ccc1OCc1ccccc1,7.100015437450609
CHEMBL254958,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,199.53,nM,CHEMBL937605,B,Displacement of [3H]PGE2 from human PGE2-EP1 receptor expressed in CHO-K1 cells,CHEMBL1143088,IC50,Cc1cc(C(=O)Nc2cccc(F)c2)nn1Cc1cc(Cl)ccc1OCc1ccccc1,6.699991797446187
CHEMBL404698,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,39.81,nM,CHEMBL937605,B,Displacement of [3H]PGE2 from human PGE2-EP1 receptor expressed in CHO-K1 cells,CHEMBL1143088,IC50,Cc1cc(C(=O)Nc2ccccc2)nn1Cc1cc(Cl)ccc1OCc1ccccc1,7.400007822415902
CHEMBL257970,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,125.89,nM,CHEMBL937605,B,Displacement of [3H]PGE2 from human PGE2-EP1 receptor expressed in CHO-K1 cells,CHEMBL1143088,IC50,Cc1cc(C(=O)NC(C)C)nn1Cc1cc(Cl)ccc1OCc1ccccc1,6.900008766455316
CHEMBL258171,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,100.0,nM,CHEMBL937605,B,Displacement of [3H]PGE2 from human PGE2-EP1 receptor expressed in CHO-K1 cells,CHEMBL1143088,IC50,CNC(=O)c1cc(C)n(Cc2cc(Cl)ccc2OCc2ccccc2)n1,7.0
CHEMBL437399,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,125.89,nM,CHEMBL937605,B,Displacement of [3H]PGE2 from human PGE2-EP1 receptor expressed in CHO-K1 cells,CHEMBL1143088,IC50,Cc1cc(C(N)=O)nn1Cc1cc(Cl)ccc1OCc1ccccc1,6.900008766455316
CHEMBL256785,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,10.0,nM,CHEMBL937605,B,Displacement of [3H]PGE2 from human PGE2-EP1 receptor expressed in CHO-K1 cells,CHEMBL1143088,IC50,Cc1cc(C(=O)[O-])nn1C(C)c1cc(Cl)ccc1OCc1ccccc1.[Na+],8.0
CHEMBL258184,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,6.31,nM,CHEMBL937605,B,Displacement of [3H]PGE2 from human PGE2-EP1 receptor expressed in CHO-K1 cells,CHEMBL1143088,IC50,Cc1cc(C(=O)[O-])nn1Cc1cc(Br)ccc1OCc1ccccc1.[Na+],8.199970640755865
CHEMBL232117,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,2.512,nM,CHEMBL937605,B,Displacement of [3H]PGE2 from human PGE2-EP1 receptor expressed in CHO-K1 cells,CHEMBL1143088,IC50,Cc1ccc(-c2cc(Cl)ccc2OCc2ccccc2)n1-c1ccc(C(=O)NCc2ccccn2)cc1,8.599980364934842
CHEMBL233140,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,25.12,nM,CHEMBL937605,B,Displacement of [3H]PGE2 from human PGE2-EP1 receptor expressed in CHO-K1 cells,CHEMBL1143088,IC50,Cc1ccc(-c2cc(Cl)ccc2OCc2ccccc2)n1-c1cccc(C(=O)NCc2ccccc2)c1,7.599980364934842
CHEMBL521609,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,1420.0,nM,CHEMBL960843,B,Displacement of radioligand from EP1 receptor,CHEMBL1153263,IC50,Cn1cc(/C=C/C(=O)NS(=O)(=O)c2ccc(F)c(F)c2)c2c(Oc3ccc4ccccc4c3)cccc21,5.847711655616943
CHEMBL459885,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,3860.0,nM,CHEMBL960843,B,Displacement of radioligand from EP1 receptor,CHEMBL1153263,IC50,Cn1cc(/C=C/C(=O)NS(=O)(=O)c2ccc(F)c(F)c2)c2c(Oc3ccc(Cl)cc3Cl)cccc21,5.413412695328245
CHEMBL475348,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,5320.0,nM,CHEMBL960843,B,Displacement of radioligand from EP1 receptor,CHEMBL1153263,IC50,Cn1cc(/C=C/C(=O)NS(=O)(=O)c2cc(F)c(F)cc2F)c2c(Oc3ccc(Cl)c(Cl)c3)cccc21,5.274088367704952
CHEMBL521777,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,1370.0,nM,CHEMBL960843,B,Displacement of radioligand from EP1 receptor,CHEMBL1153263,IC50,Cn1cc(/C=C/C(=O)NS(=O)(=O)c2cc(F)c(F)cc2F)c2c(Oc3ccc(Cl)c(F)c3)cccc21,5.863279432843593
CHEMBL404525,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,10.0,nM,CHEMBL1022751,B,Displacement of [H3PGE2 from human EP1 receptor expressed in CHOK1 cells,CHEMBL1155060,IC50,Cc1cc(C(=O)[O-])nn1Cc1cc(Cl)ccc1OCc1ccccc1.[Na+],8.0
CHEMBL479591,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,10.0,nM,CHEMBL1022751,B,Displacement of [H3PGE2 from human EP1 receptor expressed in CHOK1 cells,CHEMBL1155060,IC50,Cc1cc(C(=O)Nc2ccc(CN3CCOCC3)cc2)nn1Cc1cc(Cl)ccc1OCc1ccccc1.Cl,8.0
CHEMBL480181,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,12.59,nM,CHEMBL1022751,B,Displacement of [H3PGE2 from human EP1 receptor expressed in CHOK1 cells,CHEMBL1155060,IC50,Cc1cc(C(=O)Nc2ccc(CN3CCCCC3)cc2)nn1Cc1cc(Cl)ccc1OCc1ccccc1.Cl,7.899974269892137
CHEMBL479989,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,12.59,nM,CHEMBL1022751,B,Displacement of [H3PGE2 from human EP1 receptor expressed in CHOK1 cells,CHEMBL1155060,IC50,Cc1cc(C(=O)Nc2ccc(CN3CCCC3)cc2)nn1Cc1cc(Cl)ccc1OCc1ccccc1.Cl,7.899974269892137
CHEMBL480950,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,7.943,nM,CHEMBL1022751,B,Displacement of [H3PGE2 from human EP1 receptor expressed in CHOK1 cells,CHEMBL1155060,IC50,Cc1cc(C(=O)Nc2ccc(CN(C)C)cc2)nn1Cc1cc(Cl)ccc1OCc1ccccc1.Cl,8.100015437450608
CHEMBL480790,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,12.59,nM,CHEMBL1022751,B,Displacement of [H3PGE2 from human EP1 receptor expressed in CHOK1 cells,CHEMBL1155060,IC50,CCNCc1ccc(NC(=O)c2cc(C)n(Cc3cc(Cl)ccc3OCc3ccccc3)n2)cc1.Cl,7.899974269892137
CHEMBL480789,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,12.59,nM,CHEMBL1022751,B,Displacement of [H3PGE2 from human EP1 receptor expressed in CHOK1 cells,CHEMBL1155060,IC50,CNCc1ccc(NC(=O)c2cc(C)n(Cc3cc(Cl)ccc3OCc3ccccc3)n2)cc1.Cl,7.899974269892137
CHEMBL520438,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,6.31,nM,CHEMBL1022751,B,Displacement of [H3PGE2 from human EP1 receptor expressed in CHOK1 cells,CHEMBL1155060,IC50,Cc1cc(C(=O)Nc2ccc(CO)cc2)nn1Cc1cc(Cl)ccc1OCc1ccccc1.Cl,8.199970640755865
CHEMBL523216,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,15.85,nM,CHEMBL1022751,B,Displacement of [H3PGE2 from human EP1 receptor expressed in CHOK1 cells,CHEMBL1155060,IC50,Cc1cc(C(=O)Nc2ccc(CN(CCO)CCO)cc2)nn1Cc1cc(Cl)ccc1OCC(C)C.Cl,7.79997073344623
CHEMBL495107,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,25.12,nM,CHEMBL1022751,B,Displacement of [H3PGE2 from human EP1 receptor expressed in CHOK1 cells,CHEMBL1155060,IC50,Cc1cc(C(=O)Nc2ccc(CNCCO)cc2)nn1Cc1cc(Cl)ccc1OCC(C)C.Cl,7.599980364934842
CHEMBL523679,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,7.943,nM,CHEMBL1022751,B,Displacement of [H3PGE2 from human EP1 receptor expressed in CHOK1 cells,CHEMBL1155060,IC50,Cc1cc(C(=O)Nc2ccc(CN3CCOCC3)cc2)nn1Cc1cc(Cl)ccc1OCC(C)C.Cl,8.100015437450608
CHEMBL493065,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,6.31,nM,CHEMBL1022751,B,Displacement of [H3PGE2 from human EP1 receptor expressed in CHOK1 cells,CHEMBL1155060,IC50,Cc1cc(C(=O)Nc2ccc(CN3CCCCC3)cc2)nn1Cc1cc(Cl)ccc1OCC(C)C.Cl,8.199970640755865
CHEMBL494282,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,6.31,nM,CHEMBL1022751,B,Displacement of [H3PGE2 from human EP1 receptor expressed in CHOK1 cells,CHEMBL1155060,IC50,Cc1cc(C(=O)Nc2ccc(CN3CCCC3)cc2)nn1Cc1cc(Cl)ccc1OCC(C)C.Cl,8.199970640755865
CHEMBL492238,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,5.012,nM,CHEMBL1022751,B,Displacement of [H3PGE2 from human EP1 receptor expressed in CHOK1 cells,CHEMBL1155060,IC50,Cc1cc(C(=O)Nc2ccc(CN(C)C)cc2)nn1Cc1cc(Cl)ccc1OCC(C)C.Cl,8.299988937677888
CHEMBL523158,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,7.943,nM,CHEMBL1022751,B,Displacement of [H3PGE2 from human EP1 receptor expressed in CHOK1 cells,CHEMBL1155060,IC50,CCNCc1ccc(NC(=O)c2cc(C)n(Cc3cc(Cl)ccc3OCC(C)C)n2)cc1.Cl,8.100015437450608
CHEMBL492237,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,7.943,nM,CHEMBL1022751,B,Displacement of [H3PGE2 from human EP1 receptor expressed in CHOK1 cells,CHEMBL1155060,IC50,CNCc1ccc(NC(=O)c2cc(C)n(Cc3cc(Cl)ccc3OCC(C)C)n2)cc1.Cl,8.100015437450608
CHEMBL495294,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,31.62,nM,CHEMBL1022751,B,Displacement of [H3PGE2 from human EP1 receptor expressed in CHOK1 cells,CHEMBL1155060,IC50,Cc1cc(C(=O)Nc2ccc(CO)cc2)nn1Cc1cc(Cl)ccc1OCC(C)C.Cl,7.50003813440381
CHEMBL495091,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,50.12,nM,CHEMBL1022751,B,Displacement of [H3PGE2 from human EP1 receptor expressed in CHOK1 cells,CHEMBL1155060,IC50,CCN1CCc2ccc(C(=O)Nc3cc(C)n(Cc4cc(Cl)ccc4OCC(C)C)n3)cc2CC1.Cl,7.299988937677888
CHEMBL495090,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,79.43,nM,CHEMBL1022751,B,Displacement of [H3PGE2 from human EP1 receptor expressed in CHOK1 cells,CHEMBL1155060,IC50,Cc1cc(NC(=O)c2ccc3c(c2)CCNCC3)nn1Cc1cc(Cl)ccc1OCC(C)C.Cl,7.100015437450609
CHEMBL492840,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,100.0,nM,CHEMBL1022751,B,Displacement of [H3PGE2 from human EP1 receptor expressed in CHOK1 cells,CHEMBL1155060,IC50,Cc1cc(NC(=O)c2ccc3c(c2)CCN(C(C)C)C3)nn1Cc1cc(Cl)ccc1OCC(C)C.Cl,7.0
CHEMBL493254,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,39.81,nM,CHEMBL1022751,B,Displacement of [H3PGE2 from human EP1 receptor expressed in CHOK1 cells,CHEMBL1155060,IC50,Cc1cc(NC(=O)c2ccc3c(c2)CCNC3)nn1Cc1cc(Cl)ccc1OCC(C)C.Cl,7.400007822415902
CHEMBL494466,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,100.0,nM,CHEMBL1022751,B,Displacement of [H3PGE2 from human EP1 receptor expressed in CHOK1 cells,CHEMBL1155060,IC50,Cc1cc(NC(=O)c2ccc(C3CCCN3)cc2)nn1Cc1cc(Cl)ccc1OCC(C)C.Cl,7.0
CHEMBL494269,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,50.12,nM,CHEMBL1022751,B,Displacement of [H3PGE2 from human EP1 receptor expressed in CHOK1 cells,CHEMBL1155060,IC50,Cc1cc(NC(=O)c2ccc(C(C)N3CCCC3)cc2)nn1Cc1cc(Cl)ccc1OCC(C)C.Cl,7.299988937677888
CHEMBL494268,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,50.12,nM,CHEMBL1022751,B,Displacement of [H3PGE2 from human EP1 receptor expressed in CHOK1 cells,CHEMBL1155060,IC50,Cc1cc(NC(=O)c2ccc(C(C)NCC(C)C)cc2)nn1Cc1cc(Cl)ccc1OCC(C)C.Cl,7.299988937677888
CHEMBL521988,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,50.12,nM,CHEMBL1022751,B,Displacement of [H3PGE2 from human EP1 receptor expressed in CHOK1 cells,CHEMBL1155060,IC50,Cc1cc(NC(=O)c2ccc(CN3CCOCC3)cc2)nn1Cc1cc(Cl)ccc1OCC(C)C.Cl,7.299988937677888
CHEMBL492829,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,39.81,nM,CHEMBL1022751,B,Displacement of [H3PGE2 from human EP1 receptor expressed in CHOK1 cells,CHEMBL1155060,IC50,Cc1cc(NC(=O)c2ccc(CN3CCCCC3)cc2)nn1Cc1cc(Cl)ccc1OCC(C)C.Cl,7.400007822415902
CHEMBL481689,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,50.12,nM,CHEMBL1022751,B,Displacement of [H3PGE2 from human EP1 receptor expressed in CHOK1 cells,CHEMBL1155060,IC50,Cc1cc(NC(=O)c2ccc(CN3CCCC3)cc2)nn1Cc1cc(Cl)ccc1OCC(C)C.Cl,7.299988937677888
CHEMBL481519,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,100.0,nM,CHEMBL1022751,B,Displacement of [H3PGE2 from human EP1 receptor expressed in CHOK1 cells,CHEMBL1155060,IC50,Cc1cc(NC(=O)c2ccc(CN(C)C)cc2)nn1Cc1cc(Cl)ccc1OCC(C)C.Cl,7.0
CHEMBL481870,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,100.0,nM,CHEMBL1022751,B,Displacement of [H3PGE2 from human EP1 receptor expressed in CHOK1 cells,CHEMBL1155060,IC50,CCNCc1ccc(C(=O)Nc2cc(C)n(Cc3cc(Cl)ccc3OCC(C)C)n2)cc1.Cl,7.0
CHEMBL447709,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,12.59,nM,CHEMBL1022751,B,Displacement of [H3PGE2 from human EP1 receptor expressed in CHOK1 cells,CHEMBL1155060,IC50,Cc1cc(NC(=O)c2ccc(CO)cc2)nn1Cc1cc(Cl)ccc1OCC(C)C.Cl,7.899974269892137
CHEMBL520950,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,251.19,nM,CHEMBL1022751,B,Displacement of [H3PGE2 from human EP1 receptor expressed in CHOK1 cells,CHEMBL1155060,IC50,Cc1cc(NC(=O)c2cccc(CN3CCOCC3)c2)nn1Cc1cc(Cl)ccc1OCC(C)C.Cl,6.599997654072045
CHEMBL482132,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,501.19,nM,CHEMBL1022751,B,Displacement of [H3PGE2 from human EP1 receptor expressed in CHOK1 cells,CHEMBL1155060,IC50,Cc1cc(NC(=O)c2cccc(CN3CCCCC3)c2)nn1Cc1cc(Cl)ccc1OCC(C)C.Cl,6.299997602857746
CHEMBL481137,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,125.89,nM,CHEMBL1022751,B,Displacement of [H3PGE2 from human EP1 receptor expressed in CHOK1 cells,CHEMBL1155060,IC50,Cc1cc(NC(=O)c2cccc(CN3CCCC3)c2)nn1Cc1cc(Cl)ccc1OCC(C)C.Cl,6.900008766455316
CHEMBL480979,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,630.96,nM,CHEMBL1022751,B,Displacement of [H3PGE2 from human EP1 receptor expressed in CHOK1 cells,CHEMBL1155060,IC50,Cc1cc(NC(=O)c2cccc(CN(C)C)c2)nn1Cc1cc(Cl)ccc1OCC(C)C.Cl,6.199998172182031
CHEMBL516608,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,501.19,nM,CHEMBL1022751,B,Displacement of [H3PGE2 from human EP1 receptor expressed in CHOK1 cells,CHEMBL1155060,IC50,CCNCc1cccc(C(=O)Nc2cc(C)n(Cc3cc(Cl)ccc3OCC(C)C)n2)c1.Cl,6.299997602857746
CHEMBL480002,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,25.12,nM,CHEMBL1022751,B,Displacement of [H3PGE2 from human EP1 receptor expressed in CHOK1 cells,CHEMBL1155060,IC50,Cc1cc(NC(=O)c2ccccc2CO)nn1Cc1cc(Cl)ccc1OCC(C)C.Cl,7.599980364934842
CHEMBL254990,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,15.85,nM,CHEMBL1022751,B,Displacement of [H3PGE2 from human EP1 receptor expressed in CHOK1 cells,CHEMBL1155060,IC50,Cc1cc(NC(=O)c2ccccc2)nn1Cc1cc(Cl)ccc1OCc1ccccc1,7.79997073344623
CHEMBL404698,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,39.81,nM,CHEMBL1022751,B,Displacement of [H3PGE2 from human EP1 receptor expressed in CHOK1 cells,CHEMBL1155060,IC50,Cc1cc(C(=O)Nc2ccccc2)nn1Cc1cc(Cl)ccc1OCc1ccccc1,7.400007822415902
CHEMBL481813,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,6900.0,nM,CHEMBL1023726,B,Binding affinity to human EP1 receptor by radioligand binding assay,CHEMBL1143334,IC50,CC12CCCC(/C=C/C(=O)NS(=O)(=O)c3cc(Cl)c(Cl)s3)=C1N(Cc1ccc3ccccc3c1)C(=O)C2,5.161150909262744
CHEMBL482330,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,1400.0,nM,CHEMBL1023726,B,Binding affinity to human EP1 receptor by radioligand binding assay,CHEMBL1143334,IC50,COc1cccc(CN2C(=O)CC3(C)CCCC(/C=C/C(=O)NS(=O)(=O)c4ccc(F)c(F)c4)=C23)c1,5.853871964321762
CHEMBL479439,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,11600.0,nM,CHEMBL1023726,B,Binding affinity to human EP1 receptor by radioligand binding assay,CHEMBL1143334,IC50,CC12CCCC(/C=C/C(=O)NS(=O)(=O)c3cc(F)c(F)cc3F)=C1N(Cc1ccc(Cl)cc1Cl)C(=O)C2,4.935542010773082
CHEMBL234940,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,2.512,nM,CHEMBL1009646,B,Displacement of [3H]PGE2 from human EP1 receptor expressed in CHO cells,CHEMBL1138602,IC50,O=C(O)c1cccc(C2=C(c3cc(Cl)ccc3OCc3ccc(F)cc3F)CCC2)n1,8.599980364934842
CHEMBL467510,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,15.85,nM,CHEMBL1009646,B,Displacement of [3H]PGE2 from human EP1 receptor expressed in CHO cells,CHEMBL1138602,IC50,CC(C)COc1ccc(Cl)cc1-c1ccccc1-c1cccc(C(=O)[O-])n1.[Na+],7.79997073344623
CHEMBL233043,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,10.0,nM,CHEMBL1009646,B,Displacement of [3H]PGE2 from human EP1 receptor expressed in CHO cells,CHEMBL1138602,IC50,O=C(O)c1cncc(C2=C(c3cc(C(F)(F)F)ccc3OCc3ccccc3)CCC2)c1,8.0
CHEMBL2110364,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,0.1288,nM,CHEMBL1009646,B,Displacement of [3H]PGE2 from human EP1 receptor expressed in CHO cells,CHEMBL1138602,IC50,Cc1cc(C(=O)[O-])nn1Cc1cc(Br)ccc1OCc1ccc(Cl)cc1Cl.[Na+],9.890084136976206
CHEMBL258041,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,158.49,nM,CHEMBL1009646,B,Displacement of [3H]PGE2 from human EP1 receptor expressed in CHO cells,CHEMBL1138602,IC50,O=C([O-])c1cccc(Cc2cc(Cl)ccc2OCc2ccccc2)n1.[Na+],6.799998134593398
CHEMBL508276,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,79.43,nM,CHEMBL1009646,B,Displacement of [3H]PGE2 from human EP1 receptor expressed in CHO cells,CHEMBL1138602,IC50,O=C([O-])c1cccc(Cc2cc(Cl)ccc2OCc2ccccc2F)n1.[Na+],7.100015437450609
CHEMBL511733,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,100.0,nM,CHEMBL1009646,B,Displacement of [3H]PGE2 from human EP1 receptor expressed in CHO cells,CHEMBL1138602,IC50,O=C([O-])c1cccc(Cc2cc(Cl)ccc2OCc2ccc(F)cc2)n1.[Na+],7.0
CHEMBL466101,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,25.12,nM,CHEMBL1009646,B,Displacement of [3H]PGE2 from human EP1 receptor expressed in CHO cells,CHEMBL1138602,IC50,O=C([O-])c1cccc(Cc2cc(Cl)ccc2OCc2ccc(F)cc2F)n1.[Na+],7.599980364934842
CHEMBL466102,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,79.43,nM,CHEMBL1009646,B,Displacement of [3H]PGE2 from human EP1 receptor expressed in CHO cells,CHEMBL1138602,IC50,O=C([O-])c1cccc(Cc2cc(Cl)ccc2OCc2c(F)cc(F)cc2F)n1.[Na+],7.100015437450609
CHEMBL466103,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,39.81,nM,CHEMBL1009646,B,Displacement of [3H]PGE2 from human EP1 receptor expressed in CHO cells,CHEMBL1138602,IC50,O=C([O-])c1cccc(Cc2cc(Cl)ccc2OCc2ccccc2Cl)n1.[Na+],7.400007822415902
CHEMBL467113,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,39.81,nM,CHEMBL1009646,B,Displacement of [3H]PGE2 from human EP1 receptor expressed in CHO cells,CHEMBL1138602,IC50,O=C([O-])c1cccc(Cc2cc(Cl)ccc2OCc2ccc(Cl)cc2)n1.[Na+],7.400007822415902
CHEMBL467114,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,12.59,nM,CHEMBL1009646,B,Displacement of [3H]PGE2 from human EP1 receptor expressed in CHO cells,CHEMBL1138602,IC50,O=C([O-])c1cccc(Cc2cc(Cl)ccc2OCc2ccc(Cl)cc2F)n1.[Na+],7.899974269892137
CHEMBL513491,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,12.59,nM,CHEMBL1009646,B,Displacement of [3H]PGE2 from human EP1 receptor expressed in CHO cells,CHEMBL1138602,IC50,O=C([O-])c1cccc(Cc2cc(Cl)ccc2OCc2ccc(F)cc2Cl)n1.[Na+],7.899974269892137
CHEMBL467720,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,10.0,nM,CHEMBL1009646,B,Displacement of [3H]PGE2 from human EP1 receptor expressed in CHO cells,CHEMBL1138602,IC50,O=C([O-])c1cccc(Cc2cc(Cl)ccc2OCc2ccc(Cl)cc2Cl)n1.[Na+],8.0
CHEMBL257998,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,39.81,nM,CHEMBL1009646,B,Displacement of [3H]PGE2 from human EP1 receptor expressed in CHO cells,CHEMBL1138602,IC50,CC(C)COc1ccc(Cl)cc1Cc1cccc(C(=O)[O-])n1.[Na+],7.400007822415902
CHEMBL468723,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,100.0,nM,CHEMBL1009646,B,Displacement of [3H]PGE2 from human EP1 receptor expressed in CHO cells,CHEMBL1138602,IC50,O=C([O-])c1cccc(Cc2cc(Cl)ccc2OCC2CCCCC2)n1.[Na+],7.0
CHEMBL511252,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,31.62,nM,CHEMBL1009646,B,Displacement of [3H]PGE2 from human EP1 receptor expressed in CHO cells,CHEMBL1138602,IC50,O=C([O-])c1cccc(Cc2cc(Cl)ccc2OCC2CCCC2)n1.[Na+],7.50003813440381
CHEMBL511919,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,199.53,nM,CHEMBL1009646,B,Displacement of [3H]PGE2 from human EP1 receptor expressed in CHO cells,CHEMBL1138602,IC50,O=C([O-])c1cccc(Cc2cc(Cl)ccc2OCC2CC2)n1.[Na+],6.699991797446187
CHEMBL467510,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,16.0,nM,CHEMBL1010712,B,Binding affinity to human EP1 receptor,CHEMBL1154508,IC50,CC(C)COc1ccc(Cl)cc1-c1ccccc1-c1cccc(C(=O)[O-])n1.[Na+],7.795880017344075
CHEMBL467510,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,15.85,nM,CHEMBL1014228,B,Binding affinity to EP1 receptor,CHEMBL1154508,IC50,CC(C)COc1ccc(Cl)cc1-c1ccccc1-c1cccc(C(=O)[O-])n1.[Na+],7.79997073344623
CHEMBL459537,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,39.81,nM,CHEMBL1014228,B,Binding affinity to EP1 receptor,CHEMBL1154508,IC50,O=C([O-])c1cccc(-c2ccccc2-c2cc(Cl)ccc2OCc2ccccc2F)n1.[Na+],7.400007822415902
CHEMBL466549,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,12.59,nM,CHEMBL1014228,B,Binding affinity to EP1 receptor,CHEMBL1154508,IC50,O=C([O-])c1cccc(-c2ccccc2-c2cc(Cl)ccc2OCc2c(F)cc(F)cc2F)n1.[Na+],7.899974269892137
CHEMBL467579,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,19.95,nM,CHEMBL1014228,B,Binding affinity to EP1 receptor,CHEMBL1154508,IC50,O=C([O-])c1cccc(-c2ccccc2-c2cc(Cl)ccc2OCc2ccc(Cl)cc2F)n1.[Na+],7.700057099977233
CHEMBL467578,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,50.12,nM,CHEMBL1014228,B,Binding affinity to EP1 receptor,CHEMBL1154508,IC50,O=C([O-])c1cccc(-c2ccccc2-c2cc(Cl)ccc2OCc2ccc(Br)cc2F)n1.[Na+],7.299988937677888
CHEMBL512617,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,63.1,nM,CHEMBL1014228,B,Binding affinity to EP1 receptor,CHEMBL1154508,IC50,O=C([O-])c1cccc(-c2ccccc2-c2cc(Cl)ccc2OCc2ccc(F)cc2Cl)n1.[Na+],7.199970640755866
CHEMBL514574,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,3.981,nM,CHEMBL1014228,B,Binding affinity to EP1 receptor,CHEMBL1154508,IC50,O=C(O)c1cccc(-c2ccccc2-c2cc(Cl)ccc2OCc2ccc(F)cc2F)n1,8.400007822415901
CHEMBL457142,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,5.012,nM,CHEMBL1014228,B,Binding affinity to EP1 receptor,CHEMBL1154508,IC50,O=C(O)c1cccc(-c2ccccc2-c2cc(Cl)ccc2OCc2ccc(F)cc2)n1,8.299988937677888
CHEMBL515981,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,10.0,nM,CHEMBL1014228,B,Binding affinity to EP1 receptor,CHEMBL1154508,IC50,O=C(O)c1cccc(-c2ccccc2-c2cc(Cl)ccc2OCc2ccccc2)n1,8.0
CHEMBL458452,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,3.981,nM,CHEMBL1014228,B,Binding affinity to EP1 receptor,CHEMBL1154508,IC50,COCC(=O)Nc1cc(C(=O)O)cc(-c2ccccc2-c2cc(Cl)ccc2OCc2ccccc2)c1,8.400007822415901
CHEMBL458448,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,10.0,nM,CHEMBL1014228,B,Binding affinity to EP1 receptor,CHEMBL1154508,IC50,CC(C)C(=O)Nc1cc(C(=O)O)cc(-c2ccccc2-c2cc(Cl)ccc2OCc2ccccc2)c1,8.0
CHEMBL516324,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,1.995,nM,CHEMBL1014228,B,Binding affinity to EP1 receptor,CHEMBL1154508,IC50,CCCC(=O)Nc1cc(C(=O)O)cc(-c2ccccc2-c2cc(Cl)ccc2OCc2ccccc2)c1,8.700057099977233
CHEMBL456496,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,6.31,nM,CHEMBL1014228,B,Binding affinity to EP1 receptor,CHEMBL1154508,IC50,CCC(=O)Nc1cc(C(=O)O)cc(-c2ccccc2-c2cc(Cl)ccc2OCc2ccccc2)c1,8.199970640755865
CHEMBL456495,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,10.0,nM,CHEMBL1014228,B,Binding affinity to EP1 receptor,CHEMBL1154508,IC50,CC(=O)Nc1cc(C(=O)O)cc(-c2ccccc2-c2cc(Cl)ccc2OCc2ccccc2)c1,8.0
CHEMBL514425,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,63.1,nM,CHEMBL1014228,B,Binding affinity to EP1 receptor,CHEMBL1154508,IC50,O=C(O)c1cc(F)cc(-c2ccccc2-c2ccccc2OCc2ccccc2)c1,7.199970640755866
CHEMBL457797,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,125.89,nM,CHEMBL1014228,B,Binding affinity to EP1 receptor,CHEMBL1154508,IC50,O=C(O)c1cc(-c2ccccc2-c2ccccc2OCc2ccccc2)ccc1Cl,6.900008766455316
CHEMBL459091,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,79.43,nM,CHEMBL1014228,B,Binding affinity to EP1 receptor,CHEMBL1154508,IC50,O=C(O)c1ccc(F)c(-c2ccccc2-c2ccccc2OCc2ccccc2)c1,7.100015437450609
CHEMBL515697,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,501.19,nM,CHEMBL1014228,B,Binding affinity to EP1 receptor,CHEMBL1154508,IC50,Cc1c(C(=O)O)cccc1-c1ccccc1-c1ccccc1OCc1ccccc1,6.299997602857746
CHEMBL456919,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,794.33,nM,CHEMBL1014228,B,Binding affinity to EP1 receptor,CHEMBL1154508,IC50,O=C(O)c1ccc(-c2ccccc2-c2cc(Cl)ccc2OCc2ccccc2)cc1,6.0999990348465305
CHEMBL456707,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,19.95,nM,CHEMBL1014228,B,Binding affinity to EP1 receptor,CHEMBL1154508,IC50,O=C(O)c1ccccc1-c1ccccc1-c1cc(Cl)ccc1OCc1ccccc1,7.700057099977233
CHEMBL458008,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,100.0,nM,CHEMBL1014228,B,Binding affinity to EP1 receptor,CHEMBL1154508,IC50,Cc1cccc(-c2cc(Cl)ccc2OCc2ccccc2)c1-c1cccc(C(=O)[O-])c1.[Na+],7.0
CHEMBL460168,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,316.23,nM,CHEMBL1014228,B,Binding affinity to EP1 receptor,CHEMBL1154508,IC50,O=C(O)c1cccc(-c2ccccc2-c2ccc(Cl)cc2OCc2ccccc2)c1,6.499996931948306
CHEMBL516787,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,19.95,nM,CHEMBL1014228,B,Binding affinity to EP1 receptor,CHEMBL1154508,IC50,O=C(O)c1cccc(-c2ccccc2-c2ccccc2OCc2ccccc2)c1,7.700057099977233
CHEMBL207174,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,50.12,nM,CHEMBL1014228,B,Binding affinity to EP1 receptor,CHEMBL1154508,IC50,O=C(O)c1cccc(-c2ccccc2-c2cc(Cl)ccc2OCc2ccccc2)c1,7.299988937677888
CHEMBL207174,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,50.12,nM,CHEMBL1013438,B,Displacement of [3H]PGE2 from EP1 receptor,CHEMBL1154508,IC50,O=C(O)c1cccc(-c2ccccc2-c2cc(Cl)ccc2OCc2ccccc2)c1,7.299988937677888
CHEMBL499155,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,100.0,nM,CHEMBL1014228,B,Binding affinity to EP1 receptor,CHEMBL1154508,IC50,CCCCOc1ccc(Cl)cc1-c1ccccc1-c1cccc(C(=O)[O-])n1.[Na+],7.0
CHEMBL456679,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,251.19,nM,CHEMBL1014228,B,Binding affinity to EP1 receptor,CHEMBL1154508,IC50,CCCOc1ccc(Cl)cc1-c1ccccc1-c1cccc(C(=O)[O-])n1.[Na+],6.599997654072045
CHEMBL458858,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,158.49,nM,CHEMBL1014228,B,Binding affinity to EP1 receptor,CHEMBL1154508,IC50,O=C([O-])c1cccc(-c2ccccc2-c2cc(Cl)ccc2OCC2CCCC2)n1.[Na+],6.799998134593398
CHEMBL565992,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,7959.0,nM,CHEMBL1042658,B,Displacement of [3H]PGE2 from human EP1 receptor after 1 hr by liquid scintillation counting,CHEMBL1156787,IC50,O=C(COc1cccc2ncn(Cc3ccc(Cl)cc3Cl)c12)NS(=O)(=O)c1cc(Cl)c(Cl)s1,5.099141495298008
CHEMBL467632,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,6354.0,nM,CHEMBL1042658,B,Displacement of [3H]PGE2 from human EP1 receptor after 1 hr by liquid scintillation counting,CHEMBL1156787,IC50,O=C(COc1cccc2[nH]cc(Cc3ccc4ccccc4c3)c12)NS(=O)(=O)c1cc(Cl)c(Cl)s1,5.196952789508871
CHEMBL585581,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,8104.0,nM,CHEMBL1042658,B,Displacement of [3H]PGE2 from human EP1 receptor after 1 hr by liquid scintillation counting,CHEMBL1156787,IC50,O=C(/C=C/c1cccc2ccn(Cc3ccc(Cl)cc3Cl)c12)NS(=O)(=O)c1cccs1,5.091300567647776
CHEMBL565799,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,360.0,nM,CHEMBL1042658,B,Displacement of [3H]PGE2 from human EP1 receptor after 1 hr by liquid scintillation counting,CHEMBL1156787,IC50,Cc1cn(Cc2ccc3ccccc3c2)c2c(/C=C/C(=O)NS(=O)(=O)c3cc(Cl)c(Cl)s3)cc(F)cc12,6.443697499232712
CHEMBL548,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,1.1,nM,CHEMBL1120700,B,Binding affinity to EP1 receptor,CHEMBL1155461,IC50,CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O,8.958607314841775
CHEMBL1915012,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,5.012,nM,CHEMBL1920204,B,Displacement of [3H]PGE2 from human prostanoid EP1 receptor expressed in CHO-K1 cells after 30 mins by topcount liquid scintillation counting,CHEMBL1914431,IC50,Cc1cc(C(=O)O)nn1Cc1cc(Cl)cc2cc(C(C)C)oc12,8.299988937677888
CHEMBL1915013,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,50.12,nM,CHEMBL1920205,B,Displacement of [3H]GW875240X from human prostanoid EP1 receptor expressed in CHO-K1 cells after 45 mins by topcount liquid scintillation counting,CHEMBL1914431,IC50,Cc1cc(C(=O)O)nn1Cc1cc(Cl)cc2cc(C3CC3)oc12,7.299988937677888
CHEMBL1915014,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,25.12,nM,CHEMBL1920205,B,Displacement of [3H]GW875240X from human prostanoid EP1 receptor expressed in CHO-K1 cells after 45 mins by topcount liquid scintillation counting,CHEMBL1914431,IC50,CCCc1cc2cc(Cl)cc(Cn3nc(C(=O)O)cc3C)c2o1,7.599980364934842
CHEMBL1915015,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,3.981,nM,CHEMBL1920205,B,Displacement of [3H]GW875240X from human prostanoid EP1 receptor expressed in CHO-K1 cells after 45 mins by topcount liquid scintillation counting,CHEMBL1914431,IC50,Cc1cc(C(=O)O)nn1Cc1cc(Cl)cc2cc(C3CCCCC3)oc12,8.400007822415901
CHEMBL1915016,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,63.1,nM,CHEMBL1920205,B,Displacement of [3H]GW875240X from human prostanoid EP1 receptor expressed in CHO-K1 cells after 45 mins by topcount liquid scintillation counting,CHEMBL1914431,IC50,Cc1cc(C(=O)O)nn1Cc1cc(Cl)cc2cc(C(C)(C)C)oc12,7.199970640755866
CHEMBL1915264,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,10.0,nM,CHEMBL1920205,B,Displacement of [3H]GW875240X from human prostanoid EP1 receptor expressed in CHO-K1 cells after 45 mins by topcount liquid scintillation counting,CHEMBL1914431,IC50,Cc1cc(C(=O)NN2CCOCC2)nn1Cc1cc(Cl)cc2cc(-c3ccccc3)oc12,8.0
CHEMBL1915017,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,251.19,nM,CHEMBL1920205,B,Displacement of [3H]GW875240X from human prostanoid EP1 receptor expressed in CHO-K1 cells after 45 mins by topcount liquid scintillation counting,CHEMBL1914431,IC50,Cc1cc(C(=O)O)nn1Cc1cc(Cl)cc2oc(C(C)C)cc12,6.599997654072045
CHEMBL1915018,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,125.89,nM,CHEMBL1920204,B,Displacement of [3H]PGE2 from human prostanoid EP1 receptor expressed in CHO-K1 cells after 30 mins by topcount liquid scintillation counting,CHEMBL1914431,IC50,Cc1cc(C(=O)O)nn1Cc1cc(Cl)cn2cc(C(C)C)cc12,6.900008766455316
CHEMBL1915019,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,501.19,nM,CHEMBL1920204,B,Displacement of [3H]PGE2 from human prostanoid EP1 receptor expressed in CHO-K1 cells after 30 mins by topcount liquid scintillation counting,CHEMBL1914431,IC50,Cc1cc(C(=O)O)nn1Cc1cc(Cl)cn2cc(C(C)C)nc12,6.299997602857746
CHEMBL1915245,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,50.12,nM,CHEMBL1920204,B,Displacement of [3H]PGE2 from human prostanoid EP1 receptor expressed in CHO-K1 cells after 30 mins by topcount liquid scintillation counting,CHEMBL1914431,IC50,Cc1cc(-c2nc3ccccc3[nH]2)nn1Cc1cc(Cl)cc2cc(C(C)C)oc12,7.299988937677888
CHEMBL1915246,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,63.1,nM,CHEMBL1920204,B,Displacement of [3H]PGE2 from human prostanoid EP1 receptor expressed in CHO-K1 cells after 30 mins by topcount liquid scintillation counting,CHEMBL1914431,IC50,CNCc1ccc(NC(=O)c2cc(C)n(Cc3cc(Cl)cc4cc(C(C)C)oc34)n2)cc1,7.199970640755866
CHEMBL1915247,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,63.1,nM,CHEMBL1920204,B,Displacement of [3H]PGE2 from human prostanoid EP1 receptor expressed in CHO-K1 cells after 30 mins by topcount liquid scintillation counting,CHEMBL1914431,IC50,Cc1cc(C(=O)NC2CCOCC2)nn1Cc1cc(Cl)cc2cc(C(C)C)oc12,7.199970640755866
CHEMBL1915248,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,316.23,nM,CHEMBL1920205,B,Displacement of [3H]GW875240X from human prostanoid EP1 receptor expressed in CHO-K1 cells after 45 mins by topcount liquid scintillation counting,CHEMBL1914431,IC50,CO[C@H]1CC[C@H](NC(=O)c2cc(C)n(Cc3cc(Cl)cc4cc(C(C)C)oc34)n2)CC1,6.499996931948306
CHEMBL1915249,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,794.33,nM,CHEMBL1920204,B,Displacement of [3H]PGE2 from human prostanoid EP1 receptor expressed in CHO-K1 cells after 30 mins by topcount liquid scintillation counting,CHEMBL1914431,IC50,Cc1cc(C(=O)NC2CCNCC2)nn1Cc1cc(Cl)cc2cc(C(C)C)oc12,6.0999990348465305
CHEMBL1915250,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,100.0,nM,CHEMBL1920204,B,Displacement of [3H]PGE2 from human prostanoid EP1 receptor expressed in CHO-K1 cells after 30 mins by topcount liquid scintillation counting,CHEMBL1914431,IC50,Cc1cc(C(=O)NN2CCCCC2)nn1Cc1cc(Cl)cc2cc(C(C)C)oc12,7.0
CHEMBL1915251,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,50.12,nM,CHEMBL1920204,B,Displacement of [3H]PGE2 from human prostanoid EP1 receptor expressed in CHO-K1 cells after 30 mins by topcount liquid scintillation counting,CHEMBL1914431,IC50,Cc1cc(C(=O)NN2CCOCC2)nn1Cc1cc(Cl)cc2cc(C(C)C)oc12,7.299988937677888
CHEMBL1915253,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,10.0,nM,CHEMBL1920205,B,Displacement of [3H]GW875240X from human prostanoid EP1 receptor expressed in CHO-K1 cells after 45 mins by topcount liquid scintillation counting,CHEMBL1914431,IC50,Cc1cc(C(=O)NC(C)C)nn1Cc1cc(Cl)cc2cc(-c3ccccc3)oc12,8.0
CHEMBL1915254,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,5.012,nM,CHEMBL1920205,B,Displacement of [3H]GW875240X from human prostanoid EP1 receptor expressed in CHO-K1 cells after 45 mins by topcount liquid scintillation counting,CHEMBL1914431,IC50,Cc1cc(C(N)=O)nn1Cc1cc(Cl)cc2cc(-c3ccccc3)oc12,8.299988937677888
CHEMBL1915255,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,10.0,nM,CHEMBL1920205,B,Displacement of [3H]GW875240X from human prostanoid EP1 receptor expressed in CHO-K1 cells after 45 mins by topcount liquid scintillation counting,CHEMBL1914431,IC50,Cc1cc(C(=O)NC(C)(C)C)nn1Cc1cc(Cl)cc2cc(-c3ccccc3)oc12,8.0
CHEMBL1914467,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,5.012,nM,CHEMBL1920205,B,Displacement of [3H]GW875240X from human prostanoid EP1 receptor expressed in CHO-K1 cells after 45 mins by topcount liquid scintillation counting,CHEMBL1914431,IC50,Cc1cc(C(=O)NC2CC2)nn1Cc1cc(Cl)cc2cc(-c3ccccc3)oc12,8.299988937677888
CHEMBL1915256,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,19.95,nM,CHEMBL1920205,B,Displacement of [3H]GW875240X from human prostanoid EP1 receptor expressed in CHO-K1 cells after 45 mins by topcount liquid scintillation counting,CHEMBL1914431,IC50,Cc1cc(C(=O)NCC2CCNCC2)nn1Cc1cc(Cl)cc2cc(-c3ccccc3)oc12,7.700057099977233
CHEMBL1915257,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,63.1,nM,CHEMBL1920205,B,Displacement of [3H]GW875240X from human prostanoid EP1 receptor expressed in CHO-K1 cells after 45 mins by topcount liquid scintillation counting,CHEMBL1914431,IC50,Cc1cc(NC(=O)CC2CCNCC2)nn1Cc1cc(Cl)cc2cc(-c3ccccc3)oc12,7.199970640755866
CHEMBL1915258,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,100.0,nM,CHEMBL1920205,B,Displacement of [3H]GW875240X from human prostanoid EP1 receptor expressed in CHO-K1 cells after 45 mins by topcount liquid scintillation counting,CHEMBL1914431,IC50,Cc1cc(NC(=O)C2CCNCC2)nn1Cc1cc(Cl)cc2cc(-c3ccccc3)oc12,7.0
CHEMBL1915259,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,39.81,nM,CHEMBL1920205,B,Displacement of [3H]GW875240X from human prostanoid EP1 receptor expressed in CHO-K1 cells after 45 mins by topcount liquid scintillation counting,CHEMBL1914431,IC50,Cc1cc(NC(=O)C2(F)CCNCC2)nn1Cc1cc(Cl)cc2cc(-c3ccccc3)oc12,7.400007822415902
CHEMBL1915260,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,25.12,nM,CHEMBL1920205,B,Displacement of [3H]GW875240X from human prostanoid EP1 receptor expressed in CHO-K1 cells after 45 mins by topcount liquid scintillation counting,CHEMBL1914431,IC50,Cc1cc(NC(=O)C2CCN(CC(F)(F)F)CC2)nn1Cc1cc(Cl)cc2cc(-c3ccccc3)oc12,7.599980364934842
CHEMBL1915261,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,7.943,nM,CHEMBL1920205,B,Displacement of [3H]GW875240X from human prostanoid EP1 receptor expressed in CHO-K1 cells after 45 mins by topcount liquid scintillation counting,CHEMBL1914431,IC50,Cc1cc(C(=O)N[C@H]2CC[C@H](O)CC2)nn1Cc1cc(Cl)cc2cc(-c3ccccc3)oc12,8.100015437450608
CHEMBL1915262,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,6.31,nM,CHEMBL1920205,B,Displacement of [3H]GW875240X from human prostanoid EP1 receptor expressed in CHO-K1 cells after 45 mins by topcount liquid scintillation counting,CHEMBL1914431,IC50,Cc1cc(C(=O)NC[C@H]2CCCO2)nn1Cc1cc(Cl)cc2cc(-c3ccccc3)oc12,8.199970640755865
CHEMBL1915263,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,25.12,nM,CHEMBL1920205,B,Displacement of [3H]GW875240X from human prostanoid EP1 receptor expressed in CHO-K1 cells after 45 mins by topcount liquid scintillation counting,CHEMBL1914431,IC50,Cc1cc(C(=O)NCC(O)C(F)(F)F)nn1Cc1cc(Cl)cc2cc(-c3ccccc3)oc12,7.599980364934842
CHEMBL1915252,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,1.995,nM,CHEMBL1920205,B,Displacement of [3H]GW875240X from human prostanoid EP1 receptor expressed in CHO-K1 cells after 45 mins by topcount liquid scintillation counting,CHEMBL1914431,IC50,Cc1cc(C(=O)O)nn1Cc1cc(Cl)cc2cc(-c3ccccc3)oc12,8.700057099977233
CHEMBL2442497,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,500.0,nM,CHEMBL2443717,B,Antagonist activity at human EP1 receptor by reporter gene assay,CHEMBL2440026,IC50,Cn1c(-c2ccccc2)nc(-c2nc(C(=O)O)cs2)c1-c1ccccc1,6.301029995663981
CHEMBL2442495,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,50.0,nM,CHEMBL2443717,B,Antagonist activity at human EP1 receptor by reporter gene assay,CHEMBL2440026,IC50,Cc1c(-c2ccccc2)nn(-c2nc(C(=O)O)cs2)c1-c1ccccc1,7.301029995663981
CHEMBL2442494,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,84.0,nM,CHEMBL2443717,B,Antagonist activity at human EP1 receptor by reporter gene assay,CHEMBL2440026,IC50,Cc1c(-c2ccccc2)nn(-c2nc(C(=O)O)cs2)c1C(F)(F)F,7.075720713938118
CHEMBL2442490,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,180.0,nM,CHEMBL2443717,B,Antagonist activity at human EP1 receptor by reporter gene assay,CHEMBL2440026,IC50,O=C(O)c1csc(-n2nc(-c3ccccc3O)cc2C(F)(F)F)n1,6.7447274948966935
CHEMBL2442489,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,580.0,nM,CHEMBL2443717,B,Antagonist activity at human EP1 receptor by reporter gene assay,CHEMBL2440026,IC50,O=C(O)c1csc(-n2nc(-c3cccc(O)c3)cc2C(F)(F)F)n1,6.236572006437063
CHEMBL2442488,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,320.0,nM,CHEMBL2443717,B,Antagonist activity at human EP1 receptor by reporter gene assay,CHEMBL2440026,IC50,O=C(O)c1csc(-n2nc(-c3ccc(O)cc3)cc2C(F)(F)F)n1,6.494850021680094
CHEMBL2442487,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,3000.0,nM,CHEMBL2443717,B,Antagonist activity at human EP1 receptor by reporter gene assay,CHEMBL2440026,IC50,Cc1ccc(-c2cc(C(F)(F)F)n(-c3nc(C(=O)O)cs3)n2)cc1,5.522878745280337
CHEMBL1479261,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,320.0,nM,CHEMBL2443717,B,Antagonist activity at human EP1 receptor by reporter gene assay,CHEMBL2440026,IC50,O=C(O)c1csc(-n2nc(-c3ccccc3)cc2C(F)(F)F)n1,6.494850021680094
CHEMBL2442486,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,430.0,nM,CHEMBL2443717,B,Antagonist activity at human EP1 receptor by reporter gene assay,CHEMBL2440026,IC50,COc1ccc(-c2cc(C(F)(F)F)n(-c3nc(C(=O)O)cs3)n2)cc1,6.366531544420413
CHEMBL2442485,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,1000.0,nM,CHEMBL2443717,B,Antagonist activity at human EP1 receptor by reporter gene assay,CHEMBL2440026,IC50,COc1ccc(-c2cc(C(F)(F)F)nn2-c2nc(C(=O)O)cs2)cc1,6.0
CHEMBL3092133,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,2.0,nM,CHEMBL3095969,B,Antagonist activity human EP1 receptor assessed as inhibition of PGE2-induced effect by reporter gene assay,CHEMBL3091274,IC50,O=C(O)c1csc(-n2nc3c(c2-c2ccccc2)CCc2ccccc2-3)n1,8.698970004336019
CHEMBL3092132,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,20.0,nM,CHEMBL3095969,B,Antagonist activity human EP1 receptor assessed as inhibition of PGE2-induced effect by reporter gene assay,CHEMBL3091274,IC50,O=C(O)c1csc(-n2nc(-c3ccccc3)c3oc4ccccc4c32)n1,7.698970004336019
CHEMBL3092131,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,0.9,nM,CHEMBL3095969,B,Antagonist activity human EP1 receptor assessed as inhibition of PGE2-induced effect by reporter gene assay,CHEMBL3091274,IC50,O=C(O)c1csc(-n2nc(-c3ccccc3)c3c2-c2ccccc2C3)n1,9.045757490560675
CHEMBL3092130,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,20.0,nM,CHEMBL3095969,B,Antagonist activity human EP1 receptor assessed as inhibition of PGE2-induced effect by reporter gene assay,CHEMBL3091274,IC50,Nc1c(-c2ccccc2)nn(-c2nc(C(=O)O)cs2)c1-c1ccccc1,7.698970004336019
CHEMBL3092155,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,60.0,nM,CHEMBL3095969,B,Antagonist activity human EP1 receptor assessed as inhibition of PGE2-induced effect by reporter gene assay,CHEMBL3091274,IC50,O=C(O)c1csc(-n2nc(-c3ccccc3)c(O)c2-c2ccccc2)n1,7.221848749616356
CHEMBL3092154,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,130.0,nM,CHEMBL3095969,B,Antagonist activity human EP1 receptor assessed as inhibition of PGE2-induced effect by reporter gene assay,CHEMBL3091274,IC50,O=C(O)c1csc(-n2nc(-c3ccccc3)c(I)c2-c2ccccc2)n1,6.886056647693163
CHEMBL3092153,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,20.0,nM,CHEMBL3095969,B,Antagonist activity human EP1 receptor assessed as inhibition of PGE2-induced effect by reporter gene assay,CHEMBL3091274,IC50,O=C(O)c1csc(-n2nc(-c3ccccc3)c(Br)c2-c2ccccc2)n1,7.698970004336019
CHEMBL3092152,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,60.0,nM,CHEMBL3095969,B,Antagonist activity human EP1 receptor assessed as inhibition of PGE2-induced effect by reporter gene assay,CHEMBL3091274,IC50,O=C(O)c1csc(-n2nc(-c3ccccc3)c(Cl)c2-c2ccccc2)n1,7.221848749616356
CHEMBL3092151,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,30.0,nM,CHEMBL3095969,B,Antagonist activity human EP1 receptor assessed as inhibition of PGE2-induced effect by reporter gene assay,CHEMBL3091274,IC50,O=C(O)c1csc(-n2nc(-c3ccccc3)c(F)c2-c2ccccc2)n1,7.522878745280337
CHEMBL3092150,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,150.0,nM,CHEMBL3095969,B,Antagonist activity human EP1 receptor assessed as inhibition of PGE2-induced effect by reporter gene assay,CHEMBL3091274,IC50,O=C(O)c1csc(-n2nc(-c3ccccc3)c(C(F)(F)F)c2-c2ccccc2)n1,6.823908740944319
CHEMBL3092148,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,500.0,nM,CHEMBL3095969,B,Antagonist activity human EP1 receptor assessed as inhibition of PGE2-induced effect by reporter gene assay,CHEMBL3091274,IC50,Cc1c(-c2ccccc2)nn(-c2nc(/C=C/C(=O)O)cs2)c1-c1ccccc1,6.301029995663981
CHEMBL3092147,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,330.0,nM,CHEMBL3095969,B,Antagonist activity human EP1 receptor assessed as inhibition of PGE2-induced effect by reporter gene assay,CHEMBL3091274,IC50,Cc1sc(-n2nc(-c3ccccc3)c(C)c2-c2ccccc2)nc1C(=O)O,6.481486060122112
CHEMBL3092146,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,1000.0,nM,CHEMBL3095969,B,Antagonist activity human EP1 receptor assessed as inhibition of PGE2-induced effect by reporter gene assay,CHEMBL3091274,IC50,Cc1c(-c2ccccc2)nn(-c2ccc(C(=O)O)s2)c1-c1ccccc1,6.0
CHEMBL3092141,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,100.0,nM,CHEMBL3095969,B,Antagonist activity human EP1 receptor assessed as inhibition of PGE2-induced effect by reporter gene assay,CHEMBL3091274,IC50,Cc1c(-c2ccccc2)nn(-c2nc(C(=O)O)cs2)c1-c1ccc(F)cc1,7.0
CHEMBL3092140,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,50.0,nM,CHEMBL3095969,B,Antagonist activity human EP1 receptor assessed as inhibition of PGE2-induced effect by reporter gene assay,CHEMBL3091274,IC50,Cc1c(-c2ccccc2)nn(-c2nc(C(=O)O)cs2)c1-c1cccc(F)c1,7.301029995663981
CHEMBL3092135,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,80.0,nM,CHEMBL3095969,B,Antagonist activity human EP1 receptor assessed as inhibition of PGE2-induced effect by reporter gene assay,CHEMBL3091274,IC50,Cc1c(-c2ccccc2)nn(-c2nc(C(=O)O)cs2)c1-c1ccsc1,7.096910013008056
CHEMBL3092134,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,120.0,nM,CHEMBL3095969,B,Antagonist activity human EP1 receptor assessed as inhibition of PGE2-induced effect by reporter gene assay,CHEMBL3091274,IC50,Cc1c(-c2ccccc2)nn(-c2nc(C(=O)O)cs2)c1-c1cccs1,6.920818753952375
CHEMBL2442495,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,50.0,nM,CHEMBL3095969,B,Antagonist activity human EP1 receptor assessed as inhibition of PGE2-induced effect by reporter gene assay,CHEMBL3091274,IC50,Cc1c(-c2ccccc2)nn(-c2nc(C(=O)O)cs2)c1-c1ccccc1,7.301029995663981
CHEMBL3127174,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,32.0,nM,CHEMBL3131142,B,Antagonist activity at human EP1 receptor assessed as inhibition of PGE-induced effect by reporter gene assay,CHEMBL3124785,IC50,CC1CCN(c2nn(-c3nc(C(=O)O)cs3)c3ccccc23)CC1,7.494850021680094
CHEMBL3127173,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,16.0,nM,CHEMBL3131142,B,Antagonist activity at human EP1 receptor assessed as inhibition of PGE-induced effect by reporter gene assay,CHEMBL3124785,IC50,O=C(O)c1csc(-n2nc(N3CCCCC3)c3ccccc32)n1,7.795880017344075
CHEMBL3127171,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,30.0,nM,CHEMBL3131142,B,Antagonist activity at human EP1 receptor assessed as inhibition of PGE-induced effect by reporter gene assay,CHEMBL3124785,IC50,O=C(O)c1csc(-n2nc(-c3ccsc3)c3ccccc32)n1,7.522878745280337
CHEMBL3127170,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,4.0,nM,CHEMBL3131142,B,Antagonist activity at human EP1 receptor assessed as inhibition of PGE-induced effect by reporter gene assay,CHEMBL3124785,IC50,O=C(O)c1csc(-n2nc(C3=CCCCC3)c3ccccc32)n1,8.397940008672037
CHEMBL3127169,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,80.0,nM,CHEMBL3131142,B,Antagonist activity at human EP1 receptor assessed as inhibition of PGE-induced effect by reporter gene assay,CHEMBL3124785,IC50,O=C(O)c1csc(-n2nc(C3=CCCC3)c3ccccc32)n1,7.096910013008056
CHEMBL3127168,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,140.0,nM,CHEMBL3131142,B,Antagonist activity at human EP1 receptor assessed as inhibition of PGE-induced effect by reporter gene assay,CHEMBL3124785,IC50,O=C(O)c1csc(-n2nc(-c3ccc(C(F)(F)F)cc3)c3ccccc32)n1,6.853871964321762
CHEMBL3127167,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,4.0,nM,CHEMBL3131142,B,Antagonist activity at human EP1 receptor assessed as inhibition of PGE-induced effect by reporter gene assay,CHEMBL3124785,IC50,COc1ccc(-c2nn(-c3nc(C(=O)O)cs3)c3ccccc23)cc1,8.397940008672037
CHEMBL3127166,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,12.0,nM,CHEMBL3131142,B,Antagonist activity at human EP1 receptor assessed as inhibition of PGE-induced effect by reporter gene assay,CHEMBL3124785,IC50,O=C(O)c1csc(-n2nc(-c3ccc(Cl)cc3)c3ccccc32)n1,7.920818753952375
CHEMBL3127165,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,20.0,nM,CHEMBL3131142,B,Antagonist activity at human EP1 receptor assessed as inhibition of PGE-induced effect by reporter gene assay,CHEMBL3124785,IC50,O=C(O)c1csc(-n2nc(-c3cccc(F)c3)c3ccccc32)n1,7.698970004336019
CHEMBL3127164,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,4.5,nM,CHEMBL3131142,B,Antagonist activity at human EP1 receptor assessed as inhibition of PGE-induced effect by reporter gene assay,CHEMBL3124785,IC50,O=C(O)c1csc(-n2nc(-c3ccc(F)cc3)c3ccccc32)n1,8.346787486224656
CHEMBL3127163,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,0.6,nM,CHEMBL3131142,B,Antagonist activity at human EP1 receptor assessed as inhibition of PGE-induced effect by reporter gene assay,CHEMBL3124785,IC50,O=C(O)c1csc(-n2nc(-c3ccccc3)c3ccc(C(F)(F)F)cc32)n1,9.221848749616356
CHEMBL3127162,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,50.0,nM,CHEMBL3131142,B,Antagonist activity at human EP1 receptor assessed as inhibition of PGE-induced effect by reporter gene assay,CHEMBL3124785,IC50,CNc1ccc2c(-c3ccccc3)nn(-c3nc(C(=O)O)cs3)c2c1,7.301029995663981
CHEMBL3127161,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,19.0,nM,CHEMBL3131142,B,Antagonist activity at human EP1 receptor assessed as inhibition of PGE-induced effect by reporter gene assay,CHEMBL3124785,IC50,Nc1ccc2c(-c3ccccc3)nn(-c3nc(C(=O)O)cs3)c2c1,7.721246399047171
CHEMBL3127160,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,100.0,nM,CHEMBL3131142,B,Antagonist activity at human EP1 receptor assessed as inhibition of PGE-induced effect by reporter gene assay,CHEMBL3124785,IC50,CCOc1ccc2c(-c3ccccc3)nn(-c3nc(C(=O)O)cs3)c2c1,7.0
CHEMBL3127159,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,1.1,nM,CHEMBL3131142,B,Antagonist activity at human EP1 receptor assessed as inhibition of PGE-induced effect by reporter gene assay,CHEMBL3124785,IC50,COc1ccc2c(-c3ccccc3)nn(-c3nc(C(=O)O)cs3)c2c1,8.958607314841775
CHEMBL3127158,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,140.0,nM,CHEMBL3131142,B,Antagonist activity at human EP1 receptor assessed as inhibition of PGE-induced effect by reporter gene assay,CHEMBL3124785,IC50,O=C(O)c1csc(-n2nc(-c3ccccc3)c3ccc(O)cc32)n1,6.853871964321762
CHEMBL3127157,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,1.0,nM,CHEMBL3131142,B,Antagonist activity at human EP1 receptor assessed as inhibition of PGE-induced effect by reporter gene assay,CHEMBL3124785,IC50,Cc1ccc2c(-c3ccccc3)nn(-c3nc(C(=O)O)cs3)c2c1,9.0
CHEMBL3127156,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,2.0,nM,CHEMBL3131142,B,Antagonist activity at human EP1 receptor assessed as inhibition of PGE-induced effect by reporter gene assay,CHEMBL3124785,IC50,O=C(O)c1csc(-n2nc(-c3ccccc3)c3ccc(F)cc32)n1,8.698970004336019
CHEMBL3127155,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,80.0,nM,CHEMBL3131142,B,Antagonist activity at human EP1 receptor assessed as inhibition of PGE-induced effect by reporter gene assay,CHEMBL3124785,IC50,O=C(O)c1csc(-n2nc(-c3ccccc3)c3cc(F)ccc32)n1,7.096910013008056
CHEMBL3127154,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,500.0,nM,CHEMBL3131142,B,Antagonist activity at human EP1 receptor assessed as inhibition of PGE-induced effect by reporter gene assay,CHEMBL3124785,IC50,O=C(O)c1csc(-n2nc(-c3ccccc3)c3c(F)cccc32)n1,6.301029995663981
CHEMBL3127152,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,39.0,nM,CHEMBL3131142,B,Antagonist activity at human EP1 receptor assessed as inhibition of PGE-induced effect by reporter gene assay,CHEMBL3124785,IC50,O=C(O)c1csc(-n2nc(-c3ccccc3)c3ccncc32)n1,7.4089353929735005
CHEMBL3127151,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,200.0,nM,CHEMBL3131142,B,Antagonist activity at human EP1 receptor assessed as inhibition of PGE-induced effect by reporter gene assay,CHEMBL3124785,IC50,O=C(O)c1csc(-n2nc(-c3ccccc3)c3cccnc32)n1,6.698970004336019
CHEMBL3127178,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,1000.0,nM,CHEMBL3131142,B,Antagonist activity at human EP1 receptor assessed as inhibition of PGE-induced effect by reporter gene assay,CHEMBL3124785,IC50,O=C(O)c1csc(-n2nc(-c3ccccc3)c3c2CCCCC3)n1,6.0
CHEMBL3127177,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,16.0,nM,CHEMBL3131142,B,Antagonist activity at human EP1 receptor assessed as inhibition of PGE-induced effect by reporter gene assay,CHEMBL3124785,IC50,O=C(O)c1csc(-n2nc(-c3ccccc3)c3c2CCCC3)n1,7.795880017344075
CHEMBL3127176,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,120.0,nM,CHEMBL3131142,B,Antagonist activity at human EP1 receptor assessed as inhibition of PGE-induced effect by reporter gene assay,CHEMBL3124785,IC50,O=C(O)c1csc(-n2cc(-c3ccccc3)c3ccccc32)n1,6.920818753952375
CHEMBL3127175,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,2.4,nM,CHEMBL3131142,B,Antagonist activity at human EP1 receptor assessed as inhibition of PGE-induced effect by reporter gene assay,CHEMBL3124785,IC50,O=C(O)c1csc(-n2nc(-c3ccccc3)c3ccccc32)n1,8.619788758288394
CHEMBL3964563,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,290.0,nM,CHEMBL3887096,B,"Radioligand Binding: HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bottom of the flasks, and homogenized for 30 sec using a Brinkman PT 10/35 polytron. TME buffer was added to achieve a final 40 ml volume in the centrifuge tubes (the composition of TME is 100 mM TRIS base, 20 mM MgCl2, 2M EDTA; 10 N HCl is added to achieve a pH of 7.4).The cell homogenate was centrifuged at 19000 r.p.m. for 20 min at 4 C. using a Beckman Ti-60 rotor. The resultant pellet was resuspended in TME buffer to give a final 1 mg/ml protein concentration, as determined by Biorad assay. Radioligand binding competition assays vs. [3H-]17-phenyl PGF2 (5 nM) were performed in a 100 ul volume for 60 min. Binding reactions were started by adding plasma membrane fraction. The reaction was terminated by the addition of 4 ml ice-cold TRIS-HCl buffer and rapid filtration through glass fiber GF/B filters using a Brandel cell.",CHEMBL3886165,IC50,CC1(C)C(=O)[C@H](C/C=C\CCCC(=O)O)[C@@H](/C=C/C(O)Cc2ccccc2)[C@@H]1O,6.537602002101044
CHEMBL3895324,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,782.0,nM,CHEMBL3887096,B,"Radioligand Binding: HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bottom of the flasks, and homogenized for 30 sec using a Brinkman PT 10/35 polytron. TME buffer was added to achieve a final 40 ml volume in the centrifuge tubes (the composition of TME is 100 mM TRIS base, 20 mM MgCl2, 2M EDTA; 10 N HCl is added to achieve a pH of 7.4).The cell homogenate was centrifuged at 19000 r.p.m. for 20 min at 4 C. using a Beckman Ti-60 rotor. The resultant pellet was resuspended in TME buffer to give a final 1 mg/ml protein concentration, as determined by Biorad assay. Radioligand binding competition assays vs. [3H-]17-phenyl PGF2 (5 nM) were performed in a 100 ul volume for 60 min. Binding reactions were started by adding plasma membrane fraction. The reaction was terminated by the addition of 4 ml ice-cold TRIS-HCl buffer and rapid filtration through glass fiber GF/B filters using a Brandel cell.",CHEMBL3886165,IC50,CCCCC[C@H](O)/C=C/[C@@H]1[C@@H](C/C=C\CCCC(=O)O)C(=O)C(C)(C)[C@H]1O,6.106793246940152
CHEMBL3964563,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,963.0,nM,CHEMBL3887096,B,"Radioligand Binding: HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bottom of the flasks, and homogenized for 30 sec using a Brinkman PT 10/35 polytron. TME buffer was added to achieve a final 40 ml volume in the centrifuge tubes (the composition of TME is 100 mM TRIS base, 20 mM MgCl2, 2M EDTA; 10 N HCl is added to achieve a pH of 7.4).The cell homogenate was centrifuged at 19000 r.p.m. for 20 min at 4 C. using a Beckman Ti-60 rotor. The resultant pellet was resuspended in TME buffer to give a final 1 mg/ml protein concentration, as determined by Biorad assay. Radioligand binding competition assays vs. [3H-]17-phenyl PGF2 (5 nM) were performed in a 100 ul volume for 60 min. Binding reactions were started by adding plasma membrane fraction. The reaction was terminated by the addition of 4 ml ice-cold TRIS-HCl buffer and rapid filtration through glass fiber GF/B filters using a Brandel cell.",CHEMBL3886165,IC50,CC1(C)C(=O)[C@H](C/C=C\CCCC(=O)O)[C@@H](/C=C/C(O)Cc2ccccc2)[C@@H]1O,6.016373712875465
CHEMBL3954031,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,2376.0,nM,CHEMBL3887096,B,"Radioligand Binding: HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bottom of the flasks, and homogenized for 30 sec using a Brinkman PT 10/35 polytron. TME buffer was added to achieve a final 40 ml volume in the centrifuge tubes (the composition of TME is 100 mM TRIS base, 20 mM MgCl2, 2M EDTA; 10 N HCl is added to achieve a pH of 7.4).The cell homogenate was centrifuged at 19000 r.p.m. for 20 min at 4 C. using a Beckman Ti-60 rotor. The resultant pellet was resuspended in TME buffer to give a final 1 mg/ml protein concentration, as determined by Biorad assay. Radioligand binding competition assays vs. [3H-]17-phenyl PGF2 (5 nM) were performed in a 100 ul volume for 60 min. Binding reactions were started by adding plasma membrane fraction. The reaction was terminated by the addition of 4 ml ice-cold TRIS-HCl buffer and rapid filtration through glass fiber GF/B filters using a Brandel cell.",CHEMBL3886165,IC50,CC1(C)C(=O)[C@H](CC#CCCCC(=O)O)[C@@H](/C=C/C(O)Cc2cc3ccccc3s2)[C@@H]1O,5.624153563690844
CHEMBL3954031,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,2050.0,nM,CHEMBL3887096,B,"Radioligand Binding: HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bottom of the flasks, and homogenized for 30 sec using a Brinkman PT 10/35 polytron. TME buffer was added to achieve a final 40 ml volume in the centrifuge tubes (the composition of TME is 100 mM TRIS base, 20 mM MgCl2, 2M EDTA; 10 N HCl is added to achieve a pH of 7.4).The cell homogenate was centrifuged at 19000 r.p.m. for 20 min at 4 C. using a Beckman Ti-60 rotor. The resultant pellet was resuspended in TME buffer to give a final 1 mg/ml protein concentration, as determined by Biorad assay. Radioligand binding competition assays vs. [3H-]17-phenyl PGF2 (5 nM) were performed in a 100 ul volume for 60 min. Binding reactions were started by adding plasma membrane fraction. The reaction was terminated by the addition of 4 ml ice-cold TRIS-HCl buffer and rapid filtration through glass fiber GF/B filters using a Brandel cell.",CHEMBL3886165,IC50,CC1(C)C(=O)[C@H](CC#CCCCC(=O)O)[C@@H](/C=C/C(O)Cc2cc3ccccc3s2)[C@@H]1O,5.688246138944246
CHEMBL3928703,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,638.0,nM,CHEMBL3887096,B,"Radioligand Binding: HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bottom of the flasks, and homogenized for 30 sec using a Brinkman PT 10/35 polytron. TME buffer was added to achieve a final 40 ml volume in the centrifuge tubes (the composition of TME is 100 mM TRIS base, 20 mM MgCl2, 2M EDTA; 10 N HCl is added to achieve a pH of 7.4).The cell homogenate was centrifuged at 19000 r.p.m. for 20 min at 4 C. using a Beckman Ti-60 rotor. The resultant pellet was resuspended in TME buffer to give a final 1 mg/ml protein concentration, as determined by Biorad assay. Radioligand binding competition assays vs. [3H-]17-phenyl PGF2 (5 nM) were performed in a 100 ul volume for 60 min. Binding reactions were started by adding plasma membrane fraction. The reaction was terminated by the addition of 4 ml ice-cold TRIS-HCl buffer and rapid filtration through glass fiber GF/B filters using a Brandel cell.",CHEMBL3886165,IC50,COC(=O)CCC/C=C\C[C@H]1C(=O)C(C)(C)[C@@H](O)[C@@H]1/C=C/C(O)CCc1ccccc1,6.195179321278838
CHEMBL3922155,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,308.0,nM,CHEMBL3887096,B,"Radioligand Binding: HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bottom of the flasks, and homogenized for 30 sec using a Brinkman PT 10/35 polytron. TME buffer was added to achieve a final 40 ml volume in the centrifuge tubes (the composition of TME is 100 mM TRIS base, 20 mM MgCl2, 2M EDTA; 10 N HCl is added to achieve a pH of 7.4).The cell homogenate was centrifuged at 19000 r.p.m. for 20 min at 4 C. using a Beckman Ti-60 rotor. The resultant pellet was resuspended in TME buffer to give a final 1 mg/ml protein concentration, as determined by Biorad assay. Radioligand binding competition assays vs. [3H-]17-phenyl PGF2 (5 nM) were performed in a 100 ul volume for 60 min. Binding reactions were started by adding plasma membrane fraction. The reaction was terminated by the addition of 4 ml ice-cold TRIS-HCl buffer and rapid filtration through glass fiber GF/B filters using a Brandel cell.",CHEMBL3886165,IC50,CC1(C)C(=O)[C@H](C/C=C\CCCC(=O)O)[C@@H](/C=C/C(O)Cc2cc3ccccc3s2)[C@@H]1O,6.511449283499555
CHEMBL3922155,CHEMBL1811,Prostanoid EP1 receptor,IC50,=,758.0,nM,CHEMBL3887096,B,"Radioligand Binding: HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bottom of the flasks, and homogenized for 30 sec using a Brinkman PT 10/35 polytron. TME buffer was added to achieve a final 40 ml volume in the centrifuge tubes (the composition of TME is 100 mM TRIS base, 20 mM MgCl2, 2M EDTA; 10 N HCl is added to achieve a pH of 7.4).The cell homogenate was centrifuged at 19000 r.p.m. for 20 min at 4 C. using a Beckman Ti-60 rotor. The resultant pellet was resuspended in TME buffer to give a final 1 mg/ml protein concentration, as determined by Biorad assay. Radioligand binding competition assays vs. [3H-]17-phenyl PGF2 (5 nM) were performed in a 100 ul volume for 60 min. Binding reactions were started by adding plasma membrane fraction. The reaction was terminated by the addition of 4 ml ice-cold TRIS-HCl buffer and rapid filtration through glass fiber GF/B filters using a Brandel cell.",CHEMBL3886165,IC50,CC1(C)C(=O)[C@H](C/C=C\CCCC(=O)O)[C@@H](/C=C/C(O)Cc2cc3ccccc3s2)[C@@H]1O,6.120330794367947
CHEMBL3946494,CHEMBL1811,Prostanoid EP1 receptor,EC50,=,27.0,nM,CHEMBL3887096,B,"Radioligand Binding: HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bottom of the flasks, and homogenized for 30 sec using a Brinkman PT 10/35 polytron. TME buffer was added to achieve a final 40 ml volume in the centrifuge tubes (the composition of TME is 100 mM TRIS base, 20 mM MgCl2, 2M EDTA; 10 N HCl is added to achieve a pH of 7.4).The cell homogenate was centrifuged at 19000 r.p.m. for 20 min at 4 C. using a Beckman Ti-60 rotor. The resultant pellet was resuspended in TME buffer to give a final 1 mg/ml protein concentration, as determined by Biorad assay. Radioligand binding competition assays vs. [3H-]17-phenyl PGF2 (5 nM) were performed in a 100 ul volume for 60 min. Binding reactions were started by adding plasma membrane fraction. The reaction was terminated by the addition of 4 ml ice-cold TRIS-HCl buffer and rapid filtration through glass fiber GF/B filters using a Brandel cell.",CHEMBL3886165,EC50,CC1(C)C(=O)[C@H](C/C=C\CCCC(=O)O)[C@@H](/C=C/C(O)CCc2ccccc2)[C@@H]1O,7.568636235841012
CHEMBL3946494,CHEMBL1811,Prostanoid EP1 receptor,EC50,=,1020.0,nM,CHEMBL3887096,B,"Radioligand Binding: HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bottom of the flasks, and homogenized for 30 sec using a Brinkman PT 10/35 polytron. TME buffer was added to achieve a final 40 ml volume in the centrifuge tubes (the composition of TME is 100 mM TRIS base, 20 mM MgCl2, 2M EDTA; 10 N HCl is added to achieve a pH of 7.4).The cell homogenate was centrifuged at 19000 r.p.m. for 20 min at 4 C. using a Beckman Ti-60 rotor. The resultant pellet was resuspended in TME buffer to give a final 1 mg/ml protein concentration, as determined by Biorad assay. Radioligand binding competition assays vs. [3H-]17-phenyl PGF2 (5 nM) were performed in a 100 ul volume for 60 min. Binding reactions were started by adding plasma membrane fraction. The reaction was terminated by the addition of 4 ml ice-cold TRIS-HCl buffer and rapid filtration through glass fiber GF/B filters using a Brandel cell.",CHEMBL3886165,EC50,CC1(C)C(=O)[C@H](C/C=C\CCCC(=O)O)[C@@H](/C=C/C(O)CCc2ccccc2)[C@@H]1O,5.991399828238082
CHEMBL37853,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,3700.0,nM,CHEMBL763183,B,Affinity for Prostanoid EP2 receptor expressed in CHO cells,CHEMBL1132967,IC50,O=C(O)CCC/C=C\C[C@@H]1[C@@H](/C=C/[C@@H](O)COc2cccc(Cl)c2)[C@H](O)C[C@@H]1O,5.431798275933005
CHEMBL290969,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,2500.0,nM,CHEMBL763183,B,Affinity for Prostanoid EP2 receptor expressed in CHO cells,CHEMBL1132967,IC50,O=C(O)CCCCCC[C@@H]1[C@@H](CC[C@@H](O)CCc2ccccc2)[C@H](O)C[C@@H]1O,5.6020599913279625
CHEMBL36817,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,4900.0,nM,CHEMBL763183,B,Affinity for Prostanoid EP2 receptor expressed in CHO cells,CHEMBL1132967,IC50,CCCCC[C@H](O)CC[C@@H]1[C@@H](CCCCCCC(=O)O)[C@@H](O)C[C@H]1O,5.309803919971486
CHEMBL369797,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,1300.0,nM,CHEMBL763183,B,Affinity for Prostanoid EP2 receptor expressed in CHO cells,CHEMBL1132967,IC50,O=C(O)CCCCCC[C@@H]1[C@@H](CCC(O)CSc2cccs2)[C@H](O)C[C@@H]1O,5.886056647693163
CHEMBL173680,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,2400.0,nM,CHEMBL763183,B,Affinity for Prostanoid EP2 receptor expressed in CHO cells,CHEMBL1132967,IC50,O=C(O)CCCCCC[C@@H]1[C@@H](CCC(O)CSc2cccc(Cl)c2)[C@H](O)C[C@@H]1O,5.619788758288394
CHEMBL36041,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,6700.0,nM,CHEMBL763183,B,Affinity for Prostanoid EP2 receptor expressed in CHO cells,CHEMBL1132967,IC50,O=C(O)CCCCCC[C@@H]1[C@@H](CC[C@@H](O)COc2cccc(Cl)c2)[C@H](O)C[C@@H]1O,5.173925197299173
CHEMBL400404,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,32000.0,nM,CHEMBL896002,B,Inhibition of human recombinant EP2 receptor expressed in 293EBNA cells,CHEMBL1148848,IC50,CC(=O)Nc1cccc(-c2ccc(Cc3ocnc3C(=O)N[C@@H](Cc3ccccc3)C(=O)O)cc2)c1,4.494850021680094
CHEMBL521609,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,12500.0,nM,CHEMBL960018,B,Displacement of radioligand from EP2 receptor,CHEMBL1153263,IC50,Cn1cc(/C=C/C(=O)NS(=O)(=O)c2ccc(F)c(F)c2)c2c(Oc3ccc4ccccc4c3)cccc21,4.903089986991944
CHEMBL489310,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,4200.0,nM,CHEMBL960018,B,Displacement of radioligand from EP2 receptor,CHEMBL1153263,IC50,Cn1cc(/C=C/C(=O)NS(=O)(=O)c2ccc(F)c(F)c2)c2c(Oc3ccc(Cl)c(Cl)c3)cccc21,5.376750709602099
CHEMBL459885,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,9600.0,nM,CHEMBL960018,B,Displacement of radioligand from EP2 receptor,CHEMBL1153263,IC50,Cn1cc(/C=C/C(=O)NS(=O)(=O)c2ccc(F)c(F)c2)c2c(Oc3ccc(Cl)cc3Cl)cccc21,5.017728766960431
CHEMBL475348,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,7680.0,nM,CHEMBL960018,B,Displacement of radioligand from EP2 receptor,CHEMBL1153263,IC50,Cn1cc(/C=C/C(=O)NS(=O)(=O)c2cc(F)c(F)cc2F)c2c(Oc3ccc(Cl)c(Cl)c3)cccc21,5.114638779968488
CHEMBL475349,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,9300.0,nM,CHEMBL960018,B,Displacement of radioligand from EP2 receptor,CHEMBL1153263,IC50,Cn1cc(/C=C/C(=O)NS(=O)(=O)c2cc(F)c(F)cc2F)c2c(Oc3ccc(Cl)cc3Cl)cccc21,5.031517051446064
CHEMBL521777,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,10000.0,nM,CHEMBL960018,B,Displacement of radioligand from EP2 receptor,CHEMBL1153263,IC50,Cn1cc(/C=C/C(=O)NS(=O)(=O)c2cc(F)c(F)cc2F)c2c(Oc3ccc(Cl)c(F)c3)cccc21,5.0
CHEMBL479664,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,2300.0,nM,CHEMBL1023728,B,Binding affinity to human EP2 receptor by radioligand binding assay,CHEMBL1143334,IC50,CC12CCCC(/C=C/C(=O)NS(=O)(=O)c3ccc(F)c(F)c3)=C1N(Cc1ccc(F)c(F)c1)C(=O)C2,5.638272163982407
CHEMBL479263,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,13900.0,nM,CHEMBL1023728,B,Binding affinity to human EP2 receptor by radioligand binding assay,CHEMBL1143334,IC50,CC12CCCC(/C=C/C(=O)NS(=O)(=O)c3cc(F)c(F)cc3F)=C1N(Cc1ccc(F)c(F)c1)C(=O)C2,4.856985199745905
CHEMBL467114,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,1584.89,nM,CHEMBL1009657,B,Inhibition of EP2 receptor,CHEMBL1138602,IC50,O=C([O-])c1cccc(Cc2cc(Cl)ccc2OCc2ccc(Cl)cc2F)n1.[Na+],5.800000874803203
CHEMBL565591,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,4169.0,nM,CHEMBL1045307,B,Displacement of [3H]PGE2 from human EP2 receptor after 1 hr by liquid scintillation counting,CHEMBL1156787,IC50,Cc1cn(Cc2ccc(Cl)cc2Cl)c2c(/C=C/C(=O)NS(=O)(=O)c3cc(Cl)c(Cl)s3)cc(F)cc12,5.3799681048737025
CHEMBL565992,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,4832.0,nM,CHEMBL1045307,B,Displacement of [3H]PGE2 from human EP2 receptor after 1 hr by liquid scintillation counting,CHEMBL1156787,IC50,O=C(COc1cccc2ncn(Cc3ccc(Cl)cc3Cl)c12)NS(=O)(=O)c1cc(Cl)c(Cl)s1,5.315873074386925
CHEMBL467632,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,12261.0,nM,CHEMBL1045307,B,Displacement of [3H]PGE2 from human EP2 receptor after 1 hr by liquid scintillation counting,CHEMBL1156787,IC50,O=C(COc1cccc2[nH]cc(Cc3ccc4ccccc4c3)c12)NS(=O)(=O)c1cc(Cl)c(Cl)s1,4.911474107568744
CHEMBL565799,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,32921.0,nM,CHEMBL1045307,B,Displacement of [3H]PGE2 from human EP2 receptor after 1 hr by liquid scintillation counting,CHEMBL1156787,IC50,Cc1cn(Cc2ccc3ccccc3c2)c2c(/C=C/C(=O)NS(=O)(=O)c3cc(Cl)c(Cl)s3)cc(F)cc12,4.482526981239664
CHEMBL1081186,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,19800.0,nM,CHEMBL1101722,B,Binding affinity to human EP2 receptor by radioligand displacement assay,CHEMBL1154363,IC50,Cc1cn(Cc2ccc(Cl)cc2Cl)c2c(-c3cc(NS(=O)(=O)c4ccc(F)c(F)c4)no3)cc(F)cc12,4.703334809738469
CHEMBL548,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,37.7,nM,CHEMBL1120701,B,Binding affinity to EP2 receptor,CHEMBL1155461,IC50,CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O,7.423658649794207
CHEMBL2385903,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,9500.0,nM,CHEMBL2388930,B,Inhibition of beta-arrestin binding to recombinant human prostanoid EP2 receptor expressed in HEK293 cell membranes by beta-lactamase complementation assay,CHEMBL2385063,IC50,O=C(O)Cn1c2c(c3cc(F)ccc31)CN(C(=O)CCc1cccc3ccccc13)CC2,5.022276394711152
CHEMBL2386080,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,7400.0,nM,CHEMBL2388930,B,Inhibition of beta-arrestin binding to recombinant human prostanoid EP2 receptor expressed in HEK293 cell membranes by beta-lactamase complementation assay,CHEMBL2385063,IC50,O=C(O)Cn1c2c(c3cc(Cl)ccc31)CN(C(=O)c1cccc3ccccc13)CC2,5.130768280269024
CHEMBL2386079,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,6600.0,nM,CHEMBL2388930,B,Inhibition of beta-arrestin binding to recombinant human prostanoid EP2 receptor expressed in HEK293 cell membranes by beta-lactamase complementation assay,CHEMBL2385063,IC50,O=C(O)Cn1c2c(c3ccccc31)CN(C(=O)c1cccc3ccccc13)CC2,5.180456064458131
CHEMBL2385904,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,6400.0,nM,CHEMBL2388930,B,Inhibition of beta-arrestin binding to recombinant human prostanoid EP2 receptor expressed in HEK293 cell membranes by beta-lactamase complementation assay,CHEMBL2385063,IC50,CCc1ccc(-c2ccc(C(=O)N3CCc4c(c5ccccc5n4CC(=O)O)C3)cc2)cc1,5.1938200260161125
CHEMBL2385900,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,2700.0,nM,CHEMBL2388930,B,Inhibition of beta-arrestin binding to recombinant human prostanoid EP2 receptor expressed in HEK293 cell membranes by beta-lactamase complementation assay,CHEMBL2385063,IC50,O=C(O)Cn1c2c(c3cc(F)cc(Cl)c31)CN(C(=O)c1cccc3ccccc13)CC2,5.568636235841012
CHEMBL2386081,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,2600.0,nM,CHEMBL2388930,B,Inhibition of beta-arrestin binding to recombinant human prostanoid EP2 receptor expressed in HEK293 cell membranes by beta-lactamase complementation assay,CHEMBL2385063,IC50,O=C(O)Cn1c2c(c3cc(F)ccc31)CN(C(=O)c1cccc3ccccc13)CC2,5.585026652029182
CHEMBL548,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,2.2,nM,CHEMBL2394990,B,Binding affinity to human EP2 receptor (unknown origin) by radioligand displacement assay,CHEMBL2390917,IC50,CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O,8.657577319177793
CHEMBL548,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,3.3,nM,CHEMBL2394934,B,Binding affinity to human prostanoid EP2 receptor by radioligand displacement assay,CHEMBL2390830,IC50,CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O,8.481486060122112
CHEMBL3586362,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,2.0,nM,CHEMBL3588430,B,Displacement of [3H]-PGE2 from human EP2 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,C[C@@H]1COc2c(Cl)cc(-n3ccc4cc(F)ccc43)cc2CN1Cc1cc[nH]c(=O)c1,8.698970004336019
CHEMBL3586361,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,8.0,nM,CHEMBL3588430,B,Displacement of [3H]-PGE2 from human EP2 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,C[C@@H]1COc2c(Cl)cc(-c3csc4ccccc34)cc2CN1Cc1cc[nH]c(=O)c1,8.096910013008056
CHEMBL3586360,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,8.0,nM,CHEMBL3588430,B,Displacement of [3H]-PGE2 from human EP2 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,O=c1cc(CN2CCOc3c(Cl)cc(-n4ccc5cc(F)ccc54)cc3C2)cc[nH]1,8.096910013008056
CHEMBL3586359,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,20.0,nM,CHEMBL3588430,B,Displacement of [3H]-PGE2 from human EP2 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,O=c1cc(CN2CCOc3c(Cl)cc(-c4csc5ccccc45)cc3C2)cc[nH]1,7.698970004336019
CHEMBL3586357,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,13000.0,nM,CHEMBL3588430,B,Displacement of [3H]-PGE2 from human EP2 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,COc1cc(-c2csc3ccccc23)cc2c1OCC(=O)N(Cc1cccnc1)C2,4.886056647693163
CHEMBL3586356,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,4000.0,nM,CHEMBL3588430,B,Displacement of [3H]-PGE2 from human EP2 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,CN1CCN(Cc2cccnc2)Cc2cc(-c3csc4ccccc34)ccc21,5.3979400086720375
CHEMBL3586355,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,6000.0,nM,CHEMBL3588430,B,Displacement of [3H]-PGE2 from human EP2 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,c1cncc(CN2CCNc3ccc(-c4csc5ccccc45)cc3C2)c1,5.221848749616356
CHEMBL3586354,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,1600.0,nM,CHEMBL3588430,B,Displacement of [3H]-PGE2 from human EP2 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,c1cncc(CN2CCCc3ccc(-c4csc5ccccc45)cc3C2)c1,5.795880017344075
CHEMBL3586353,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,80.0,nM,CHEMBL3588430,B,Displacement of [3H]-PGE2 from human EP2 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,Clc1cc(-c2csc3ccccc23)cc2c1OCCN(Cc1cccnc1)C2,7.096910013008056
CHEMBL3586352,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,200.0,nM,CHEMBL3588430,B,Displacement of [3H]-PGE2 from human EP2 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,Cc1cc(-c2csc3ccccc23)cc2c1OCCN(Cc1cccnc1)C2,6.698970004336019
CHEMBL3586350,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,14000.0,nM,CHEMBL3588430,B,Displacement of [3H]-PGE2 from human EP2 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,CCOc1cc(-c2csc3ccccc23)cc2c1OCCN(Cc1cccnc1)C2,4.853871964321762
CHEMBL3586349,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,1500.0,nM,CHEMBL3588430,B,Displacement of [3H]-PGE2 from human EP2 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,Oc1cc(-c2csc3ccccc23)cc2c1OCCN(Cc1cccnc1)C2,5.823908740944319
CHEMBL3586348,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,1100.0,nM,CHEMBL3588430,B,Displacement of [3H]-PGE2 from human EP2 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,c1cncc(CN2CCOc3ccc(-c4csc5ccccc45)cc3C2)c1,5.958607314841775
CHEMBL3586347,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,30.0,nM,CHEMBL3588430,B,Displacement of [3H]-PGE2 from human EP2 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,COc1cc(N2CCc3cc(Cl)ccc32)cc2c1OCCN(Cc1cccnc1)C2,7.522878745280337
CHEMBL3586346,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,90.0,nM,CHEMBL3588430,B,Displacement of [3H]-PGE2 from human EP2 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,COc1cc(-n2ccc3cc(F)ccc32)cc2c1OCCN(Cc1cccnc1)C2,7.045757490560675
CHEMBL3586345,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,100.0,nM,CHEMBL3588430,B,Displacement of [3H]-PGE2 from human EP2 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,COc1cc(-n2ccc3cc(C#N)ccc32)cc2c1OCCN(Cc1cccnc1)C2,7.0
CHEMBL3586344,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,5600.0,nM,CHEMBL3588430,B,Displacement of [3H]-PGE2 from human EP2 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,COc1cc(-n2ccc3cccc(Cl)c32)cc2c1OCCN(Cc1cccnc1)C2,5.251811972993799
CHEMBL3586343,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,800.0,nM,CHEMBL3588430,B,Displacement of [3H]-PGE2 from human EP2 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,COc1cc(-n2ccc3ccc(Cl)cc32)cc2c1OCCN(Cc1cccnc1)C2,6.096910013008056
CHEMBL3586342,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,80.0,nM,CHEMBL3588430,B,Displacement of [3H]-PGE2 from human EP2 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,COc1cc(-n2ccc3cc(Cl)ccc32)cc2c1OCCN(Cc1cccnc1)C2,7.096910013008056
CHEMBL3586341,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,400.0,nM,CHEMBL3588430,B,Displacement of [3H]-PGE2 from human EP2 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,COc1cc(-n2ccc3c(Cl)cccc32)cc2c1OCCN(Cc1cccnc1)C2,6.3979400086720375
CHEMBL3586340,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,60.0,nM,CHEMBL3588430,B,Displacement of [3H]-PGE2 from human EP2 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,COc1cc(-n2cc(Cl)c3ccccc32)cc2c1OCCN(Cc1cccnc1)C2,7.221848749616356
CHEMBL3586339,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,1100.0,nM,CHEMBL3588430,B,Displacement of [3H]-PGE2 from human EP2 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,COc1cc(-c2cn(C)c3ccccc23)cc2c1OCCN(Cc1cccnc1)C2,5.958607314841775
CHEMBL3586338,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,2700.0,nM,CHEMBL3588430,B,Displacement of [3H]-PGE2 from human EP2 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,COc1cc(-c2c[nH]c3ccccc23)cc2c1OCCN(Cc1cccnc1)C2,5.568636235841012
CHEMBL3586337,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,300.0,nM,CHEMBL3588430,B,Displacement of [3H]-PGE2 from human EP2 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,COc1cc(-n2ccc3ccccc32)cc2c1OCCN(Cc1cccnc1)C2,6.522878745280337
CHEMBL3586336,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,6400.0,nM,CHEMBL3588430,B,Displacement of [3H]-PGE2 from human EP2 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,COc1cc(-n2cnc3ccccc32)cc2c1OCCN(Cc1cccnc1)C2,5.1938200260161125
CHEMBL3586335,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,400.0,nM,CHEMBL3588430,B,Displacement of [3H]-PGE2 from human EP2 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,COc1cc(-c2nsc3ccccc23)cc2c1OCCN(Cc1cccnc1)C2,6.3979400086720375
CHEMBL3586334,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,10000.0,nM,CHEMBL3588430,B,Displacement of [3H]-PGE2 from human EP2 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,COc1cc(-c2ccc(Cl)cc2)cc2c1OCCN(Cc1cccnc1)C2,5.0
CHEMBL3586333,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,700.0,nM,CHEMBL3588430,B,Displacement of [3H]-PGE2 from human EP2 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,COc1cc(-c2cccc(Cl)c2)cc2c1OCCN(Cc1cccnc1)C2,6.154901959985743
CHEMBL3586332,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,12000.0,nM,CHEMBL3588430,B,Displacement of [3H]-PGE2 from human EP2 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,COc1cc(-c2ccccc2Cl)cc2c1OCCN(Cc1cccnc1)C2,4.920818753952375
CHEMBL3586330,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,15000.0,nM,CHEMBL3588430,B,Displacement of [3H]-PGE2 from human EP2 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,COc1cc(-c2cccc(C)c2)cc2c1OCCN(Cc1cccnc1)C2,4.823908740944319
CHEMBL3586328,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,300.0,nM,CHEMBL3588430,B,Displacement of [3H]-PGE2 from human EP2 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,COc1cc(-c2cccc3ccccc23)cc2c1OCCN(Cc1cccnc1)C2,6.522878745280337
CHEMBL3586327,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,15000.0,nM,CHEMBL3588430,B,Displacement of [3H]-PGE2 from human EP2 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,COc1cc(-c2ccccc2)cc2c1OCCN(Cc1cccnc1)C2,4.823908740944319
CHEMBL3586326,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,2800.0,nM,CHEMBL3588430,B,Displacement of [3H]-PGE2 from human EP2 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,COc1cc(-c2cc3ccccc3s2)cc2c1OCCN(Cc1cccnc1)C2,5.552841968657781
CHEMBL3586324,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,100.0,nM,CHEMBL3588430,B,Displacement of [3H]-PGE2 from human EP2 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,COc1cc(-c2csc3ccccc23)cc2c1OCCN(Cc1cccc(C#N)c1)C2,7.0
CHEMBL3586323,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,30000.0,nM,CHEMBL3588430,B,Displacement of [3H]-PGE2 from human EP2 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,COc1cc(-c2csc3ccccc23)cc2c1OCCN(Cc1cccc(Cl)c1)C2,4.522878745280337
CHEMBL3586322,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,100.0,nM,CHEMBL3588430,B,Displacement of [3H]-PGE2 from human EP2 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,COc1cc(-c2csc3ccccc23)cc2c1OCCN(Cc1ccc(S(C)(=O)=O)cc1)C2,7.0
CHEMBL3586321,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,600.0,nM,CHEMBL3588430,B,Displacement of [3H]-PGE2 from human EP2 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,COc1cc(-c2csc3ccccc23)cc2c1OCCN(Cc1ccc(C#N)cc1)C2,6.221848749616356
CHEMBL3586320,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,600.0,nM,CHEMBL3588430,B,Displacement of [3H]-PGE2 from human EP2 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,COC(=O)c1ccc(CN2CCOc3c(cc(-c4csc5ccccc45)cc3OC)C2)cc1,6.221848749616356
CHEMBL3586319,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,1800.0,nM,CHEMBL3588430,B,Displacement of [3H]-PGE2 from human EP2 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,COc1ccc(CN2CCOc3c(cc(-c4csc5ccccc45)cc3OC)C2)cc1,5.7447274948966935
CHEMBL3586318,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,30000.0,nM,CHEMBL3588430,B,Displacement of [3H]-PGE2 from human EP2 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,COc1cc(-c2csc3ccccc23)cc2c1OCCN(Cc1ccc(C)cc1)C2,4.522878745280337
CHEMBL3586317,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,30000.0,nM,CHEMBL3588430,B,Displacement of [3H]-PGE2 from human EP2 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,COc1cc(-c2csc3ccccc23)cc2c1OCCN(Cc1ccc(Cl)cc1)C2,4.522878745280337
CHEMBL3586316,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,10000.0,nM,CHEMBL3588430,B,Displacement of [3H]-PGE2 from human EP2 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,COc1cc(-c2csc3ccccc23)cc2c1OCCN(Cc1ccccc1)C2,5.0
CHEMBL3586315,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,200.0,nM,CHEMBL3588430,B,Displacement of [3H]-PGE2 from human EP2 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,COc1cc(-c2csc3ccccc23)cc2c1OCCN(Cc1ccc(=O)[nH]c1)C2,6.698970004336019
CHEMBL3586314,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,100.0,nM,CHEMBL3588430,B,Displacement of [3H]-PGE2 from human EP2 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,COc1ccc(CN2CCOc3c(cc(-c4csc5ccccc45)cc3OC)C2)cn1,7.0
CHEMBL3586313,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,200.0,nM,CHEMBL3588430,B,Displacement of [3H]-PGE2 from human EP2 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,COc1cc(-c2csc3ccccc23)cc2c1OCCN(Cc1cccnc1OC)C2,6.698970004336019
CHEMBL3586312,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,20.0,nM,CHEMBL3588430,B,Displacement of [3H]-PGE2 from human EP2 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,COc1cc(-c2csc3ccccc23)cc2c1OCCN(Cc1cncnc1)C2,7.698970004336019
CHEMBL3586311,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,200.0,nM,CHEMBL3588430,B,Displacement of [3H]-PGE2 from human EP2 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,COc1cc(-c2csc3ccccc23)cc2c1OCCN(Cc1ccncc1)C2,6.698970004336019
CHEMBL3586310,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,700.0,nM,CHEMBL3588430,B,Displacement of [3H]-PGE2 from human EP2 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,COc1cc(-c2csc3ccccc23)cc2c1OCCN(Cc1ccccn1)C2,6.154901959985743
CHEMBL3586309,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,70.0,nM,CHEMBL3588430,B,Displacement of [3H]-PGE2 from human EP2 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,COc1cc(-c2csc3ccccc23)cc2c1OCCN(Cc1cccnc1)C2,7.154901959985743
CHEMBL3115074,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,1630.0,nM,CHEMBL3603414,B,Displacement of [3H]-PGE2 from human EP2 receptor by liquid scintillation counting analysis,CHEMBL3600314,IC50,C[C@H](NC(=O)[C@H]1CCCCN1CCOc1ccccc1)c1ccc(C(=O)O)cc1.Cl,5.787812395596042
CHEMBL3740325,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,3700.0,nM,CHEMBL3744264,B,Antagonist activity at human EP2 receptor,CHEMBL3739413,IC50,Cc1ccc(C(=O)O)c(C)c1NC(=O)c1cc(-c2cccc(Cl)c2)cc2ccccc12,5.431798275933005
CHEMBL548,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,2.6,nM,CHEMBL3779739,B,Displacement of [3H]PGE2 from human recombinant prostanoid EP2 receptor expressed in HEK293 cells,CHEMBL3774372,IC50,CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O,8.585026652029182
CHEMBL548,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,2.6,nM,CHEMBL3876385,B,Displacement of [3H]PGE2 from human recombinant EP2 receptor expressed in HEK293 cells measured after 120 mins by scintillation counting method,CHEMBL3875185,IC50,CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O,8.585026652029182
CHEMBL3956391,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,2281.0,nM,CHEMBL3883093,B,Displacement of [3H]PGE2 from from human EP2 receptor expressed in HEK293 cells at pH 7.3 membranes incubated for 60 mins,CHEMBL3882734,IC50,O=C(O)CCC/C=C\C[C@H]1C(=O)C[C@@H](O)[C@@H]1c1ccc2c(c1)CCC2O,5.641874714723351
CHEMBL3986829,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,5200.0,nM,CHEMBL3883093,B,Displacement of [3H]PGE2 from from human EP2 receptor expressed in HEK293 cells at pH 7.3 membranes incubated for 60 mins,CHEMBL3882734,IC50,CCCC1(C(O)c2cccc([C@@H]3[C@@H](Cc4cccc(OCC(=O)O)c4)[C@H](Cl)C[C@H]3O)c2)CCC1,5.2839966563652006
CHEMBL3983069,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,3630.0,nM,CHEMBL3883093,B,Displacement of [3H]PGE2 from from human EP2 receptor expressed in HEK293 cells at pH 7.3 membranes incubated for 60 mins,CHEMBL3882734,IC50,CC(C)(C)C(O)c1ccc([C@@H]2[C@@H](CCCCCCC(=O)O)[C@H](Cl)C[C@H]2O)cc1,5.440093374963888
CHEMBL3920560,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,1537.0,nM,CHEMBL3883093,B,Displacement of [3H]PGE2 from from human EP2 receptor expressed in HEK293 cells at pH 7.3 membranes incubated for 60 mins,CHEMBL3882734,IC50,CC(C)(C)C(O)c1ccc([C@@H]2[C@@H](C/C=C\CCCC(=O)O)[C@H](Cl)C[C@H]2O)cc1,5.813326132500254
CHEMBL3934202,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,13150.0,nM,CHEMBL3883093,B,Displacement of [3H]PGE2 from from human EP2 receptor expressed in HEK293 cells at pH 7.3 membranes incubated for 60 mins,CHEMBL3882734,IC50,O=C(O)CCC/C=C\C[C@@H]1[C@@H](c2ccc(CO)cc2)[C@H](O)C[C@H]1Cl,4.881074247174223
CHEMBL3922121,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,8950.0,nM,CHEMBL3883093,B,Displacement of [3H]PGE2 from from human EP2 receptor expressed in HEK293 cells at pH 7.3 membranes incubated for 60 mins,CHEMBL3882734,IC50,CC(C)(CO)c1ccc([C@@H]2[C@@H](CCCCCCC(=O)O)[C@H](Cl)C[C@H]2O)cc1,5.048176964684088
CHEMBL3919393,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,18735.0,nM,CHEMBL3883093,B,Displacement of [3H]PGE2 from from human EP2 receptor expressed in HEK293 cells at pH 7.3 membranes incubated for 60 mins,CHEMBL3882734,IC50,CC(C)(CO)c1ccc([C@H]2[C@H](O)CC(=O)[C@@H]2CCCCCCC(=O)O)cc1,4.727346302570183
CHEMBL3971493,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,48765.0,nM,CHEMBL3883093,B,Displacement of [3H]PGE2 from from human EP2 receptor expressed in HEK293 cells at pH 7.3 membranes incubated for 60 mins,CHEMBL3882734,IC50,COC(=O)CCC/C=C\C[C@@H]1[C@@H](c2ccc(C(C)(C)CO)cc2)[C@H](O)C[C@H]1Cl,4.311891771448192
CHEMBL3976116,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,6251.0,nM,CHEMBL3883093,B,Displacement of [3H]PGE2 from from human EP2 receptor expressed in HEK293 cells at pH 7.3 membranes incubated for 60 mins,CHEMBL3882734,IC50,O=C(O)CCCCCC[C@@H]1[C@@H](c2ccc3c(c2)CCC3)[C@H](O)C[C@H]1Cl,5.204050501097196
CHEMBL3909111,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,13139.0,nM,CHEMBL3883093,B,Displacement of [3H]PGE2 from from human EP2 receptor expressed in HEK293 cells at pH 7.3 membranes incubated for 60 mins,CHEMBL3882734,IC50,O=C(O)CCCCCC[C@@H]1[C@@H](c2ccc3c(c2)CCC3O)[C@H](O)C[C@H]1Cl,4.8814376873643965
CHEMBL3973312,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,4185.0,nM,CHEMBL3883093,B,Displacement of [3H]PGE2 from from human EP2 receptor expressed in HEK293 cells at pH 7.3 membranes incubated for 60 mins,CHEMBL3882734,IC50,CC(C)(CO)c1ccc([C@@H]2[C@@H](C/C=C\CCCC(=O)O)[C@H](Cl)C[C@H]2O)cc1,5.378304537670721
CHEMBL3895324,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,1500.0,nM,CHEMBL3887097,B,"Radioligand Binding: HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bottom of the flasks, and homogenized for 30 sec using a Brinkman PT 10/35 polytron. TME buffer was added to achieve a final 40 ml volume in the centrifuge tubes (the composition of TME is 100 mM TRIS base, 20 mM MgCl2, 2M EDTA; 10 N HCl is added to achieve a pH of 7.4).The cell homogenate was centrifuged at 19000 r.p.m. for 20 min at 4 C. using a Beckman Ti-60 rotor. The resultant pellet was resuspended in TME buffer to give a final 1 mg/ml protein concentration, as determined by Biorad assay. Radioligand binding competition assays vs. [3H-]17-phenyl PGF2 (5 nM) were performed in a 100 ul volume for 60 min. Binding reactions were started by adding plasma membrane fraction. The reaction was terminated by the addition of 4 ml ice-cold TRIS-HCl buffer and rapid filtration through glass fiber GF/B filters using a Brandel cell.",CHEMBL3886165,IC50,CCCCC[C@H](O)/C=C/[C@@H]1[C@@H](C/C=C\CCCC(=O)O)C(=O)C(C)(C)[C@H]1O,5.823908740944319
CHEMBL4092846,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,236.0,nM,CHEMBL3997116,B,Antagonist activity at human EP2 receptor,CHEMBL3994644,IC50,O=C(O)c1ccc(CNC(=O)c2cc(F)ccc2Oc2ccc(F)cc2)cc1,6.627087997029893
CHEMBL4065183,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,1290.0,nM,CHEMBL3997116,B,Antagonist activity at human EP2 receptor,CHEMBL3994644,IC50,O=C(O)c1ccc(CNC(=O)c2cc(Cl)cnc2Oc2ccc(F)cc2)cc1,5.889410289700751
CHEMBL4096216,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,4360.0,nM,CHEMBL3997116,B,Antagonist activity at human EP2 receptor,CHEMBL3994644,IC50,C[C@H](NC(=O)c1cc(Cl)cnc1Oc1ccc(F)cc1)c1ccc(C(=O)O)cc1,5.360513510731414
CHEMBL591666,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,709.0,nM,CHEMBL3997116,B,Antagonist activity at human EP2 receptor,CHEMBL3994644,IC50,C[C@H](NC(=O)c1cc(Cl)ccc1Oc1ccc(F)cc1)c1ccc(C(=O)O)cc1,6.149353764816933
CHEMBL4099851,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,1890.0,nM,CHEMBL3997116,B,Antagonist activity at human EP2 receptor,CHEMBL3994644,IC50,C[C@H](NC(=O)c1cc(Cl)cnc1Oc1cccc(F)c1)c1ccc(C(=O)O)cc1,5.723538195826755
CHEMBL4094572,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,3320.0,nM,CHEMBL3997116,B,Antagonist activity at human EP2 receptor,CHEMBL3994644,IC50,C[C@H](NC(=O)c1cc(Cl)cnc1Oc1cccc(C#N)c1)c1ccc(C(=O)O)cc1,5.478861916295964
CHEMBL4078648,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,1620.0,nM,CHEMBL3997116,B,Antagonist activity at human EP2 receptor,CHEMBL3994644,IC50,C[C@H](NC(=O)c1cc(Cl)ccc1Oc1cccc(F)c1)c1ccc(C(=O)O)cc1,5.790484985457369
CHEMBL3707245,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,10.0,nM,CHEMBL4326150,B,Displacement of [3H]prostaglandin E2 from human EP2 receptor expressed in HEK293 cell membranes after 60 mins by liquid scintillation counting,CHEMBL4325826,IC50,O=C(O)CNc1cccc(CN(Cc2ccc(-n3cccn3)cc2)S(=O)(=O)c2cccnc2)n1,8.0
CHEMBL4297666,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,4180.0,nM,CHEMBL4326150,B,Displacement of [3H]prostaglandin E2 from human EP2 receptor expressed in HEK293 cell membranes after 60 mins by liquid scintillation counting,CHEMBL4325826,IC50,CC(C)OC(=O)CNc1cccc(CN(Cc2ccc(-n3cccn3)cc2)S(=O)(=O)c2cccnc2)n1,5.3788237182249645
CHEMBL548,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,4.0,nM,CHEMBL4326150,B,Displacement of [3H]prostaglandin E2 from human EP2 receptor expressed in HEK293 cell membranes after 60 mins by liquid scintillation counting,CHEMBL4325826,IC50,CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O,8.397940008672037
CHEMBL4790821,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,4400.0,nM,CHEMBL4671518,B,Displacement of [3H]prostaglandin E2 from full-length recombinant human EP2 receptor expressed in HEK293 cell membranes measured after 120 mins by scintillation counting method,CHEMBL4665834,IC50,Cc1c(-c2cccs2)nc2ccc(Br)cc2c1C(=O)NCCc1cccnc1,5.356547323513812
CHEMBL3286797,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,5.0,nM,CHEMBL4886922,B,Inhibition of binding to PTGER2,CHEMBL4507298,IC50,COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1,8.301029995663981
CHEMBL4552554,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,1300.0,nM,CHEMBL4886922,B,Inhibition of binding to PTGER2,CHEMBL4507298,IC50,O=C(c1ccc(F)cc1)N1CC(COc2ccc(Br)cc2)(C(=O)O)C1,5.886056647693163
CHEMBL4552554,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,1300.0,nM,CHEMBL5210562,B,Affinity Biochemical interaction (Enzymatic inhibition assay) EUB0000342a PTGER2,CHEMBL5210307,IC50,O=C(c1ccc(F)cc1)N1CC(COc2ccc(Br)cc2)(C(=O)O)C1,5.886056647693163
CHEMBL3286797,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,5.0,nM,CHEMBL5210567,B,Affinity Biochemical interaction (Enzymatic inhibition assay) EUB0000351a PTGER2,CHEMBL5210307,IC50,COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1,8.301029995663981
CHEMBL3670685,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,928.2,nM,CHEMBL5321025,B,Antagonist activity at EP2 receptor (unknown origin),CHEMBL5316375,IC50,C[C@H](NC(=O)c1c(C(F)F)nn(C)c1Oc1cccc(C(F)(F)F)c1)c1ccc(C(=O)O)cc1,6.032358435916988
CHEMBL548,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,2.1,nM,CHEMBL3294249,B,Agonist activity at EP2 receptor (unknown origin) by functional assay,CHEMBL3286161,EC50,CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O,8.67778070526608
CHEMBL271896,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,33.0,nM,CHEMBL3294249,B,Agonist activity at EP2 receptor (unknown origin) by functional assay,CHEMBL3286161,EC50,CCCC1([C@H](O)C/C=C/[C@H]2[C@H](O)CC(=O)[C@@H]2CCCCCCC(=O)OC)CCC1,7.481486060122112
CHEMBL1628262,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,32.0,nM,CHEMBL3294249,B,Agonist activity at EP2 receptor (unknown origin) by functional assay,CHEMBL3286161,EC50,CCCC1([C@@H](O)C/C=C/[C@H]2[C@H](O)CC(=O)[C@@H]2CCCCCCC(=O)O)CCC1,7.494850021680094
CHEMBL64246,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,3.8,nM,CHEMBL3294249,B,Agonist activity at EP2 receptor (unknown origin) by functional assay,CHEMBL3286161,EC50,CCC1([C@@H](O)C/C=C/[C@@H]2[C@@H](C/C=C\CCCC(=O)O)[C@H](Cl)C[C@H]2O)CCC1,8.42021640338319
CHEMBL3286796,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,1.8,nM,CHEMBL3294249,B,Agonist activity at EP2 receptor (unknown origin) by functional assay,CHEMBL3286161,EC50,C=CCC1([C@@H](O)C/C=C/[C@@H]2[C@@H](C/C=C\CCCC(=O)O)[C@H](Cl)C[C@H]2O)CCC1,8.744727494896694
CHEMBL563646,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,5.0,nM,CHEMBL3294249,B,Agonist activity at EP2 receptor (unknown origin) by functional assay,CHEMBL3286161,EC50,CC(C)(C)c1ccc(CN(Cc2cccc(OCC(=O)O)c2)S(=O)(=O)c2cccnc2)cc1,8.301029995663981
CHEMBL2107783,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,2.8,nM,CHEMBL3294249,B,Agonist activity at EP2 receptor (unknown origin) by functional assay,CHEMBL3286161,EC50,O=C(O)COc1cccc(CN(Cc2ccc(-n3cccn3)cc2)S(=O)(=O)c2cccnc2)c1,8.55284196865778
CHEMBL3754586,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,0.39,nM,CHEMBL3757317,B,Agonist activity at human EP2 receptor,CHEMBL3751723,EC50,CCCC[C@H](C)C[C@H](O)/C=C/[C@H]1CCC(=O)N1CCSc1nc(C(=O)O)cs1,9.4089353929735
CHEMBL3752377,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,0.91,nM,CHEMBL3757317,B,Agonist activity at human EP2 receptor,CHEMBL3751723,EC50,CCCCC(C)(C)[C@H](O)/C=C/[C@H]1CCC(=O)N1CCSc1nc(C(=O)O)cs1,9.040958607678906
CHEMBL3753853,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,7.4,nM,CHEMBL3757317,B,Agonist activity at human EP2 receptor,CHEMBL3751723,EC50,CCCCC(C)(C)[C@H](O)/C=C/[C@H]1COC(=O)N1CCSc1nc(C(=O)O)cs1,8.130768280269024
CHEMBL3752406,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,5.7,nM,CHEMBL3757317,B,Agonist activity at human EP2 receptor,CHEMBL3751723,EC50,CC(C)(CCCCF)[C@H](O)/C=C/[C@H]1COC(=O)N1CCSc1nc(C(=O)O)cs1,8.244125144327509
CHEMBL3753221,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,2.9,nM,CHEMBL3757317,B,Agonist activity at human EP2 receptor,CHEMBL3751723,EC50,CCCCC1([C@H](O)/C=C/[C@H]2COC(=O)N2CCSc2nc(C(=O)O)cs2)CCC1,8.537602002101044
CHEMBL3751951,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,2.9,nM,CHEMBL3757317,B,Agonist activity at human EP2 receptor,CHEMBL3751723,EC50,O=C(O)c1csc(SCCN2C(=O)OC[C@@H]2/C=C/[C@@H](O)C2(CCCCF)CCC2)n1,8.537602002101044
CHEMBL3753788,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,18.0,nM,CHEMBL3757317,B,Agonist activity at human EP2 receptor,CHEMBL3751723,EC50,COCCCC1([C@H](O)/C=C/[C@H]2COC(=O)N2CCSc2nc(C(=O)O)cs2)CCC1,7.7447274948966935
CHEMBL3753898,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,29.0,nM,CHEMBL3757317,B,Agonist activity at human EP2 receptor,CHEMBL3751723,EC50,CCOCCC1([C@H](O)/C=C/[C@H]2COC(=O)N2CCSc2nc(C(=O)O)cs2)CCC1,7.537602002101044
CHEMBL3753622,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,160.0,nM,CHEMBL3757317,B,Agonist activity at human EP2 receptor,CHEMBL3751723,EC50,O=C(O)c1csc(SCCN2C(=O)OC[C@@H]2/C=C/[C@@H](O)C2(CCc3ccccc3)CCC2)n1,6.795880017344075
CHEMBL3754197,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,60.0,nM,CHEMBL3757317,B,Agonist activity at human EP2 receptor,CHEMBL3751723,EC50,O=C(O)c1csc(SCCN2C(=O)OC[C@@H]2/C=C/[C@@H](O)C2(CCC3CCCCC3)CCC2)n1,7.221848749616356
CHEMBL3753268,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,21.0,nM,CHEMBL3757317,B,Agonist activity at human EP2 receptor,CHEMBL3751723,EC50,CC#CCC1([C@H](O)/C=C/[C@H]2COC(=O)N2CCSc2nc(C(=O)O)cs2)CCC1,7.6777807052660805
CHEMBL3752435,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,3700.0,nM,CHEMBL3757317,B,Agonist activity at human EP2 receptor,CHEMBL3751723,EC50,CC(C)(C)CCC1([C@H](O)/C=C/[C@H]2COC(=O)N2CCSc2nc(C(=O)O)cs2)CCC1,5.431798275933005
CHEMBL3793045,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,9.0,nM,CHEMBL3794974,B,Agonist activity at human EP2 receptor expressed in HEK293 cells after 24 hrs beta-arrestin recruitment assay,CHEMBL3792278,EC50,O=C(O)c1csc([C@H]2CC[C@@H]3[C@@H](COc4cccc(C(F)(F)F)c4)[C@H](O)C[C@@H]3O2)n1,8.045757490560675
CHEMBL3794016,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,2.3,nM,CHEMBL3794974,B,Agonist activity at human EP2 receptor expressed in HEK293 cells after 24 hrs beta-arrestin recruitment assay,CHEMBL3792278,EC50,Cc1cc(OC[C@@H]2[C@H]3CC[C@H](c4nc(C(=O)O)cs4)O[C@H]3C[C@H]2O)cc(C)c1Cl,8.638272163982407
CHEMBL3793862,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,3.7,nM,CHEMBL3794974,B,Agonist activity at human EP2 receptor expressed in HEK293 cells after 24 hrs beta-arrestin recruitment assay,CHEMBL3792278,EC50,O=C(O)c1csc([C@H]2CC[C@@H]3[C@@H](COc4cc(Cl)c(Cl)cc4Cl)[C@H](O)C[C@@H]3O2)n1,8.431798275933005
CHEMBL3792632,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,2.3,nM,CHEMBL3794974,B,Agonist activity at human EP2 receptor expressed in HEK293 cells after 24 hrs beta-arrestin recruitment assay,CHEMBL3792278,EC50,O=C(O)c1csc([C@H]2CC[C@@H]3[C@@H](COc4ccc(Cl)c(Cl)c4Cl)[C@H](O)C[C@@H]3O2)n1,8.638272163982407
CHEMBL548,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,346.0,nM,CHEMBL3808246,B,Agonist activity at PK2-tagged human EP2 receptor expressed in HEK293 cells assessed as induction of EA-tagged beta-arrestin recruitment incubated for 90 mins by beta-galactosidase reporter gene assay,CHEMBL3804774,EC50,CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O,6.460923901207224
CHEMBL3805767,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,203.0,nM,CHEMBL3808246,B,Agonist activity at PK2-tagged human EP2 receptor expressed in HEK293 cells assessed as induction of EA-tagged beta-arrestin recruitment incubated for 90 mins by beta-galactosidase reporter gene assay,CHEMBL3804774,EC50,O=C(O)c1csc([C@H]2CC[C@@H]3[C@@H](COc4ccccc4Cl)[C@H](O)C[C@@H]3O2)n1,6.692503962086787
CHEMBL3806284,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,11.0,nM,CHEMBL3808246,B,Agonist activity at PK2-tagged human EP2 receptor expressed in HEK293 cells assessed as induction of EA-tagged beta-arrestin recruitment incubated for 90 mins by beta-galactosidase reporter gene assay,CHEMBL3804774,EC50,O=C(O)c1csc([C@H]2CC[C@@H]3[C@@H](COc4ccccc4C(F)(F)F)[C@H](O)C[C@@H]3O2)n1,7.958607314841775
CHEMBL3805981,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,69.0,nM,CHEMBL3808246,B,Agonist activity at PK2-tagged human EP2 receptor expressed in HEK293 cells assessed as induction of EA-tagged beta-arrestin recruitment incubated for 90 mins by beta-galactosidase reporter gene assay,CHEMBL3804774,EC50,O=C(O)c1csc([C@H]2CC[C@@H]3[C@@H](COc4cccc(OC(F)(F)F)c4)[C@H](O)C[C@@H]3O2)n1,7.161150909262744
CHEMBL3793045,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,9.0,nM,CHEMBL3808246,B,Agonist activity at PK2-tagged human EP2 receptor expressed in HEK293 cells assessed as induction of EA-tagged beta-arrestin recruitment incubated for 90 mins by beta-galactosidase reporter gene assay,CHEMBL3804774,EC50,O=C(O)c1csc([C@H]2CC[C@@H]3[C@@H](COc4cccc(C(F)(F)F)c4)[C@H](O)C[C@@H]3O2)n1,8.045757490560675
CHEMBL3805122,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,4500.0,nM,CHEMBL3808246,B,Agonist activity at PK2-tagged human EP2 receptor expressed in HEK293 cells assessed as induction of EA-tagged beta-arrestin recruitment incubated for 90 mins by beta-galactosidase reporter gene assay,CHEMBL3804774,EC50,O=C(O)c1csc([C@H]2CC[C@@H]3[C@@H](COc4ccc(OC(F)(F)F)cc4)[C@H](O)C[C@@H]3O2)n1,5.346787486224656
CHEMBL3891401,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,28.0,nM,CHEMBL3881176,B,Agonist activity at recombinant human EP2 receptor expressed in HEK293-EBNA cells co-expressing Gqs5 assessed as induction of c-AMP accumulation,CHEMBL3880426,EC50,CC(C)(C)c1ccc(N2C(=O)CC[C@@H]2COCc2ccc(C(=O)O)o2)cc1,7.552841968657781
CHEMBL3908484,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,51.0,nM,CHEMBL3881176,B,Agonist activity at recombinant human EP2 receptor expressed in HEK293-EBNA cells co-expressing Gqs5 assessed as induction of c-AMP accumulation,CHEMBL3880426,EC50,CC(C)(C)c1ccc(N2C(=O)CC[C@@H]2COCc2ccc(C(=O)O)s2)cc1,7.292429823902063
CHEMBL3929446,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,548.0,nM,CHEMBL3881176,B,Agonist activity at recombinant human EP2 receptor expressed in HEK293-EBNA cells co-expressing Gqs5 assessed as induction of c-AMP accumulation,CHEMBL3880426,EC50,CC(C)(C)c1ccc(N2C(=O)CC[C@@H]2CCCCCCC(=O)O)cc1,6.261219441515631
CHEMBL3928130,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,26.0,nM,CHEMBL3881176,B,Agonist activity at recombinant human EP2 receptor expressed in HEK293-EBNA cells co-expressing Gqs5 assessed as induction of c-AMP accumulation,CHEMBL3880426,EC50,CCCCCC(O)c1ccc(N2C(=O)CC[C@@H]2COCc2ccc(C(=O)O)o2)cc1,7.585026652029182
CHEMBL3905811,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,1218.0,nM,CHEMBL3881176,B,Agonist activity at recombinant human EP2 receptor expressed in HEK293-EBNA cells co-expressing Gqs5 assessed as induction of c-AMP accumulation,CHEMBL3880426,EC50,CC(C)C(O)c1ccc(N2C(=O)CC[C@@H]2COCc2ccc(C(=O)O)o2)cc1,5.914352711703144
CHEMBL3906402,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,148.0,nM,CHEMBL3881176,B,Agonist activity at recombinant human EP2 receptor expressed in HEK293-EBNA cells co-expressing Gqs5 assessed as induction of c-AMP accumulation,CHEMBL3880426,EC50,O=C(O)c1ccc(COC[C@H]2CCC(=O)N2c2ccc(C(O)Cc3ccccc3)cc2)o1,6.8297382846050425
CHEMBL3892847,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,1.5,nM,CHEMBL3881176,B,Agonist activity at recombinant human EP2 receptor expressed in HEK293-EBNA cells co-expressing Gqs5 assessed as induction of c-AMP accumulation,CHEMBL3880426,EC50,CCCCCC(O)c1ccc(N2C(=O)CC[C@@H]2COCc2ccc(C(=O)O)s2)cc1,8.823908740944319
CHEMBL3924987,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,517.0,nM,CHEMBL3881176,B,Agonist activity at recombinant human EP2 receptor expressed in HEK293-EBNA cells co-expressing Gqs5 assessed as induction of c-AMP accumulation,CHEMBL3880426,EC50,CCCCCC(O)c1ccc(N2C(=O)CC[C@@H]2COCc2cccc(C(=O)O)c2)cc1,6.286509456906058
CHEMBL3975238,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,8.0,nM,CHEMBL3881176,B,Agonist activity at recombinant human EP2 receptor expressed in HEK293-EBNA cells co-expressing Gqs5 assessed as induction of c-AMP accumulation,CHEMBL3880426,EC50,CCCCC(O)c1ccc(N2C(=O)CC[C@@H]2COCc2ccc(C(=O)O)s2)cc1,8.096910013008056
CHEMBL3977724,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,1.5,nM,CHEMBL3881176,B,Agonist activity at recombinant human EP2 receptor expressed in HEK293-EBNA cells co-expressing Gqs5 assessed as induction of c-AMP accumulation,CHEMBL3880426,EC50,CCCCCCC(O)c1ccc(N2C(=O)CC[C@@H]2COCc2ccc(C(=O)O)s2)cc1,8.823908740944319
CHEMBL3907809,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,27.0,nM,CHEMBL3881176,B,Agonist activity at recombinant human EP2 receptor expressed in HEK293-EBNA cells co-expressing Gqs5 assessed as induction of c-AMP accumulation,CHEMBL3880426,EC50,CCCC(O)c1ccc(N2C(=O)CC[C@@H]2COCc2ccc(C(=O)O)s2)cc1,7.568636235841012
CHEMBL3918349,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,312.0,nM,CHEMBL3881176,B,Agonist activity at recombinant human EP2 receptor expressed in HEK293-EBNA cells co-expressing Gqs5 assessed as induction of c-AMP accumulation,CHEMBL3880426,EC50,CCC(O)c1ccc(N2C(=O)CC[C@@H]2COCc2ccc(C(=O)O)s2)cc1,6.505845405981557
CHEMBL3962183,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,15.0,nM,CHEMBL3881176,B,Agonist activity at recombinant human EP2 receptor expressed in HEK293-EBNA cells co-expressing Gqs5 assessed as induction of c-AMP accumulation,CHEMBL3880426,EC50,CCCCCC(O)c1ccc(N2C(=O)CC[C@@H]2C=CCc2ccc(C(=O)O)s2)cc1,7.823908740944319
CHEMBL3971632,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,0.15,nM,CHEMBL3881176,B,Agonist activity at recombinant human EP2 receptor expressed in HEK293-EBNA cells co-expressing Gqs5 assessed as induction of c-AMP accumulation,CHEMBL3880426,EC50,CCCCCC(O)c1ccc(N2C(=O)CC[C@@H]2CCCc2ccc(C(=O)O)s2)cc1,9.823908740944319
CHEMBL3920756,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,1.6,nM,CHEMBL3881176,B,Agonist activity at recombinant human EP2 receptor expressed in HEK293-EBNA cells co-expressing Gqs5 assessed as induction of c-AMP accumulation,CHEMBL3880426,EC50,CCCCCC(=O)c1ccc(N2C(=O)CC[C@@H]2CCCc2ccc(C(=O)O)s2)cc1,8.795880017344075
CHEMBL3921784,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,8.0,nM,CHEMBL3881176,B,Agonist activity at recombinant human EP2 receptor expressed in HEK293-EBNA cells co-expressing Gqs5 assessed as induction of c-AMP accumulation,CHEMBL3880426,EC50,CCCCCC(=O)c1ccc(N2C(=O)CC[C@@H]2COCc2ccc(C(=O)O)s2)cc1,8.096910013008056
CHEMBL3947001,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,0.6,nM,CHEMBL3881176,B,Agonist activity at recombinant human EP2 receptor expressed in HEK293-EBNA cells co-expressing Gqs5 assessed as induction of c-AMP accumulation,CHEMBL3880426,EC50,CCCCCCC(O)c1ccc(N2C(=O)CC[C@@H]2CCCc2ccc(C(=O)O)s2)cc1,9.221848749616356
CHEMBL3891401,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,189.0,nM,CHEMBL3883104,B,Displacement of [3H]PGE2 from from human EP2 receptor expressed in HEK293 cells at pH 6.0 membranes incubated for 60 mins,CHEMBL3882734,EC50,CC(C)(C)c1ccc(N2C(=O)CC[C@@H]2COCc2ccc(C(=O)O)o2)cc1,6.723538195826755
CHEMBL3908484,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,27.0,nM,CHEMBL3883104,B,Displacement of [3H]PGE2 from from human EP2 receptor expressed in HEK293 cells at pH 6.0 membranes incubated for 60 mins,CHEMBL3882734,EC50,CC(C)(C)c1ccc(N2C(=O)CC[C@@H]2COCc2ccc(C(=O)O)s2)cc1,7.568636235841012
CHEMBL3895324,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,944.0,nM,CHEMBL3887097,B,"Radioligand Binding: HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bottom of the flasks, and homogenized for 30 sec using a Brinkman PT 10/35 polytron. TME buffer was added to achieve a final 40 ml volume in the centrifuge tubes (the composition of TME is 100 mM TRIS base, 20 mM MgCl2, 2M EDTA; 10 N HCl is added to achieve a pH of 7.4).The cell homogenate was centrifuged at 19000 r.p.m. for 20 min at 4 C. using a Beckman Ti-60 rotor. The resultant pellet was resuspended in TME buffer to give a final 1 mg/ml protein concentration, as determined by Biorad assay. Radioligand binding competition assays vs. [3H-]17-phenyl PGF2 (5 nM) were performed in a 100 ul volume for 60 min. Binding reactions were started by adding plasma membrane fraction. The reaction was terminated by the addition of 4 ml ice-cold TRIS-HCl buffer and rapid filtration through glass fiber GF/B filters using a Brandel cell.",CHEMBL3886165,EC50,CCCCC[C@H](O)/C=C/[C@@H]1[C@@H](C/C=C\CCCC(=O)O)C(=O)C(C)(C)[C@H]1O,6.025028005701931
CHEMBL64804,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,59.0,nM,CHEMBL3887484,B,"SEAP Activity Assay: 1. Seed cells on an EP2 or EP4 STEP plate at a density of 40,000-80,000 cells/well in 200 ul of reduced serum medium containing 0.5% FBS. Place the plate in a 37 C. incubator with 5% CO2 and incubate overnight. 2. After 16-18 hours of incubation, aspirate the culture media from each well. 3. Add 200 ul of culture medium containing different concentration of test compounds to the assigned wells. For each test compound, at least 8 concentrations starting at highest 10 M and lowest 0.01 pM were tested. In addition each concentration had triplicates. A PGE2 curve (concentrations from lowest to highest, 0 pM, 0.384 pM, 1.92 pM, 9.6 pM, 48 pM, 240 pM, 1200 pM, and 6000 pM) was always run in parallel with test compounds. 4. After 6-8 hours of stimulation with test compounds and PGE2, 10 ul of culture media from each well was transferred to a corresponding well of a 96-well solid black plate. Cover the plate with the lid.",CHEMBL3886335,EC50,CCCCC[C@@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O,7.229147988357855
CHEMBL62570,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,16.5,nM,CHEMBL3887484,B,"SEAP Activity Assay: 1. Seed cells on an EP2 or EP4 STEP plate at a density of 40,000-80,000 cells/well in 200 ul of reduced serum medium containing 0.5% FBS. Place the plate in a 37 C. incubator with 5% CO2 and incubate overnight. 2. After 16-18 hours of incubation, aspirate the culture media from each well. 3. Add 200 ul of culture medium containing different concentration of test compounds to the assigned wells. For each test compound, at least 8 concentrations starting at highest 10 M and lowest 0.01 pM were tested. In addition each concentration had triplicates. A PGE2 curve (concentrations from lowest to highest, 0 pM, 0.384 pM, 1.92 pM, 9.6 pM, 48 pM, 240 pM, 1200 pM, and 6000 pM) was always run in parallel with test compounds. 4. After 6-8 hours of stimulation with test compounds and PGE2, 10 ul of culture media from each well was transferred to a corresponding well of a 96-well solid black plate. Cover the plate with the lid.",CHEMBL3886335,EC50,CCCCC[C@@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O,7.782516055786093
CHEMBL3955128,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,205.0,nM,CHEMBL3887484,B,"SEAP Activity Assay: 1. Seed cells on an EP2 or EP4 STEP plate at a density of 40,000-80,000 cells/well in 200 ul of reduced serum medium containing 0.5% FBS. Place the plate in a 37 C. incubator with 5% CO2 and incubate overnight. 2. After 16-18 hours of incubation, aspirate the culture media from each well. 3. Add 200 ul of culture medium containing different concentration of test compounds to the assigned wells. For each test compound, at least 8 concentrations starting at highest 10 M and lowest 0.01 pM were tested. In addition each concentration had triplicates. A PGE2 curve (concentrations from lowest to highest, 0 pM, 0.384 pM, 1.92 pM, 9.6 pM, 48 pM, 240 pM, 1200 pM, and 6000 pM) was always run in parallel with test compounds. 4. After 6-8 hours of stimulation with test compounds and PGE2, 10 ul of culture media from each well was transferred to a corresponding well of a 96-well solid black plate. Cover the plate with the lid.",CHEMBL3886335,EC50,CCCCC[C@H](O)/C=C/[C@H]1CC(F)(F)C(=O)N1CCCCCCC(=O)O,6.688246138944246
CHEMBL3895047,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,1630.0,nM,CHEMBL3887484,B,"SEAP Activity Assay: 1. Seed cells on an EP2 or EP4 STEP plate at a density of 40,000-80,000 cells/well in 200 ul of reduced serum medium containing 0.5% FBS. Place the plate in a 37 C. incubator with 5% CO2 and incubate overnight. 2. After 16-18 hours of incubation, aspirate the culture media from each well. 3. Add 200 ul of culture medium containing different concentration of test compounds to the assigned wells. For each test compound, at least 8 concentrations starting at highest 10 M and lowest 0.01 pM were tested. In addition each concentration had triplicates. A PGE2 curve (concentrations from lowest to highest, 0 pM, 0.384 pM, 1.92 pM, 9.6 pM, 48 pM, 240 pM, 1200 pM, and 6000 pM) was always run in parallel with test compounds. 4. After 6-8 hours of stimulation with test compounds and PGE2, 10 ul of culture media from each well was transferred to a corresponding well of a 96-well solid black plate. Cover the plate with the lid.",CHEMBL3886335,EC50,CCC#CC[C@H](C)[C@H](O)/C=C/[C@H]1CC(F)(F)C(=O)N1CCc1ccc(C(=O)O)cc1,5.787812395596042
CHEMBL3923027,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,1960.0,nM,CHEMBL3887484,B,"SEAP Activity Assay: 1. Seed cells on an EP2 or EP4 STEP plate at a density of 40,000-80,000 cells/well in 200 ul of reduced serum medium containing 0.5% FBS. Place the plate in a 37 C. incubator with 5% CO2 and incubate overnight. 2. After 16-18 hours of incubation, aspirate the culture media from each well. 3. Add 200 ul of culture medium containing different concentration of test compounds to the assigned wells. For each test compound, at least 8 concentrations starting at highest 10 M and lowest 0.01 pM were tested. In addition each concentration had triplicates. A PGE2 curve (concentrations from lowest to highest, 0 pM, 0.384 pM, 1.92 pM, 9.6 pM, 48 pM, 240 pM, 1200 pM, and 6000 pM) was always run in parallel with test compounds. 4. After 6-8 hours of stimulation with test compounds and PGE2, 10 ul of culture media from each well was transferred to a corresponding well of a 96-well solid black plate. Cover the plate with the lid.",CHEMBL3886335,EC50,CCCCC[C@H](O)/C=C/[C@H]1CC(F)(F)C(=O)N1CCc1ccc(C(=O)O)cc1,5.707743928643524
CHEMBL3949856,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,763.0,nM,CHEMBL3887484,B,"SEAP Activity Assay: 1. Seed cells on an EP2 or EP4 STEP plate at a density of 40,000-80,000 cells/well in 200 ul of reduced serum medium containing 0.5% FBS. Place the plate in a 37 C. incubator with 5% CO2 and incubate overnight. 2. After 16-18 hours of incubation, aspirate the culture media from each well. 3. Add 200 ul of culture medium containing different concentration of test compounds to the assigned wells. For each test compound, at least 8 concentrations starting at highest 10 M and lowest 0.01 pM were tested. In addition each concentration had triplicates. A PGE2 curve (concentrations from lowest to highest, 0 pM, 0.384 pM, 1.92 pM, 9.6 pM, 48 pM, 240 pM, 1200 pM, and 6000 pM) was always run in parallel with test compounds. 4. After 6-8 hours of stimulation with test compounds and PGE2, 10 ul of culture media from each well was transferred to a corresponding well of a 96-well solid black plate. Cover the plate with the lid.",CHEMBL3886335,EC50,CCC#CC[C@H](C)[C@H](O)/C=C/[C@H]1CC(F)(F)C(=O)N1CCCc1ccc(C(=O)O)s1,6.117475462045119
CHEMBL3975743,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,148.0,nM,CHEMBL3887484,B,"SEAP Activity Assay: 1. Seed cells on an EP2 or EP4 STEP plate at a density of 40,000-80,000 cells/well in 200 ul of reduced serum medium containing 0.5% FBS. Place the plate in a 37 C. incubator with 5% CO2 and incubate overnight. 2. After 16-18 hours of incubation, aspirate the culture media from each well. 3. Add 200 ul of culture medium containing different concentration of test compounds to the assigned wells. For each test compound, at least 8 concentrations starting at highest 10 M and lowest 0.01 pM were tested. In addition each concentration had triplicates. A PGE2 curve (concentrations from lowest to highest, 0 pM, 0.384 pM, 1.92 pM, 9.6 pM, 48 pM, 240 pM, 1200 pM, and 6000 pM) was always run in parallel with test compounds. 4. After 6-8 hours of stimulation with test compounds and PGE2, 10 ul of culture media from each well was transferred to a corresponding well of a 96-well solid black plate. Cover the plate with the lid.",CHEMBL3886335,EC50,C[C@@H](CCCc1ccccc1)[C@H](O)/C=C/[C@H]1CC(F)(F)C(=O)N1CCCc1ccc(C(=O)O)s1,6.8297382846050425
CHEMBL3937596,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,65.0,nM,CHEMBL3887484,B,"SEAP Activity Assay: 1. Seed cells on an EP2 or EP4 STEP plate at a density of 40,000-80,000 cells/well in 200 ul of reduced serum medium containing 0.5% FBS. Place the plate in a 37 C. incubator with 5% CO2 and incubate overnight. 2. After 16-18 hours of incubation, aspirate the culture media from each well. 3. Add 200 ul of culture medium containing different concentration of test compounds to the assigned wells. For each test compound, at least 8 concentrations starting at highest 10 M and lowest 0.01 pM were tested. In addition each concentration had triplicates. A PGE2 curve (concentrations from lowest to highest, 0 pM, 0.384 pM, 1.92 pM, 9.6 pM, 48 pM, 240 pM, 1200 pM, and 6000 pM) was always run in parallel with test compounds. 4. After 6-8 hours of stimulation with test compounds and PGE2, 10 ul of culture media from each well was transferred to a corresponding well of a 96-well solid black plate. Cover the plate with the lid.",CHEMBL3886335,EC50,C[C@@H](CCCc1ccccc1)[C@@H](O)/C=C/[C@H]1CC(F)(F)C(=O)N1CCCc1ccc(C(=O)O)s1,7.187086643357144
CHEMBL3900979,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,1310.0,nM,CHEMBL3887484,B,"SEAP Activity Assay: 1. Seed cells on an EP2 or EP4 STEP plate at a density of 40,000-80,000 cells/well in 200 ul of reduced serum medium containing 0.5% FBS. Place the plate in a 37 C. incubator with 5% CO2 and incubate overnight. 2. After 16-18 hours of incubation, aspirate the culture media from each well. 3. Add 200 ul of culture medium containing different concentration of test compounds to the assigned wells. For each test compound, at least 8 concentrations starting at highest 10 M and lowest 0.01 pM were tested. In addition each concentration had triplicates. A PGE2 curve (concentrations from lowest to highest, 0 pM, 0.384 pM, 1.92 pM, 9.6 pM, 48 pM, 240 pM, 1200 pM, and 6000 pM) was always run in parallel with test compounds. 4. After 6-8 hours of stimulation with test compounds and PGE2, 10 ul of culture media from each well was transferred to a corresponding well of a 96-well solid black plate. Cover the plate with the lid.",CHEMBL3886335,EC50,C[C@@H](CCCc1ccccc1)[C@H](O)CC[C@H]1CC(F)(F)C(=O)N1CCCc1ccc(C(=O)O)s1,5.882728704344236
CHEMBL3916499,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,326.0,nM,CHEMBL3887484,B,"SEAP Activity Assay: 1. Seed cells on an EP2 or EP4 STEP plate at a density of 40,000-80,000 cells/well in 200 ul of reduced serum medium containing 0.5% FBS. Place the plate in a 37 C. incubator with 5% CO2 and incubate overnight. 2. After 16-18 hours of incubation, aspirate the culture media from each well. 3. Add 200 ul of culture medium containing different concentration of test compounds to the assigned wells. For each test compound, at least 8 concentrations starting at highest 10 M and lowest 0.01 pM were tested. In addition each concentration had triplicates. A PGE2 curve (concentrations from lowest to highest, 0 pM, 0.384 pM, 1.92 pM, 9.6 pM, 48 pM, 240 pM, 1200 pM, and 6000 pM) was always run in parallel with test compounds. 4. After 6-8 hours of stimulation with test compounds and PGE2, 10 ul of culture media from each well was transferred to a corresponding well of a 96-well solid black plate. Cover the plate with the lid.",CHEMBL3886335,EC50,CCCCC[C@H](O)/C=C/[C@H]1CC(F)(F)C(=O)N1CCCc1ccc(C(=O)O)s1,6.486782399932061
CHEMBL3902065,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,1000.0,nM,CHEMBL3887484,B,"SEAP Activity Assay: 1. Seed cells on an EP2 or EP4 STEP plate at a density of 40,000-80,000 cells/well in 200 ul of reduced serum medium containing 0.5% FBS. Place the plate in a 37 C. incubator with 5% CO2 and incubate overnight. 2. After 16-18 hours of incubation, aspirate the culture media from each well. 3. Add 200 ul of culture medium containing different concentration of test compounds to the assigned wells. For each test compound, at least 8 concentrations starting at highest 10 M and lowest 0.01 pM were tested. In addition each concentration had triplicates. A PGE2 curve (concentrations from lowest to highest, 0 pM, 0.384 pM, 1.92 pM, 9.6 pM, 48 pM, 240 pM, 1200 pM, and 6000 pM) was always run in parallel with test compounds. 4. After 6-8 hours of stimulation with test compounds and PGE2, 10 ul of culture media from each well was transferred to a corresponding well of a 96-well solid black plate. Cover the plate with the lid.",CHEMBL3886335,EC50,C[C@@H](Cc1ccccc1)[C@H](O)/C=C/[C@H]1CC(F)(F)C(=O)N1CCCc1ccc(C(=O)O)s1,6.0
CHEMBL3966743,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,743.0,nM,CHEMBL3887484,B,"SEAP Activity Assay: 1. Seed cells on an EP2 or EP4 STEP plate at a density of 40,000-80,000 cells/well in 200 ul of reduced serum medium containing 0.5% FBS. Place the plate in a 37 C. incubator with 5% CO2 and incubate overnight. 2. After 16-18 hours of incubation, aspirate the culture media from each well. 3. Add 200 ul of culture medium containing different concentration of test compounds to the assigned wells. For each test compound, at least 8 concentrations starting at highest 10 M and lowest 0.01 pM were tested. In addition each concentration had triplicates. A PGE2 curve (concentrations from lowest to highest, 0 pM, 0.384 pM, 1.92 pM, 9.6 pM, 48 pM, 240 pM, 1200 pM, and 6000 pM) was always run in parallel with test compounds. 4. After 6-8 hours of stimulation with test compounds and PGE2, 10 ul of culture media from each well was transferred to a corresponding well of a 96-well solid black plate. Cover the plate with the lid.",CHEMBL3886335,EC50,C[C@@H](CCc1ccccc1)[C@@H](O)/C=C/[C@H]1CC(F)(F)C(=O)N1CCCc1ccc(C(=O)O)s1,6.129011186239424
CHEMBL3945327,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,157.0,nM,CHEMBL3887484,B,"SEAP Activity Assay: 1. Seed cells on an EP2 or EP4 STEP plate at a density of 40,000-80,000 cells/well in 200 ul of reduced serum medium containing 0.5% FBS. Place the plate in a 37 C. incubator with 5% CO2 and incubate overnight. 2. After 16-18 hours of incubation, aspirate the culture media from each well. 3. Add 200 ul of culture medium containing different concentration of test compounds to the assigned wells. For each test compound, at least 8 concentrations starting at highest 10 M and lowest 0.01 pM were tested. In addition each concentration had triplicates. A PGE2 curve (concentrations from lowest to highest, 0 pM, 0.384 pM, 1.92 pM, 9.6 pM, 48 pM, 240 pM, 1200 pM, and 6000 pM) was always run in parallel with test compounds. 4. After 6-8 hours of stimulation with test compounds and PGE2, 10 ul of culture media from each well was transferred to a corresponding well of a 96-well solid black plate. Cover the plate with the lid.",CHEMBL3886335,EC50,C[C@@H](CCCCc1ccccc1)[C@H](O)/C=C/[C@H]1CC(F)(F)C(=O)N1CCCc1ccc(C(=O)O)s1,6.804100347590767
CHEMBL3968443,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,1020.0,nM,CHEMBL3887484,B,"SEAP Activity Assay: 1. Seed cells on an EP2 or EP4 STEP plate at a density of 40,000-80,000 cells/well in 200 ul of reduced serum medium containing 0.5% FBS. Place the plate in a 37 C. incubator with 5% CO2 and incubate overnight. 2. After 16-18 hours of incubation, aspirate the culture media from each well. 3. Add 200 ul of culture medium containing different concentration of test compounds to the assigned wells. For each test compound, at least 8 concentrations starting at highest 10 M and lowest 0.01 pM were tested. In addition each concentration had triplicates. A PGE2 curve (concentrations from lowest to highest, 0 pM, 0.384 pM, 1.92 pM, 9.6 pM, 48 pM, 240 pM, 1200 pM, and 6000 pM) was always run in parallel with test compounds. 4. After 6-8 hours of stimulation with test compounds and PGE2, 10 ul of culture media from each well was transferred to a corresponding well of a 96-well solid black plate. Cover the plate with the lid.",CHEMBL3886335,EC50,C[C@@H](CCCCCc1ccccc1)[C@H](O)/C=C/[C@H]1CC(F)(F)C(=O)N1CCCc1ccc(C(=O)O)s1,5.991399828238082
CHEMBL3893847,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,79000.0,nM,CHEMBL3887484,B,"SEAP Activity Assay: 1. Seed cells on an EP2 or EP4 STEP plate at a density of 40,000-80,000 cells/well in 200 ul of reduced serum medium containing 0.5% FBS. Place the plate in a 37 C. incubator with 5% CO2 and incubate overnight. 2. After 16-18 hours of incubation, aspirate the culture media from each well. 3. Add 200 ul of culture medium containing different concentration of test compounds to the assigned wells. For each test compound, at least 8 concentrations starting at highest 10 M and lowest 0.01 pM were tested. In addition each concentration had triplicates. A PGE2 curve (concentrations from lowest to highest, 0 pM, 0.384 pM, 1.92 pM, 9.6 pM, 48 pM, 240 pM, 1200 pM, and 6000 pM) was always run in parallel with test compounds. 4. After 6-8 hours of stimulation with test compounds and PGE2, 10 ul of culture media from each well was transferred to a corresponding well of a 96-well solid black plate. Cover the plate with the lid.",CHEMBL3886335,EC50,C[C@@H](CCCCCc1ccccc1)[C@@H](O)/C=C/[C@H]1CC(F)(F)C(=O)N1CCCc1ccc(C(=O)O)s1,4.102372908709558
CHEMBL3965497,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,96.0,nM,CHEMBL3888401,B,"Radioligand Binding: HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, or EP4 receptors were washed with TME buffer, scraped from the bottom of the flasks, and homogenized for 30 sec using a Brinkman PT 10/35 polytron. TME buffer was added to achieve a final 40 ml volume in the centrifuge tubes (the composition of TME is 100 mM TRIS base, 20 mM MgCl2, 2M EDTA; 10N HCl is added to achieve a pH of 7.4). The cell homogenate was centrifuged at 19000 r.p.m. for 20 min at 4 C. using a Beckman Ti-60 rotor. The resultant pellet was resuspended in TME buffer to give a final 1 mg/ml protein concentration, as determined by Biorad assay. Radioligand binding competition assays vs. [3H-]17-phenyl PGF2a (5 nM) were performed in a 100 l volume for 60 min. Binding reactions were started by adding plasma membrane fraction. The reaction was terminated by the addition of 4 ml ice-cold TRIS-HCl buffer and rapid filtration through glass fiber GF/B filters using a Brandel cell harvester. The filters were washed 3 times with ice-cold buffer and oven dried for one hour. [3H] PGE2 (specific activity 180 Ci mmol) was used as the radioligand for EP receptors. [3H] 17-phenyl PGF2a was employed for FP receptor binding studies. Binding studies employing EP1, EP2, EP4 and FP receptors were performed in duplicate in at least three separate experiments. A 200 l assay volume was used. Incubations were for 60 min at 25 C. and were terminated by the addition of 4 ml of ice-cold 50 mM TRIS-HCl, followed by rapid filtration through Whatman GF/B filters and three additional 4 ml washes in a cell harvester (Brandel). Competition studies were performed using a final concentration of 5 nM [3H]-PGE2, or 5 nM [3H] 17-phenyl PGF2a and non-specific binding determined with 10^5M of unlabeled PGE2, or 17-phenyl PGF2a, according to receptor subtype studied.",CHEMBL3886696,EC50,O=C(O)c1ccc(CCCN2[C@@H](/C=C/C(O)Cc3cccc(OC(F)(F)F)c3)CCS2(=O)=O)s1,7.017728766960431
CHEMBL815,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,4200.0,nM,CHEMBL767812,B,Affinity for Prostanoid EP4 receptor expressed in CHO cells,CHEMBL1132967,IC50,CCCCC[C@H](O)/C=C/[C@@H]1[C@@H](C/C=C\CCCC(=O)O)[C@@H](O)C[C@H]1O,5.376750709602099
CHEMBL815,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,4200.0,nM,CHEMBL767813,B,In vitro binding at EP4 human prostaglandin receptor using [3H]PGE-2 as radioligand,CHEMBL1134785,IC50,CCCCC[C@H](O)/C=C/[C@@H]1[C@@H](C/C=C\CCCC(=O)O)[C@@H](O)C[C@H]1O,5.376750709602099
CHEMBL548,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,0.7,nM,CHEMBL765917,B,Inhibitory activity against human EP4 receptor expressed in HEK293 ebna cells,CHEMBL1136653,IC50,CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O,9.154901959985743
CHEMBL275667,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,1.4,nM,CHEMBL767814,B,Inhibitory activity against human EP4 receptor expressed in HEK293 ebna cells,CHEMBL1136653,IC50,O=C1CC[C@H](/C=C/[C@@H](O)Cc2ccccc2)N1CCCCCCc1nnn[nH]1,8.853871964321762
CHEMBL231184,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,15848.93,nM,CHEMBL887240,B,Binding affinity to human EP4 receptor expressed in CHO cells,CHEMBL1144577,IC50,Cc1ccc(-n2c(C)ccc2-c2cc(Cl)ccc2OCc2ccc(F)cc2)cc1C(=O)O,4.800000052738446
CHEMBL427844,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,158.49,nM,CHEMBL890036,B,Inhibition of EP4 receptor,CHEMBL1146289,IC50,CC(=O)Nc1cc(C(=O)O)cc(-n2c(C)ccc2-c2cc(Br)ccc2OCc2ccc(F)cc2F)c1,6.799998134593398
CHEMBL400404,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,24000.0,nM,CHEMBL896001,B,Inhibition of human recombinant EP4 receptor expressed in 293EBNA cells,CHEMBL1148848,IC50,CC(=O)Nc1cccc(-c2ccc(Cc3ocnc3C(=O)N[C@@H](Cc3ccccc3)C(=O)O)cc2)c1,4.619788758288394
CHEMBL521609,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,12500.0,nM,CHEMBL960019,B,Displacement of radioligand from EP4 receptor,CHEMBL1153263,IC50,Cn1cc(/C=C/C(=O)NS(=O)(=O)c2ccc(F)c(F)c2)c2c(Oc3ccc4ccccc4c3)cccc21,4.903089986991944
CHEMBL489310,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,20400.0,nM,CHEMBL960019,B,Displacement of radioligand from EP4 receptor,CHEMBL1153263,IC50,Cn1cc(/C=C/C(=O)NS(=O)(=O)c2ccc(F)c(F)c2)c2c(Oc3ccc(Cl)c(Cl)c3)cccc21,4.690369832574102
CHEMBL459885,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,14600.0,nM,CHEMBL960019,B,Displacement of radioligand from EP4 receptor,CHEMBL1153263,IC50,Cn1cc(/C=C/C(=O)NS(=O)(=O)c2ccc(F)c(F)c2)c2c(Oc3ccc(Cl)cc3Cl)cccc21,4.835647144215563
CHEMBL475348,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,13000.0,nM,CHEMBL960019,B,Displacement of radioligand from EP4 receptor,CHEMBL1153263,IC50,Cn1cc(/C=C/C(=O)NS(=O)(=O)c2cc(F)c(F)cc2F)c2c(Oc3ccc(Cl)c(Cl)c3)cccc21,4.886056647693163
CHEMBL521777,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,10000.0,nM,CHEMBL960019,B,Displacement of radioligand from EP4 receptor,CHEMBL1153263,IC50,Cn1cc(/C=C/C(=O)NS(=O)(=O)c2cc(F)c(F)cc2F)c2c(Oc3ccc(Cl)c(F)c3)cccc21,5.0
CHEMBL461571,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,3700.0,nM,CHEMBL980761,B,Inhibition of prostanoid EP4 receptor,CHEMBL1139415,IC50,Cc1c(C(=O)c2ccc(Cl)cc2)c2ccc(OC(F)(F)F)cc2n1Cc1cccc(O[C@H](C)C(=O)O)c1,5.431798275933005
CHEMBL548,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,3.8,nM,CHEMBL947374,B,Displacement of radiolabeled PGE2 from human prostanoid EP4 receptor,CHEMBL1140203,IC50,CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O,8.42021640338319
CHEMBL482330,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,7500.0,nM,CHEMBL1023730,B,Binding affinity to human EP4 receptor by radioligand binding assay,CHEMBL1143334,IC50,COc1cccc(CN2C(=O)CC3(C)CCCC(/C=C/C(=O)NS(=O)(=O)c4ccc(F)c(F)c4)=C23)c1,5.1249387366083
CHEMBL479664,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,7700.0,nM,CHEMBL1023730,B,Binding affinity to human EP4 receptor by radioligand binding assay,CHEMBL1143334,IC50,CC12CCCC(/C=C/C(=O)NS(=O)(=O)c3ccc(F)c(F)c3)=C1N(Cc1ccc(F)c(F)c1)C(=O)C2,5.113509274827518
CHEMBL482018,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,20800.0,nM,CHEMBL1023730,B,Binding affinity to human EP4 receptor by radioligand binding assay,CHEMBL1143334,IC50,CC12CCCC(/C=C/C(=O)NS(=O)(=O)c3cc(F)c(F)cc3F)=C1N(Cc1cccc(Cl)c1Cl)C(=O)C2,4.681936665037238
CHEMBL479439,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,20800.0,nM,CHEMBL1023730,B,Binding affinity to human EP4 receptor by radioligand binding assay,CHEMBL1143334,IC50,CC12CCCC(/C=C/C(=O)NS(=O)(=O)c3cc(F)c(F)cc3F)=C1N(Cc1ccc(Cl)cc1Cl)C(=O)C2,4.681936665037238
CHEMBL479263,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,6200.0,nM,CHEMBL1023730,B,Binding affinity to human EP4 receptor by radioligand binding assay,CHEMBL1143334,IC50,CC12CCCC(/C=C/C(=O)NS(=O)(=O)c3cc(F)c(F)cc3F)=C1N(Cc1ccc(F)c(F)c1)C(=O)C2,5.207608310501746
CHEMBL565591,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,8039.0,nM,CHEMBL1045308,B,Displacement of [3H]PGE2 from human EP4 receptor after 1 hr by liquid scintillation counting,CHEMBL1156787,IC50,Cc1cn(Cc2ccc(Cl)cc2Cl)c2c(/C=C/C(=O)NS(=O)(=O)c3cc(Cl)c(Cl)s3)cc(F)cc12,5.094797971337681
CHEMBL565992,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,10172.0,nM,CHEMBL1045308,B,Displacement of [3H]PGE2 from human EP4 receptor after 1 hr by liquid scintillation counting,CHEMBL1156787,IC50,O=C(COc1cccc2ncn(Cc3ccc(Cl)cc3Cl)c12)NS(=O)(=O)c1cc(Cl)c(Cl)s1,4.992593648496329
CHEMBL467632,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,6498.0,nM,CHEMBL1045308,B,Displacement of [3H]PGE2 from human EP4 receptor after 1 hr by liquid scintillation counting,CHEMBL1156787,IC50,O=C(COc1cccc2[nH]cc(Cc3ccc4ccccc4c3)c12)NS(=O)(=O)c1cc(Cl)c(Cl)s1,5.187220292991036
CHEMBL585581,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,8178.0,nM,CHEMBL1045308,B,Displacement of [3H]PGE2 from human EP4 receptor after 1 hr by liquid scintillation counting,CHEMBL1156787,IC50,O=C(/C=C/c1cccc2ccn(Cc3ccc(Cl)cc3Cl)c12)NS(=O)(=O)c1cccs1,5.0873528937816825
CHEMBL565799,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,3647.0,nM,CHEMBL1045308,B,Displacement of [3H]PGE2 from human EP4 receptor after 1 hr by liquid scintillation counting,CHEMBL1156787,IC50,Cc1cn(Cc2ccc3ccccc3c2)c2c(/C=C/C(=O)NS(=O)(=O)c3cc(Cl)c(Cl)s3)cc(F)cc12,5.438064236686219
CHEMBL1081186,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,18600.0,nM,CHEMBL1101723,B,Binding affinity to human EP4 receptor by radioligand displacement assay,CHEMBL1154363,IC50,Cc1cn(Cc2ccc(Cl)cc2Cl)c2c(-c3cc(NS(=O)(=O)c4ccc(F)c(F)c4)no3)cc(F)cc12,4.730487055782084
CHEMBL1093791,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,15100.0,nM,CHEMBL1107243,B,Binding affinity to human EP4 receptor by radioligand displacement assay,CHEMBL1156157,IC50,O=C(/C=C/c1cccc2c1N(Cc1ccc3ccccc3c1)C(=O)C2O)NS(=O)(=O)c1ccc(F)cc1,4.82102305270683
CHEMBL1093792,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,2300.0,nM,CHEMBL1107243,B,Binding affinity to human EP4 receptor by radioligand displacement assay,CHEMBL1156157,IC50,O=C(/C=C/c1cccc2c1N(Cc1ccc3ccccc3c1)C(=O)C2O)NS(=O)(=O)c1ccc(F)c(F)c1,5.638272163982407
CHEMBL1093125,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,8700.0,nM,CHEMBL1107243,B,Binding affinity to human EP4 receptor by radioligand displacement assay,CHEMBL1156157,IC50,O=C(/C=C/c1cccc2c1N(Cc1ccc3ccccc3c1)C(=O)C2O)NS(=O)(=O)c1cc(F)c(F)cc1F,5.060480747381382
CHEMBL548,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,9.9,nM,CHEMBL1120703,B,Binding affinity to EP4 receptor,CHEMBL1155461,IC50,CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O,8.00436480540245
CHEMBL1669018,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,4.6,nM,CHEMBL1671179,B,Displacement of [3H]PGE2 from human EP4 receptor expressed in HEK293 cells by scintillation counting,CHEMBL1667778,IC50,CCOc1c2c(c(OCC)c3ccccc13)C(=O)N(c1ccc(CC3(NC(=O)Cc4ccccc4OC)CC3)cc1C)C2,8.337242168318426
CHEMBL1669017,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,4.9,nM,CHEMBL1671179,B,Displacement of [3H]PGE2 from human EP4 receptor expressed in HEK293 cells by scintillation counting,CHEMBL1667778,IC50,CCOc1c2c(c(OCC)c3ccccc13)C(=O)N(c1ccc(CC3(NC(=O)Cc4ncccc4OC)CC3)cc1C)C2,8.309803919971486
CHEMBL1669016,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,3.8,nM,CHEMBL1671179,B,Displacement of [3H]PGE2 from human EP4 receptor expressed in HEK293 cells by scintillation counting,CHEMBL1667778,IC50,CCOc1c2c(c(OCC)c3ccccc13)C(=O)N(c1ccc(CC3(NC(=O)Cc4cc(C(=O)O)ccc4OC)CC3)cc1C)C2,8.42021640338319
CHEMBL1669015,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,6.0,nM,CHEMBL1671179,B,Displacement of [3H]PGE2 from human EP4 receptor expressed in HEK293 cells by scintillation counting,CHEMBL1667778,IC50,CCOc1c2c(c(OCC)c3ccccc13)C(=O)N(c1ccc(CC3(NC(=O)Cc4ccccc4Cl)CC3)cc1C)C2,8.221848749616356
CHEMBL1669014,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,2.1,nM,CHEMBL1671179,B,Displacement of [3H]PGE2 from human EP4 receptor expressed in HEK293 cells by scintillation counting,CHEMBL1667778,IC50,CCOc1c2c(c(OCC)c3ccccc13)C(=O)N(c1ccc(CC3(NC(=O)Cc4ccc(Cl)cc4Cl)CC3)cc1C)C2,8.67778070526608
CHEMBL1669018,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,16.0,nM,CHEMBL1671180,B,Displacement of [3H]PGE2 from human EP4 receptor expressed in HEK293 cells by scintillation counting in presence of 10% human serum,CHEMBL1667778,IC50,CCOc1c2c(c(OCC)c3ccccc13)C(=O)N(c1ccc(CC3(NC(=O)Cc4ccccc4OC)CC3)cc1C)C2,7.795880017344075
CHEMBL1669017,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,23.6,nM,CHEMBL1671180,B,Displacement of [3H]PGE2 from human EP4 receptor expressed in HEK293 cells by scintillation counting in presence of 10% human serum,CHEMBL1667778,IC50,CCOc1c2c(c(OCC)c3ccccc13)C(=O)N(c1ccc(CC3(NC(=O)Cc4ncccc4OC)CC3)cc1C)C2,7.627087997029893
CHEMBL1669016,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,60.6,nM,CHEMBL1671180,B,Displacement of [3H]PGE2 from human EP4 receptor expressed in HEK293 cells by scintillation counting in presence of 10% human serum,CHEMBL1667778,IC50,CCOc1c2c(c(OCC)c3ccccc13)C(=O)N(c1ccc(CC3(NC(=O)Cc4cc(C(=O)O)ccc4OC)CC3)cc1C)C2,7.217527375833714
CHEMBL1669015,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,35.1,nM,CHEMBL1671180,B,Displacement of [3H]PGE2 from human EP4 receptor expressed in HEK293 cells by scintillation counting in presence of 10% human serum,CHEMBL1667778,IC50,CCOc1c2c(c(OCC)c3ccccc13)C(=O)N(c1ccc(CC3(NC(=O)Cc4ccccc4Cl)CC3)cc1C)C2,7.454692883534176
CHEMBL1669014,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,10.2,nM,CHEMBL1671180,B,Displacement of [3H]PGE2 from human EP4 receptor expressed in HEK293 cells by scintillation counting in presence of 10% human serum,CHEMBL1667778,IC50,CCOc1c2c(c(OCC)c3ccccc13)C(=O)N(c1ccc(CC3(NC(=O)Cc4ccc(Cl)cc4Cl)CC3)cc1C)C2,7.991399828238082
CHEMBL1669013,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,1.5,nM,CHEMBL1671179,B,Displacement of [3H]PGE2 from human EP4 receptor expressed in HEK293 cells by scintillation counting,CHEMBL1667778,IC50,CCOc1c2c(c(OCC)c3ccccc13)C(=O)N(c1ccc(CC3(NC(=O)NS(=O)(=O)c4ccc(C)cc4)CC3)cc1C)C2,8.823908740944319
CHEMBL1669013,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,17.0,nM,CHEMBL1671180,B,Displacement of [3H]PGE2 from human EP4 receptor expressed in HEK293 cells by scintillation counting in presence of 10% human serum,CHEMBL1667778,IC50,CCOc1c2c(c(OCC)c3ccccc13)C(=O)N(c1ccc(CC3(NC(=O)NS(=O)(=O)c4ccc(C)cc4)CC3)cc1C)C2,7.769551078621726
CHEMBL1669012,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,2.4,nM,CHEMBL1671179,B,Displacement of [3H]PGE2 from human EP4 receptor expressed in HEK293 cells by scintillation counting,CHEMBL1667778,IC50,CCOc1c2c(c(OCC)c3ccccc13)C(=O)N(c1ccc(CC3(NC(=O)NS(=O)(=O)c4ccccc4Cl)CC3)cc1C)C2,8.619788758288394
CHEMBL1669012,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,33.0,nM,CHEMBL1671180,B,Displacement of [3H]PGE2 from human EP4 receptor expressed in HEK293 cells by scintillation counting in presence of 10% human serum,CHEMBL1667778,IC50,CCOc1c2c(c(OCC)c3ccccc13)C(=O)N(c1ccc(CC3(NC(=O)NS(=O)(=O)c4ccccc4Cl)CC3)cc1C)C2,7.481486060122112
CHEMBL1669011,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,3.0,nM,CHEMBL1671179,B,Displacement of [3H]PGE2 from human EP4 receptor expressed in HEK293 cells by scintillation counting,CHEMBL1667778,IC50,Cc1cc(CC2(NC(=O)NS(=O)(=O)c3ccccc3Cl)CC2)ccc1N1Cc2c(c(OCC(F)(F)F)c3cccnc3c2OCC(F)(F)F)C1=O,8.522878745280337
CHEMBL1669011,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,48.0,nM,CHEMBL1671180,B,Displacement of [3H]PGE2 from human EP4 receptor expressed in HEK293 cells by scintillation counting in presence of 10% human serum,CHEMBL1667778,IC50,Cc1cc(CC2(NC(=O)NS(=O)(=O)c3ccccc3Cl)CC2)ccc1N1Cc2c(c(OCC(F)(F)F)c3cccnc3c2OCC(F)(F)F)C1=O,7.318758762624412
CHEMBL1669010,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,3.3,nM,CHEMBL1671179,B,Displacement of [3H]PGE2 from human EP4 receptor expressed in HEK293 cells by scintillation counting,CHEMBL1667778,IC50,CCOc1c2c(c(OCC)c3ccccc13)C(=O)N(c1ccc(CC3(NC(=O)NS(=O)(=O)c4ccccc4C)CC3)cc1C)C2,8.481486060122112
CHEMBL1669010,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,14.0,nM,CHEMBL1671180,B,Displacement of [3H]PGE2 from human EP4 receptor expressed in HEK293 cells by scintillation counting in presence of 10% human serum,CHEMBL1667778,IC50,CCOc1c2c(c(OCC)c3ccccc13)C(=O)N(c1ccc(CC3(NC(=O)NS(=O)(=O)c4ccccc4C)CC3)cc1C)C2,7.853871964321762
CHEMBL1669009,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,3.8,nM,CHEMBL1671179,B,Displacement of [3H]PGE2 from human EP4 receptor expressed in HEK293 cells by scintillation counting,CHEMBL1667778,IC50,CCOc1c2c(c(OCC)c3ccccc13)C(=O)N(c1ccc(CC3(NC(=O)NS(=O)(=O)c4ccccc4OC)CC3)cc1C)C2,8.42021640338319
CHEMBL1669009,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,23.0,nM,CHEMBL1671180,B,Displacement of [3H]PGE2 from human EP4 receptor expressed in HEK293 cells by scintillation counting in presence of 10% human serum,CHEMBL1667778,IC50,CCOc1c2c(c(OCC)c3ccccc13)C(=O)N(c1ccc(CC3(NC(=O)NS(=O)(=O)c4ccccc4OC)CC3)cc1C)C2,7.638272163982407
CHEMBL1669008,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,3.0,nM,CHEMBL1671179,B,Displacement of [3H]PGE2 from human EP4 receptor expressed in HEK293 cells by scintillation counting,CHEMBL1667778,IC50,CCOc1c2c(c(OCC)c3ccccc13)C(=O)N(c1ccc(CC3(NC(=O)NS(=O)(=O)c4c(Cl)cccc4Cl)CC3)cc1C)C2,8.522878745280337
CHEMBL1669008,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,14.0,nM,CHEMBL1671180,B,Displacement of [3H]PGE2 from human EP4 receptor expressed in HEK293 cells by scintillation counting in presence of 10% human serum,CHEMBL1667778,IC50,CCOc1c2c(c(OCC)c3ccccc13)C(=O)N(c1ccc(CC3(NC(=O)NS(=O)(=O)c4c(Cl)cccc4Cl)CC3)cc1C)C2,7.853871964321762
CHEMBL1669007,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,2.5,nM,CHEMBL1671179,B,Displacement of [3H]PGE2 from human EP4 receptor expressed in HEK293 cells by scintillation counting,CHEMBL1667778,IC50,CCOc1c2c(c(OCC)c3ccccc13)C(=O)N(c1ccc(CC3(NC(=O)NS(=O)(=O)c4ccc5ccccc5c4)CC3)cc1C)C2,8.602059991327963
CHEMBL1669007,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,37.0,nM,CHEMBL1671180,B,Displacement of [3H]PGE2 from human EP4 receptor expressed in HEK293 cells by scintillation counting in presence of 10% human serum,CHEMBL1667778,IC50,CCOc1c2c(c(OCC)c3ccccc13)C(=O)N(c1ccc(CC3(NC(=O)NS(=O)(=O)c4ccc5ccccc5c4)CC3)cc1C)C2,7.431798275933005
CHEMBL1669006,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,3.3,nM,CHEMBL1671179,B,Displacement of [3H]PGE2 from human EP4 receptor expressed in HEK293 cells by scintillation counting,CHEMBL1667778,IC50,CCOc1c2c(c(OCC)c3ccccc13)C(=O)N(c1ccc(CC3(NC(=O)NS(=O)(=O)c4ccccc4C(F)(F)F)CC3)cc1C)C2,8.481486060122112
CHEMBL1669006,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,28.0,nM,CHEMBL1671180,B,Displacement of [3H]PGE2 from human EP4 receptor expressed in HEK293 cells by scintillation counting in presence of 10% human serum,CHEMBL1667778,IC50,CCOc1c2c(c(OCC)c3ccccc13)C(=O)N(c1ccc(CC3(NC(=O)NS(=O)(=O)c4ccccc4C(F)(F)F)CC3)cc1C)C2,7.552841968657781
CHEMBL1669005,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,3.3,nM,CHEMBL1671179,B,Displacement of [3H]PGE2 from human EP4 receptor expressed in HEK293 cells by scintillation counting,CHEMBL1667778,IC50,CCOc1c2c(c(OCC)c3ccccc13)C(=O)N(c1ccc(CC3(NC(=O)NS(=O)(=O)c4c(OC)cccc4OC)CC3)cc1C)C2,8.481486060122112
CHEMBL1669005,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,21.0,nM,CHEMBL1671180,B,Displacement of [3H]PGE2 from human EP4 receptor expressed in HEK293 cells by scintillation counting in presence of 10% human serum,CHEMBL1667778,IC50,CCOc1c2c(c(OCC)c3ccccc13)C(=O)N(c1ccc(CC3(NC(=O)NS(=O)(=O)c4c(OC)cccc4OC)CC3)cc1C)C2,7.6777807052660805
CHEMBL1669004,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,2.2,nM,CHEMBL1671179,B,Displacement of [3H]PGE2 from human EP4 receptor expressed in HEK293 cells by scintillation counting,CHEMBL1667778,IC50,CCOc1c2c(c(OCC)c3ccccc13)C(=O)N(c1ccc(CC3(NC(=O)NS(=O)(=O)c4ccccc4Br)CC3)cc1C)C2,8.657577319177793
CHEMBL1669004,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,22.0,nM,CHEMBL1671180,B,Displacement of [3H]PGE2 from human EP4 receptor expressed in HEK293 cells by scintillation counting in presence of 10% human serum,CHEMBL1667778,IC50,CCOc1c2c(c(OCC)c3ccccc13)C(=O)N(c1ccc(CC3(NC(=O)NS(=O)(=O)c4ccccc4Br)CC3)cc1C)C2,7.657577319177793
CHEMBL1669003,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,8.9,nM,CHEMBL1671179,B,Displacement of [3H]PGE2 from human EP4 receptor expressed in HEK293 cells by scintillation counting,CHEMBL1667778,IC50,Cc1cc(CC2(NC(=O)NS(=O)(=O)c3ccc4ccccc4c3)CC2)ccc1N1Cc2c(c(OCC(F)(F)F)c3cccnc3c2OCC(F)(F)F)C1=O,8.050609993355087
CHEMBL1669003,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,103.0,nM,CHEMBL1671180,B,Displacement of [3H]PGE2 from human EP4 receptor expressed in HEK293 cells by scintillation counting in presence of 10% human serum,CHEMBL1667778,IC50,Cc1cc(CC2(NC(=O)NS(=O)(=O)c3ccc4ccccc4c3)CC2)ccc1N1Cc2c(c(OCC(F)(F)F)c3cccnc3c2OCC(F)(F)F)C1=O,6.987162775294828
CHEMBL1669002,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,8.3,nM,CHEMBL1671179,B,Displacement of [3H]PGE2 from human EP4 receptor expressed in HEK293 cells by scintillation counting,CHEMBL1667778,IC50,CCOc1c2c(c(OCC)c3ccccc13)C(=O)N(c1ccc(CC3(NC(=O)NS(=O)(=O)c4ccc(OC(F)(F)F)cc4)CC3)cc1C)C2,8.080921907623926
CHEMBL1669002,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,370.0,nM,CHEMBL1671180,B,Displacement of [3H]PGE2 from human EP4 receptor expressed in HEK293 cells by scintillation counting in presence of 10% human serum,CHEMBL1667778,IC50,CCOc1c2c(c(OCC)c3ccccc13)C(=O)N(c1ccc(CC3(NC(=O)NS(=O)(=O)c4ccc(OC(F)(F)F)cc4)CC3)cc1C)C2,6.431798275933005
CHEMBL1669024,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,4.6,nM,CHEMBL1671179,B,Displacement of [3H]PGE2 from human EP4 receptor expressed in HEK293 cells by scintillation counting,CHEMBL1667778,IC50,CCOc1c2c(c(OCC)c3ccccc13)C(=O)N(c1ccc(CC3(NC(=O)NS(=O)(=O)c4ccc(F)cc4)CC3)cc1C)C2,8.337242168318426
CHEMBL1669024,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,80.0,nM,CHEMBL1671180,B,Displacement of [3H]PGE2 from human EP4 receptor expressed in HEK293 cells by scintillation counting in presence of 10% human serum,CHEMBL1667778,IC50,CCOc1c2c(c(OCC)c3ccccc13)C(=O)N(c1ccc(CC3(NC(=O)NS(=O)(=O)c4ccc(F)cc4)CC3)cc1C)C2,7.096910013008056
CHEMBL1669025,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,2.0,nM,CHEMBL1671179,B,Displacement of [3H]PGE2 from human EP4 receptor expressed in HEK293 cells by scintillation counting,CHEMBL1667778,IC50,CCOc1c2c(c(OCC)c3ccccc13)C(=O)N(c1ccc(CC3(NC(=O)NS(=O)(=O)c4cccc(Cl)c4Cl)CC3)cc1C)C2,8.698970004336019
CHEMBL1669025,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,28.0,nM,CHEMBL1671180,B,Displacement of [3H]PGE2 from human EP4 receptor expressed in HEK293 cells by scintillation counting in presence of 10% human serum,CHEMBL1667778,IC50,CCOc1c2c(c(OCC)c3ccccc13)C(=O)N(c1ccc(CC3(NC(=O)NS(=O)(=O)c4cccc(Cl)c4Cl)CC3)cc1C)C2,7.552841968657781
CHEMBL1669026,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,3.2,nM,CHEMBL1671179,B,Displacement of [3H]PGE2 from human EP4 receptor expressed in HEK293 cells by scintillation counting,CHEMBL1667778,IC50,CCOc1c2c(c(OCC)c3ccccc13)C(=O)N(c1ccc(CC3(NC(=O)NS(=O)(=O)c4c(C)cccc4C)CC3)cc1C)C2,8.494850021680094
CHEMBL1669026,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,19.0,nM,CHEMBL1671180,B,Displacement of [3H]PGE2 from human EP4 receptor expressed in HEK293 cells by scintillation counting in presence of 10% human serum,CHEMBL1667778,IC50,CCOc1c2c(c(OCC)c3ccccc13)C(=O)N(c1ccc(CC3(NC(=O)NS(=O)(=O)c4c(C)cccc4C)CC3)cc1C)C2,7.721246399047171
CHEMBL591666,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,10.0,nM,CHEMBL1913308,B,Displacement of [3H]-PGE2 from human EP4 receptor expressed in HEK293 cells,CHEMBL1909549,IC50,C[C@H](NC(=O)c1cc(Cl)ccc1Oc1ccc(F)cc1)c1ccc(C(=O)O)cc1,8.0
CHEMBL1910022,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,2.0,nM,CHEMBL1913308,B,Displacement of [3H]-PGE2 from human EP4 receptor expressed in HEK293 cells,CHEMBL1909549,IC50,C[C@H](NC(=O)c1cccc2c1Oc1cc(C(F)(F)F)ccc1CC2)c1ccc(C(=O)O)cc1,8.698970004336019
CHEMBL1910023,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,4.0,nM,CHEMBL1913308,B,Displacement of [3H]-PGE2 from human EP4 receptor expressed in HEK293 cells,CHEMBL1909549,IC50,O=C(O)c1ccc(C2(NC(=O)c3cccc4c3Oc3cc(C(F)(F)F)ccc3CC4)CC2)cc1,8.397940008672037
CHEMBL1910024,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,63.0,nM,CHEMBL1913308,B,Displacement of [3H]-PGE2 from human EP4 receptor expressed in HEK293 cells,CHEMBL1909549,IC50,C[C@H](NC(=O)c1cccc2c1Oc1ccc(C(F)(F)F)cc1CC2)c1ccc(C(=O)O)cc1,7.200659450546418
CHEMBL1910025,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,27.0,nM,CHEMBL1913308,B,Displacement of [3H]-PGE2 from human EP4 receptor expressed in HEK293 cells,CHEMBL1909549,IC50,O=C(O)c1ccc(C2(NC(=O)c3cccc4c3Oc3ccc(C(F)(F)F)cc3CC4)CC2)cc1,7.568636235841012
CHEMBL548,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,1.1,nM,CHEMBL2395082,B,Displacement of [3H]PGE2 from human recombinant prostanoid EP4 receptor in CHEM1 cells after 2 hrs,CHEMBL2390918,IC50,CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O,8.958607314841775
CHEMBL548,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,0.45,nM,CHEMBL2394932,B,Binding affinity to human prostanoid EP4 receptor by radioligand displacement assay,CHEMBL2390830,IC50,CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O,9.346787486224656
CHEMBL3115074,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,123.0,nM,CHEMBL3116956,B,Antagonist activity at EP4 receptor in human whole blood assessed as reversal of PGE2 inhibitory effect on LPS-induced TNF-alpha production preincubated for 30 mins followed by LPS/PGE2 addition measured after 20 to 24 hrs by enzyme immunoassay,CHEMBL3112423,IC50,C[C@H](NC(=O)[C@H]1CCCCN1CCOc1ccccc1)c1ccc(C(=O)O)cc1.Cl,6.910094888560602
CHEMBL3260419,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,1000.0,nM,CHEMBL3266970,B,Displacement of [3H]PGE2 from human prostanoid EP4 receptor expressed in cell membranes by scintillation counting,CHEMBL3259671,IC50,Cc1oc(C(=O)O)cc1COc1ccc(-c2ccccc2)cc1,6.0
CHEMBL3260420,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,1200.0,nM,CHEMBL3266970,B,Displacement of [3H]PGE2 from human prostanoid EP4 receptor expressed in cell membranes by scintillation counting,CHEMBL3259671,IC50,CC(C)c1c(C(=O)O)cnn1-c1nc(-c2ccc3ccccc3c2)cs1,5.920818753952375
CHEMBL3260421,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,460.0,nM,CHEMBL3266970,B,Displacement of [3H]PGE2 from human prostanoid EP4 receptor expressed in cell membranes by scintillation counting,CHEMBL3259671,IC50,O=C(O)c1ccc2c(c1)C(=O)N(c1ccc3c(c1)oc1ccccc13)C2=O,6.337242168318426
CHEMBL1537470,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,2600.0,nM,CHEMBL3266970,B,Displacement of [3H]PGE2 from human prostanoid EP4 receptor expressed in cell membranes by scintillation counting,CHEMBL3259671,IC50,O=C(Cc1cccc2ccccc12)Nc1ccccc1C(=O)O,5.585026652029182
CHEMBL3260422,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,1000.0,nM,CHEMBL3266970,B,Displacement of [3H]PGE2 from human prostanoid EP4 receptor expressed in cell membranes by scintillation counting,CHEMBL3259671,IC50,CC(=O)c1ccc(NS(=O)(=O)c2cc(C(=O)Nc3ccc(C(=O)O)cc3)ccc2C)cc1,6.0
CHEMBL3260423,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,4600.0,nM,CHEMBL3266970,B,Displacement of [3H]PGE2 from human prostanoid EP4 receptor expressed in cell membranes by scintillation counting,CHEMBL3259671,IC50,Cc1oc(C(=O)O)cc1COc1ccc2oc3ccccc3c2c1,5.337242168318426
CHEMBL3260426,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,10000.0,nM,CHEMBL3266970,B,Displacement of [3H]PGE2 from human prostanoid EP4 receptor expressed in cell membranes by scintillation counting,CHEMBL3259671,IC50,Cc1oc(C(=O)O)cc1COc1cccc(-c2ccccc2)c1,5.0
CHEMBL3586359,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,18000.0,nM,CHEMBL3588433,B,Displacement of [3H]-PGE2 from human EP4 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,O=c1cc(CN2CCOc3c(Cl)cc(-c4csc5ccccc45)cc3C2)cc[nH]1,4.7447274948966935
CHEMBL3586353,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,3200.0,nM,CHEMBL3588433,B,Displacement of [3H]-PGE2 from human EP4 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,Clc1cc(-c2csc3ccccc23)cc2c1OCCN(Cc1cccnc1)C2,5.494850021680094
CHEMBL3586362,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,20000.0,nM,CHEMBL3588433,B,Displacement of [3H]-PGE2 from human EP4 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,C[C@@H]1COc2c(Cl)cc(-n3ccc4cc(F)ccc43)cc2CN1Cc1cc[nH]c(=O)c1,4.698970004336019
CHEMBL3586361,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,30000.0,nM,CHEMBL3588433,B,Displacement of [3H]-PGE2 from human EP4 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,C[C@@H]1COc2c(Cl)cc(-c3csc4ccccc34)cc2CN1Cc1cc[nH]c(=O)c1,4.522878745280337
CHEMBL3586360,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,30000.0,nM,CHEMBL3588433,B,Displacement of [3H]-PGE2 from human EP4 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,O=c1cc(CN2CCOc3c(Cl)cc(-n4ccc5cc(F)ccc54)cc3C2)cc[nH]1,4.522878745280337
CHEMBL3586309,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,3500.0,nM,CHEMBL3588433,B,Displacement of [3H]-PGE2 from human EP4 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,COc1cc(-c2csc3ccccc23)cc2c1OCCN(Cc1cccnc1)C2,5.455931955649724
CHEMBL3600884,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,121.0,nM,CHEMBL3603412,B,Antagonist activity at EP4 receptor in LPS-stimulated human whole blood assessed as inhibition of PGE2-induced TNF-alpha reduction preincubated for 30 mins followed by PGE2 addition measured after 24 hrs by ELISA,CHEMBL3600314,IC50,C[C@H](NC(=O)[C@H]1CCCCN1CCOc1ccc(F)cc1)c1ccc(C(=O)O)cc1.Cl,6.91721462968355
CHEMBL3600883,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,1209.0,nM,CHEMBL3603412,B,Antagonist activity at EP4 receptor in LPS-stimulated human whole blood assessed as inhibition of PGE2-induced TNF-alpha reduction preincubated for 30 mins followed by PGE2 addition measured after 24 hrs by ELISA,CHEMBL3600314,IC50,C[C@H](NC(=O)[C@H]1CCCCN1CCOc1ccc(C#N)cc1)c1ccc(C(=O)O)cc1.Cl,5.917573699139228
CHEMBL3600788,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,586.0,nM,CHEMBL3603412,B,Antagonist activity at EP4 receptor in LPS-stimulated human whole blood assessed as inhibition of PGE2-induced TNF-alpha reduction preincubated for 30 mins followed by PGE2 addition measured after 24 hrs by ELISA,CHEMBL3600314,IC50,Cl.O=C(O)c1ccc(C2(NC(=O)[C@H]3CCCCN3CCOc3ccccc3)CC2)cc1,6.232102383981909
CHEMBL3600787,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,291.0,nM,CHEMBL3603412,B,Antagonist activity at EP4 receptor in LPS-stimulated human whole blood assessed as inhibition of PGE2-induced TNF-alpha reduction preincubated for 30 mins followed by PGE2 addition measured after 24 hrs by ELISA,CHEMBL3600314,IC50,CC[C@H](NC(=O)[C@H]1CCCCN1CCOc1ccccc1)c1ccc(C(=O)O)cc1.Cl,6.536107011014092
CHEMBL3115074,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,126.0,nM,CHEMBL3603412,B,Antagonist activity at EP4 receptor in LPS-stimulated human whole blood assessed as inhibition of PGE2-induced TNF-alpha reduction preincubated for 30 mins followed by PGE2 addition measured after 24 hrs by ELISA,CHEMBL3600314,IC50,C[C@H](NC(=O)[C@H]1CCCCN1CCOc1ccccc1)c1ccc(C(=O)O)cc1.Cl,6.899629454882437
CHEMBL3600786,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,899.0,nM,CHEMBL3603412,B,Antagonist activity at EP4 receptor in LPS-stimulated human whole blood assessed as inhibition of PGE2-induced TNF-alpha reduction preincubated for 30 mins followed by PGE2 addition measured after 24 hrs by ELISA,CHEMBL3600314,IC50,Cl.O=C(O)c1ccc(CNC(=O)[C@H]2CCCCN2CCOc2ccccc2)cc1,6.046240308266771
CHEMBL3039498,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,1614.0,nM,CHEMBL3603412,B,Antagonist activity at EP4 receptor in LPS-stimulated human whole blood assessed as inhibition of PGE2-induced TNF-alpha reduction preincubated for 30 mins followed by PGE2 addition measured after 24 hrs by ELISA,CHEMBL3600314,IC50,CCc1nc2c(C)nc(C)cc2n1-c1ccc(CCNC(=O)NS(=O)(=O)c2ccc(C)cc2)cc1,5.7920964696139485
CHEMBL3600884,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,71.8,nM,CHEMBL3603410,B,Displacement of [3H]-PGE2 from recombinant human EP4 receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysis,CHEMBL3600314,IC50,C[C@H](NC(=O)[C@H]1CCCCN1CCOc1ccc(F)cc1)c1ccc(C(=O)O)cc1.Cl,7.1438755557577
CHEMBL3600883,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,621.0,nM,CHEMBL3603410,B,Displacement of [3H]-PGE2 from recombinant human EP4 receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysis,CHEMBL3600314,IC50,C[C@H](NC(=O)[C@H]1CCCCN1CCOc1ccc(C#N)cc1)c1ccc(C(=O)O)cc1.Cl,6.20690839982342
CHEMBL3600788,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,77.8,nM,CHEMBL3603410,B,Displacement of [3H]-PGE2 from recombinant human EP4 receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysis,CHEMBL3600314,IC50,Cl.O=C(O)c1ccc(C2(NC(=O)[C@H]3CCCCN3CCOc3ccccc3)CC2)cc1,7.109020403010311
CHEMBL3600787,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,232.0,nM,CHEMBL3603410,B,Displacement of [3H]-PGE2 from recombinant human EP4 receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysis,CHEMBL3600314,IC50,CC[C@H](NC(=O)[C@H]1CCCCN1CCOc1ccccc1)c1ccc(C(=O)O)cc1.Cl,6.634512015109101
CHEMBL3115074,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,68.8,nM,CHEMBL3603410,B,Displacement of [3H]-PGE2 from recombinant human EP4 receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysis,CHEMBL3600314,IC50,C[C@H](NC(=O)[C@H]1CCCCN1CCOc1ccccc1)c1ccc(C(=O)O)cc1.Cl,7.162411561764489
CHEMBL3600786,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,203.0,nM,CHEMBL3603410,B,Displacement of [3H]-PGE2 from recombinant human EP4 receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysis,CHEMBL3600314,IC50,Cl.O=C(O)c1ccc(CNC(=O)[C@H]2CCCCN2CCOc2ccccc2)cc1,6.692503962086787
CHEMBL3039498,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,689.0,nM,CHEMBL3603410,B,Displacement of [3H]-PGE2 from recombinant human EP4 receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysis,CHEMBL3600314,IC50,CCc1nc2c(C)nc(C)cc2n1-c1ccc(CCNC(=O)NS(=O)(=O)c2ccc(C)cc2)cc1,6.161780778092375
CHEMBL3039498,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,1520.0,nM,CHEMBL3744252,B,"Antagonist activity at EP4 receptor in human whole blood assessed as reversal of inhibition of PGE2 mediated LPS-induced TNF alpha production pretreated for 30 mins using 3,3',5,5' tetramethylbiphenyl-4,4'-diamine substrate measured after 20 to 24 hrs by immunoassay",CHEMBL3739413,IC50,CCc1nc2c(C)nc(C)cc2n1-c1ccc(CCNC(=O)NS(=O)(=O)c2ccc(C)cc2)cc1,5.818156412055227
CHEMBL3741642,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,1980.0,nM,CHEMBL3744252,B,"Antagonist activity at EP4 receptor in human whole blood assessed as reversal of inhibition of PGE2 mediated LPS-induced TNF alpha production pretreated for 30 mins using 3,3',5,5' tetramethylbiphenyl-4,4'-diamine substrate measured after 20 to 24 hrs by immunoassay",CHEMBL3739413,IC50,Cc1cc(C(=O)O)cc(C)c1NC(=O)c1cc(-c2ccccc2)nc2ccccc12,5.703334809738469
CHEMBL3739779,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,501.0,nM,CHEMBL3744252,B,"Antagonist activity at EP4 receptor in human whole blood assessed as reversal of inhibition of PGE2 mediated LPS-induced TNF alpha production pretreated for 30 mins using 3,3',5,5' tetramethylbiphenyl-4,4'-diamine substrate measured after 20 to 24 hrs by immunoassay",CHEMBL3739413,IC50,Cc1cc(C(=O)O)cc(C)c1NC(=O)c1cc(-c2cccc(CO)c2)nc2ccccc12,6.300162274132754
CHEMBL3741902,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,312.0,nM,CHEMBL3744252,B,"Antagonist activity at EP4 receptor in human whole blood assessed as reversal of inhibition of PGE2 mediated LPS-induced TNF alpha production pretreated for 30 mins using 3,3',5,5' tetramethylbiphenyl-4,4'-diamine substrate measured after 20 to 24 hrs by immunoassay",CHEMBL3739413,IC50,Cc1ccc(C(=O)O)c(C)c1NC(=O)c1cc(-c2cccc(CO)c2)nc2ccccc12,6.505845405981557
CHEMBL3742015,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,623.0,nM,CHEMBL3744252,B,"Antagonist activity at EP4 receptor in human whole blood assessed as reversal of inhibition of PGE2 mediated LPS-induced TNF alpha production pretreated for 30 mins using 3,3',5,5' tetramethylbiphenyl-4,4'-diamine substrate measured after 20 to 24 hrs by immunoassay",CHEMBL3739413,IC50,Cc1cc(C(=O)O)cc(C)c1NC(=O)c1cc(-c2ccccc2)cc2ccccc12,6.20551195334083
CHEMBL3739435,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,577.0,nM,CHEMBL3744252,B,"Antagonist activity at EP4 receptor in human whole blood assessed as reversal of inhibition of PGE2 mediated LPS-induced TNF alpha production pretreated for 30 mins using 3,3',5,5' tetramethylbiphenyl-4,4'-diamine substrate measured after 20 to 24 hrs by immunoassay",CHEMBL3739413,IC50,Cc1ccc(C(=O)O)c(C)c1NC(=O)c1cc(-c2ccccc2)cc2ccccc12,6.238824186844269
CHEMBL3741430,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,136.0,nM,CHEMBL3744252,B,"Antagonist activity at EP4 receptor in human whole blood assessed as reversal of inhibition of PGE2 mediated LPS-induced TNF alpha production pretreated for 30 mins using 3,3',5,5' tetramethylbiphenyl-4,4'-diamine substrate measured after 20 to 24 hrs by immunoassay",CHEMBL3739413,IC50,Cc1cc(C(=O)O)cc(C)c1NC(=O)c1cc(-c2cccc(CO)c2)cc2ccccc12,6.866461091629782
CHEMBL3740223,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,6.2,nM,CHEMBL3744252,B,"Antagonist activity at EP4 receptor in human whole blood assessed as reversal of inhibition of PGE2 mediated LPS-induced TNF alpha production pretreated for 30 mins using 3,3',5,5' tetramethylbiphenyl-4,4'-diamine substrate measured after 20 to 24 hrs by immunoassay",CHEMBL3739413,IC50,Cc1ccc(C(=O)O)c(C)c1NC(=O)c1cc(-c2cccc(CO)c2)cc2ccccc12,8.207608310501746
CHEMBL3740325,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,243.0,nM,CHEMBL3744252,B,"Antagonist activity at EP4 receptor in human whole blood assessed as reversal of inhibition of PGE2 mediated LPS-induced TNF alpha production pretreated for 30 mins using 3,3',5,5' tetramethylbiphenyl-4,4'-diamine substrate measured after 20 to 24 hrs by immunoassay",CHEMBL3739413,IC50,Cc1ccc(C(=O)O)c(C)c1NC(=O)c1cc(-c2cccc(Cl)c2)cc2ccccc12,6.614393726401688
CHEMBL3039498,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,1600.0,nM,CHEMBL3754944,B,Antagonist activity at EP4 receptor in LPS-stimulated human whole blood assessed as inhibition of PGE2-induced TNF-alpha release pretreated for 30 mins followed by addition of PGE2 measured after 20 to 24 hrs by immunoassay,CHEMBL3751833,IC50,CCc1nc2c(C)nc(C)cc2n1-c1ccc(CCNC(=O)NS(=O)(=O)c2ccc(C)cc2)cc1,5.795880017344075
CHEMBL1669008,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,78.0,nM,CHEMBL3754944,B,Antagonist activity at EP4 receptor in LPS-stimulated human whole blood assessed as inhibition of PGE2-induced TNF-alpha release pretreated for 30 mins followed by addition of PGE2 measured after 20 to 24 hrs by immunoassay,CHEMBL3751833,IC50,CCOc1c2c(c(OCC)c3ccccc13)C(=O)N(c1ccc(CC3(NC(=O)NS(=O)(=O)c4c(Cl)cccc4Cl)CC3)cc1C)C2,7.107905397309519
CHEMBL3740223,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,6.2,nM,CHEMBL3754944,B,Antagonist activity at EP4 receptor in LPS-stimulated human whole blood assessed as inhibition of PGE2-induced TNF-alpha release pretreated for 30 mins followed by addition of PGE2 measured after 20 to 24 hrs by immunoassay,CHEMBL3751833,IC50,Cc1ccc(C(=O)O)c(C)c1NC(=O)c1cc(-c2cccc(CO)c2)cc2ccccc12,8.207608310501746
CHEMBL3740325,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,243.0,nM,CHEMBL3754944,B,Antagonist activity at EP4 receptor in LPS-stimulated human whole blood assessed as inhibition of PGE2-induced TNF-alpha release pretreated for 30 mins followed by addition of PGE2 measured after 20 to 24 hrs by immunoassay,CHEMBL3751833,IC50,Cc1ccc(C(=O)O)c(C)c1NC(=O)c1cc(-c2cccc(Cl)c2)cc2ccccc12,6.614393726401688
CHEMBL3753274,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,59.5,nM,CHEMBL3754944,B,Antagonist activity at EP4 receptor in LPS-stimulated human whole blood assessed as inhibition of PGE2-induced TNF-alpha release pretreated for 30 mins followed by addition of PGE2 measured after 20 to 24 hrs by immunoassay,CHEMBL3751833,IC50,Cc1ccc(-c2cccc(CO)c2)cc1C(=O)Nc1c(C)ccc(C(=O)O)c1C,7.22548303427145
CHEMBL3753133,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,72.4,nM,CHEMBL3754944,B,Antagonist activity at EP4 receptor in LPS-stimulated human whole blood assessed as inhibition of PGE2-induced TNF-alpha release pretreated for 30 mins followed by addition of PGE2 measured after 20 to 24 hrs by immunoassay,CHEMBL3751833,IC50,Cc1ccc(C(=O)O)c(C)c1NC(=O)c1cc(-c2cccc(CO)c2)ccc1F,7.140261433802853
CHEMBL3753860,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,18.7,nM,CHEMBL3754944,B,Antagonist activity at EP4 receptor in LPS-stimulated human whole blood assessed as inhibition of PGE2-induced TNF-alpha release pretreated for 30 mins followed by addition of PGE2 measured after 20 to 24 hrs by immunoassay,CHEMBL3751833,IC50,Cc1ccc(-c2cccc(CO)c2)cc1C(=O)Nc1c(C)cc(C(=O)O)cc1C,7.7281583934635005
CHEMBL3753567,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,47.8,nM,CHEMBL3754944,B,Antagonist activity at EP4 receptor in LPS-stimulated human whole blood assessed as inhibition of PGE2-induced TNF-alpha release pretreated for 30 mins followed by addition of PGE2 measured after 20 to 24 hrs by immunoassay,CHEMBL3751833,IC50,Cc1cc(C(=O)O)cc(C)c1NC(=O)c1cc(-c2cccc(CO)c2)ccc1F,7.320572103387882
CHEMBL3754085,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,38.7,nM,CHEMBL3754944,B,Antagonist activity at EP4 receptor in LPS-stimulated human whole blood assessed as inhibition of PGE2-induced TNF-alpha release pretreated for 30 mins followed by addition of PGE2 measured after 20 to 24 hrs by immunoassay,CHEMBL3751833,IC50,Cc1ccc(-c2cccc(CO)c2)nc1C(=O)Nc1c(C)ccc(C(=O)O)c1C,7.412289034981089
CHEMBL3753286,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,59.0,nM,CHEMBL3754944,B,Antagonist activity at EP4 receptor in LPS-stimulated human whole blood assessed as inhibition of PGE2-induced TNF-alpha release pretreated for 30 mins followed by addition of PGE2 measured after 20 to 24 hrs by immunoassay,CHEMBL3751833,IC50,Cc1ccc(C(=O)O)c(C)c1NC(=O)c1nc(-c2cccc(CO)c2)ccc1C(F)(F)F,7.229147988357855
CHEMBL3753835,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,56.3,nM,CHEMBL3754944,B,Antagonist activity at EP4 receptor in LPS-stimulated human whole blood assessed as inhibition of PGE2-induced TNF-alpha release pretreated for 30 mins followed by addition of PGE2 measured after 20 to 24 hrs by immunoassay,CHEMBL3751833,IC50,Cc1ccc(-c2cccc(CO)c2)nc1C(=O)Nc1c(C)cc(C(=O)O)cc1C,7.249491605148654
CHEMBL3752948,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,121.0,nM,CHEMBL3754944,B,Antagonist activity at EP4 receptor in LPS-stimulated human whole blood assessed as inhibition of PGE2-induced TNF-alpha release pretreated for 30 mins followed by addition of PGE2 measured after 20 to 24 hrs by immunoassay,CHEMBL3751833,IC50,Cc1cc(C(=O)O)cc(C)c1NC(=O)c1nc(-c2cccc(CO)c2)ccc1C(F)(F)F,6.91721462968355
CHEMBL3753372,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,637.0,nM,CHEMBL3754944,B,Antagonist activity at EP4 receptor in LPS-stimulated human whole blood assessed as inhibition of PGE2-induced TNF-alpha release pretreated for 30 mins followed by addition of PGE2 measured after 20 to 24 hrs by immunoassay,CHEMBL3751833,IC50,Cc1ccc(-c2cccc(Cl)c2)nc1C(=O)Nc1c(C)ccc(C(=O)O)c1C,6.195860567664649
CHEMBL3686863,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,123.0,nM,CHEMBL3795721,B,Antagonist activity against EP4 in human whole blood assessed as reversal of PGE2-mediated suppression of LPS-induced TNF-alpha production preincubated for 30 mins followed by LPS stimulation measured after 20 to 24 hrs by enzyme immunoassay,CHEMBL3792364,IC50,Cc1ccc(N2CCC(O)CC2)nc1C(=O)Nc1c(C)cc(C(=O)O)cc1C,6.910094888560602
CHEMBL3793924,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,3600.0,nM,CHEMBL3795721,B,Antagonist activity against EP4 in human whole blood assessed as reversal of PGE2-mediated suppression of LPS-induced TNF-alpha production preincubated for 30 mins followed by LPS stimulation measured after 20 to 24 hrs by enzyme immunoassay,CHEMBL3792364,IC50,Cc1ccc(N2CCC(C)(O)CC2)nc1C(=O)Nc1c(C)cc(C(=O)O)cc1C,5.443697499232712
CHEMBL3793002,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,1160.0,nM,CHEMBL3795721,B,Antagonist activity against EP4 in human whole blood assessed as reversal of PGE2-mediated suppression of LPS-induced TNF-alpha production preincubated for 30 mins followed by LPS stimulation measured after 20 to 24 hrs by enzyme immunoassay,CHEMBL3792364,IC50,Cc1ccc(N2CCC(F)(F)CC2)nc1C(=O)Nc1c(C)cc(C(=O)O)cc1C,5.935542010773082
CHEMBL3793956,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,1450.0,nM,CHEMBL3795721,B,Antagonist activity against EP4 in human whole blood assessed as reversal of PGE2-mediated suppression of LPS-induced TNF-alpha production preincubated for 30 mins followed by LPS stimulation measured after 20 to 24 hrs by enzyme immunoassay,CHEMBL3792364,IC50,Cc1ccc(N2CCCC(CO)C2)nc1C(=O)Nc1c(C)cc(C(=O)O)cc1C,5.838631997765026
CHEMBL3792709,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,1450.0,nM,CHEMBL3795721,B,Antagonist activity against EP4 in human whole blood assessed as reversal of PGE2-mediated suppression of LPS-induced TNF-alpha production preincubated for 30 mins followed by LPS stimulation measured after 20 to 24 hrs by enzyme immunoassay,CHEMBL3792364,IC50,Cc1ccc(N2CCC(O)CC2)nc1C(=O)Nc1c(C)ccc(C(=O)O)c1C,5.838631997765026
CHEMBL3793928,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,2890.0,nM,CHEMBL3795721,B,Antagonist activity against EP4 in human whole blood assessed as reversal of PGE2-mediated suppression of LPS-induced TNF-alpha production preincubated for 30 mins followed by LPS stimulation measured after 20 to 24 hrs by enzyme immunoassay,CHEMBL3792364,IC50,Cc1ccc(N2CCCC(CO)C2)nc1C(=O)Nc1c(C)ccc(C(=O)O)c1C,5.539102157243452
CHEMBL3754085,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,38.7,nM,CHEMBL3795721,B,Antagonist activity against EP4 in human whole blood assessed as reversal of PGE2-mediated suppression of LPS-induced TNF-alpha production preincubated for 30 mins followed by LPS stimulation measured after 20 to 24 hrs by enzyme immunoassay,CHEMBL3792364,IC50,Cc1ccc(-c2cccc(CO)c2)nc1C(=O)Nc1c(C)ccc(C(=O)O)c1C,7.412289034981089
CHEMBL3039498,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,1520.0,nM,CHEMBL3795721,B,Antagonist activity against EP4 in human whole blood assessed as reversal of PGE2-mediated suppression of LPS-induced TNF-alpha production preincubated for 30 mins followed by LPS stimulation measured after 20 to 24 hrs by enzyme immunoassay,CHEMBL3792364,IC50,CCc1nc2c(C)nc(C)cc2n1-c1ccc(CCNC(=O)NS(=O)(=O)c2ccc(C)cc2)cc1,5.818156412055227
CHEMBL548,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,0.55,nM,CHEMBL3876386,B,Displacement of [3H]PGE2 from human recombinant EP4 receptor expressed in HEK293 cells measured after 120 mins by scintillation counting method,CHEMBL3875185,IC50,CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O,9.259637310505756
CHEMBL3939358,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,13100.0,nM,CHEMBL3883095,B,Displacement of [3H]PGE2 from from human EP4 receptor expressed in HEK293 cells membranes incubated for 60 mins,CHEMBL3882734,IC50,COC(=O)CCCCCC[C@@H]1[C@@H](c2ccc3c(c2)CCC3)[C@H](O)C[C@H]1Cl,4.882728704344236
CHEMBL3954286,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,98.0,nM,CHEMBL3887098,B,"Radioligand Binding: HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bottom of the flasks, and homogenized for 30 sec using a Brinkman PT 10/35 polytron. TME buffer was added to achieve a final 40 ml volume in the centrifuge tubes (the composition of TME is 100 mM TRIS base, 20 mM MgCl2, 2M EDTA; 10 N HCl is added to achieve a pH of 7.4).The cell homogenate was centrifuged at 19000 r.p.m. for 20 min at 4 C. using a Beckman Ti-60 rotor. The resultant pellet was resuspended in TME buffer to give a final 1 mg/ml protein concentration, as determined by Biorad assay. Radioligand binding competition assays vs. [3H-]17-phenyl PGF2 (5 nM) were performed in a 100 ul volume for 60 min. Binding reactions were started by adding plasma membrane fraction. The reaction was terminated by the addition of 4 ml ice-cold TRIS-HCl buffer and rapid filtration through glass fiber GF/B filters using a Brandel cell.",CHEMBL3886165,IC50,COC(=O)CSCCCS[C@H]1C(=O)C(C)(C)[C@@H](O)[C@@H]1/C=C/C(O)CCc1sc2ccccc2c1Cl,7.008773924307505
CHEMBL3954286,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,300.0,nM,CHEMBL3887098,B,"Radioligand Binding: HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bottom of the flasks, and homogenized for 30 sec using a Brinkman PT 10/35 polytron. TME buffer was added to achieve a final 40 ml volume in the centrifuge tubes (the composition of TME is 100 mM TRIS base, 20 mM MgCl2, 2M EDTA; 10 N HCl is added to achieve a pH of 7.4).The cell homogenate was centrifuged at 19000 r.p.m. for 20 min at 4 C. using a Beckman Ti-60 rotor. The resultant pellet was resuspended in TME buffer to give a final 1 mg/ml protein concentration, as determined by Biorad assay. Radioligand binding competition assays vs. [3H-]17-phenyl PGF2 (5 nM) were performed in a 100 ul volume for 60 min. Binding reactions were started by adding plasma membrane fraction. The reaction was terminated by the addition of 4 ml ice-cold TRIS-HCl buffer and rapid filtration through glass fiber GF/B filters using a Brandel cell.",CHEMBL3886165,IC50,COC(=O)CSCCCS[C@H]1C(=O)C(C)(C)[C@@H](O)[C@@H]1/C=C/C(O)CCc1sc2ccccc2c1Cl,6.522878745280337
CHEMBL3960625,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,44.0,nM,CHEMBL3887098,B,"Radioligand Binding: HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bottom of the flasks, and homogenized for 30 sec using a Brinkman PT 10/35 polytron. TME buffer was added to achieve a final 40 ml volume in the centrifuge tubes (the composition of TME is 100 mM TRIS base, 20 mM MgCl2, 2M EDTA; 10 N HCl is added to achieve a pH of 7.4).The cell homogenate was centrifuged at 19000 r.p.m. for 20 min at 4 C. using a Beckman Ti-60 rotor. The resultant pellet was resuspended in TME buffer to give a final 1 mg/ml protein concentration, as determined by Biorad assay. Radioligand binding competition assays vs. [3H-]17-phenyl PGF2 (5 nM) were performed in a 100 ul volume for 60 min. Binding reactions were started by adding plasma membrane fraction. The reaction was terminated by the addition of 4 ml ice-cold TRIS-HCl buffer and rapid filtration through glass fiber GF/B filters using a Brandel cell.",CHEMBL3886165,IC50,CC1(C)C(=O)[C@H](SCCCSCC(=O)O)[C@@H](/C=C/C(O)CCc2sc3ccccc3c2Cl)[C@@H]1O,7.356547323513812
CHEMBL3960625,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,29.0,nM,CHEMBL3887098,B,"Radioligand Binding: HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bottom of the flasks, and homogenized for 30 sec using a Brinkman PT 10/35 polytron. TME buffer was added to achieve a final 40 ml volume in the centrifuge tubes (the composition of TME is 100 mM TRIS base, 20 mM MgCl2, 2M EDTA; 10 N HCl is added to achieve a pH of 7.4).The cell homogenate was centrifuged at 19000 r.p.m. for 20 min at 4 C. using a Beckman Ti-60 rotor. The resultant pellet was resuspended in TME buffer to give a final 1 mg/ml protein concentration, as determined by Biorad assay. Radioligand binding competition assays vs. [3H-]17-phenyl PGF2 (5 nM) were performed in a 100 ul volume for 60 min. Binding reactions were started by adding plasma membrane fraction. The reaction was terminated by the addition of 4 ml ice-cold TRIS-HCl buffer and rapid filtration through glass fiber GF/B filters using a Brandel cell.",CHEMBL3886165,IC50,CC1(C)C(=O)[C@H](SCCCSCC(=O)O)[C@@H](/C=C/C(O)CCc2sc3ccccc3c2Cl)[C@@H]1O,7.537602002101044
CHEMBL3971666,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,2455.0,nM,CHEMBL3887098,B,"Radioligand Binding: HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bottom of the flasks, and homogenized for 30 sec using a Brinkman PT 10/35 polytron. TME buffer was added to achieve a final 40 ml volume in the centrifuge tubes (the composition of TME is 100 mM TRIS base, 20 mM MgCl2, 2M EDTA; 10 N HCl is added to achieve a pH of 7.4).The cell homogenate was centrifuged at 19000 r.p.m. for 20 min at 4 C. using a Beckman Ti-60 rotor. The resultant pellet was resuspended in TME buffer to give a final 1 mg/ml protein concentration, as determined by Biorad assay. Radioligand binding competition assays vs. [3H-]17-phenyl PGF2 (5 nM) were performed in a 100 ul volume for 60 min. Binding reactions were started by adding plasma membrane fraction. The reaction was terminated by the addition of 4 ml ice-cold TRIS-HCl buffer and rapid filtration through glass fiber GF/B filters using a Brandel cell.",CHEMBL3886165,IC50,COC(=O)CCCC#CC[C@H]1C(=O)C(C)(C)[C@@H](O)[C@@H]1/C=C\C(O)CCc1sc2ccccc2c1Cl,5.609948503541013
CHEMBL3950189,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,200.0,nM,CHEMBL3887098,B,"Radioligand Binding: HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bottom of the flasks, and homogenized for 30 sec using a Brinkman PT 10/35 polytron. TME buffer was added to achieve a final 40 ml volume in the centrifuge tubes (the composition of TME is 100 mM TRIS base, 20 mM MgCl2, 2M EDTA; 10 N HCl is added to achieve a pH of 7.4).The cell homogenate was centrifuged at 19000 r.p.m. for 20 min at 4 C. using a Beckman Ti-60 rotor. The resultant pellet was resuspended in TME buffer to give a final 1 mg/ml protein concentration, as determined by Biorad assay. Radioligand binding competition assays vs. [3H-]17-phenyl PGF2 (5 nM) were performed in a 100 ul volume for 60 min. Binding reactions were started by adding plasma membrane fraction. The reaction was terminated by the addition of 4 ml ice-cold TRIS-HCl buffer and rapid filtration through glass fiber GF/B filters using a Brandel cell.",CHEMBL3886165,IC50,CC1(C)C(=O)[C@H](CC#CCCCC(=O)O)[C@@H](/C=C\C(O)CCc2sc3ccccc3c2Cl)[C@@H]1O,6.698970004336019
CHEMBL3950189,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,100.0,nM,CHEMBL3887098,B,"Radioligand Binding: HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bottom of the flasks, and homogenized for 30 sec using a Brinkman PT 10/35 polytron. TME buffer was added to achieve a final 40 ml volume in the centrifuge tubes (the composition of TME is 100 mM TRIS base, 20 mM MgCl2, 2M EDTA; 10 N HCl is added to achieve a pH of 7.4).The cell homogenate was centrifuged at 19000 r.p.m. for 20 min at 4 C. using a Beckman Ti-60 rotor. The resultant pellet was resuspended in TME buffer to give a final 1 mg/ml protein concentration, as determined by Biorad assay. Radioligand binding competition assays vs. [3H-]17-phenyl PGF2 (5 nM) were performed in a 100 ul volume for 60 min. Binding reactions were started by adding plasma membrane fraction. The reaction was terminated by the addition of 4 ml ice-cold TRIS-HCl buffer and rapid filtration through glass fiber GF/B filters using a Brandel cell.",CHEMBL3886165,IC50,CC1(C)C(=O)[C@H](CC#CCCCC(=O)O)[C@@H](/C=C\C(O)CCc2sc3ccccc3c2Cl)[C@@H]1O,7.0
CHEMBL3979233,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,2700.0,nM,CHEMBL3887098,B,"Radioligand Binding: HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bottom of the flasks, and homogenized for 30 sec using a Brinkman PT 10/35 polytron. TME buffer was added to achieve a final 40 ml volume in the centrifuge tubes (the composition of TME is 100 mM TRIS base, 20 mM MgCl2, 2M EDTA; 10 N HCl is added to achieve a pH of 7.4).The cell homogenate was centrifuged at 19000 r.p.m. for 20 min at 4 C. using a Beckman Ti-60 rotor. The resultant pellet was resuspended in TME buffer to give a final 1 mg/ml protein concentration, as determined by Biorad assay. Radioligand binding competition assays vs. [3H-]17-phenyl PGF2 (5 nM) were performed in a 100 ul volume for 60 min. Binding reactions were started by adding plasma membrane fraction. The reaction was terminated by the addition of 4 ml ice-cold TRIS-HCl buffer and rapid filtration through glass fiber GF/B filters using a Brandel cell.",CHEMBL3886165,IC50,COC(=O)CCC/C=C\C[C@H]1C(=O)C(C)(C)[C@@H](O)[C@@H]1/C=C/C(O)CCc1sc2ccccc2c1Cl,5.568636235841012
CHEMBL3979233,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,2300.0,nM,CHEMBL3887098,B,"Radioligand Binding: HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bottom of the flasks, and homogenized for 30 sec using a Brinkman PT 10/35 polytron. TME buffer was added to achieve a final 40 ml volume in the centrifuge tubes (the composition of TME is 100 mM TRIS base, 20 mM MgCl2, 2M EDTA; 10 N HCl is added to achieve a pH of 7.4).The cell homogenate was centrifuged at 19000 r.p.m. for 20 min at 4 C. using a Beckman Ti-60 rotor. The resultant pellet was resuspended in TME buffer to give a final 1 mg/ml protein concentration, as determined by Biorad assay. Radioligand binding competition assays vs. [3H-]17-phenyl PGF2 (5 nM) were performed in a 100 ul volume for 60 min. Binding reactions were started by adding plasma membrane fraction. The reaction was terminated by the addition of 4 ml ice-cold TRIS-HCl buffer and rapid filtration through glass fiber GF/B filters using a Brandel cell.",CHEMBL3886165,IC50,COC(=O)CCC/C=C\C[C@H]1C(=O)C(C)(C)[C@@H](O)[C@@H]1/C=C/C(O)CCc1sc2ccccc2c1Cl,5.638272163982407
CHEMBL3955476,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,200.0,nM,CHEMBL3887098,B,"Radioligand Binding: HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bottom of the flasks, and homogenized for 30 sec using a Brinkman PT 10/35 polytron. TME buffer was added to achieve a final 40 ml volume in the centrifuge tubes (the composition of TME is 100 mM TRIS base, 20 mM MgCl2, 2M EDTA; 10 N HCl is added to achieve a pH of 7.4).The cell homogenate was centrifuged at 19000 r.p.m. for 20 min at 4 C. using a Beckman Ti-60 rotor. The resultant pellet was resuspended in TME buffer to give a final 1 mg/ml protein concentration, as determined by Biorad assay. Radioligand binding competition assays vs. [3H-]17-phenyl PGF2 (5 nM) were performed in a 100 ul volume for 60 min. Binding reactions were started by adding plasma membrane fraction. The reaction was terminated by the addition of 4 ml ice-cold TRIS-HCl buffer and rapid filtration through glass fiber GF/B filters using a Brandel cell.",CHEMBL3886165,IC50,CC1(C)C(=O)[C@H](C/C=C\CCCC(=O)O)[C@@H](/C=C/C(O)CCc2sc3ccccc3c2Cl)[C@@H]1O,6.698970004336019
CHEMBL3955476,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,20.0,nM,CHEMBL3887098,B,"Radioligand Binding: HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bottom of the flasks, and homogenized for 30 sec using a Brinkman PT 10/35 polytron. TME buffer was added to achieve a final 40 ml volume in the centrifuge tubes (the composition of TME is 100 mM TRIS base, 20 mM MgCl2, 2M EDTA; 10 N HCl is added to achieve a pH of 7.4).The cell homogenate was centrifuged at 19000 r.p.m. for 20 min at 4 C. using a Beckman Ti-60 rotor. The resultant pellet was resuspended in TME buffer to give a final 1 mg/ml protein concentration, as determined by Biorad assay. Radioligand binding competition assays vs. [3H-]17-phenyl PGF2 (5 nM) were performed in a 100 ul volume for 60 min. Binding reactions were started by adding plasma membrane fraction. The reaction was terminated by the addition of 4 ml ice-cold TRIS-HCl buffer and rapid filtration through glass fiber GF/B filters using a Brandel cell.",CHEMBL3886165,IC50,CC1(C)C(=O)[C@H](C/C=C\CCCC(=O)O)[C@@H](/C=C/C(O)CCc2sc3ccccc3c2Cl)[C@@H]1O,7.698970004336019
CHEMBL3966610,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,400.0,nM,CHEMBL3887098,B,"Radioligand Binding: HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bottom of the flasks, and homogenized for 30 sec using a Brinkman PT 10/35 polytron. TME buffer was added to achieve a final 40 ml volume in the centrifuge tubes (the composition of TME is 100 mM TRIS base, 20 mM MgCl2, 2M EDTA; 10 N HCl is added to achieve a pH of 7.4).The cell homogenate was centrifuged at 19000 r.p.m. for 20 min at 4 C. using a Beckman Ti-60 rotor. The resultant pellet was resuspended in TME buffer to give a final 1 mg/ml protein concentration, as determined by Biorad assay. Radioligand binding competition assays vs. [3H-]17-phenyl PGF2 (5 nM) were performed in a 100 ul volume for 60 min. Binding reactions were started by adding plasma membrane fraction. The reaction was terminated by the addition of 4 ml ice-cold TRIS-HCl buffer and rapid filtration through glass fiber GF/B filters using a Brandel cell.",CHEMBL3886165,IC50,CCCCC[C@H](O)/C=C/[C@@H]1[C@@H](CC#CCCCC(=O)O)C(=O)C(C)(C)[C@H]1O,6.3979400086720375
CHEMBL3895324,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,5.5,nM,CHEMBL3887098,B,"Radioligand Binding: HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bottom of the flasks, and homogenized for 30 sec using a Brinkman PT 10/35 polytron. TME buffer was added to achieve a final 40 ml volume in the centrifuge tubes (the composition of TME is 100 mM TRIS base, 20 mM MgCl2, 2M EDTA; 10 N HCl is added to achieve a pH of 7.4).The cell homogenate was centrifuged at 19000 r.p.m. for 20 min at 4 C. using a Beckman Ti-60 rotor. The resultant pellet was resuspended in TME buffer to give a final 1 mg/ml protein concentration, as determined by Biorad assay. Radioligand binding competition assays vs. [3H-]17-phenyl PGF2 (5 nM) were performed in a 100 ul volume for 60 min. Binding reactions were started by adding plasma membrane fraction. The reaction was terminated by the addition of 4 ml ice-cold TRIS-HCl buffer and rapid filtration through glass fiber GF/B filters using a Brandel cell.",CHEMBL3886165,IC50,CCCCC[C@H](O)/C=C/[C@@H]1[C@@H](C/C=C\CCCC(=O)O)C(=O)C(C)(C)[C@H]1O,8.259637310505756
CHEMBL3978305,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,400.0,nM,CHEMBL3887098,B,"Radioligand Binding: HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bottom of the flasks, and homogenized for 30 sec using a Brinkman PT 10/35 polytron. TME buffer was added to achieve a final 40 ml volume in the centrifuge tubes (the composition of TME is 100 mM TRIS base, 20 mM MgCl2, 2M EDTA; 10 N HCl is added to achieve a pH of 7.4).The cell homogenate was centrifuged at 19000 r.p.m. for 20 min at 4 C. using a Beckman Ti-60 rotor. The resultant pellet was resuspended in TME buffer to give a final 1 mg/ml protein concentration, as determined by Biorad assay. Radioligand binding competition assays vs. [3H-]17-phenyl PGF2 (5 nM) were performed in a 100 ul volume for 60 min. Binding reactions were started by adding plasma membrane fraction. The reaction was terminated by the addition of 4 ml ice-cold TRIS-HCl buffer and rapid filtration through glass fiber GF/B filters using a Brandel cell.",CHEMBL3886165,IC50,CCCCC[C@H](O)/C=C/[C@@H]1[C@@H](C/C=C\CCCC(=O)OC)C(=O)C(C)(C)[C@H]1O,6.3979400086720375
CHEMBL3964563,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,4.0,nM,CHEMBL3887098,B,"Radioligand Binding: HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bottom of the flasks, and homogenized for 30 sec using a Brinkman PT 10/35 polytron. TME buffer was added to achieve a final 40 ml volume in the centrifuge tubes (the composition of TME is 100 mM TRIS base, 20 mM MgCl2, 2M EDTA; 10 N HCl is added to achieve a pH of 7.4).The cell homogenate was centrifuged at 19000 r.p.m. for 20 min at 4 C. using a Beckman Ti-60 rotor. The resultant pellet was resuspended in TME buffer to give a final 1 mg/ml protein concentration, as determined by Biorad assay. Radioligand binding competition assays vs. [3H-]17-phenyl PGF2 (5 nM) were performed in a 100 ul volume for 60 min. Binding reactions were started by adding plasma membrane fraction. The reaction was terminated by the addition of 4 ml ice-cold TRIS-HCl buffer and rapid filtration through glass fiber GF/B filters using a Brandel cell.",CHEMBL3886165,IC50,CC1(C)C(=O)[C@H](C/C=C\CCCC(=O)O)[C@@H](/C=C/C(O)Cc2ccccc2)[C@@H]1O,8.397940008672037
CHEMBL3964563,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,76.0,nM,CHEMBL3887098,B,"Radioligand Binding: HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bottom of the flasks, and homogenized for 30 sec using a Brinkman PT 10/35 polytron. TME buffer was added to achieve a final 40 ml volume in the centrifuge tubes (the composition of TME is 100 mM TRIS base, 20 mM MgCl2, 2M EDTA; 10 N HCl is added to achieve a pH of 7.4).The cell homogenate was centrifuged at 19000 r.p.m. for 20 min at 4 C. using a Beckman Ti-60 rotor. The resultant pellet was resuspended in TME buffer to give a final 1 mg/ml protein concentration, as determined by Biorad assay. Radioligand binding competition assays vs. [3H-]17-phenyl PGF2 (5 nM) were performed in a 100 ul volume for 60 min. Binding reactions were started by adding plasma membrane fraction. The reaction was terminated by the addition of 4 ml ice-cold TRIS-HCl buffer and rapid filtration through glass fiber GF/B filters using a Brandel cell.",CHEMBL3886165,IC50,CC1(C)C(=O)[C@H](C/C=C\CCCC(=O)O)[C@@H](/C=C/C(O)Cc2ccccc2)[C@@H]1O,7.119186407719209
CHEMBL3986534,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,45.0,nM,CHEMBL3887098,B,"Radioligand Binding: HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bottom of the flasks, and homogenized for 30 sec using a Brinkman PT 10/35 polytron. TME buffer was added to achieve a final 40 ml volume in the centrifuge tubes (the composition of TME is 100 mM TRIS base, 20 mM MgCl2, 2M EDTA; 10 N HCl is added to achieve a pH of 7.4).The cell homogenate was centrifuged at 19000 r.p.m. for 20 min at 4 C. using a Beckman Ti-60 rotor. The resultant pellet was resuspended in TME buffer to give a final 1 mg/ml protein concentration, as determined by Biorad assay. Radioligand binding competition assays vs. [3H-]17-phenyl PGF2 (5 nM) were performed in a 100 ul volume for 60 min. Binding reactions were started by adding plasma membrane fraction. The reaction was terminated by the addition of 4 ml ice-cold TRIS-HCl buffer and rapid filtration through glass fiber GF/B filters using a Brandel cell.",CHEMBL3886165,IC50,COC(=O)CCC/C=C\C[C@H]1C(=O)C(C)(C)[C@@H](O)[C@@H]1/C=C/C(O)Cc1ccccc1,7.346787486224656
CHEMBL3986534,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,1400.0,nM,CHEMBL3887098,B,"Radioligand Binding: HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bottom of the flasks, and homogenized for 30 sec using a Brinkman PT 10/35 polytron. TME buffer was added to achieve a final 40 ml volume in the centrifuge tubes (the composition of TME is 100 mM TRIS base, 20 mM MgCl2, 2M EDTA; 10 N HCl is added to achieve a pH of 7.4).The cell homogenate was centrifuged at 19000 r.p.m. for 20 min at 4 C. using a Beckman Ti-60 rotor. The resultant pellet was resuspended in TME buffer to give a final 1 mg/ml protein concentration, as determined by Biorad assay. Radioligand binding competition assays vs. [3H-]17-phenyl PGF2 (5 nM) were performed in a 100 ul volume for 60 min. Binding reactions were started by adding plasma membrane fraction. The reaction was terminated by the addition of 4 ml ice-cold TRIS-HCl buffer and rapid filtration through glass fiber GF/B filters using a Brandel cell.",CHEMBL3886165,IC50,COC(=O)CCC/C=C\C[C@H]1C(=O)C(C)(C)[C@@H](O)[C@@H]1/C=C/C(O)Cc1ccccc1,5.853871964321762
CHEMBL3928703,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,2400.0,nM,CHEMBL3887098,B,"Radioligand Binding: HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bottom of the flasks, and homogenized for 30 sec using a Brinkman PT 10/35 polytron. TME buffer was added to achieve a final 40 ml volume in the centrifuge tubes (the composition of TME is 100 mM TRIS base, 20 mM MgCl2, 2M EDTA; 10 N HCl is added to achieve a pH of 7.4).The cell homogenate was centrifuged at 19000 r.p.m. for 20 min at 4 C. using a Beckman Ti-60 rotor. The resultant pellet was resuspended in TME buffer to give a final 1 mg/ml protein concentration, as determined by Biorad assay. Radioligand binding competition assays vs. [3H-]17-phenyl PGF2 (5 nM) were performed in a 100 ul volume for 60 min. Binding reactions were started by adding plasma membrane fraction. The reaction was terminated by the addition of 4 ml ice-cold TRIS-HCl buffer and rapid filtration through glass fiber GF/B filters using a Brandel cell.",CHEMBL3886165,IC50,COC(=O)CCC/C=C\C[C@H]1C(=O)C(C)(C)[C@@H](O)[C@@H]1/C=C/C(O)CCc1ccccc1,5.619788758288394
CHEMBL3928703,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,700.0,nM,CHEMBL3887098,B,"Radioligand Binding: HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bottom of the flasks, and homogenized for 30 sec using a Brinkman PT 10/35 polytron. TME buffer was added to achieve a final 40 ml volume in the centrifuge tubes (the composition of TME is 100 mM TRIS base, 20 mM MgCl2, 2M EDTA; 10 N HCl is added to achieve a pH of 7.4).The cell homogenate was centrifuged at 19000 r.p.m. for 20 min at 4 C. using a Beckman Ti-60 rotor. The resultant pellet was resuspended in TME buffer to give a final 1 mg/ml protein concentration, as determined by Biorad assay. Radioligand binding competition assays vs. [3H-]17-phenyl PGF2 (5 nM) were performed in a 100 ul volume for 60 min. Binding reactions were started by adding plasma membrane fraction. The reaction was terminated by the addition of 4 ml ice-cold TRIS-HCl buffer and rapid filtration through glass fiber GF/B filters using a Brandel cell.",CHEMBL3886165,IC50,COC(=O)CCC/C=C\C[C@H]1C(=O)C(C)(C)[C@@H](O)[C@@H]1/C=C/C(O)CCc1ccccc1,6.154901959985743
CHEMBL3946494,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,72.0,nM,CHEMBL3887098,B,"Radioligand Binding: HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bottom of the flasks, and homogenized for 30 sec using a Brinkman PT 10/35 polytron. TME buffer was added to achieve a final 40 ml volume in the centrifuge tubes (the composition of TME is 100 mM TRIS base, 20 mM MgCl2, 2M EDTA; 10 N HCl is added to achieve a pH of 7.4).The cell homogenate was centrifuged at 19000 r.p.m. for 20 min at 4 C. using a Beckman Ti-60 rotor. The resultant pellet was resuspended in TME buffer to give a final 1 mg/ml protein concentration, as determined by Biorad assay. Radioligand binding competition assays vs. [3H-]17-phenyl PGF2 (5 nM) were performed in a 100 ul volume for 60 min. Binding reactions were started by adding plasma membrane fraction. The reaction was terminated by the addition of 4 ml ice-cold TRIS-HCl buffer and rapid filtration through glass fiber GF/B filters using a Brandel cell.",CHEMBL3886165,IC50,CC1(C)C(=O)[C@H](C/C=C\CCCC(=O)O)[C@@H](/C=C/C(O)CCc2ccccc2)[C@@H]1O,7.142667503568731
CHEMBL3946494,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,59.0,nM,CHEMBL3887098,B,"Radioligand Binding: HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bottom of the flasks, and homogenized for 30 sec using a Brinkman PT 10/35 polytron. TME buffer was added to achieve a final 40 ml volume in the centrifuge tubes (the composition of TME is 100 mM TRIS base, 20 mM MgCl2, 2M EDTA; 10 N HCl is added to achieve a pH of 7.4).The cell homogenate was centrifuged at 19000 r.p.m. for 20 min at 4 C. using a Beckman Ti-60 rotor. The resultant pellet was resuspended in TME buffer to give a final 1 mg/ml protein concentration, as determined by Biorad assay. Radioligand binding competition assays vs. [3H-]17-phenyl PGF2 (5 nM) were performed in a 100 ul volume for 60 min. Binding reactions were started by adding plasma membrane fraction. The reaction was terminated by the addition of 4 ml ice-cold TRIS-HCl buffer and rapid filtration through glass fiber GF/B filters using a Brandel cell.",CHEMBL3886165,IC50,CC1(C)C(=O)[C@H](C/C=C\CCCC(=O)O)[C@@H](/C=C/C(O)CCc2ccccc2)[C@@H]1O,7.229147988357855
CHEMBL3922155,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,20.0,nM,CHEMBL3887098,B,"Radioligand Binding: HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bottom of the flasks, and homogenized for 30 sec using a Brinkman PT 10/35 polytron. TME buffer was added to achieve a final 40 ml volume in the centrifuge tubes (the composition of TME is 100 mM TRIS base, 20 mM MgCl2, 2M EDTA; 10 N HCl is added to achieve a pH of 7.4).The cell homogenate was centrifuged at 19000 r.p.m. for 20 min at 4 C. using a Beckman Ti-60 rotor. The resultant pellet was resuspended in TME buffer to give a final 1 mg/ml protein concentration, as determined by Biorad assay. Radioligand binding competition assays vs. [3H-]17-phenyl PGF2 (5 nM) were performed in a 100 ul volume for 60 min. Binding reactions were started by adding plasma membrane fraction. The reaction was terminated by the addition of 4 ml ice-cold TRIS-HCl buffer and rapid filtration through glass fiber GF/B filters using a Brandel cell.",CHEMBL3886165,IC50,CC1(C)C(=O)[C@H](C/C=C\CCCC(=O)O)[C@@H](/C=C/C(O)Cc2cc3ccccc3s2)[C@@H]1O,7.698970004336019
CHEMBL3922155,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,310.0,nM,CHEMBL3887098,B,"Radioligand Binding: HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bottom of the flasks, and homogenized for 30 sec using a Brinkman PT 10/35 polytron. TME buffer was added to achieve a final 40 ml volume in the centrifuge tubes (the composition of TME is 100 mM TRIS base, 20 mM MgCl2, 2M EDTA; 10 N HCl is added to achieve a pH of 7.4).The cell homogenate was centrifuged at 19000 r.p.m. for 20 min at 4 C. using a Beckman Ti-60 rotor. The resultant pellet was resuspended in TME buffer to give a final 1 mg/ml protein concentration, as determined by Biorad assay. Radioligand binding competition assays vs. [3H-]17-phenyl PGF2 (5 nM) were performed in a 100 ul volume for 60 min. Binding reactions were started by adding plasma membrane fraction. The reaction was terminated by the addition of 4 ml ice-cold TRIS-HCl buffer and rapid filtration through glass fiber GF/B filters using a Brandel cell.",CHEMBL3886165,IC50,CC1(C)C(=O)[C@H](C/C=C\CCCC(=O)O)[C@@H](/C=C/C(O)Cc2cc3ccccc3s2)[C@@H]1O,6.508638306165727
CHEMBL3909714,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,832.0,nM,CHEMBL3887098,B,"Radioligand Binding: HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bottom of the flasks, and homogenized for 30 sec using a Brinkman PT 10/35 polytron. TME buffer was added to achieve a final 40 ml volume in the centrifuge tubes (the composition of TME is 100 mM TRIS base, 20 mM MgCl2, 2M EDTA; 10 N HCl is added to achieve a pH of 7.4).The cell homogenate was centrifuged at 19000 r.p.m. for 20 min at 4 C. using a Beckman Ti-60 rotor. The resultant pellet was resuspended in TME buffer to give a final 1 mg/ml protein concentration, as determined by Biorad assay. Radioligand binding competition assays vs. [3H-]17-phenyl PGF2 (5 nM) were performed in a 100 ul volume for 60 min. Binding reactions were started by adding plasma membrane fraction. The reaction was terminated by the addition of 4 ml ice-cold TRIS-HCl buffer and rapid filtration through glass fiber GF/B filters using a Brandel cell.",CHEMBL3886165,IC50,CCN(CC)C(=O)CCC/C=C\C[C@H]1C(=O)C(C)(C)[C@@H](O)[C@@H]1/C=C/C(O)Cc1cc2ccccc2s1,6.0798766737092755
CHEMBL3909714,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,478.0,nM,CHEMBL3887098,B,"Radioligand Binding: HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bottom of the flasks, and homogenized for 30 sec using a Brinkman PT 10/35 polytron. TME buffer was added to achieve a final 40 ml volume in the centrifuge tubes (the composition of TME is 100 mM TRIS base, 20 mM MgCl2, 2M EDTA; 10 N HCl is added to achieve a pH of 7.4).The cell homogenate was centrifuged at 19000 r.p.m. for 20 min at 4 C. using a Beckman Ti-60 rotor. The resultant pellet was resuspended in TME buffer to give a final 1 mg/ml protein concentration, as determined by Biorad assay. Radioligand binding competition assays vs. [3H-]17-phenyl PGF2 (5 nM) were performed in a 100 ul volume for 60 min. Binding reactions were started by adding plasma membrane fraction. The reaction was terminated by the addition of 4 ml ice-cold TRIS-HCl buffer and rapid filtration through glass fiber GF/B filters using a Brandel cell.",CHEMBL3886165,IC50,CCN(CC)C(=O)CCC/C=C\C[C@H]1C(=O)C(C)(C)[C@@H](O)[C@@H]1/C=C/C(O)Cc1cc2ccccc2s1,6.320572103387882
CHEMBL3896491,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,4154.0,nM,CHEMBL3887098,B,"Radioligand Binding: HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bottom of the flasks, and homogenized for 30 sec using a Brinkman PT 10/35 polytron. TME buffer was added to achieve a final 40 ml volume in the centrifuge tubes (the composition of TME is 100 mM TRIS base, 20 mM MgCl2, 2M EDTA; 10 N HCl is added to achieve a pH of 7.4).The cell homogenate was centrifuged at 19000 r.p.m. for 20 min at 4 C. using a Beckman Ti-60 rotor. The resultant pellet was resuspended in TME buffer to give a final 1 mg/ml protein concentration, as determined by Biorad assay. Radioligand binding competition assays vs. [3H-]17-phenyl PGF2 (5 nM) were performed in a 100 ul volume for 60 min. Binding reactions were started by adding plasma membrane fraction. The reaction was terminated by the addition of 4 ml ice-cold TRIS-HCl buffer and rapid filtration through glass fiber GF/B filters using a Brandel cell.",CHEMBL3886165,IC50,CC1(C)C(=O)[C@H](C/C=C\CCCC(=O)NCCO)[C@@H](/C=C/C(O)Cc2cc3ccccc3s2)[C@@H]1O,5.38153350780092
CHEMBL3900651,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,678.0,nM,CHEMBL3887098,B,"Radioligand Binding: HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bottom of the flasks, and homogenized for 30 sec using a Brinkman PT 10/35 polytron. TME buffer was added to achieve a final 40 ml volume in the centrifuge tubes (the composition of TME is 100 mM TRIS base, 20 mM MgCl2, 2M EDTA; 10 N HCl is added to achieve a pH of 7.4).The cell homogenate was centrifuged at 19000 r.p.m. for 20 min at 4 C. using a Beckman Ti-60 rotor. The resultant pellet was resuspended in TME buffer to give a final 1 mg/ml protein concentration, as determined by Biorad assay. Radioligand binding competition assays vs. [3H-]17-phenyl PGF2 (5 nM) were performed in a 100 ul volume for 60 min. Binding reactions were started by adding plasma membrane fraction. The reaction was terminated by the addition of 4 ml ice-cold TRIS-HCl buffer and rapid filtration through glass fiber GF/B filters using a Brandel cell.",CHEMBL3886165,IC50,CC1(C)C(=O)[C@H](C/C=C\CCCC(N)=O)[C@@H](/C=C/C(O)Cc2cc3ccccc3s2)[C@@H]1O,6.168770306132936
CHEMBL3900651,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,5000.0,nM,CHEMBL3887098,B,"Radioligand Binding: HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bottom of the flasks, and homogenized for 30 sec using a Brinkman PT 10/35 polytron. TME buffer was added to achieve a final 40 ml volume in the centrifuge tubes (the composition of TME is 100 mM TRIS base, 20 mM MgCl2, 2M EDTA; 10 N HCl is added to achieve a pH of 7.4).The cell homogenate was centrifuged at 19000 r.p.m. for 20 min at 4 C. using a Beckman Ti-60 rotor. The resultant pellet was resuspended in TME buffer to give a final 1 mg/ml protein concentration, as determined by Biorad assay. Radioligand binding competition assays vs. [3H-]17-phenyl PGF2 (5 nM) were performed in a 100 ul volume for 60 min. Binding reactions were started by adding plasma membrane fraction. The reaction was terminated by the addition of 4 ml ice-cold TRIS-HCl buffer and rapid filtration through glass fiber GF/B filters using a Brandel cell.",CHEMBL3886165,IC50,CC1(C)C(=O)[C@H](C/C=C\CCCC(N)=O)[C@@H](/C=C/C(O)Cc2cc3ccccc3s2)[C@@H]1O,5.301029995663981
CHEMBL3923193,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,219.0,nM,CHEMBL3887098,B,"Radioligand Binding: HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bottom of the flasks, and homogenized for 30 sec using a Brinkman PT 10/35 polytron. TME buffer was added to achieve a final 40 ml volume in the centrifuge tubes (the composition of TME is 100 mM TRIS base, 20 mM MgCl2, 2M EDTA; 10 N HCl is added to achieve a pH of 7.4).The cell homogenate was centrifuged at 19000 r.p.m. for 20 min at 4 C. using a Beckman Ti-60 rotor. The resultant pellet was resuspended in TME buffer to give a final 1 mg/ml protein concentration, as determined by Biorad assay. Radioligand binding competition assays vs. [3H-]17-phenyl PGF2 (5 nM) were performed in a 100 ul volume for 60 min. Binding reactions were started by adding plasma membrane fraction. The reaction was terminated by the addition of 4 ml ice-cold TRIS-HCl buffer and rapid filtration through glass fiber GF/B filters using a Brandel cell.",CHEMBL3886165,IC50,COC(=O)CCC/C=C\C[C@H]1C(=O)C(C)(C)[C@@H](O)[C@@H]1/C=C/C(O)Cc1cc2ccccc2s1,6.6595558851598815
CHEMBL3923193,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,10000.0,nM,CHEMBL3887098,B,"Radioligand Binding: HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bottom of the flasks, and homogenized for 30 sec using a Brinkman PT 10/35 polytron. TME buffer was added to achieve a final 40 ml volume in the centrifuge tubes (the composition of TME is 100 mM TRIS base, 20 mM MgCl2, 2M EDTA; 10 N HCl is added to achieve a pH of 7.4).The cell homogenate was centrifuged at 19000 r.p.m. for 20 min at 4 C. using a Beckman Ti-60 rotor. The resultant pellet was resuspended in TME buffer to give a final 1 mg/ml protein concentration, as determined by Biorad assay. Radioligand binding competition assays vs. [3H-]17-phenyl PGF2 (5 nM) were performed in a 100 ul volume for 60 min. Binding reactions were started by adding plasma membrane fraction. The reaction was terminated by the addition of 4 ml ice-cold TRIS-HCl buffer and rapid filtration through glass fiber GF/B filters using a Brandel cell.",CHEMBL3886165,IC50,COC(=O)CCC/C=C\C[C@H]1C(=O)C(C)(C)[C@@H](O)[C@@H]1/C=C/C(O)Cc1cc2ccccc2s1,5.0
CHEMBL3954031,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,256.0,nM,CHEMBL3887098,B,"Radioligand Binding: HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bottom of the flasks, and homogenized for 30 sec using a Brinkman PT 10/35 polytron. TME buffer was added to achieve a final 40 ml volume in the centrifuge tubes (the composition of TME is 100 mM TRIS base, 20 mM MgCl2, 2M EDTA; 10 N HCl is added to achieve a pH of 7.4).The cell homogenate was centrifuged at 19000 r.p.m. for 20 min at 4 C. using a Beckman Ti-60 rotor. The resultant pellet was resuspended in TME buffer to give a final 1 mg/ml protein concentration, as determined by Biorad assay. Radioligand binding competition assays vs. [3H-]17-phenyl PGF2 (5 nM) were performed in a 100 ul volume for 60 min. Binding reactions were started by adding plasma membrane fraction. The reaction was terminated by the addition of 4 ml ice-cold TRIS-HCl buffer and rapid filtration through glass fiber GF/B filters using a Brandel cell.",CHEMBL3886165,IC50,CC1(C)C(=O)[C@H](CC#CCCCC(=O)O)[C@@H](/C=C/C(O)Cc2cc3ccccc3s2)[C@@H]1O,6.59176003468815
CHEMBL64804,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,0.38,nM,CHEMBL3887481,B,"Radioligand Binding Assay: Assay Volume and Format:200 l in 96-well plateCell membrane homogenates (20 g protein) are incubated for 120 min at 22 C. with 0.5 nM [3H]PGE2 in the absence or presence of the test compound in a buffer containing 10 mM MES/KOH (pH 6.0), 10 mM MgCl2 and 1 mM EDTA.Nonspecific binding is determined in the presence of 10 M PGE2.Following incubation, the samples are filtered rapidly under vacuum through glass fiber filters (GF/B, Packard) presoaked with 0.3% PEI and rinsed several times with ice-cold 50 mM Tris-HCl using a 96-sample cell harvester (Unifilter, Packard). The filters are dried then counted for radioactivity in a scintillation counter (Topcount, Packard) using a scintillation cocktail (Microscint 0, Packard).",CHEMBL3886335,IC50,CCCCC[C@@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O,9.42021640338319
CHEMBL3982139,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,1.2,nM,CHEMBL3887481,B,"Radioligand Binding Assay: Assay Volume and Format:200 l in 96-well plateCell membrane homogenates (20 g protein) are incubated for 120 min at 22 C. with 0.5 nM [3H]PGE2 in the absence or presence of the test compound in a buffer containing 10 mM MES/KOH (pH 6.0), 10 mM MgCl2 and 1 mM EDTA.Nonspecific binding is determined in the presence of 10 M PGE2.Following incubation, the samples are filtered rapidly under vacuum through glass fiber filters (GF/B, Packard) presoaked with 0.3% PEI and rinsed several times with ice-cold 50 mM Tris-HCl using a 96-sample cell harvester (Unifilter, Packard). The filters are dried then counted for radioactivity in a scintillation counter (Topcount, Packard) using a scintillation cocktail (Microscint 0, Packard).",CHEMBL3886335,IC50,CC#CC[C@H](C)[C@H](O)/C=C/[C@H]1CC(F)(F)C(=O)N1CCCCCCC(=O)O,8.920818753952375
CHEMBL3918816,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,1.3,nM,CHEMBL3887481,B,"Radioligand Binding Assay: Assay Volume and Format:200 l in 96-well plateCell membrane homogenates (20 g protein) are incubated for 120 min at 22 C. with 0.5 nM [3H]PGE2 in the absence or presence of the test compound in a buffer containing 10 mM MES/KOH (pH 6.0), 10 mM MgCl2 and 1 mM EDTA.Nonspecific binding is determined in the presence of 10 M PGE2.Following incubation, the samples are filtered rapidly under vacuum through glass fiber filters (GF/B, Packard) presoaked with 0.3% PEI and rinsed several times with ice-cold 50 mM Tris-HCl using a 96-sample cell harvester (Unifilter, Packard). The filters are dried then counted for radioactivity in a scintillation counter (Topcount, Packard) using a scintillation cocktail (Microscint 0, Packard).",CHEMBL3886335,IC50,CCC#CC[C@H](C)[C@H](O)/C=C/[C@H]1CC(F)(F)C(=O)N1CCCCCCC(=O)O,8.886056647693163
CHEMBL3897335,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,2.4,nM,CHEMBL3887481,B,"Radioligand Binding Assay: Assay Volume and Format:200 l in 96-well plateCell membrane homogenates (20 g protein) are incubated for 120 min at 22 C. with 0.5 nM [3H]PGE2 in the absence or presence of the test compound in a buffer containing 10 mM MES/KOH (pH 6.0), 10 mM MgCl2 and 1 mM EDTA.Nonspecific binding is determined in the presence of 10 M PGE2.Following incubation, the samples are filtered rapidly under vacuum through glass fiber filters (GF/B, Packard) presoaked with 0.3% PEI and rinsed several times with ice-cold 50 mM Tris-HCl using a 96-sample cell harvester (Unifilter, Packard). The filters are dried then counted for radioactivity in a scintillation counter (Topcount, Packard) using a scintillation cocktail (Microscint 0, Packard).",CHEMBL3886335,IC50,C[C@@H](CCCc1ccccc1)[C@H](O)/C=C/[C@H]1CC(F)(F)C(=O)N1CCCCCCC(=O)O,8.619788758288394
CHEMBL3955128,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,0.57,nM,CHEMBL3887481,B,"Radioligand Binding Assay: Assay Volume and Format:200 l in 96-well plateCell membrane homogenates (20 g protein) are incubated for 120 min at 22 C. with 0.5 nM [3H]PGE2 in the absence or presence of the test compound in a buffer containing 10 mM MES/KOH (pH 6.0), 10 mM MgCl2 and 1 mM EDTA.Nonspecific binding is determined in the presence of 10 M PGE2.Following incubation, the samples are filtered rapidly under vacuum through glass fiber filters (GF/B, Packard) presoaked with 0.3% PEI and rinsed several times with ice-cold 50 mM Tris-HCl using a 96-sample cell harvester (Unifilter, Packard). The filters are dried then counted for radioactivity in a scintillation counter (Topcount, Packard) using a scintillation cocktail (Microscint 0, Packard).",CHEMBL3886335,IC50,CCCCC[C@H](O)/C=C/[C@H]1CC(F)(F)C(=O)N1CCCCCCC(=O)O,9.244125144327509
CHEMBL3959605,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,4.9,nM,CHEMBL3887481,B,"Radioligand Binding Assay: Assay Volume and Format:200 l in 96-well plateCell membrane homogenates (20 g protein) are incubated for 120 min at 22 C. with 0.5 nM [3H]PGE2 in the absence or presence of the test compound in a buffer containing 10 mM MES/KOH (pH 6.0), 10 mM MgCl2 and 1 mM EDTA.Nonspecific binding is determined in the presence of 10 M PGE2.Following incubation, the samples are filtered rapidly under vacuum through glass fiber filters (GF/B, Packard) presoaked with 0.3% PEI and rinsed several times with ice-cold 50 mM Tris-HCl using a 96-sample cell harvester (Unifilter, Packard). The filters are dried then counted for radioactivity in a scintillation counter (Topcount, Packard) using a scintillation cocktail (Microscint 0, Packard).",CHEMBL3886335,IC50,O=C(O)CCCCCCN1C(=O)C(F)(F)C[C@@H]1/C=C/[C@@H](O)CCCCc1ccccc1,8.309803919971486
CHEMBL3895047,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,0.32,nM,CHEMBL3887481,B,"Radioligand Binding Assay: Assay Volume and Format:200 l in 96-well plateCell membrane homogenates (20 g protein) are incubated for 120 min at 22 C. with 0.5 nM [3H]PGE2 in the absence or presence of the test compound in a buffer containing 10 mM MES/KOH (pH 6.0), 10 mM MgCl2 and 1 mM EDTA.Nonspecific binding is determined in the presence of 10 M PGE2.Following incubation, the samples are filtered rapidly under vacuum through glass fiber filters (GF/B, Packard) presoaked with 0.3% PEI and rinsed several times with ice-cold 50 mM Tris-HCl using a 96-sample cell harvester (Unifilter, Packard). The filters are dried then counted for radioactivity in a scintillation counter (Topcount, Packard) using a scintillation cocktail (Microscint 0, Packard).",CHEMBL3886335,IC50,CCC#CC[C@H](C)[C@H](O)/C=C/[C@H]1CC(F)(F)C(=O)N1CCc1ccc(C(=O)O)cc1,9.494850021680094
CHEMBL3923027,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,0.22,nM,CHEMBL3887481,B,"Radioligand Binding Assay: Assay Volume and Format:200 l in 96-well plateCell membrane homogenates (20 g protein) are incubated for 120 min at 22 C. with 0.5 nM [3H]PGE2 in the absence or presence of the test compound in a buffer containing 10 mM MES/KOH (pH 6.0), 10 mM MgCl2 and 1 mM EDTA.Nonspecific binding is determined in the presence of 10 M PGE2.Following incubation, the samples are filtered rapidly under vacuum through glass fiber filters (GF/B, Packard) presoaked with 0.3% PEI and rinsed several times with ice-cold 50 mM Tris-HCl using a 96-sample cell harvester (Unifilter, Packard). The filters are dried then counted for radioactivity in a scintillation counter (Topcount, Packard) using a scintillation cocktail (Microscint 0, Packard).",CHEMBL3886335,IC50,CCCCC[C@H](O)/C=C/[C@H]1CC(F)(F)C(=O)N1CCc1ccc(C(=O)O)cc1,9.657577319177793
CHEMBL3949856,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,3.3,nM,CHEMBL3887481,B,"Radioligand Binding Assay: Assay Volume and Format:200 l in 96-well plateCell membrane homogenates (20 g protein) are incubated for 120 min at 22 C. with 0.5 nM [3H]PGE2 in the absence or presence of the test compound in a buffer containing 10 mM MES/KOH (pH 6.0), 10 mM MgCl2 and 1 mM EDTA.Nonspecific binding is determined in the presence of 10 M PGE2.Following incubation, the samples are filtered rapidly under vacuum through glass fiber filters (GF/B, Packard) presoaked with 0.3% PEI and rinsed several times with ice-cold 50 mM Tris-HCl using a 96-sample cell harvester (Unifilter, Packard). The filters are dried then counted for radioactivity in a scintillation counter (Topcount, Packard) using a scintillation cocktail (Microscint 0, Packard).",CHEMBL3886335,IC50,CCC#CC[C@H](C)[C@H](O)/C=C/[C@H]1CC(F)(F)C(=O)N1CCCc1ccc(C(=O)O)s1,8.481486060122112
CHEMBL3975743,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,0.74,nM,CHEMBL3887481,B,"Radioligand Binding Assay: Assay Volume and Format:200 l in 96-well plateCell membrane homogenates (20 g protein) are incubated for 120 min at 22 C. with 0.5 nM [3H]PGE2 in the absence or presence of the test compound in a buffer containing 10 mM MES/KOH (pH 6.0), 10 mM MgCl2 and 1 mM EDTA.Nonspecific binding is determined in the presence of 10 M PGE2.Following incubation, the samples are filtered rapidly under vacuum through glass fiber filters (GF/B, Packard) presoaked with 0.3% PEI and rinsed several times with ice-cold 50 mM Tris-HCl using a 96-sample cell harvester (Unifilter, Packard). The filters are dried then counted for radioactivity in a scintillation counter (Topcount, Packard) using a scintillation cocktail (Microscint 0, Packard).",CHEMBL3886335,IC50,C[C@@H](CCCc1ccccc1)[C@H](O)/C=C/[C@H]1CC(F)(F)C(=O)N1CCCc1ccc(C(=O)O)s1,9.130768280269024
CHEMBL3916499,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,0.28,nM,CHEMBL3887481,B,"Radioligand Binding Assay: Assay Volume and Format:200 l in 96-well plateCell membrane homogenates (20 g protein) are incubated for 120 min at 22 C. with 0.5 nM [3H]PGE2 in the absence or presence of the test compound in a buffer containing 10 mM MES/KOH (pH 6.0), 10 mM MgCl2 and 1 mM EDTA.Nonspecific binding is determined in the presence of 10 M PGE2.Following incubation, the samples are filtered rapidly under vacuum through glass fiber filters (GF/B, Packard) presoaked with 0.3% PEI and rinsed several times with ice-cold 50 mM Tris-HCl using a 96-sample cell harvester (Unifilter, Packard). The filters are dried then counted for radioactivity in a scintillation counter (Topcount, Packard) using a scintillation cocktail (Microscint 0, Packard).",CHEMBL3886335,IC50,CCCCC[C@H](O)/C=C/[C@H]1CC(F)(F)C(=O)N1CCCc1ccc(C(=O)O)s1,9.55284196865778
CHEMBL4103046,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,104.0,nM,CHEMBL3997110,B,Displacement of [3H]PGE from human EP4 receptor expressed in HEK293 cell membranes,CHEMBL3994644,IC50,O=C(O)c1ccc(CNC(=O)c2cc(F)cnc2Oc2ccc(F)cc2)cc1,6.982966660701219
CHEMBL4092846,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,124.0,nM,CHEMBL3997110,B,Displacement of [3H]PGE from human EP4 receptor expressed in HEK293 cell membranes,CHEMBL3994644,IC50,O=C(O)c1ccc(CNC(=O)c2cc(F)ccc2Oc2ccc(F)cc2)cc1,6.906578314837764
CHEMBL4065183,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,37.9,nM,CHEMBL3997110,B,Displacement of [3H]PGE from human EP4 receptor expressed in HEK293 cell membranes,CHEMBL3994644,IC50,O=C(O)c1ccc(CNC(=O)c2cc(Cl)cnc2Oc2ccc(F)cc2)cc1,7.421360790031928
CHEMBL4066230,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,21.6,nM,CHEMBL3997110,B,Displacement of [3H]PGE from human EP4 receptor expressed in HEK293 cell membranes,CHEMBL3994644,IC50,O=C(O)c1ccc(CNC(=O)c2cc(Cl)ccc2Oc2ccc(F)cc2)cc1,7.665546248849069
CHEMBL4095293,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,28.7,nM,CHEMBL3997110,B,Displacement of [3H]PGE from human EP4 receptor expressed in HEK293 cell membranes,CHEMBL3994644,IC50,C[C@H](NC(=O)c1cc(F)cnc1Oc1ccc(F)cc1)c1ccc(C(=O)O)cc1,7.542118103266008
CHEMBL4096216,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,9.68,nM,CHEMBL3997110,B,Displacement of [3H]PGE from human EP4 receptor expressed in HEK293 cell membranes,CHEMBL3994644,IC50,C[C@H](NC(=O)c1cc(Cl)cnc1Oc1ccc(F)cc1)c1ccc(C(=O)O)cc1,8.014124642691606
CHEMBL591666,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,6.59,nM,CHEMBL3997110,B,Displacement of [3H]PGE from human EP4 receptor expressed in HEK293 cell membranes,CHEMBL3994644,IC50,C[C@H](NC(=O)c1cc(Cl)ccc1Oc1ccc(F)cc1)c1ccc(C(=O)O)cc1,8.18111458540599
CHEMBL4061595,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,545.0,nM,CHEMBL3997110,B,Displacement of [3H]PGE from human EP4 receptor expressed in HEK293 cell membranes,CHEMBL3994644,IC50,CC(C)(NC(=O)c1cc(F)cnc1Oc1ccc(F)cc1)c1ccc(C(=O)O)cc1,6.2636034977233574
CHEMBL4072974,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,181.0,nM,CHEMBL3997110,B,Displacement of [3H]PGE from human EP4 receptor expressed in HEK293 cell membranes,CHEMBL3994644,IC50,CCC(NC(=O)c1cc(F)cnc1Oc1ccc(F)cc1)c1ccc(C(=O)O)cc1,6.7423214251308154
CHEMBL4099851,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,2.4,nM,CHEMBL3997110,B,Displacement of [3H]PGE from human EP4 receptor expressed in HEK293 cell membranes,CHEMBL3994644,IC50,C[C@H](NC(=O)c1cc(Cl)cnc1Oc1cccc(F)c1)c1ccc(C(=O)O)cc1,8.619788758288394
CHEMBL4062620,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,5.02,nM,CHEMBL3997110,B,Displacement of [3H]PGE from human EP4 receptor expressed in HEK293 cell membranes,CHEMBL3994644,IC50,C[C@H](NC(=O)c1cc(Cl)cnc1Oc1cccc(Cl)c1)c1ccc(C(=O)O)cc1,8.29929628285498
CHEMBL4094572,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,13.4,nM,CHEMBL3997110,B,Displacement of [3H]PGE from human EP4 receptor expressed in HEK293 cell membranes,CHEMBL3994644,IC50,C[C@H](NC(=O)c1cc(Cl)cnc1Oc1cccc(C#N)c1)c1ccc(C(=O)O)cc1,7.872895201635192
CHEMBL4078648,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,8.76,nM,CHEMBL3997110,B,Displacement of [3H]PGE from human EP4 receptor expressed in HEK293 cell membranes,CHEMBL3994644,IC50,C[C@H](NC(=O)c1cc(Cl)ccc1Oc1cccc(F)c1)c1ccc(C(=O)O)cc1,8.05749589383192
CHEMBL4535971,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,0.4,nM,CHEMBL4380455,B,Inhibition of human EP4 transfected in human HEK293 cells co transfected with SmBit-beta-arrestin. assessed as reduction in PGE2 induced-beta-arrestin recruitment by NanoBiT beta-arrestin recruitment assay,CHEMBL4376865,IC50,C/C=C/c1nnn(Cc2ccc(C(F)(F)F)cc2)c1C(=O)N[C@@H](C)c1ccc(C(=O)O)cc1,9.397940008672037
CHEMBL4448899,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,1120.0,nM,CHEMBL5214528,B,Selectivity interaction (Eurofins-Panlabs radioligand binding assay ) EUB0000307b PTGER4,CHEMBL5212743,IC50,Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1,5.950781977329818
CHEMBL5272661,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,2.0,nM,CHEMBL5242761,B,Agonist activity at human EP4 receptor expressed in CHO cells co-transfected with CRE-beta-lactamase reporter gene assessed as increase in intracellular cAMP measured after 3 hrs by TR FRET based assay,CHEMBL5241102,IC50,CC(C)CC(=O)c1ccc(CCCN2C(=O)CC[C@@H]2CC[C@@H](O)Cc2cccc(C(F)(F)F)c2)s1,8.698970004336019
CHEMBL378376,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,2.0,nM,CHEMBL5242761,B,Agonist activity at human EP4 receptor expressed in CHO cells co-transfected with CRE-beta-lactamase reporter gene assessed as increase in intracellular cAMP measured after 3 hrs by TR FRET based assay,CHEMBL5241102,IC50,O=C(O)c1ccc(CCCN2C(=O)CC[C@@H]2CC[C@@H](O)Cc2cccc(C(F)(F)F)c2)s1,8.698970004336019
CHEMBL3670685,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,13.5,nM,CHEMBL5321070,B,Antagonist activity at EP4 receptor (unknown origin),CHEMBL5316375,IC50,C[C@H](NC(=O)c1c(C(F)F)nn(C)c1Oc1cccc(C(F)(F)F)c1)c1ccc(C(=O)O)cc1,7.8696662315049934
CHEMBL3754586,CHEMBL1836,Prostanoid EP4 receptor,EC50,=,3.0,nM,CHEMBL3757319,B,Agonist activity at human EP4 receptor,CHEMBL3751723,EC50,CCCC[C@H](C)C[C@H](O)/C=C/[C@H]1CCC(=O)N1CCSc1nc(C(=O)O)cs1,8.522878745280337
CHEMBL3752377,CHEMBL1836,Prostanoid EP4 receptor,EC50,=,4.2,nM,CHEMBL3757319,B,Agonist activity at human EP4 receptor,CHEMBL3751723,EC50,CCCCC(C)(C)[C@H](O)/C=C/[C@H]1CCC(=O)N1CCSc1nc(C(=O)O)cs1,8.3767507096021
CHEMBL3753853,CHEMBL1836,Prostanoid EP4 receptor,EC50,=,320.0,nM,CHEMBL3757319,B,Agonist activity at human EP4 receptor,CHEMBL3751723,EC50,CCCCC(C)(C)[C@H](O)/C=C/[C@H]1COC(=O)N1CCSc1nc(C(=O)O)cs1,6.494850021680094
CHEMBL3752406,CHEMBL1836,Prostanoid EP4 receptor,EC50,=,1220.0,nM,CHEMBL3757319,B,Agonist activity at human EP4 receptor,CHEMBL3751723,EC50,CC(C)(CCCCF)[C@H](O)/C=C/[C@H]1COC(=O)N1CCSc1nc(C(=O)O)cs1,5.913640169325252
CHEMBL3753221,CHEMBL1836,Prostanoid EP4 receptor,EC50,=,73.0,nM,CHEMBL3757319,B,Agonist activity at human EP4 receptor,CHEMBL3751723,EC50,CCCCC1([C@H](O)/C=C/[C@H]2COC(=O)N2CCSc2nc(C(=O)O)cs2)CCC1,7.136677139879544
CHEMBL3751951,CHEMBL1836,Prostanoid EP4 receptor,EC50,=,195.0,nM,CHEMBL3757319,B,Agonist activity at human EP4 receptor,CHEMBL3751723,EC50,O=C(O)c1csc(SCCN2C(=O)OC[C@@H]2/C=C/[C@@H](O)C2(CCCCF)CCC2)n1,6.709965388637482
CHEMBL3753788,CHEMBL1836,Prostanoid EP4 receptor,EC50,=,705.0,nM,CHEMBL3757319,B,Agonist activity at human EP4 receptor,CHEMBL3751723,EC50,COCCCC1([C@H](O)/C=C/[C@H]2COC(=O)N2CCSc2nc(C(=O)O)cs2)CCC1,6.151810883008601
CHEMBL3753898,CHEMBL1836,Prostanoid EP4 receptor,EC50,=,745.0,nM,CHEMBL3757319,B,Agonist activity at human EP4 receptor,CHEMBL3751723,EC50,CCOCCC1([C@H](O)/C=C/[C@H]2COC(=O)N2CCSc2nc(C(=O)O)cs2)CCC1,6.127843727251707
CHEMBL3753622,CHEMBL1836,Prostanoid EP4 receptor,EC50,=,465.0,nM,CHEMBL3757319,B,Agonist activity at human EP4 receptor,CHEMBL3751723,EC50,O=C(O)c1csc(SCCN2C(=O)OC[C@@H]2/C=C/[C@@H](O)C2(CCc3ccccc3)CCC2)n1,6.332547047110046
CHEMBL3754197,CHEMBL1836,Prostanoid EP4 receptor,EC50,=,8390.0,nM,CHEMBL3757319,B,Agonist activity at human EP4 receptor,CHEMBL3751723,EC50,O=C(O)c1csc(SCCN2C(=O)OC[C@@H]2/C=C/[C@@H](O)C2(CCC3CCCCC3)CCC2)n1,5.076238039171299
CHEMBL3753268,CHEMBL1836,Prostanoid EP4 receptor,EC50,=,240.0,nM,CHEMBL3757319,B,Agonist activity at human EP4 receptor,CHEMBL3751723,EC50,CC#CCC1([C@H](O)/C=C/[C@H]2COC(=O)N2CCSc2nc(C(=O)O)cs2)CCC1,6.619788758288394
CHEMBL3752435,CHEMBL1836,Prostanoid EP4 receptor,EC50,=,4710.0,nM,CHEMBL3757319,B,Agonist activity at human EP4 receptor,CHEMBL3751723,EC50,CC(C)(C)CCC1([C@H](O)/C=C/[C@H]2COC(=O)N2CCSc2nc(C(=O)O)cs2)CCC1,5.326979092871104
CHEMBL3954286,CHEMBL1836,Prostanoid EP4 receptor,EC50,=,300.0,nM,CHEMBL3887098,B,"Radioligand Binding: HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bottom of the flasks, and homogenized for 30 sec using a Brinkman PT 10/35 polytron. TME buffer was added to achieve a final 40 ml volume in the centrifuge tubes (the composition of TME is 100 mM TRIS base, 20 mM MgCl2, 2M EDTA; 10 N HCl is added to achieve a pH of 7.4).The cell homogenate was centrifuged at 19000 r.p.m. for 20 min at 4 C. using a Beckman Ti-60 rotor. The resultant pellet was resuspended in TME buffer to give a final 1 mg/ml protein concentration, as determined by Biorad assay. Radioligand binding competition assays vs. [3H-]17-phenyl PGF2 (5 nM) were performed in a 100 ul volume for 60 min. Binding reactions were started by adding plasma membrane fraction. The reaction was terminated by the addition of 4 ml ice-cold TRIS-HCl buffer and rapid filtration through glass fiber GF/B filters using a Brandel cell.",CHEMBL3886165,EC50,COC(=O)CSCCCS[C@H]1C(=O)C(C)(C)[C@@H](O)[C@@H]1/C=C/C(O)CCc1sc2ccccc2c1Cl,6.522878745280337
CHEMBL3960625,CHEMBL1836,Prostanoid EP4 receptor,EC50,=,0.1,nM,CHEMBL3887098,B,"Radioligand Binding: HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bottom of the flasks, and homogenized for 30 sec using a Brinkman PT 10/35 polytron. TME buffer was added to achieve a final 40 ml volume in the centrifuge tubes (the composition of TME is 100 mM TRIS base, 20 mM MgCl2, 2M EDTA; 10 N HCl is added to achieve a pH of 7.4).The cell homogenate was centrifuged at 19000 r.p.m. for 20 min at 4 C. using a Beckman Ti-60 rotor. The resultant pellet was resuspended in TME buffer to give a final 1 mg/ml protein concentration, as determined by Biorad assay. Radioligand binding competition assays vs. [3H-]17-phenyl PGF2 (5 nM) were performed in a 100 ul volume for 60 min. Binding reactions were started by adding plasma membrane fraction. The reaction was terminated by the addition of 4 ml ice-cold TRIS-HCl buffer and rapid filtration through glass fiber GF/B filters using a Brandel cell.",CHEMBL3886165,EC50,CC1(C)C(=O)[C@H](SCCCSCC(=O)O)[C@@H](/C=C/C(O)CCc2sc3ccccc3c2Cl)[C@@H]1O,10.0
CHEMBL3960625,CHEMBL1836,Prostanoid EP4 receptor,EC50,=,0.1,nM,CHEMBL3887098,B,"Radioligand Binding: HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bottom of the flasks, and homogenized for 30 sec using a Brinkman PT 10/35 polytron. TME buffer was added to achieve a final 40 ml volume in the centrifuge tubes (the composition of TME is 100 mM TRIS base, 20 mM MgCl2, 2M EDTA; 10 N HCl is added to achieve a pH of 7.4).The cell homogenate was centrifuged at 19000 r.p.m. for 20 min at 4 C. using a Beckman Ti-60 rotor. The resultant pellet was resuspended in TME buffer to give a final 1 mg/ml protein concentration, as determined by Biorad assay. Radioligand binding competition assays vs. [3H-]17-phenyl PGF2 (5 nM) were performed in a 100 ul volume for 60 min. Binding reactions were started by adding plasma membrane fraction. The reaction was terminated by the addition of 4 ml ice-cold TRIS-HCl buffer and rapid filtration through glass fiber GF/B filters using a Brandel cell.",CHEMBL3886165,EC50,CC1(C)C(=O)[C@H](SCCCSCC(=O)O)[C@@H](/C=C/C(O)CCc2sc3ccccc3c2Cl)[C@@H]1O,10.0
CHEMBL3950189,CHEMBL1836,Prostanoid EP4 receptor,EC50,=,66.0,nM,CHEMBL3887098,B,"Radioligand Binding: HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bottom of the flasks, and homogenized for 30 sec using a Brinkman PT 10/35 polytron. TME buffer was added to achieve a final 40 ml volume in the centrifuge tubes (the composition of TME is 100 mM TRIS base, 20 mM MgCl2, 2M EDTA; 10 N HCl is added to achieve a pH of 7.4).The cell homogenate was centrifuged at 19000 r.p.m. for 20 min at 4 C. using a Beckman Ti-60 rotor. The resultant pellet was resuspended in TME buffer to give a final 1 mg/ml protein concentration, as determined by Biorad assay. Radioligand binding competition assays vs. [3H-]17-phenyl PGF2 (5 nM) were performed in a 100 ul volume for 60 min. Binding reactions were started by adding plasma membrane fraction. The reaction was terminated by the addition of 4 ml ice-cold TRIS-HCl buffer and rapid filtration through glass fiber GF/B filters using a Brandel cell.",CHEMBL3886165,EC50,CC1(C)C(=O)[C@H](CC#CCCCC(=O)O)[C@@H](/C=C\C(O)CCc2sc3ccccc3c2Cl)[C@@H]1O,7.180456064458131
CHEMBL3950189,CHEMBL1836,Prostanoid EP4 receptor,EC50,=,32.0,nM,CHEMBL3887098,B,"Radioligand Binding: HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bottom of the flasks, and homogenized for 30 sec using a Brinkman PT 10/35 polytron. TME buffer was added to achieve a final 40 ml volume in the centrifuge tubes (the composition of TME is 100 mM TRIS base, 20 mM MgCl2, 2M EDTA; 10 N HCl is added to achieve a pH of 7.4).The cell homogenate was centrifuged at 19000 r.p.m. for 20 min at 4 C. using a Beckman Ti-60 rotor. The resultant pellet was resuspended in TME buffer to give a final 1 mg/ml protein concentration, as determined by Biorad assay. Radioligand binding competition assays vs. [3H-]17-phenyl PGF2 (5 nM) were performed in a 100 ul volume for 60 min. Binding reactions were started by adding plasma membrane fraction. The reaction was terminated by the addition of 4 ml ice-cold TRIS-HCl buffer and rapid filtration through glass fiber GF/B filters using a Brandel cell.",CHEMBL3886165,EC50,CC1(C)C(=O)[C@H](CC#CCCCC(=O)O)[C@@H](/C=C\C(O)CCc2sc3ccccc3c2Cl)[C@@H]1O,7.494850021680094
CHEMBL3979233,CHEMBL1836,Prostanoid EP4 receptor,EC50,=,269.0,nM,CHEMBL3887098,B,"Radioligand Binding: HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bottom of the flasks, and homogenized for 30 sec using a Brinkman PT 10/35 polytron. TME buffer was added to achieve a final 40 ml volume in the centrifuge tubes (the composition of TME is 100 mM TRIS base, 20 mM MgCl2, 2M EDTA; 10 N HCl is added to achieve a pH of 7.4).The cell homogenate was centrifuged at 19000 r.p.m. for 20 min at 4 C. using a Beckman Ti-60 rotor. The resultant pellet was resuspended in TME buffer to give a final 1 mg/ml protein concentration, as determined by Biorad assay. Radioligand binding competition assays vs. [3H-]17-phenyl PGF2 (5 nM) were performed in a 100 ul volume for 60 min. Binding reactions were started by adding plasma membrane fraction. The reaction was terminated by the addition of 4 ml ice-cold TRIS-HCl buffer and rapid filtration through glass fiber GF/B filters using a Brandel cell.",CHEMBL3886165,EC50,COC(=O)CCC/C=C\C[C@H]1C(=O)C(C)(C)[C@@H](O)[C@@H]1/C=C/C(O)CCc1sc2ccccc2c1Cl,6.570247719997592
CHEMBL3979233,CHEMBL1836,Prostanoid EP4 receptor,EC50,=,141.0,nM,CHEMBL3887098,B,"Radioligand Binding: HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bottom of the flasks, and homogenized for 30 sec using a Brinkman PT 10/35 polytron. TME buffer was added to achieve a final 40 ml volume in the centrifuge tubes (the composition of TME is 100 mM TRIS base, 20 mM MgCl2, 2M EDTA; 10 N HCl is added to achieve a pH of 7.4).The cell homogenate was centrifuged at 19000 r.p.m. for 20 min at 4 C. using a Beckman Ti-60 rotor. The resultant pellet was resuspended in TME buffer to give a final 1 mg/ml protein concentration, as determined by Biorad assay. Radioligand binding competition assays vs. [3H-]17-phenyl PGF2 (5 nM) were performed in a 100 ul volume for 60 min. Binding reactions were started by adding plasma membrane fraction. The reaction was terminated by the addition of 4 ml ice-cold TRIS-HCl buffer and rapid filtration through glass fiber GF/B filters using a Brandel cell.",CHEMBL3886165,EC50,COC(=O)CCC/C=C\C[C@H]1C(=O)C(C)(C)[C@@H](O)[C@@H]1/C=C/C(O)CCc1sc2ccccc2c1Cl,6.85078088734462
CHEMBL3955476,CHEMBL1836,Prostanoid EP4 receptor,EC50,=,0.3,nM,CHEMBL3887098,B,"Radioligand Binding: HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bottom of the flasks, and homogenized for 30 sec using a Brinkman PT 10/35 polytron. TME buffer was added to achieve a final 40 ml volume in the centrifuge tubes (the composition of TME is 100 mM TRIS base, 20 mM MgCl2, 2M EDTA; 10 N HCl is added to achieve a pH of 7.4).The cell homogenate was centrifuged at 19000 r.p.m. for 20 min at 4 C. using a Beckman Ti-60 rotor. The resultant pellet was resuspended in TME buffer to give a final 1 mg/ml protein concentration, as determined by Biorad assay. Radioligand binding competition assays vs. [3H-]17-phenyl PGF2 (5 nM) were performed in a 100 ul volume for 60 min. Binding reactions were started by adding plasma membrane fraction. The reaction was terminated by the addition of 4 ml ice-cold TRIS-HCl buffer and rapid filtration through glass fiber GF/B filters using a Brandel cell.",CHEMBL3886165,EC50,CC1(C)C(=O)[C@H](C/C=C\CCCC(=O)O)[C@@H](/C=C/C(O)CCc2sc3ccccc3c2Cl)[C@@H]1O,9.522878745280337
CHEMBL3966610,CHEMBL1836,Prostanoid EP4 receptor,EC50,=,63.0,nM,CHEMBL3887098,B,"Radioligand Binding: HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bottom of the flasks, and homogenized for 30 sec using a Brinkman PT 10/35 polytron. TME buffer was added to achieve a final 40 ml volume in the centrifuge tubes (the composition of TME is 100 mM TRIS base, 20 mM MgCl2, 2M EDTA; 10 N HCl is added to achieve a pH of 7.4).The cell homogenate was centrifuged at 19000 r.p.m. for 20 min at 4 C. using a Beckman Ti-60 rotor. The resultant pellet was resuspended in TME buffer to give a final 1 mg/ml protein concentration, as determined by Biorad assay. Radioligand binding competition assays vs. [3H-]17-phenyl PGF2 (5 nM) were performed in a 100 ul volume for 60 min. Binding reactions were started by adding plasma membrane fraction. The reaction was terminated by the addition of 4 ml ice-cold TRIS-HCl buffer and rapid filtration through glass fiber GF/B filters using a Brandel cell.",CHEMBL3886165,EC50,CCCCC[C@H](O)/C=C/[C@@H]1[C@@H](CC#CCCCC(=O)O)C(=O)C(C)(C)[C@H]1O,7.200659450546418
CHEMBL3895324,CHEMBL1836,Prostanoid EP4 receptor,EC50,=,0.2,nM,CHEMBL3887098,B,"Radioligand Binding: HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bottom of the flasks, and homogenized for 30 sec using a Brinkman PT 10/35 polytron. TME buffer was added to achieve a final 40 ml volume in the centrifuge tubes (the composition of TME is 100 mM TRIS base, 20 mM MgCl2, 2M EDTA; 10 N HCl is added to achieve a pH of 7.4).The cell homogenate was centrifuged at 19000 r.p.m. for 20 min at 4 C. using a Beckman Ti-60 rotor. The resultant pellet was resuspended in TME buffer to give a final 1 mg/ml protein concentration, as determined by Biorad assay. Radioligand binding competition assays vs. [3H-]17-phenyl PGF2 (5 nM) were performed in a 100 ul volume for 60 min. Binding reactions were started by adding plasma membrane fraction. The reaction was terminated by the addition of 4 ml ice-cold TRIS-HCl buffer and rapid filtration through glass fiber GF/B filters using a Brandel cell.",CHEMBL3886165,EC50,CCCCC[C@H](O)/C=C/[C@@H]1[C@@H](C/C=C\CCCC(=O)O)C(=O)C(C)(C)[C@H]1O,9.698970004336019
CHEMBL3978305,CHEMBL1836,Prostanoid EP4 receptor,EC50,=,51.0,nM,CHEMBL3887098,B,"Radioligand Binding: HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bottom of the flasks, and homogenized for 30 sec using a Brinkman PT 10/35 polytron. TME buffer was added to achieve a final 40 ml volume in the centrifuge tubes (the composition of TME is 100 mM TRIS base, 20 mM MgCl2, 2M EDTA; 10 N HCl is added to achieve a pH of 7.4).The cell homogenate was centrifuged at 19000 r.p.m. for 20 min at 4 C. using a Beckman Ti-60 rotor. The resultant pellet was resuspended in TME buffer to give a final 1 mg/ml protein concentration, as determined by Biorad assay. Radioligand binding competition assays vs. [3H-]17-phenyl PGF2 (5 nM) were performed in a 100 ul volume for 60 min. Binding reactions were started by adding plasma membrane fraction. The reaction was terminated by the addition of 4 ml ice-cold TRIS-HCl buffer and rapid filtration through glass fiber GF/B filters using a Brandel cell.",CHEMBL3886165,EC50,CCCCC[C@H](O)/C=C/[C@@H]1[C@@H](C/C=C\CCCC(=O)OC)C(=O)C(C)(C)[C@H]1O,7.292429823902063
CHEMBL3964563,CHEMBL1836,Prostanoid EP4 receptor,EC50,=,0.4,nM,CHEMBL3887098,B,"Radioligand Binding: HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bottom of the flasks, and homogenized for 30 sec using a Brinkman PT 10/35 polytron. TME buffer was added to achieve a final 40 ml volume in the centrifuge tubes (the composition of TME is 100 mM TRIS base, 20 mM MgCl2, 2M EDTA; 10 N HCl is added to achieve a pH of 7.4).The cell homogenate was centrifuged at 19000 r.p.m. for 20 min at 4 C. using a Beckman Ti-60 rotor. The resultant pellet was resuspended in TME buffer to give a final 1 mg/ml protein concentration, as determined by Biorad assay. Radioligand binding competition assays vs. [3H-]17-phenyl PGF2 (5 nM) were performed in a 100 ul volume for 60 min. Binding reactions were started by adding plasma membrane fraction. The reaction was terminated by the addition of 4 ml ice-cold TRIS-HCl buffer and rapid filtration through glass fiber GF/B filters using a Brandel cell.",CHEMBL3886165,EC50,CC1(C)C(=O)[C@H](C/C=C\CCCC(=O)O)[C@@H](/C=C/C(O)Cc2ccccc2)[C@@H]1O,9.397940008672037
CHEMBL3928703,CHEMBL1836,Prostanoid EP4 receptor,EC50,=,3162.0,nM,CHEMBL3887098,B,"Radioligand Binding: HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bottom of the flasks, and homogenized for 30 sec using a Brinkman PT 10/35 polytron. TME buffer was added to achieve a final 40 ml volume in the centrifuge tubes (the composition of TME is 100 mM TRIS base, 20 mM MgCl2, 2M EDTA; 10 N HCl is added to achieve a pH of 7.4).The cell homogenate was centrifuged at 19000 r.p.m. for 20 min at 4 C. using a Beckman Ti-60 rotor. The resultant pellet was resuspended in TME buffer to give a final 1 mg/ml protein concentration, as determined by Biorad assay. Radioligand binding competition assays vs. [3H-]17-phenyl PGF2 (5 nM) were performed in a 100 ul volume for 60 min. Binding reactions were started by adding plasma membrane fraction. The reaction was terminated by the addition of 4 ml ice-cold TRIS-HCl buffer and rapid filtration through glass fiber GF/B filters using a Brandel cell.",CHEMBL3886165,EC50,COC(=O)CCC/C=C\C[C@H]1C(=O)C(C)(C)[C@@H](O)[C@@H]1/C=C/C(O)CCc1ccccc1,5.50003813440381
CHEMBL3946494,CHEMBL1836,Prostanoid EP4 receptor,EC50,=,18.0,nM,CHEMBL3887098,B,"Radioligand Binding: HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bottom of the flasks, and homogenized for 30 sec using a Brinkman PT 10/35 polytron. TME buffer was added to achieve a final 40 ml volume in the centrifuge tubes (the composition of TME is 100 mM TRIS base, 20 mM MgCl2, 2M EDTA; 10 N HCl is added to achieve a pH of 7.4).The cell homogenate was centrifuged at 19000 r.p.m. for 20 min at 4 C. using a Beckman Ti-60 rotor. The resultant pellet was resuspended in TME buffer to give a final 1 mg/ml protein concentration, as determined by Biorad assay. Radioligand binding competition assays vs. [3H-]17-phenyl PGF2 (5 nM) were performed in a 100 ul volume for 60 min. Binding reactions were started by adding plasma membrane fraction. The reaction was terminated by the addition of 4 ml ice-cold TRIS-HCl buffer and rapid filtration through glass fiber GF/B filters using a Brandel cell.",CHEMBL3886165,EC50,CC1(C)C(=O)[C@H](C/C=C\CCCC(=O)O)[C@@H](/C=C/C(O)CCc2ccccc2)[C@@H]1O,7.7447274948966935
CHEMBL3946494,CHEMBL1836,Prostanoid EP4 receptor,EC50,=,6.4,nM,CHEMBL3887098,B,"Radioligand Binding: HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bottom of the flasks, and homogenized for 30 sec using a Brinkman PT 10/35 polytron. TME buffer was added to achieve a final 40 ml volume in the centrifuge tubes (the composition of TME is 100 mM TRIS base, 20 mM MgCl2, 2M EDTA; 10 N HCl is added to achieve a pH of 7.4).The cell homogenate was centrifuged at 19000 r.p.m. for 20 min at 4 C. using a Beckman Ti-60 rotor. The resultant pellet was resuspended in TME buffer to give a final 1 mg/ml protein concentration, as determined by Biorad assay. Radioligand binding competition assays vs. [3H-]17-phenyl PGF2 (5 nM) were performed in a 100 ul volume for 60 min. Binding reactions were started by adding plasma membrane fraction. The reaction was terminated by the addition of 4 ml ice-cold TRIS-HCl buffer and rapid filtration through glass fiber GF/B filters using a Brandel cell.",CHEMBL3886165,EC50,CC1(C)C(=O)[C@H](C/C=C\CCCC(=O)O)[C@@H](/C=C/C(O)CCc2ccccc2)[C@@H]1O,8.193820026016112
CHEMBL3922155,CHEMBL1836,Prostanoid EP4 receptor,EC50,=,0.3,nM,CHEMBL3887098,B,"Radioligand Binding: HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bottom of the flasks, and homogenized for 30 sec using a Brinkman PT 10/35 polytron. TME buffer was added to achieve a final 40 ml volume in the centrifuge tubes (the composition of TME is 100 mM TRIS base, 20 mM MgCl2, 2M EDTA; 10 N HCl is added to achieve a pH of 7.4).The cell homogenate was centrifuged at 19000 r.p.m. for 20 min at 4 C. using a Beckman Ti-60 rotor. The resultant pellet was resuspended in TME buffer to give a final 1 mg/ml protein concentration, as determined by Biorad assay. Radioligand binding competition assays vs. [3H-]17-phenyl PGF2 (5 nM) were performed in a 100 ul volume for 60 min. Binding reactions were started by adding plasma membrane fraction. The reaction was terminated by the addition of 4 ml ice-cold TRIS-HCl buffer and rapid filtration through glass fiber GF/B filters using a Brandel cell.",CHEMBL3886165,EC50,CC1(C)C(=O)[C@H](C/C=C\CCCC(=O)O)[C@@H](/C=C/C(O)Cc2cc3ccccc3s2)[C@@H]1O,9.522878745280337
CHEMBL3922155,CHEMBL1836,Prostanoid EP4 receptor,EC50,=,38.0,nM,CHEMBL3887098,B,"Radioligand Binding: HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bottom of the flasks, and homogenized for 30 sec using a Brinkman PT 10/35 polytron. TME buffer was added to achieve a final 40 ml volume in the centrifuge tubes (the composition of TME is 100 mM TRIS base, 20 mM MgCl2, 2M EDTA; 10 N HCl is added to achieve a pH of 7.4).The cell homogenate was centrifuged at 19000 r.p.m. for 20 min at 4 C. using a Beckman Ti-60 rotor. The resultant pellet was resuspended in TME buffer to give a final 1 mg/ml protein concentration, as determined by Biorad assay. Radioligand binding competition assays vs. [3H-]17-phenyl PGF2 (5 nM) were performed in a 100 ul volume for 60 min. Binding reactions were started by adding plasma membrane fraction. The reaction was terminated by the addition of 4 ml ice-cold TRIS-HCl buffer and rapid filtration through glass fiber GF/B filters using a Brandel cell.",CHEMBL3886165,EC50,CC1(C)C(=O)[C@H](C/C=C\CCCC(=O)O)[C@@H](/C=C/C(O)Cc2cc3ccccc3s2)[C@@H]1O,7.42021640338319
CHEMBL64804,CHEMBL1836,Prostanoid EP4 receptor,EC50,=,0.05,nM,CHEMBL3887483,B,"SEAP Activity Assay: 1. Seed cells on an EP2 or EP4 STEP plate at a density of 40,000-80,000 cells/well in 200 ul of reduced serum medium containing 0.5% FBS. Place the plate in a 37 C. incubator with 5% CO2 and incubate overnight. 2. After 16-18 hours of incubation, aspirate the culture media from each well. 3. Add 200 ul of culture medium containing different concentration of test compounds to the assigned wells. For each test compound, at least 8 concentrations starting at highest 10 M and lowest 0.01 pM were tested. In addition each concentration had triplicates. A PGE2 curve (concentrations from lowest to highest, 0 pM, 0.384 pM, 1.92 pM, 9.6 pM, 48 pM, 240 pM, 1200 pM, and 6000 pM) was always run in parallel with test compounds. 4. After 6-8 hours of stimulation with test compounds and PGE2, 10 ul of culture media from each well was transferred to a corresponding well of a 96-well solid black plate. Cover the plate with the lid.",CHEMBL3886335,EC50,CCCCC[C@@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O,10.301029995663981
CHEMBL3982139,CHEMBL1836,Prostanoid EP4 receptor,EC50,=,0.059,nM,CHEMBL3887483,B,"SEAP Activity Assay: 1. Seed cells on an EP2 or EP4 STEP plate at a density of 40,000-80,000 cells/well in 200 ul of reduced serum medium containing 0.5% FBS. Place the plate in a 37 C. incubator with 5% CO2 and incubate overnight. 2. After 16-18 hours of incubation, aspirate the culture media from each well. 3. Add 200 ul of culture medium containing different concentration of test compounds to the assigned wells. For each test compound, at least 8 concentrations starting at highest 10 M and lowest 0.01 pM were tested. In addition each concentration had triplicates. A PGE2 curve (concentrations from lowest to highest, 0 pM, 0.384 pM, 1.92 pM, 9.6 pM, 48 pM, 240 pM, 1200 pM, and 6000 pM) was always run in parallel with test compounds. 4. After 6-8 hours of stimulation with test compounds and PGE2, 10 ul of culture media from each well was transferred to a corresponding well of a 96-well solid black plate. Cover the plate with the lid.",CHEMBL3886335,EC50,CC#CC[C@H](C)[C@H](O)/C=C/[C@H]1CC(F)(F)C(=O)N1CCCCCCC(=O)O,10.229147988357855
CHEMBL3918816,CHEMBL1836,Prostanoid EP4 receptor,EC50,=,0.038,nM,CHEMBL3887483,B,"SEAP Activity Assay: 1. Seed cells on an EP2 or EP4 STEP plate at a density of 40,000-80,000 cells/well in 200 ul of reduced serum medium containing 0.5% FBS. Place the plate in a 37 C. incubator with 5% CO2 and incubate overnight. 2. After 16-18 hours of incubation, aspirate the culture media from each well. 3. Add 200 ul of culture medium containing different concentration of test compounds to the assigned wells. For each test compound, at least 8 concentrations starting at highest 10 M and lowest 0.01 pM were tested. In addition each concentration had triplicates. A PGE2 curve (concentrations from lowest to highest, 0 pM, 0.384 pM, 1.92 pM, 9.6 pM, 48 pM, 240 pM, 1200 pM, and 6000 pM) was always run in parallel with test compounds. 4. After 6-8 hours of stimulation with test compounds and PGE2, 10 ul of culture media from each well was transferred to a corresponding well of a 96-well solid black plate. Cover the plate with the lid.",CHEMBL3886335,EC50,CCC#CC[C@H](C)[C@H](O)/C=C/[C@H]1CC(F)(F)C(=O)N1CCCCCCC(=O)O,10.42021640338319
CHEMBL3955128,CHEMBL1836,Prostanoid EP4 receptor,EC50,=,0.059,nM,CHEMBL3887483,B,"SEAP Activity Assay: 1. Seed cells on an EP2 or EP4 STEP plate at a density of 40,000-80,000 cells/well in 200 ul of reduced serum medium containing 0.5% FBS. Place the plate in a 37 C. incubator with 5% CO2 and incubate overnight. 2. After 16-18 hours of incubation, aspirate the culture media from each well. 3. Add 200 ul of culture medium containing different concentration of test compounds to the assigned wells. For each test compound, at least 8 concentrations starting at highest 10 M and lowest 0.01 pM were tested. In addition each concentration had triplicates. A PGE2 curve (concentrations from lowest to highest, 0 pM, 0.384 pM, 1.92 pM, 9.6 pM, 48 pM, 240 pM, 1200 pM, and 6000 pM) was always run in parallel with test compounds. 4. After 6-8 hours of stimulation with test compounds and PGE2, 10 ul of culture media from each well was transferred to a corresponding well of a 96-well solid black plate. Cover the plate with the lid.",CHEMBL3886335,EC50,CCCCC[C@H](O)/C=C/[C@H]1CC(F)(F)C(=O)N1CCCCCCC(=O)O,10.229147988357855
CHEMBL3959605,CHEMBL1836,Prostanoid EP4 receptor,EC50,=,0.01,nM,CHEMBL3887483,B,"SEAP Activity Assay: 1. Seed cells on an EP2 or EP4 STEP plate at a density of 40,000-80,000 cells/well in 200 ul of reduced serum medium containing 0.5% FBS. Place the plate in a 37 C. incubator with 5% CO2 and incubate overnight. 2. After 16-18 hours of incubation, aspirate the culture media from each well. 3. Add 200 ul of culture medium containing different concentration of test compounds to the assigned wells. For each test compound, at least 8 concentrations starting at highest 10 M and lowest 0.01 pM were tested. In addition each concentration had triplicates. A PGE2 curve (concentrations from lowest to highest, 0 pM, 0.384 pM, 1.92 pM, 9.6 pM, 48 pM, 240 pM, 1200 pM, and 6000 pM) was always run in parallel with test compounds. 4. After 6-8 hours of stimulation with test compounds and PGE2, 10 ul of culture media from each well was transferred to a corresponding well of a 96-well solid black plate. Cover the plate with the lid.",CHEMBL3886335,EC50,O=C(O)CCCCCCN1C(=O)C(F)(F)C[C@@H]1/C=C/[C@@H](O)CCCCc1ccccc1,11.0
CHEMBL3895047,CHEMBL1836,Prostanoid EP4 receptor,EC50,=,0.035,nM,CHEMBL3887483,B,"SEAP Activity Assay: 1. Seed cells on an EP2 or EP4 STEP plate at a density of 40,000-80,000 cells/well in 200 ul of reduced serum medium containing 0.5% FBS. Place the plate in a 37 C. incubator with 5% CO2 and incubate overnight. 2. After 16-18 hours of incubation, aspirate the culture media from each well. 3. Add 200 ul of culture medium containing different concentration of test compounds to the assigned wells. For each test compound, at least 8 concentrations starting at highest 10 M and lowest 0.01 pM were tested. In addition each concentration had triplicates. A PGE2 curve (concentrations from lowest to highest, 0 pM, 0.384 pM, 1.92 pM, 9.6 pM, 48 pM, 240 pM, 1200 pM, and 6000 pM) was always run in parallel with test compounds. 4. After 6-8 hours of stimulation with test compounds and PGE2, 10 ul of culture media from each well was transferred to a corresponding well of a 96-well solid black plate. Cover the plate with the lid.",CHEMBL3886335,EC50,CCC#CC[C@H](C)[C@H](O)/C=C/[C@H]1CC(F)(F)C(=O)N1CCc1ccc(C(=O)O)cc1,10.455931955649724
CHEMBL3923027,CHEMBL1836,Prostanoid EP4 receptor,EC50,=,0.075,nM,CHEMBL3887483,B,"SEAP Activity Assay: 1. Seed cells on an EP2 or EP4 STEP plate at a density of 40,000-80,000 cells/well in 200 ul of reduced serum medium containing 0.5% FBS. Place the plate in a 37 C. incubator with 5% CO2 and incubate overnight. 2. After 16-18 hours of incubation, aspirate the culture media from each well. 3. Add 200 ul of culture medium containing different concentration of test compounds to the assigned wells. For each test compound, at least 8 concentrations starting at highest 10 M and lowest 0.01 pM were tested. In addition each concentration had triplicates. A PGE2 curve (concentrations from lowest to highest, 0 pM, 0.384 pM, 1.92 pM, 9.6 pM, 48 pM, 240 pM, 1200 pM, and 6000 pM) was always run in parallel with test compounds. 4. After 6-8 hours of stimulation with test compounds and PGE2, 10 ul of culture media from each well was transferred to a corresponding well of a 96-well solid black plate. Cover the plate with the lid.",CHEMBL3886335,EC50,CCCCC[C@H](O)/C=C/[C@H]1CC(F)(F)C(=O)N1CCc1ccc(C(=O)O)cc1,10.1249387366083
CHEMBL3949856,CHEMBL1836,Prostanoid EP4 receptor,EC50,=,0.11,nM,CHEMBL3887483,B,"SEAP Activity Assay: 1. Seed cells on an EP2 or EP4 STEP plate at a density of 40,000-80,000 cells/well in 200 ul of reduced serum medium containing 0.5% FBS. Place the plate in a 37 C. incubator with 5% CO2 and incubate overnight. 2. After 16-18 hours of incubation, aspirate the culture media from each well. 3. Add 200 ul of culture medium containing different concentration of test compounds to the assigned wells. For each test compound, at least 8 concentrations starting at highest 10 M and lowest 0.01 pM were tested. In addition each concentration had triplicates. A PGE2 curve (concentrations from lowest to highest, 0 pM, 0.384 pM, 1.92 pM, 9.6 pM, 48 pM, 240 pM, 1200 pM, and 6000 pM) was always run in parallel with test compounds. 4. After 6-8 hours of stimulation with test compounds and PGE2, 10 ul of culture media from each well was transferred to a corresponding well of a 96-well solid black plate. Cover the plate with the lid.",CHEMBL3886335,EC50,CCC#CC[C@H](C)[C@H](O)/C=C/[C@H]1CC(F)(F)C(=O)N1CCCc1ccc(C(=O)O)s1,9.958607314841775
CHEMBL3916499,CHEMBL1836,Prostanoid EP4 receptor,EC50,=,0.063,nM,CHEMBL3887483,B,"SEAP Activity Assay: 1. Seed cells on an EP2 or EP4 STEP plate at a density of 40,000-80,000 cells/well in 200 ul of reduced serum medium containing 0.5% FBS. Place the plate in a 37 C. incubator with 5% CO2 and incubate overnight. 2. After 16-18 hours of incubation, aspirate the culture media from each well. 3. Add 200 ul of culture medium containing different concentration of test compounds to the assigned wells. For each test compound, at least 8 concentrations starting at highest 10 M and lowest 0.01 pM were tested. In addition each concentration had triplicates. A PGE2 curve (concentrations from lowest to highest, 0 pM, 0.384 pM, 1.92 pM, 9.6 pM, 48 pM, 240 pM, 1200 pM, and 6000 pM) was always run in parallel with test compounds. 4. After 6-8 hours of stimulation with test compounds and PGE2, 10 ul of culture media from each well was transferred to a corresponding well of a 96-well solid black plate. Cover the plate with the lid.",CHEMBL3886335,EC50,CCCCC[C@H](O)/C=C/[C@H]1CC(F)(F)C(=O)N1CCCc1ccc(C(=O)O)s1,10.200659450546418
CHEMBL3965497,CHEMBL1836,Prostanoid EP4 receptor,EC50,=,53.0,nM,CHEMBL3888403,B,"Radioligand Binding: HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, or EP4 receptors were washed with TME buffer, scraped from the bottom of the flasks, and homogenized for 30 sec using a Brinkman PT 10/35 polytron. TME buffer was added to achieve a final 40 ml volume in the centrifuge tubes (the composition of TME is 100 mM TRIS base, 20 mM MgCl2, 2M EDTA; 10N HCl is added to achieve a pH of 7.4). The cell homogenate was centrifuged at 19000 r.p.m. for 20 min at 4 C. using a Beckman Ti-60 rotor. The resultant pellet was resuspended in TME buffer to give a final 1 mg/ml protein concentration, as determined by Biorad assay. Radioligand binding competition assays vs. [3H-]17-phenyl PGF2a (5 nM) were performed in a 100 l volume for 60 min. Binding reactions were started by adding plasma membrane fraction. The reaction was terminated by the addition of 4 ml ice-cold TRIS-HCl buffer and rapid filtration through glass fiber GF/B filters using a Brandel cell harvester. The filters were washed 3 times with ice-cold buffer and oven dried for one hour. [3H] PGE2 (specific activity 180 Ci mmol) was used as the radioligand for EP receptors. [3H] 17-phenyl PGF2a was employed for FP receptor binding studies. Binding studies employing EP1, EP2, EP4 and FP receptors were performed in duplicate in at least three separate experiments. A 200 l assay volume was used. Incubations were for 60 min at 25 C. and were terminated by the addition of 4 ml of ice-cold 50 mM TRIS-HCl, followed by rapid filtration through Whatman GF/B filters and three additional 4 ml washes in a cell harvester (Brandel). Competition studies were performed using a final concentration of 5 nM [3H]-PGE2, or 5 nM [3H] 17-phenyl PGF2a and non-specific binding determined with 10^5M of unlabeled PGE2, or 17-phenyl PGF2a, according to receptor subtype studied.",CHEMBL3886696,EC50,O=C(O)c1ccc(CCCN2[C@@H](/C=C/C(O)Cc3cccc(OC(F)(F)F)c3)CCS2(=O)=O)s1,7.275724130399211
